<SEC-DOCUMENT>0001437749-25-032436.txt : 20251030
<SEC-HEADER>0001437749-25-032436.hdr.sgml : 20251030
<ACCEPTANCE-DATETIME>20251030163019
ACCESSION NUMBER:		0001437749-25-032436
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20251028
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251030
DATE AS OF CHANGE:		20251030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OLYMPIC STEEL INC
		CENTRAL INDEX KEY:			0000917470
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-METALS SERVICE CENTERS & OFFICES [5051]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				341245650
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23320
		FILM NUMBER:		251436154

	BUSINESS ADDRESS:	
		STREET 1:		5096 RICHMOND RD
		CITY:			BEDFORD HEIGHTS
		STATE:			OH
		ZIP:			44146
		BUSINESS PHONE:		2162923800

	MAIL ADDRESS:	
		STREET 1:		5096 RICHMOND RD
		CITY:			BEDFORD HEIGHTS
		STATE:			OH
		ZIP:			44146
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zeus20251029_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:zeus="http://www.zeus.com/20251028"><head>
	<title>zeus20251029_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 10/30/2025 12:51:51 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20258K" name="dei:AmendmentFlag" id="ixv-357">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20258K" name="dei:EntityCentralIndexKey" id="ixv-358">0000917470</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="zeus-20251028.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20258K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000917470</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-10-28</xbrli:startDate>
<xbrli:endDate>2025-10-28</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM</b>&#160;<b><ix:nonNumeric contextRef="d20258K" name="dei:DocumentType" id="ixv-368">8-K</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT PURSUANT TO SECTION</b>&#160;<b>13 OR 15(d)</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric contextRef="d20258K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-369">October 28, 2025</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityRegistrantName" id="ixv-370">OLYMPIC STEEL, INC.</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-371">Ohio</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: bottom; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityFileNumber" id="ixv-372">000-23320</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: bottom; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityTaxIdentificationNumber" id="ixv-373">34-1245650</ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or Other Jurisdiction of</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation)</div>
			</td>
			<td style="vertical-align: bottom; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File Number)</div>
			</td>
			<td style="vertical-align: bottom; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(IRS Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75.5882352941177%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:51.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressAddressLine1" id="ixv-374">22901 Millcreek Boulevard, Suite 650</ix:nonNumeric></b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressCityOrTown" id="ixv-375">Highland Hills</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-376">Ohio</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align:bottom;width:51.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressPostalZipCode" id="ixv-377">44112</ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:51.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of Principal Executive Offices)</div>
			</td>
			<td style="vertical-align:bottom;width:51.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Zip Code)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20258K" name="dei:CityAreaCode" id="ixv-378">216</ix:nonNumeric>) <ix:nonNumeric contextRef="d20258K" name="dei:LocalPhoneNumber" id="ixv-379">292-3800</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s Telephone Number,&#160;Including Area Code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">_______________________________________________________________________</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-380">&#9746;</ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-381">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-382">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-383">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0) black; vertical-align: top; width: 33%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title of each class</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; border-top: 1px solid rgb(0, 0, 0); border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trading Symbol</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; border-top: 1px solid rgb(0, 0, 0); border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:Security12bTitle" id="ixv-384">Common Stock</ix:nonNumeric>, without par value</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:TradingSymbol" id="ixv-385">ZEUS</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20258K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-386">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Emerging growth company&#160; <ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-387">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160; &#9744;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 1.01</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Entry into a Material Definitive Agreement. </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On October 28, 2025, Olympic Steel, Inc., an Ohio corporation (the &#8220;Company&#8221;), entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with Ryerson Holding Corporation, a Delaware corporation (&#8220;Ryerson&#8221;), and Crimson MS Corp., an Ohio corporation and a wholly owned subsidiary of Ryerson (&#8220;Merger Sub&#8221; and, together with Ryerson, the &#8220;Parent Parties&#8221;). The Merger Agreement provides that, subject to the terms and conditions set forth therein, Merger Sub will merge with and into the Company (the &#8220;Merger&#8221;), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Ryerson.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The board of directors of the Company (the &#8220;Board&#8221;) has unanimously approved and declared advisable the Merger Agreement and resolved to recommend the adoption of the Merger Agreement by the shareholders of the Company (the &#8220;Company Shareholders&#8221;), who will be asked to vote on the adoption of the Merger Agreement at a special meeting of the Company Shareholders.</div>

<div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The Merger </i></b></div>

<div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At the effective time of the Merger (the &#8220;Effective Time&#8221;), and upon consummation of the Merger, subject to the terms and conditions set forth in the Merger Agreement, each share of the Company&#8217;s common stock (&#8220;Company Common Stock&#8221;) issued and outstanding immediately prior to the Effective Time will be canceled and converted into and thereafter represent the right to receive that number of validly issued, fully paid and non-assessable shares of common stock, $0.01 par value per share, of Ryerson (&#8220;Ryerson Common Stock&#8221;) equal to 1.7105 (the &#8220;Exchange Ratio&#8221;), rounded down to the nearest whole share and, if applicable, the cash amount to be paid in lieu of fractional shares (the &#8220;Merger Consideration&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Treatment of Stock-Based and Long-Term Cash Awards </i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of the Effective Time, each time-based restricted stock unit with respect to shares of Company Common Stock (each, a &#8220;Company RSU&#8221;) that is outstanding immediately prior to the Effective Time will be assumed by Ryerson and converted into a restricted stock unit award with respect to shares of Ryerson Common Stock (rounded down to the nearest whole share) equal to the product of (X) the number of shares of Company Common Stock subject to such Company RSU multiplied by (Y) the Exchange Ratio. Each assumed and converted Company RSU will remain subject to the same terms and conditions that applied to such Company RSU immediately prior to the Effective Time, including (1)&#160;accelerated vesting and payment as a result of the closing, if any, (2)&#160;any requirement for continued service, and (3)&#160;the holder&#8217;s right to make an election to receive cash in lieu of shares. If a holder of a Company RSU elects to receive a cash settlement pursuant to the terms of an applicable Company RSU award agreement, such cash payment will equal the product of (x) the number of shares of Ryerson Common Stock subject to the assumed and converted restricted stock unit award multiplied by (Y) the closing price per share of Ryerson Common Stock on the Closing Date (as defined in the Merger Agreement). Any such cash payments will be paid by the Company (or one of its affiliates) through its regular payroll practices within 30 days following the Closing Date.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of the Effective Time, each Company RSU that was contributed to and used to fund a participant&#8217;s account balance in the Company&#8217;s Supplemental Executive Retirement Plan (&#8220;SERP&#8221;) will be canceled and converted into a cash amount equal to (A) the product of (X) the number of shares of Company Common Stock subject to such Company RSU, multiplied by (Y) the Exchange Ratio, multiplied by (B) the closing price per share of Ryerson Common Stock on the Closing Date. The converted cash amount will be credited to the participant&#8217;s SERP account, subject to the payment timing requirements and other terms of the SERP.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of the Effective Time, each performance stock unit with respect to shares of Company Common Stock granted by the Company (each, a &#8220;Company PSU&#8221;) that is outstanding immediately prior to the execution of the Merger Agreement will be canceled and converted into the right to receive a cash payment equal to (i) the product of (A) the number of shares of Company Common Stock subject to such Company PSU (assuming achievement based on actual performance for outstanding Company PSUs granted in 2023 and deemed target levels of performance for outstanding Company PSUs granted in 2024 and 2025), multiplied by (B) the Exchange Ratio, multiplied by (ii) the closing price per share of Ryerson Common Stock on the Closing Date, to be paid in cash by the Company (or one of its affiliates) through its regular payroll practices within 30 days following the Closing Date. Each Company PSU that is granted following the execution of the Merger Agreement that is outstanding immediately prior to the Effective Time will be assumed by Ryerson and converted into a performance-based vesting restricted stock unit covering that number of whole shares of Ryerson Common Stock (rounded down to the nearest whole share) equal to the product of (A) the number of shares of Company Common Stock subject to such Company PSU multiplied by (B) the Exchange Ratio and will remain subject to the same terms and conditions that applied to such Company PSU immediately prior to the Effective Time (including continued service requirements and performance-based vesting conditions).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of the Effective Time, each restricted stock award with respect to shares of Company Common Stock granted by the Company (each, a &#8220;Company RSA&#8221;) that is outstanding immediately prior to the execution of the Merger Agreement will vest immediately prior to the Effective Time. Each restricted stock award granted following the date on which the Merger Agreement is executed will vest on a prorated basis based on the number of days that elapse between January 1 of the calendar year in which the grant date occurs and the Effective Time. At the Effective Time, each Company RSA that vests in connection with the closing will be canceled and converted into the right to receive the Merger Consideration and all outstanding and unvested Company RSAs will be automatically canceled and forfeited for no consideration.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of the Effective Time, each time-based long-term cash incentive award granted under the Company C-Suite Long Term Incentive Plan that is outstanding immediately prior to the Effective Time will be assumed by Ryerson and remain subject to the same terms and conditions that applied to such time-based long-term cash incentive award immediately prior to the Effective Time (including any requirement for continued service).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of the Effective Time, each performance-based cash award granted under the Company C-Suite Long Term Incentive Plan prior to the date on which the Merger Agreement is executed that is outstanding immediately prior to the Effective Time will be canceled and converted into the right to receive a cash payment equal to the amount that would be owed under such performance-based cash award (based on actual performance levels for outstanding performance-based cash awards granted in 2023 and deemed target levels of performance for outstanding performance-based cash awards granted in 2024 and 2025) to be paid in cash in accordance with the Company&#8217;s (or one of its affiliates&#8217;) regular payroll practices within 30 days following the Closing Date. Each performance-based cash award that is granted following the execution of the Merger Agreement that is outstanding immediately prior to the Effective Time will be assumed by Ryerson and converted into a performance-based cash award and will remain subject to the same terms and conditions that applied to such performance-based cash award immediately prior to the Effective Time (including any requirement for continued service and performance-based vesting conditions).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At the Effective Time, each phantom stock award granted under the Company Amended and Restated 2007 Omnibus Incentive Plan (the &#8220;Company Stock Plan&#8221;) that is outstanding immediately prior to the Effective Time (&#8220;Company Phantom Award&#8221;) will be assumed by Ryerson and converted into a phantom stock award with phantom units (rounded down to the nearest whole unit) with respect to shares of Ryerson Common Stock equal to the product of (A) the number of phantom units subject to such Company Phantom Award multiplied by (B) the Exchange Ratio (&#8220;Assumed Phantom Award&#8221;) and will otherwise remain subject to the same terms and conditions that applied to such Company Phantom Award immediately prior to the Effective Time, provided that (i) a portion of each Assumed Phantom Award will vest on a prorated basis based on the number of days completed in the applicable performance period through the Effective Time, and the vested portion will be paid in cash within 30 days following the Closing Date in accordance with the Company&#8217;s (or one of its affiliates&#8217;) regular payroll practices, based on the per-share closing price of Ryerson Common Stock on the Closing Date and (ii) a portion of the Assumed Phantom Award that does not vest at the Effective Time will be assumed and remain outstanding and will remain subject to the same terms and conditions that applied to the Company Phantom Award immediately prior to the Effective Time (including the requirement of continued service through the last day of the applicable performance period).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At the Effective Time, all other long-term cash awards granted under the Company Stock Plan will be treated in accordance with the terms of the applicable plan or award agreement, including awards outstanding under the Metal-Fab Manager Long-Term Incentive Plan and Metal-Fab Manager Retention Incentive Plan, which will remain outstanding and eligible to vest in accordance with, and subject to, the terms thereof, including (i) a portion of the award will vest on a prorated based on the number of days in the performance period that have been completed on the Closing Date and (ii) the portion of the award that does not vest at the Effective Time will continue to be outstanding and subject to the same terms and conditions that applied prior to the Effective Time (including continued service requirements through the last day of the applicable performance period). The vested portion of any such award will be paid in cash within 30 days following the Closing Date in accordance with the Company&#8217;s (or one of its affiliates&#8217;) regular payroll practices.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Conditions to the Merger</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Consummation of the Merger is subject to the satisfaction or (to the extent permitted by applicable law) waiver of certain customary closing conditions, including (a) the adoption of the Merger Agreement by (i) a majority of the Company Shareholders and (ii) a majority of the stockholders of Ryerson; (b) the common stock of Ryerson issuable in connection with the Merger having been approved for listing on the New York Stock Exchange; (c) the absence of any laws or orders in any jurisdiction in which Ryerson or the Company has material assets or material business operations prohibiting the consummation of the Merger; (d) Ryerson&#8217;s registration statement on Form S-4 having become effective under the Securities Act of 1933 and the absence of any stop order or action or proceeding by or before the Securities and Exchange Commission (the &#8220;SEC&#8221;) seeking a stop order; (e) the expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976; (f) subject to certain materiality exceptions, the accuracy of the respective representations and warranties of each of the Company and Ryerson; (g) the receipt by each of the Company and Ryerson from qualified counsel of a respective written opinion in connection with the consummation of the Merger based on the facts, representations, assumptions and exclusions set forth in such written opinion, to the effect that the Merger will qualify for the tax treatment intended by the Merger Agreement; (h) the absence of a material adverse effect on the Company and Ryerson; and (i) the performance or compliance by the Company and the Parent Parties with their respective covenants and agreements in all material respects or as otherwise specified in the Merger Agreement. Consummation of the Merger is not subject to a financing condition.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Representations, Warranties and Covenants </i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Ryerson and the Company have each made customary representations and warranties in the Merger Agreement. The Parent Parties and the Company have each agreed to use reasonable best efforts to cause the Merger to be consummated. The Company has agreed to various covenants in the Merger Agreement, including, among other things, (a) to, during the period between the execution of the Merger Agreement and the closing of the Merger, use its commercially reasonable efforts to (i) conduct its operations in the ordinary course of business consistent with past practice in all material respects and (ii) to preserve intact its business organization and comply with all applicable laws in all material respects, including continuing to prepare audited financial statements for the fiscal year ending December 31, 2025, irrespective of the anticipated date of consummation of the Merger; (b) call a special meeting of the Company Shareholders to adopt the Merger Agreement; and (c) not to solicit alternative acquisition proposals. Ryerson has also agreed to various covenants in the Merger Agreement, including (a) during the period between the execution of the Merger Agreement and the closing of the Merger, to use its commercially reasonable efforts to (i) conduct its operations in the ordinary course of business consistent with past practice in all material respects and (ii) preserve intact its business organization and comply with all applicable laws in all material respects, (b) to call a special meeting of its stockholders to adopt the Merger Agreement, (c) not to solicit alternative acquisition proposals, and (d) using reasonable best efforts to consummate the transactions contemplated by the Merger Agreement (the &#8220;Transactions&#8221;), including undertaking any remedial actions that, individually or in the aggregate, would be immaterial to the combined company taken as a whole.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Termination</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Merger Agreement contains provisions granting each of the Company and Ryerson the right to terminate the Merger Agreement under specified circumstances, including: (a) if a permanent legal prohibition enjoins the consummation of the Merger; (b) if the Merger is not completed by April 28, 2026 (which date may be extended to July 28, 2026 if certain regulatory approvals have not been obtained); (c) if either party fails to obtain stockholder approval; (d) by the Company, if, prior to the Company receiving approval of the Company Shareholders, the Company enters into a definitive written agreement providing for the consummation of a Superior Proposal (as defined in the Merger Agreement) in accordance with Section 5.4 of the Merger Agreement; (e) by either the Company or Ryerson, as applicable, if the other party has breached its representations or warranties or failed to perform its covenants in the Merger Agreement in a way that would entitle the party seeking to terminate the Merger Agreement not to consummate the Merger, subject to cure rights of the breaching party; (f) by the Company, if Ryerson&#8217;s board of directors makes a Parent Adverse Recommendation Change; (g) by Ryerson, if the Board makes a Company Adverse Recommendation Change; or (h) by either the Company or Ryerson, as applicable, if the other party committed a willful and material breach of its non-solicitation obligations.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If the Merger Agreement is terminated due to Ryerson&#8217;s board of directors changing or withdrawing its recommendation in connection with the Merger, or due to Ryerson committing a willful and material breach of its non-solicitation obligations, Ryerson will be required to pay to the Company $15,000,000. If the Merger Agreement is terminated due to the Board changing its recommendation in connection with the Merger, or due to the Company committing a willful and material breach of its non-solicitation obligations, then the Company will be required to pay Ryerson $15,000,000. In addition, if the Merger Agreement is terminated due to either party&#8217;s failure to obtain stockholder approval (and Ryerson&#8217;s board of directors has not changed or withdrawn its recommendation in connection with the Merger), Ryerson or the Company, as applicable, will be required to reimburse the other party for its expenses incurred in connection with the Transactions in an amount not to exceed $10,000,000.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The foregoing description of the Merger and the Merger Agreement, and the Transactions thereby, does not purport to be complete and is qualified in its entirety by the actual Merger Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Merger Agreement has been included to provide investors with information regarding its terms. It is not intended to provide any other factual information about the Company, Ryerson or their respective subsidiaries or affiliates or to modify or supplement any factual disclosures about the Company or Ryerson included in their public reports filed with the SEC.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Forward-Looking Statements</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">This Current Report on Form 8-K contains certain &#8220;forward-looking statements&#8221; within the meaning of federal securities laws. Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by words or phrases such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;anticipate,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; and &#8220;continue,&#8221; as well as the negative of these terms or similar expressions. Such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those implied by such statements. Readers are cautioned not to place undue reliance on these forward-looking statements. Such risks and uncertainties include, but are not limited to: the levels of imported steel in the United States, imposed tariffs and duties on imported and exported steel or other products, U.S. trade policy and its impact on the U.S. manufacturing industry, including retaliatory actions by other countries; general and global business, economic, financial and political conditions, including, but not limited to, the failure to obtain the requisite shareholder approval in connection with the Transactions and the failure to satisfy various other conditions to the closing of the Transactions; the failure to obtain governmental approvals of the Transactions on the proposed terms and timeline, and any conditions imposed on the combined company in connection with consummation of the Transactions; the risk that the cost savings and any other synergies from the Transactions may not be fully realized or may take longer to realize than expected; disruption from the proposed Transactions making it more difficult to maintain relationships with customers, partners, employees or suppliers; the risk that the proposed Transactions may be less accretive than expected, or may be dilutive, and that the combined company may fail to realize the benefits expected from the Merger; risks relating to any unforeseen liabilities of the Company or Ryerson; recessionary conditions and legislation passed under the current administration, including the impact of the enactment of the One Big Beautiful Bill Act, or OBBBA, on July 4, 2025; risks associated with shortages of skilled labor, increased labor costs and the Company&#8217;s ability to attract and retain qualified personnel; risks of volatile metals prices and inventory devaluation; risks associated with economic sanctions, and current global conflicts, or additional war, military conflict, or hostilities could adversely affect global metals supply and pricing; supplier consolidation or addition of new capacity; reduced production schedules, layoffs or work stoppages by the Company, the Company&#8217;s suppliers&#8217; or customers&#8217; personnel&#894; the Company&#8217;s ability to successfully integrate recent acquisitions into the Company&#8217;s business and risks inherent with the acquisitions in the achievement of expected results; the adequacy of the Company&#8217;s existing information technology and business system software, including duplication and security processes&#894; the inflation or deflation existing within the metals industry, as well as product mix and inventory levels on hand, which can impact the Company&#8217;s cost of materials sold as a result of the fluctuations in the last-in, first-out, or LIFO, inventory valuation; competitive factors such as the availability, and global pricing of metals and production levels, industry shipping and inventory levels and rapid fluctuations in customer demand and metals pricing; fluctuations in the value of the U.S. dollar and the related impact on foreign steel pricing, U.S. exports, and foreign imports to the United States; risks associated with infectious disease outbreaks, including, but not limited to customer closures, reduced sales and profit levels, slower payment of accounts receivable and potential increases in uncollectible accounts receivable, falling metals prices that could lead to lower of cost or net realizable value inventory adjustments and the impairment of intangible and long-lived assets, negative impacts on the Company&#8217;s liquidity position, inability to access the Company&#8217;s traditional financing sources and increased costs associated with and less ability to access funds under the Company&#8217;s asset-based credit facility, or ABL Credit Facility, and the capital markets; increased customer demand without corresponding increase in metal supply could lead to an inability to meet customer demand and result in lower sales and profits; rising interest rates and their impacts on the Company&#8217;s variable interest rate debt&#894; cyclicality and volatility within the metals industry; customer, supplier and competitor consolidation, bankruptcy or insolvency; the timing and outcomes of inventory lower of cost or net realizable value adjustments and LIFO income or expense; reduced availability and productivity of the Company&#8217;s employees, increased operational risks as a result of remote work arrangements, including the potential effects on internal controls, as well as cybersecurity risks and increased vulnerability to security breaches, information technology disruptions and other similar events; the successes of the Company&#8217;s efforts and initiatives to improve working capital turnover and cash flows, and achieve cost savings; risks and uncertainties associated with intangible assets, including impairment charges related to indefinite lived intangible assets; our ability to generate free cash flow through operations and repay debt; the impacts of union organizing activities and the success of union contract renewals; the amounts, successes and our ability to continue the Company&#8217;s capital investments and strategic growth initiatives, including acquisitions and our business information system implementations; events or circumstances that could adversely impact the successful operation of the Company&#8217;s processing equipment and operations; changes in laws or regulations or the manner of their interpretation or enforcement could impact the Company&#8217;s financial performance and restrict the Company&#8217;s ability to operate the Company&#8217;s business or execute the Company&#8217;s strategies; events or circumstances that could impair or adversely impact the carrying value of any of the Company&#8217;s assets; the Company&#8217;s ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; the Company&#8217;s ability to repurchase shares of Company common stock and the amounts and timing of repurchases, if any; the Company&#8217;s ability to sell shares of Company common stock under the at-the-market equity program; and unanticipated developments that could occur with respect to contingencies such as litigation, arbitration and environmental matters, including any developments that would require any increase in the Company&#8217;s costs for such contingencies.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Forward-looking statements are based on the estimates and opinions of management as of the date of this Current Report on Form 8-K; subsequent events and developments may cause their assessments to change. Neither the Company nor Ryerson undertakes any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law and they specifically disclaim any obligation to do so. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Additional Information and Where to Find It</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This communication is being made in respect of a proposed business combination involving the Company and Ryerson. In connection with the proposed Transactions, Ryerson will file with the SEC a Registration Statement on Form S-4 that includes a preliminary proxy statement of the Company and that will also constitute a prospectus of Ryerson. The information in the preliminary proxy statement/prospectus is not complete and may be changed. Ryerson may not sell the common stock referenced in the preliminary proxy statement/prospectus until the Registration Statement on Form S-4 filed with the SEC becomes effective. The preliminary proxy statement/prospectus and this communication are not offers to sell Ryerson securities, are not soliciting an offer to buy Ryerson securities in any state where the offer and sale is not permitted and are not a solicitation of any vote or approval. The definitive proxy statement/prospectus will be mailed to Company Shareholders.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">RYERSON AND THE COMPANY URGE INVESTORS AND SECURITY HOLDERS TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTIONS.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Investors and security holders will be able to obtain these materials (when they are available) and other documents filed with the SEC free of charge at the SEC&#8217;s website, www.sec.gov. Copies of documents filed with the SEC by Ryerson (when they become available) may be obtained free of charge on Ryerson&#8217;s website at www. ryerson.com or by directing a written request to Investor Relations, Ryerson Holding Corporation, 227 W. Monroe St., 27th Floor, Chicago, Illinois 60606. Copies of documents filed with the SEC by the Company (when they become available) may be obtained free of charge on the Company&#8217;s website at www.olysteel.com or by directing a written request to Olympic Steel, Inc., 22901 Millcreek Blvd., Suite 650, Highland Hills, Ohio 44122.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Participants in Solicitation</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each of the Company, Ryerson and their respective directors, executive officers and certain other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed Transactions. Information regarding these persons who may, under the rules of the SEC, be considered participants in the solicitation of the Company Shareholders in connection with the proposed Transactions is set forth in the proxy statement/prospectus described above, which will be filed with the SEC. Additional information regarding the Company&#8217;s executive officers and directors is included in the Company&#8217;s definitive proxy statement, which was filed with the SEC on March 28, 2025. Additional information regarding Ryerson&#8217;s executive officers and directors is included in Ryerson&#8217;s definitive proxy statement, which was filed with the SEC on March 5, 2025. You can obtain free copies of these documents using the information in the paragraph immediately above.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01</b>&#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;<b>Financial Statements and Exhibits. </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(d)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Exhibits.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Exhibit</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>No.</b></div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 88%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.1</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 88%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_878842.htm" style="-sec-extract:exhibit;">Agreement and Plan of Merger, dated October 28, 2025, by and among the Olympic Steel, Inc., Ryerson Holding Corporation and Crimson MS Corp.<b>*</b></a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">104</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 88%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">* Certain exhibits and schedules have been omitted and the Company agrees to furnish supplementally to the SEC a copy of any omitted exhibits upon request.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURE</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:27pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tbody><tr>
			<td style="width: 50%; width: 48%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 3%; width: 4%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 35%; border-bottom: 1px solid black; width: 48%;" valign="top">
			<div style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Olympic Steel, Inc.</div>
			</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 48%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 3%; width: 4%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td align="left" style="nowrap: nowrap; width: 35%; width: 48%;" valign="bottom">
			<div style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">(Registrant)</div>
			</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 48%;" valign="top">&#160;</td>
			<td style="width: 3%; width: 4%;" valign="top">&#160;</td>
			<td align="left" style="nowrap: nowrap; width: 35%; width: 48%;" valign="bottom">&#160;</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 48%;" valign="top">&#160;</td>
			<td style="width: 3%; width: 4%;" valign="top">&#160;</td>
			<td align="left" style="nowrap: nowrap; width: 35%; width: 48%;" valign="bottom">&#160;</td>
		</tr>
		<tr>
			<td align="left" style="width: 50%; text-align: left; border-bottom: 1px solid black; width: 48%;" valign="top">
			<div style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">October 30, 2025</div>
			</td>
			<td style="width: 3%; text-align: left; width: 4%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</div>
			</td>
			<td style="nowrap: nowrap; width: 35%; border-bottom: 1px solid rgb(0, 0, 0); text-align: center; width: 48%;" valign="top">/s/ Richard A. Manson</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 48%;" valign="top">
			<div style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">(Date)</div>
			</td>
			<td style="width: 3%; width: 4%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 35%; width: 48%;" valign="top">
			<div style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Richard A. Manson</div>
			</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 48%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 3%; width: 4%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</div>
			</td>
			<td style="width: 35%; width: 48%;" valign="top">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><i>Chief Financial Officer</i></div>

			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><i>(Principal Financial and Accounting Officer)</i></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 326pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex_878842.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<html><head>
	<title>ex_878842.htm</title>

	<!-- Generated by ThunderDome Portal - 10/29/2025 8:16:26 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 2.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;"><b><i>EXECUTION VERSION</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>AGREEMENT AND PLAN OF MERGER</b><br>
<br>
among<br>
<br>
<b>OLYMPIC STEEL, INC.,</b><br>
<br>
<br>
<b>RYERSON HOLDING CORPORATION,</b><br>
<br>
<br>
and<br>
<br>
<b>CRIMSON MS CORP.</b><br>
<br>
<br>
<br>
Dated as of October 28, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="i" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="lr" data-prefix="(" data-startnum="1" data-suffix=")" data-textalign="center">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TABLE OF CONTENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: bottom; width: 12%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><u>Page</u></p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;"><b>Article 1 The Merger</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>2</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">1.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Merger</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">1.2</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">1.3</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Effective Time</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">1.4</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Articles of Incorporation and Code of Regulations of the Surviving Corporation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">1.5</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Directors and Officers of the Surviving Corporation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">3</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">1.6</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Presence in Cleveland</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;"><b>Article 2 Conversion of Securities in the Merger</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>4</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">2.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conversion of Securities</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">2.2</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Adjustments</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">5</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">2.3</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fractional Shares</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">5</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">2.4</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exchange of Certificates and Book-Entry Shares</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">5</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">2.5</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stock-Based and Long-Term Cash Awards</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">9</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">2.6</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Withholding Rights</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">14</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;"><b>Article 3 Representations and Warranties of the Company</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>14</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Corporate Organization</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">14</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.2</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Capitalization</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.3</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authority; Execution and Delivery; Enforceability</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">16</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.4</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Conflicts</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.5</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SEC Documents; Financial Statements; Undisclosed Liabilities</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">18</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.6</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Certain Changes or Events</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">19</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.7</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Information Supplied</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.8</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Proceedings</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.9</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Compliance with Laws</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permits</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.11</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Benefit Plans</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">21</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.12</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee and Labor Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">24</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.13</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Environmental Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">26</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.14</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Real Property</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">27</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.15</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">28</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.16</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Material Contracts</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">30</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.17</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intellectual Property</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">32</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.18</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Data Privacy</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.19</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Anti-Corruption and Trade Sanctions</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">34</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.20</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Broker&#8217;s Fees</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.21</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Opinion of Financial Advisors</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.22</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insurance</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.23</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ownership of Parent Common Stock</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.24</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Related Party Transactions</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">36</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="i" data-prefix="(" data-suffix=")" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">(i)</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.25</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Material Customers and Company Material Suppliers</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">3.26</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Other Representations or Warranties</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;"><b>Article 4 Representations and Warranties of Parent</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>37</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Corporate Organization</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.2</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Capitalization</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.3</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authority; Execution and Delivery; Enforceability</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.4</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Conflicts</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.5</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SEC Documents; Financial Statements; Undisclosed Liabilities</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">40</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.6</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Certain Changes or Events</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">42</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.7</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Information Supplied</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">42</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.8</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Proceedings</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">42</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.9</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Compliance with Laws</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">43</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.10</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permits</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">43</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.11</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Benefit Plans</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">43</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.12</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee and Labor Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">46</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.13</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Environmental Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">47</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.14</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Real Property</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">49</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.15</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">49</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.16</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Material Contracts</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">52</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.17</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intellectual Property</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">53</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.18</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Data Privacy</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.19</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Anti-Corruption and Trade Sanctions</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">55</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.20</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Broker&#8217;s Fees</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.21</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Opinion of Financial Advisor</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.22</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insurance</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.23</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ownership of Company Common Stock</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.24</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Related Party Transactions</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.25</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Merger Sub</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">57</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.26</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financing</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">57</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.27</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Material Customers and Parent Material Suppliers</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">57</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">4.28</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Other Representations or Warranties</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">57</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;"><b>Article 5 Covenants</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>58</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 83%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conduct of Business by the Company and its Subsidiaries Pending the Effective Time</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">58</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.2</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conduct of Business by Parent and its Subsidiaries Pending the Effective Time</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">62</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.3</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Preparation of the Joint Proxy Statement and Form S-4; Stockholder and Shareholder Meetings.</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">65</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.4</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Solicitation of Transactions</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">69</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.5</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Access to Information; Confidentiality</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">72</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.6</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Appropriate Action</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">72</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.7</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Notices</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">74</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.8</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Public Announcements</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">74</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.9</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director and Officer Indemnification</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">75</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="ii" data-prefix="(" data-suffix=")" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">(ii)</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.10</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stock Exchange Listing</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">77</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.11</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section&nbsp;16 Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">77</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.12</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stockholder and Shareholder Litigation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">77</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.13</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">78</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.14</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">79</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.15</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cooperation as to Integration</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">82</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.16</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financing Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">82</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.17</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dividends</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">82</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.18</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stock Exchange Delisting and Deregistration</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">83</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.19</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 280G</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">83</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.20</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Takeover Statutes</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">83</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">5.21</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Obligations of Merger Sub</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">83</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;"><b>Article 6 Conditions to Consummation of the Merger</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>83</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">6.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conditions to Obligations of Each Party Under This Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">83</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">6.2</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conditions to Obligations of Parent and Merger Sub Under This Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">84</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">6.3</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conditions to Obligations of the Company Under This Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">85</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;"><b>Article 7 Termination, Amendment and Waiver</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>86</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">7.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Termination</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">86</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">7.2</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Effect of Termination</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">88</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">7.3</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expenses; Termination Fees</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">89</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">7.4</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amendment or Supplement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">91</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">7.5</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Extension of Time; Waiver</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">91</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;"><b>Article 8 General Provisions</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>91</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 12%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.1</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Survival</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">91</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.2</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Notices</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">92</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.3</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Definitions</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">92</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.4</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Headings</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">102</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.5</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Severability</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">102</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.6</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Entire Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">102</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.7</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Assignment</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">102</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.8</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Third Party Beneficiaries</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">103</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.9</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mutual Drafting; Interpretation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">103</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.10</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">104</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.11</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Counterparts</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">105</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.12</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Specific Performance</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">105</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">8.13</p>
			</td>
			<td style="vertical-align: middle; width: 83%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Disclosure Schedules</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">105</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Exhibit A</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Articles of Incorporation of the Surviving Corporation</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Exhibit B</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Code of Regulations of the Surviving Corporation</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Exhibit C</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Parent Tax Representation Letter</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 72pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Exhibit D</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Company Tax Representation Letter</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="iii" data-prefix="(" data-suffix=")" style="text-align: center; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">(iii)</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">TERMS DEFINED OUTSIDE OF <u>SECTION </u><u>&#8206;</u><u>8.3</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Defined Term</u></p>
			</td>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><u>Section</u></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Preamble</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Applicable Date</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.5(f)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Assumed RSU</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.5(a)(i)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Capitalization Date</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.2(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certificate of Merger</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 1.3</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 1.2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing Date</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 1.2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COBRA</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.11(h)&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Code</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Recitals</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common Stock Merger Consideration</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.1(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Preamble</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Adverse Recommendation Change</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.3(b)(iii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Benefit Plan</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.11(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Board</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Recitals</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Board Recommendation</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.3(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Book-Entry Shares</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.1(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Business Personnel</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.12(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Cash Awards</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section2.5(f)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Certificate</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.1(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company&nbsp;Charter</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.1(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Code of Regulations</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.1(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Common Stock</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Recitals</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Leased Real Property</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.14(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Material Contracts</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.16(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Material Customer</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.25</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Material Supplier</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.25</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Owned Real Property</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.14(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Pension Plan</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.11(e)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Performance-Based Cash Award</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.5(f))</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Preferred Stock</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.2(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company PSU</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.5(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Real Property</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.14(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company RSA</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.5&#8221;&#8364;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company RSU</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.5(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company SEC Documents</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.5(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company SEC Financial Statements</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.5(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Shareholder Approval</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.3(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Shareholders Meeting</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.3(b)(i)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Termination Fee</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 7.3(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Competing Proposal</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.4(g)(i), Section 7.3(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Competing Proposal Notice</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.4(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Confidentiality Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.5(a)</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="iv" data-prefix="(" data-suffix=")" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">(iv)</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Continuing Employee</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.14(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">D&amp;O Insurance</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.9(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Effective Time</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 1.3</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exchange Agent</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.4(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exchange Fund</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.4(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exchange Ratio</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.1(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Excluded Benefits</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.14(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Excluded Share</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.1(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Extended Outside Date</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 7.1(b)(ii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">FCPA</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.19(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Form&nbsp;S-4</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.7</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fractional Shares Cash Amount</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.3</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indemnitee</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.9(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indemnitees</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.9(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Initial Outside Date</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 7.1(b)(ii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intended Tax Treatment</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Recitals</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intervening Event</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.4(g)(ii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Labor Consultations</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.14(e)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Merger</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Recitals</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Merger Consideration</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.1(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Merger Sub</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Preamble</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Merger Sub Common Stock</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section&nbsp;2.1(d)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Multiemployer Plan</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.11(e)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Negotiation Period</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.4(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">NYSE Listing Application</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">OFAC</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.19(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">OGCL</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Recitals</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outside Date</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 7.1(b)(ii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Preamble</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Adverse Recommendation Change</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.3(c)(iii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Benefit Plan</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.11(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Board</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Recitals</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Board Recommendation</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.3(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Business Personnel</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section4.12(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent&nbsp;Bylaws</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.1(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent&nbsp;Charter</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.1(a)&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Common Stock</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.1(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Common Stock Issuance</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.3(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Leased Real Property</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.15(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Material Contracts</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.16(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Material Customer</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.27</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Material Supplier</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.27</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Owned Real Property</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.14(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Pension Plan</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.11(e)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Preferred Stock</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.2(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent PSUs</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.2(a)</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="v" data-prefix="(" data-suffix=")" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">(v)</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Real Property</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.14(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent RSUs</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.2(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent SEC Documents</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.5(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent SEC Financial Statements</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.5(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Stock Options</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.2(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Stockholder Approval</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 4.3(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Stockholders Meeting</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.3(c)(i)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Parent Termination Fee</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 7.3(d)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permits</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permitted Dividend</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Post-Closing Plans</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.14(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Privacy Laws</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.18</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Remedial Action</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section&nbsp;5.6(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sanctioned Country</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.19(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sanctioned Persons</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.19(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sanctions</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.19(e)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sarbanes-Oxley Act</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.5(b)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Security Incident</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.18</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SERP</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.5(a)(iii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SERP RSU Cash Amount</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 2.5(a)(iii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Superior Proposal</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 5.4(g)(iii)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Surviving Corporation</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 1.1(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Takeover Statute</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.3(c)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Trade Control Laws</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.19(e)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transactions</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Recitals</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Union</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section 3.12(a)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Withholding Agent</p>
			</td>
			<td style="vertical-align:middle;width:34.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">Section &#8206;&#8206;2.6</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="vi" data-prefix="(" data-suffix=")" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">(vi)</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AGREEMENT AND PLAN OF MERGER</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">THIS AGREEMENT AND PLAN OF MERGER (this &#8220;<u>Agreement</u>&#8221;) is dated as of October 28, 2025, by and among Olympic Steel, Inc., an Ohio corporation (the&nbsp;&#8220;<u>Company</u>&#8221;), Ryerson Holding Corporation, a Delaware corporation (&#8220;<u>Parent</u>&#8221;), and Crimson MS Corp., an Ohio corporation and a direct wholly owned subsidiary of Parent (&#8220;<u>Merger Sub</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RECITALS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">WHEREAS, Parent, Company and Merger Sub desire to effect the merger of Merger Sub with and into the Company, with the Company continuing as the surviving corporation and a direct wholly owned subsidiary of Parent (the &#8220;<u>Merger</u>&#8221;), on the terms and subject to the conditions set forth in this Agreement and in accordance with the Ohio General Corporation Law (as amended, the &#8220;<u>OGCL</u>&#8221;), pursuant to which, except as otherwise provided in <u>Article </u><u>&#8206;</u><u>2</u>, each share of common stock, without par value, of the Company (the&nbsp;&#8220;<u>Company Common Stock</u>&#8221;) issued and outstanding immediately prior to the Effective Time shall be converted into the right to receive the Merger Consideration;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">WHEREAS, the Boards of Directors of Parent, the Company and Merger Sub have each approved and declared advisable this Agreement and the Merger and the other transactions contemplated hereby (the&nbsp;&#8220;<u>Transactions</u>&#8221;) and determined that it is fair to, advisable and in the best interests of their respective companies, and that the shareholders of the Company and the stockholders of Parent adopt this Agreement and consummate the Merger and the other Transactions on the terms and conditions set forth in this Agreement;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">WHEREAS, the Board of Directors of Parent (the &#8220;<u>Parent Board</u>&#8221;) has, subject to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4</u>, resolved to recommend the approval of the Parent Common Stock Issuance by the Parent stockholders, and following the execution and delivery of this Agreement, Parent shall adopt and approve this Agreement and the Transactions as the sole shareholder of Merger Sub;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">WHEREAS, the Board of Directors of each of the Company (the &#8220;<u>Company Board</u>&#8221;) and the Board of Directors of Merger Sub has, subject to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4</u>, in each case unanimously resolved to recommend the adoption of this Agreement by the Company shareholders (in the case of the Company Board) and Parent as sole shareholder of Merger Sub (in the case of the Board of Directors of Merger Sub);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">WHEREAS, for U.S. federal income Tax purposes, the Parties intend that the Merger qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the &#8220;<u>Code</u>&#8221;) (the &#8220;<u>Intended Tax Treatment</u>&#8221;); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">WHEREAS, Parent, Merger Sub and the Company desire to make certain representations, warranties, covenants and agreements in connection with the Merger and also to prescribe various conditions to the Merger.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">NOW, THEREFORE, in consideration of the mutual covenants, premises, representations and warranties and agreements contained in this Agreement and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and intending to be legally bound, the Parties agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE 1</b><br>
<b>THE MERGER</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">1.1&nbsp; &nbsp; <u>The Merger</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the Effective Time, Merger Sub shall be merged with and into the Company in accordance with the OGCL, and upon the terms and conditions set forth in this Agreement, whereupon the separate existence of Merger Sub shall cease and the Company shall continue as the surviving corporation (the &#8220;<u>Surviving Corporation</u>&#8221;). As a result of the Merger, the Surviving Corporation shall become a direct wholly owned subsidiary of Parent. References herein to &#8220;the Company&#8221; with respect to the period from and after the Effective Time shall be deemed to be references to the &#8220;Surviving Corporation&#8221;.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Merger shall have the effects specified in the OGCL. From and after the Effective Time, the Surviving Corporation shall possess all the property, rights, powers, privileges, immunities and franchises and be subject to all of the obligations, liabilities and duties of the Company and Merger Sub, all as provided under the OGCL.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">1.2&nbsp; &nbsp; <u>Closing</u>. The closing of the Merger (the &#8220;<u>Closing</u>&#8221;) shall take place remotely by electronic exchange of executed documents, commencing at 9:00&nbsp;a.m., New York City time, as soon as practicable (and, in any event, within two&nbsp;Business Days) after satisfaction or, to the extent permitted hereunder, waiver of all applicable conditions set forth in <u>Article </u><u>&#8206;</u><u>6</u> (except for any conditions that by their nature can only be satisfied at the Closing, but subject to the satisfaction of such conditions or, to the extent permitted hereunder, waiver by the Party entitled to waive such conditions at the Closing) or at such other time and place as Parent and the Company shall agree in writing. The date and time at which the Closing occurs is referred to herein as the &#8220;<u>Closing Date</u>&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">1.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Effective Time</u>. On the Closing Date, the Company and Merger Sub shall (a)&nbsp;cause a certificate of merger executed in accordance with, and containing such information as is required by, the OGCL, and otherwise in a form and substance reasonably acceptable to Parent and the Company (the &#8220;<u>Certificate of Merger</u>&#8221;) to be filed with the Secretary of State of the State of Ohio in accordance with the OGCL and (b)&nbsp;shall make all other filings or recordings required under the OGCL. The Merger shall become effective concurrently upon the due filing of the Certificate of Merger with the Secretary of State of the State of Ohio, or such later time as Parent and the Company shall agree and specify in the Certificate of Merger in accordance with the OGCL (such time as the Merger becomes effective hereinafter referred to as the &#8220;<u>Effective Time</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">1.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Articles of Incorporation and Code of Regulations of the Surviving Corporation</u>. At the Effective Time, by virtue of the Merger and without any action by the Company, Parent, Merger Sub or any other Person, the articles of incorporation of the Company in effect immediately prior to the Effective Time shall be amended and restated in their entirety as set forth as <u>Exhibit A</u>, and as so amended and restated shall be the articles of incorporation of the Surviving Corporation until thereafter changed or amended as provided therein or by applicable Law. In addition, at the Effective Time, by virtue of the Merger and without any action by the Company, Parent, Merger Sub or any other Person, the code of regulations of the Company in effect immediately prior to the Effective Time shall be amended and restated in its entirety as set forth as <u>Exhibit B</u>, and as so amended and restated shall be the code of regulations of the Surviving Corporation until thereafter changed or amended as provided therein or by applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">1.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Directors and Officers of the Surviving Corporation</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the Effective Time, the Parties shall take all necessary action such that (i)&nbsp;the directors of Merger Sub as of immediately prior to the Effective Time shall become the initial directors of the Surviving Corporation and (ii)&nbsp;the officers of the Company as of immediately prior to the Effective Time shall become the initial officers of the Surviving Corporation and shall hold office in accordance with the articles of incorporation and code of regulations of the Surviving Corporation until their respective successors shall have been duly elected, designated or qualified, or until their earlier death, resignation or removal in accordance with the articles of incorporation and code of regulations of the Surviving Corporation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Prior to, and conditioned upon the occurrence of, the Effective Time, Parent shall take all actions necessary in order to cause, effective upon the Effective Time, the size of the Parent Board to be increased to 11 directors, consisting of seven incumbent directors of the Parent Board and four directors designated in writing by the Company at least ten Business Days prior to the Closing Date from among the directors serving on the Company Board as of immediately prior to the Effective Time, to serve in accordance with the certificate of incorporation and bylaws of Parent; <u>provided</u>, that each such director designated by the Company shall be reasonably acceptable to Parent acting in its sole discretion. In the event that the Closing occurs prior to the mailing of the proxy statement for Parent&#8217;s annual meeting of stockholders for 2026, subject to each such individual&#8217;s continued willingness and ability to serve, Parent shall take such actions as may be necessary to nominate each former director of the Company appointed to the Parent Board at the Closing, to the extent such director&#8217;s term on the Parent Board expires as of the Parent&#8217;s annual meeting for such year, for election to the Parent Board at such annual meeting of Parent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Prior to, and conditioned upon the occurrence of, the Effective Time, Parent shall take all actions necessary in order to cause, effective upon the Effective Time, to the extent such officer is employed by the Company immediately prior to the Effective Time, (i)&nbsp;Richard Marabito to be appointed the President and Chief Operating Officer of Parent, (ii)&nbsp;Andrew Greiff to be appointed an Executive Vice President of Parent and President of the Company, (iii)&nbsp;Richard Manson to be appointed the Senior Vice President of Finance of Parent and (iv)&nbsp;Zachary Siegal to be appointed the Senior Vice President of Business Development of Parent and shall hold such office in accordance with the certificate of incorporation and bylaws of Parent or the Company, as applicable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">1.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Presence in Cleveland</u>. From and after the Effective Time until the Board reasonably determines, the Surviving Corporation shall maintain a presence in the Cleveland metropolitan area.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE 2</b><br>
<b>CONVERSION OF SECURITIES IN THE MERGER</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">2.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Conversion of Securities</u>. At the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent, Merger Sub or any holder of any of the following securities:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each share of Company Common Stock held by the Company as treasury stock or held directly by Parent or Merger Sub (or any direct or indirect wholly owned Subsidiaries of the Company, Parent Merger Sub), in each case, immediately prior to the Effective Time, shall automatically be canceled (each such share of Company Common Stock, an &#8220;<u>Excluded Share</u>&#8221;) and shall cease to exist, and no consideration or payment shall be delivered in exchange therefor or in respect thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Subject to <u>Section </u><u>&#8206;</u><u>2.1(a)</u>, <u>Section </u><u>&#8206;</u><u>2.2</u>, <u>Section </u><u>&#8206;</u><u>2.3</u>, and <u>Section </u><u>&#8206;</u><u>2.4</u>, each share of Company Common Stock issued and outstanding immediately prior to the Effective Time shall be converted into and thereafter represent the right to receive that number of validly issued, fully paid and non-assessable shares of common stock, $0.01 par value per share, of Parent (&#8220;<u>Parent Common Stock</u>&#8221;), equal to the Exchange Ratio rounded down to the nearest whole share as contemplated by <u>Section </u><u>&#8206;</u><u>2.3</u> (the &#8220;<u>Common Stock Merger Consideration</u>&#8221;) and the Fractional Shares Cash Amount to be paid in lieu of fractional shares pursuant to <u>Section </u><u>&#8206;</u><u>2.3</u>. The Common Stock Merger Consideration to be issued pursuant to this <u>Section </u><u>&#8206;</u><u>2.1</u> and the Fractional Shares Cash Amount to be paid in lieu of fractional shares pursuant to <u>Section </u><u>&#8206;</u><u>2.3</u> are referred to, as applicable, as the &#8220;<u>Merger Consideration</u>&#8221;. For purposes of this Agreement, the &#8220;<u>Exchange Ratio</u>&#8221; means 1.7105.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;All of the outstanding shares of Company Common Stock (other than Excluded Shares) shall be converted into the right to receive the Merger Consideration pursuant to this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.1</u> and all such shares of Company Common Stock shall cease to be outstanding and shall cease to exist and, as of the Effective Time, each holder of a certificate representing any such shares of Company Common Stock (a&nbsp;&#8220;<u>Company Certificate</u>&#8221;) or shares of Company Common Stock held in book-entry form (&#8220;<u>Company Book-Entry Shares</u>&#8221;) shall cease to have any rights with respect thereto, except the right to receive, in accordance with (i)&nbsp;<u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.1(b)</u>, the Merger Consideration in accordance with <u>Section </u><u>&#8206;</u><u>2.4</u> and (ii)&nbsp;any dividends or other distributions with a record date prior to the Effective Time which have been declared by the Company in accordance with this Agreement (including the terms and conditions of <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.17</u>) and which remain unpaid at the Effective Time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Each share of common stock, without par value, of Merger Sub (the &#8220;<u>Merger Sub Common Stock</u>&#8221;) issued and outstanding immediately prior to the Effective Time shall be converted into and become one fully paid and non-assessable share of common stock, without par value, of the Surviving Corporation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">2.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Adjustments</u>. Notwithstanding anything in this Agreement to the contrary, if, from the date of this Agreement until the Effective Time, the outstanding shares of Parent Common Stock or Company Common Stock shall have been changed into a different number of shares or a different class by reason of any reclassification, stock split (including a reverse stock split), recapitalization, split-up, combination, exchange of shares, readjustment, or other similar transaction, or a stock dividend or stock distribution thereon shall be declared with a record date within said period, the applicable Merger Consideration and the Exchange Ratio and any other similarly dependent items, as the case may be, shall be equitably adjusted to provide the holders of Company Common Stock the same economic effect as contemplated by this Agreement prior to such event.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">2.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Fractional Shares</u>. No fractional shares of Parent Common Stock shall be issued in the Merger, but in lieu thereof each holder of Company Common Stock otherwise entitled to a fractional share of Parent Common Stock pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.1(b)</u> will be entitled to receive, from the Exchange Agent in accordance with the provisions of this <u>Section </u><u>&#8206;</u><u>2.3</u>, a cash payment (rounded down to the nearest cent) in lieu of such fractional share of Parent Common Stock determined by multiplying (a)&nbsp;the volume-weighted average closing sales price of the Parent Common Stock on the NYSE as reported by <i>The Wall Street Journal</i> for the consecutive five full trading days ending on the day preceding the Closing Date and (b)&nbsp;the fraction of a share (after taking into account all shares of Company Common Stock held by such holder immediately prior to the Effective Time and rounded to the nearest one-thousandth when expressed in decimal form) of Parent Common Stock which such holder would otherwise be entitled to receive pursuant to this Agreement (the &#8220;<u>Fractional Shares Cash Amount</u>&#8221;). The Company and Parent acknowledge that payment of the cash consideration in lieu of issuing fractional shares of Parent Common Stock was not separately bargained-for consideration but merely represents a mechanical rounding off for purposes of avoiding the expense and inconvenience to Parent that would otherwise be caused by the issuance of fractional shares of Parent Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">2.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Exchange of Certificates and Book-Entry Shares</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-indent: 99pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Prior to the dissemination of the Joint Proxy Statement to the stockholders of Parent and the shareholders of the Company, Parent shall appoint Equiniti Trust Company, LLC (or another nationally recognized financial institution or trust company reasonably satisfactory to the Company and Parent) to act as exchange agent (the &#8220;<u>Exchange Agent</u>&#8221;) for the payment and delivery of the Merger Consideration. At or prior to the Effective Time, Parent shall deposit, in trust for the benefit of the holders of Company Common Stock, with the Exchange Agent for exchange in accordance with this <u>Article </u><u>&#8206;</u><u>2</u>, (i)&nbsp;a number of shares of Parent Common Stock equal to the total shares of Parent Common Stock issuable pursuant to <u>Section </u><u>&#8206;</u><u>2.1</u> and (ii)&nbsp;cash in immediately available funds in an amount to pay the aggregate Fractional Shares Cash Amount payable in accordance with <u>Section </u><u>&#8206;</u><u>2.3</u> (such number of shares of Parent Common Stock, together with the aggregate Fractional Shares Cash Amount, the &#8220;<u>Exchange Fund</u>&#8221;). Parent agrees to make available to the Exchange Agent, from time to time as needed, cash sufficient to pay any dividends and other distributions payable to holders of Company Common Stock pursuant to <u>Section 2.1(c)(ii)</u>. The Exchange Agent shall, pursuant to irrevocable instructions, deliver the whole shares of Parent Common Stock contemplated to be issued pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.1</u> and the Fractional Shares Cash Amount out of the Exchange Fund. The Exchange Fund shall not be used for any other purpose.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Exchange Procedures.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 90pt; text-align: justify; text-indent: 54pt;">(i)<i>&nbsp;&nbsp;&nbsp;&nbsp;Certificates</i>. As promptly as practicable after the Effective Time (but in no event later than five Business Days after the Effective Time), Parent shall direct the Exchange Agent to mail to each holder of record of a Company Certificate: (A)&nbsp;a letter of transmittal, which shall specify that delivery shall be effected, and risk of loss and title to the Company Certificates shall pass, only upon delivery of the Company Certificates to the Exchange Agent, and shall otherwise be in such form and have such other provisions as Parent, the Company and the Exchange Agent may reasonably agree prior to the Effective Time and (B)&nbsp;instructions for effecting the surrender of the Company Certificates (or affidavits of loss in lieu of the Company Certificates as provided in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.4(e)</u>) in exchange for the Merger Consideration and the method of payment of such holder&#8217;s Fractional Shares Cash Amount. Upon surrender of a Company Certificate (or affidavit of loss in lieu of the Company Certificate as provided in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.4(e)</u>) to the Exchange Agent or to such other agent or agents as may be appointed by Parent and the Company, and upon delivery of a letter of transmittal, duly executed and in proper form, with all required enclosures and attachments, with respect to such Company Certificates, the holder of such Company Certificates shall be entitled to receive in exchange therefor the whole shares of Parent Common Stock that such holder is entitled to receive pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.1</u> and, if applicable, the Fractional Shares Cash Amount for each share of Company Common Stock formerly represented by such Company Certificates, and any Company Certificate so surrendered shall forthwith be canceled. If payment of the Merger Consideration is to be made to a Person other than the Person in whose name any surrendered Company Certificate is registered, it shall be a condition precedent of payment that the Company Certificate so surrendered shall be properly endorsed or shall be otherwise in proper form for transfer, and the Person requesting such payment shall have paid any transfer and other similar Taxes required by reason of the delivery of the Merger Consideration to a Person other than the registered holder of the Company Certificate so surrendered and shall have established to the satisfaction of Parent that such Taxes either have been paid or are not required to be paid. No interest will be paid or accrued on any amount payable upon due surrender of Company Certificates. Until surrendered as contemplated hereby, each Company Certificate shall be deemed at any time after the Effective Time to represent only the right to receive the Merger Consideration provided in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 90pt; text-align: justify; text-indent: 54pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 90pt; text-align: justify; text-indent: 54pt;">(ii)<i>&nbsp;&nbsp;&nbsp;&nbsp;Book-Entry Shares</i>. Notwithstanding anything to the contrary contained in this Agreement, no holder of Company Book-Entry Shares shall be required to deliver a Company Certificate or, in the case of holders of Company Book-Entry Shares held through The Depository Trust Company, an executed letter of transmittal to the Exchange Agent, to receive the Merger Consideration that such holder is entitled to receive pursuant to <u>Section </u><u>&#8206;</u><u>2.1</u>. In lieu thereof, each holder of record of one or more Company Book-Entry Shares held through The Depository Trust Company whose shares of Company Common Stock were converted into the right to receive the Merger Consideration shall automatically upon the Effective Time be entitled to receive, and Parent shall cause the Exchange Agent to pay and deliver to The Depository Trust Company or its nominee as promptly as practicable after the Effective Time, the whole shares of Parent Common Stock that such holder is entitled to receive pursuant to <u>Section </u><u>&#8206;</u><u>2.1</u> and, if applicable, the Fractional Shares Cash Amount for each share of Company Common Stock formerly represented by such Company Book-Entry Shares, and such Company Book-Entry Shares of such holder shall be canceled. As promptly as practicable after the Effective Time (but in no event later than two Business Days after the Effective Time), Parent shall cause the Exchange Agent to mail to each holder of record of Company Book-Entry Shares: (A)&nbsp;a letter of transmittal, which shall be in such form and have such provisions as Parent, the Company and the Exchange Agent shall reasonably agree prior to the Effective Time; and (B)&nbsp;instructions for returning such letter of transmittal in exchange for the Merger Consideration. Upon delivery of such letter of transmittal, in accordance with the terms of such letter of transmittal, duly executed and in proper form with all required enclosures and attachments, the holder of such Company Book-Entry Shares shall be entitled to receive in exchange therefor the whole shares of Parent Common Stock that such holder is entitled to receive pursuant to <u>Section </u><u>&#8206;</u><u>2.1</u> and, if applicable, the Fractional Shares Cash Amount for each share of Company Common Stock formerly represented by such Company Book-Entry Shares, and such Company Book-Entry Shares so surrendered shall at the Effective Time be canceled. Payment of the Merger Consideration with respect to Company Book-Entry Shares shall only be made to the Person in whose name such Company Book-Entry Shares are registered. No interest will be paid or accrued on any amount payable upon due surrender of Company Book-Entry Shares. Until paid or surrendered as contemplated hereby, each Company Book-Entry Share or share of Company Common Stock held through the Depository Trust Company shall be deemed at any time after the Effective Time to represent only the right to receive the Merger Consideration provided in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfer Books</u>. At the Effective Time, the stock transfer books of the Company shall be closed and thereafter there shall be no further registration of transfers of shares of Company Common Stock on the records of the Company. From and after the Effective Time, the holders of Company Certificates and Company Book-Entry Shares representing shares of Company Common Stock outstanding immediately prior to the Effective Time shall cease to have any rights with respect to such shares except as otherwise provided for herein or by applicable Law. If, after the Effective Time, Company Certificates representing shares of Company Common Stock are presented to Parent or the Surviving Corporation for any reason, they shall be canceled and exchanged for the whole shares of Parent Common Stock that such holder is entitled to receive pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.1</u> and, if applicable, the Fractional Shares Cash Amount as provided in this Agreement subject, in each case, to any applicable abandoned property, escheat or similar Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination of Fund; Abandoned Property</u>. At any time following one year after the Closing Date, Parent shall be entitled to require the Exchange Agent to deliver to it any shares of Parent Common Stock or cash remaining in the Exchange Fund made available to the Exchange Agent and not delivered to holders of Company Certificates or Company Book-Entry Shares, and thereafter such holders shall be entitled to look only to Parent (subject to abandoned property, escheat or other similar Laws) as general creditors thereof with respect to the applicable Merger Consideration payable upon due surrender of their Company Certificates or Company Book-Entry Shares and compliance with the procedures in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.4</u>. If, prior to six years after the Closing Date (or otherwise immediately prior to such time on which any payment in respect hereof would escheat to or become the property of any Governmental Entity pursuant to any applicable abandoned property, escheat or similar Laws), any holder of Company Certificates or Company Book-Entry Shares has not complied with the procedures in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.4</u> to receive the applicable Merger Consideration to which such holder would otherwise be entitled, the applicable Merger Consideration to which such holder would otherwise be entitled in respect of such Company Certificates or Company Book-Entry Shares shall, to the extent permitted by applicable Law, become the property of Parent, free and clear of all claims or interest of any Person previously entitled thereto. Notwithstanding the foregoing, none of Parent, the Surviving Corporation or the Exchange Agent, or any Representative or affiliate thereof, shall be liable to any holder of a Company Certificate or Company Book-Entry Shares for Merger Consideration delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Lost, Stolen or Destroyed Certificates</u>. In the event that any Company Certificates shall have been lost, stolen or destroyed, the Exchange Agent shall issue in exchange for such lost, stolen or destroyed Company Certificates, upon the making of an affidavit of that fact by the holder thereof, the applicable Merger Consideration payable in respect thereof pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.1(b)</u>; <u>provided</u>, <u>however</u>, that Parent or the Exchange Agent may, in its reasonable discretion and as a condition precedent to the payment of the applicable Merger Consideration, require the owners of such lost, stolen or destroyed Company Certificates to deliver a customary indemnity against any claim that may be made against Parent, the Surviving Corporation or the Exchange Agent with respect to Company Certificates alleged to have been lost, stolen or destroyed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Distributions with Respect to Unexchanged Company Common Stock</u>. No dividends or other distributions declared or made after the Effective Time with respect to Parent Common Stock with a record date after the Effective Time shall be paid to the holder of any unsurrendered Company Certificate or Company Book-Entry Share with respect to any shares of Parent Common Stock represented thereby, and, if applicable, no portion of the Fractional Shares Cash Amount shall be paid to any such holder pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.3</u>, unless and until the holder of such Company Certificate or Company Book-Entry Share shall surrender such Company Certificate or Company Book-Entry Share in accordance with this <u>Section </u><u>&#8206;</u><u>2.4</u>. All such dividends and other distributions with respect to the shares of Parent Common Stock issuable to such holder of any unsurrendered Company Certificate or Company Book-Entry Share in accordance with this Agreement shall be paid by Parent to the Exchange Agent and shall be included in the Exchange Fund until the surrender of such Company Certificate or Company Book-Entry Share (or affidavit of loss in lieu thereof) or payment of the Merger Consideration.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -9pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the effect of applicable abandoned property, escheat, Tax or other Laws, following surrender of any such Company Certificate or Company Book-Entry Share in accordance with this <u>Section </u><u>&#8206;</u><u>2.4</u>, there shall be paid by Parent to the holder of the certificates representing whole shares of Parent Common Stock issued in exchange therefor, without interest, (i)&nbsp;promptly, the portion of the Fractional Shares Cash Amount, if applicable, payable with respect to a fractional share of Parent Common Stock to which such holder is entitled pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.3</u> and the amount of dividends or other distributions with a record date after the Effective Time theretofore paid with respect to such whole shares of Parent Common Stock and (ii)&nbsp;at the appropriate payment date, the amount of dividends or other distributions, with a record date after the Effective Time but prior to surrender and a payment date occurring after surrender, payable with respect to such whole shares of Parent Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">2.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Stock-Based and Long-Term Cash Awards</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Treatment of Company RSUs</u>. As of the Effective Time, by virtue of the Merger and without any action on the part of the holders thereof, each time-based restricted stock unit with respect to shares of Company Common Stock granted by Company (each, a &#8220;<u>Company RSU</u>&#8221;) that is outstanding immediately prior to the Effective Time shall be treated as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 54pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Assumed RSUs</u>. Each Company RSU other than the SERP RSUs described in Section &#8206;2.5(a)(iii) below shall be assumed by Parent and shall be converted into a restricted stock unit award with respect to shares of Parent Common Stock in accordance with this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.5(a)(i)</u>. Each such Company RSU as so assumed and converted shall continue to have, and shall be subject to, the same terms and conditions as applied to such Company RSU immediately prior to the Effective Time (which, for the avoidance of doubt, includes, in each case, to the extent set forth in the underlying Company Stock Plan and/or award agreement (1) accelerated vesting and payment as a result of the Closing, if any, (2) any requirement for continued service with Company or its affiliates, and (3) the holder&#8217;s right to make an election to receive cash in lieu of shares (each Assumed RSU containing such election, an &#8220;<u>Assumed Settlement Election RSU</u>&#8221;)), except for terms rendered inoperative by reason of the Transactions and other administrative or ministerial changes determined by Parent and that, as of the Effective Time, each such Company RSU as so assumed and converted shall be a restricted stock unit covering that number of whole shares of Parent Common Stock (rounded down to the nearest whole share) equal to the product of (X)&nbsp;the number of shares of Company Common Stock subject to such Company RSU multiplied by (Y)&nbsp;the Exchange Ratio (after such conversion, an &#8220;<u>Assumed RSU</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 90pt; text-align: justify; text-indent: 63pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 54pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Assumed Settlement Election RSUs.</u> If a holder of an Assumed Settlement Election RSU makes a timely written election to receive a cash settlement in respect of their Assumed RSUs in accordance with the terms of their applicable award agreement, the Surviving Corporation shall (or shall cause one of its affiliates to) pay an amount in cash (without interest) equal to (X)&nbsp;the number of shares of Parent Common Stock subject to such Assumed Settlement Election RSU multiplied by (Y)&nbsp;the closing price per share of Parent Common Stock on the Closing Date, less any applicable tax withholding obligations, and such cash amount shall be paid within thirty days of Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 90pt; text-align: justify; text-indent: 63pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 54pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<u>SERP RSU</u>s. Each Company RSU that was contributed to and used to fund a participant&#8217;s account balance in the Company&#8217;s Supplemental Executive Retirement Plan (the &#8220;<u>SERP</u>&#8221;) shall be canceled and converted into a cash amount (&#8220;<u>SERP RSU Cash Amount</u>&#8221;) equal to (A) the product of (X) the number of shares of Company Common Stock subject to such Company RSU, multiplied by (Y) the Exchange Ratio, multiplied by (B) the closing price per share of Parent Common Stock on the Closing Date. Effective as of the Closing Date, the SERP RSU Cash Amount shall be credited to the account established under the SERP for the holder of the Company RSU associated with such SERP RSU Cash Amount, and will otherwise remain subject to the payment timing requirements and other terms of the SERP.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-indent: 108pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Treatment of Company PSUs.</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 54pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;As of the Effective Time, by virtue of the Merger and without any action on the part of the holders thereof, each performance stock unit award with respect to shares of Company Common Stock granted by the Company (each, a &#8220;<u>Company PSU</u>&#8221;) that was granted prior to the date hereof and is outstanding immediately prior to the Effective Time shall be canceled and assumed by Parent and shall be converted into the right of the holder to receive an amount in cash equal to (i) the product of (A) the number of shares of Company Common Stock subject to such Company PSU (assuming achievement based on actual performance for outstanding Company PSUs granted in 2023 and deemed target levels of performance for outstanding Company PSUs granted in 2024 and 2025), multiplied by (B) the Exchange Ratio, multiplied by (ii) the closing price per share of Parent Common Stock on the Closing Date. Each holder of such Company PSU shall, within 30 days of the Closing Date, be paid by the Surviving Corporation (or one of its affiliates) in accordance with its regular payroll practices the cash amount (without interest) payable to such holder pursuant to this <u>Section 2.5(b)</u>.<u> </u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 54pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;As of the Effective Time, by virtue of the Merger and without any action on the part of the holders thereof, each Company PSU that is granted following the date hereof and outstanding immediately prior to the Effective Time shall be assumed by Parent and shall be converted into a restricted stock unit award with respect to each share of Company Common Stock subject to such Company PSU in accordance with this <u>Section 2.5(b)</u>. Each such Company PSU as so assumed and converted shall continue to have, and shall be subject to, the same terms and conditions as applied to such Company PSU immediately prior to the Effective Time (including any requirement for continued service with Parent or its affiliates and performance-based vesting conditions set forth in the applicable Company Stock Plan or award agreement), except for terms rendered inoperative by reason of the Transactions and other administrative or ministerial changes determined by Parent, and as of the Effective Time, each such Company PSU as so assumed and converted shall be a performance-based vesting restricted stock unit covering that number of whole shares of Parent Common Stock (rounded down to the nearest whole share) equal to the product of (A) the number of shares of Company Common Stock subject to such Company PSU multiplied by (B) the Exchange Ratio (after such conversion, an &#8220;<u>Assumed PSU</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Treatment of Company RSAs</u>. As of the Effective Time, by virtue of the Merger and without any action on the part of the holders thereof, each restricted stock award with respect to shares of Company Common Stock granted by the Company (each, a&nbsp;&#8220;<u>Company RSA</u>&#8221;) that is (i) outstanding immediately prior to the date hereof, shall become vested immediately prior to the Effective Time (each, a &#8220;<u>Fully Vested Company RSA</u>&#8221;) or (ii) granted following the date hereof in accordance with and subject to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.1(b)</u>, shall become vested in an amount equal to the total of such Company RSAs multiplied by a fraction, the numerator of which is the number of days elapsed between January 1 of the calendar year in which the grant date occurs and the Closing Date and the denominator of which is the total number of days in the applicable vesting period with respect such Company RSAs (each, a&nbsp;&#8220;<u>Prorated Vested Company RSA</u>,&#8221; and together with the Fully Vested Company RSAs, the &#8220;<u>Vested Company RSAs</u>&#8221;). Each Vested Company RSA shall be canceled and converted into the right of the holder to receive, with respect to each restricted share of Company Common Stock subject to such Vested Company RSA, the Merger Consideration. At the Effective Time, any Company RSAs that are granted pursuant to clause (ii) of the preceding sentence that do not become Prorated Vested Company RSAs shall be automatically canceled and forfeited for no consideration.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Treatment of Company Phantom Awards</u>. At the Effective Time, each phantom stock award (each, a &#8220;<u>Company Phantom Award</u>&#8221;) granted under the Company Stock Plan that is outstanding immediately prior to the Effective Time shall, by virtue of the Merger and without any action on the part of the holders thereof, be assumed by Parent and shall be converted into a phantom stock award with phantom units (rounded down to the nearest whole unit) covering that number of whole phantom units with respect to Parent Common Stock equal to the product of (A) the number of phantom units subject to such Company Phantom Award multiplied by (B) the Exchange Ratio (after such conversion, an &#8220;<u>Assumed Phantom Award</u>&#8221;). Each Assumed Phantom Award shall continue to have, and shall be subject to, the same terms and conditions as applied to such Company Phantom Award immediately prior to the Effective Time, including the following: (a) a portion of the Assumed Phantom Award shall vest pursuant to the terms of the applicable award agreement in an amount equal to the total phantom units subject to such Assumed Phantom Award multiplied by a fraction, the numerator of which is the number of days in the performance period applicable to such Company Phantom Award that have been completed on the Closing Date and the denominator of which is the total number of days in the performance period applicable to such Company Phantom Award (&#8220;<u>Vested Phantom Units</u>&#8221;), and (b) the portion of the Assumed Phantom Award that is not a Vested Phantom Unit shall continue to be outstanding and shall be subject to the same terms and conditions as applied to the Company Phantom Award immediately prior to the Effective Time (including, for the avoidance of doubt, the requirement of continued service through the last day of the applicable performance period), except for terms rendered inoperative by reason of the Transactions and other administrative or ministerial changes determined by Parent. The holder of such Vested Phantom Units shall, within thirty days of the Closing Date, be paid by the Surviving Corporation (or one of its affiliates) in accordance with its regular payroll practices a cash amount (without interest) equal to the product of (x) the total number of Vested Phantom Units multiplied by (y) the closing price of one share of the Parent Common Stock on the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Treatment of Company Time-Based Cash Awards</u>. Each time-based long-term cash incentive award granted under the C-suite Long Term Incentive Plan under the Company Stock Plan (the &#8220;<u>C-suite LTIP</u>&#8221;) (each, a&nbsp;&#8220;<u>Company Time-Based Cash Award</u>&#8221;) that, in each case, is outstanding immediately prior to the Effective Time shall, by virtue of the Merger and without any action on the part of the holders thereof, be assumed by Parent or one of its Subsidiaries (as designated by Parent), and such Company Time-Based Cash Award as so assumed shall continue to have, and shall be subject to, the same terms and conditions as applied to such Company Time-Based Cash Award immediately prior to the Effective Time (including any requirement for continued service with the Company or its affiliates), except for terms rendered inoperative by reason of the Transactions and other administrative or ministerial changes determined by Parent (such awards, the &#8220;<u>Assumed Time-Based Cash Awards</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Treatment of Company Performance-Based Cash Awards</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Each award of a performance-based long-term cash incentive award granted under the C-suite LTIP (each, a &#8220;<u>Company Performance-Based Cash Award</u>&#8221; and, together with the Company Time-Based Cash Awards, the &#8220;<u>Company Cash Awards</u>&#8221;) that was granted prior to the date hereof and is outstanding immediately prior to the Effective Time shall, by virtue of the Merger and without any action on the part of the holders thereof, be canceled and converted into the right to receive an amount in cash equal to the cash amount that would be owed under such Company Performance-Based Cash Awards based on actual performance for a Company Performance-Based Cash Award subject to a 2023-2025 performance period and assuming achievement of 100% of target performance for all other Company Performance-Based Cash Awards. The holder of such Company Performance-Based Cash Award shall, within thirty days of the Closing Date, be paid by the Surviving Corporation (or one of its affiliates) in accordance with its regular payroll practices the cash amount (without interest) payable to such holder pursuant to this <u>Section </u><u>&#8206;</u><u>2.5(f)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: 72pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Each award of a Company Performance-Based Cash Award that is granted following the date hereof and outstanding immediately prior to the Effective Time shall, by virtue of the Merger and without any action on the part of the holders thereof, be assumed by Parent or one of its Subsidiaries (as designated by Parent), and such Company Performance-Based Cash Award shall remain outstanding and continue to be eligible to vest in accordance with, and subject to, the terms thereof (such award, the&nbsp;&#8220;<u>Assumed Performance-Based Cash Awards</u>&#8221;). Each Assumed Performance-Based Cash Award shall continue to have, and shall be subject to, the same terms and conditions as applied to such Company Performance-Based Cash Award immediately prior to the Effective Time (including any requirement for continued service with Parent or its affiliates and any performance-based vesting conditions), except for terms rendered inoperative by reason of the Transactions and other administrative or ministerial changes determined by Parent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;<u>Treatment of Other Cash-Based Awards</u>. All other long-term cash awards granted under the Company Stock Plan or otherwise shall be treated in accordance with the terms of the applicable plan or award agreement. Specifically, any awards outstanding under the Metal-Fab Manager Long-Term Incentive Plan and Metal-Fab Manager Retention Incentive Plan shall, by virtue of the Merger and without any action on the part of the holders thereof, be assumed by Parent or one of its Subsidiaries (as designated by Parent), and such awards shall remain outstanding and continue to be eligible to vest in accordance with, and subject to, the terms thereof, including the following: (i) a portion of the award shall vest pursuant to the terms of the applicable plan in an amount equal to the total award value, multiplied by a fraction, the numerator of which is the number of days in the performance period applicable to such award that have been completed on the Closing Date and the denominator of which is the total number of days in the performance period applicable to such award (the &#8220;<u>Vested Other Cash-Based Award</u>&#8221;) and (ii) the portion of the award that does not vest pursuant to clause (i) above shall continue to be outstanding and shall be subject to the same terms and conditions as applied thereto immediately prior to the Effective Time (including, for the avoidance of doubt, the requirement of continued service through the last day of the applicable performance period), except for terms rendered inoperative by reason of the Transactions and other administrative or ministerial changes determined by Parent. The holder of a Vested Other Cash-Based Award shall, within thirty days of the Closing Date, be paid by the Surviving Corporation (or one of its affiliates) in accordance with its regular payroll practices a cash amount (without interest) in respect of the Vested Other Cash-Based Award.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;<u>Company Stock Plans</u>. As of the Effective Time, Parent shall, by virtue of the Merger, assume the Company Stock Plan. Following the Effective Time, Parent shall continue to maintain any such assumed plans (each, as may be amended or terminated from time to time in accordance therewith).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Company Actions</u>. Prior to the Effective Time, the Company shall take all necessary action for the adjustment and assumption of equity and cash awards under this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.5</u> (including providing Parent all information reasonably requested by Parent for preparation of any Form&nbsp;S-8), and any relevant resolutions and other documents relating to the foregoing shall be subject to Parent&#8217;s approval (such approval not to be unreasonably withheld, conditioned or delayed).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;<u>Parent Actions</u>. Parent shall take all actions that are reasonably necessary for the assumption of the Assumed RSUs, Assumed Settlement Election RSUs, Assumed PSU, Assumed Phantom Awards, the Assumed Time-Based Cash Awards, the Assumed Performance-Based Cash Awards and any other assumed cash-based awards pursuant to this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.5</u>, including the reservation, issuance and listing of Parent Common Stock as necessary to effect the transactions contemplated by this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.5</u>. By the Effective Time, Parent shall use commercially reasonable efforts to file a registration statement on Form S-8 (or any successor form), to the extent such form is available, with respect to the shares of Parent Common Stock issuable with respect to Assumed RSUs and Assumed PSU.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">2.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Withholding Rights</u>. Each of Parent, the Surviving Corporation, the Company, Merger Sub, the Exchange Agent and their respective affiliates, and any other applicable withholding agent (each, a &#8220;<u>Withholding Agent</u>&#8221;) as applicable, shall be entitled to deduct and withhold from the Merger Consideration or any other amount payable pursuant to this Agreement to any Person, such amounts as are required to be deducted and withheld under applicable Tax Law. In the event any such deduction and withholding required to be made in respect of Parent Common Stock issued in the Merger, the applicable Withholding Agent is hereby authorized to sell such portion of the Parent Common Stock otherwise payable or deliverable to the applicable holder, on behalf of and as an agent of such holder, as is necessary to provide sufficient funds to the applicable Withholding Agent to enable it to comply with any such deduction or withholding requirements; <u>provided</u> that, in such case, the applicable Withholding Agent shall notify such holder of such sale and shall remit (a)&nbsp;the applicable portion of the net proceeds of such sale to the appropriate Governmental Entity and (b)&nbsp;the remaining net proceeds of such sale (after deduction for the amounts described in <u>clause (a)</u>), if any, to such holder. To the extent that amounts are so deducted and withheld and paid over to the applicable Governmental Entity in accordance with applicable Law, such deducted and withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person(s) in respect of which such deduction and withholding was made.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE 3</b><br>
<b>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">Except (a)&nbsp;as set forth in the Company Disclosure Schedule (subject to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>8.13</u>) and (b)&nbsp;as otherwise disclosed or identified in the Company SEC Documents publicly filed, or furnished, prior to the date hereof (other than any forward-looking disclosures contained in the &#8220;Forward Looking Statements&#8221; and &#8220;Risk Factors&#8221; sections of the Company SEC Documents and any other disclosures included therein to the extent they are primarily predictive, cautionary or forward-looking in nature), the Company hereby represents and warrants to Parent as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Corporate Organization</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is a corporation duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization and has the requisite corporate power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted and is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to have such power and authority or to be so licensed or qualified, individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse Effect. The Company has made available to Parent true, complete and correct copies of the Amended and Restated Articles of Incorporation (the &#8220;<u>Company</u><u>&nbsp;</u><u>Charter</u>&nbsp;&#8221;), and Amended and Restated Code of Regulations (the &#8220;<u>Company Code of Regulations</u>&#8221;) of the Company as in effect as of the date of this Agreement. The Company is not in violation in any material respect of any of the provisions of the Company Charter or Company Code of Regulations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Subsidiary of the Company is a corporation or other entity duly organized, validly existing and, to the extent applicable, in good standing under the Laws of the jurisdiction of its incorporation or organization and has the requisite corporate or organizational, as the case may be, power and authority to own or lease its properties and assets and to carry on its business as it is now being conducted, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Each Subsidiary of the Company is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed or qualified, individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Company Capitalization</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The authorized capital stock of the Company consists of 20,000,000 shares of Company Common Stock and 5,000,000 shares of serial preferred stock, without par value, of the Company (the &#8220;<u>Company Preferred Stock</u>&#8221;). As of October 24, 2025 (the &#8220;<u>Capitalization Date</u>&#8221;), (i)&nbsp;11,197,621 shares of Company Common Stock (other than treasury shares) were issued and outstanding, all of which were validly issued and fully paid, nonassessable and free of preemptive rights, (ii)&nbsp;no shares of Company Common Stock were held in the treasury of the Company or by its Subsidiaries, (iii)&nbsp;1,400,000 shares of Company Common Stock were reserved for issuance pursuant to the Company Stock Plans, of which amount (A)&nbsp;603,480 shares of Company Common Stock were underlying outstanding Company RSUs, (B)&nbsp;23,363 shares of Company Common Stock were underlying outstanding Company RSAs and (C)&nbsp;57,243 shares of Company Common Stock were underlying outstanding Company PSUs assuming satisfaction of any performance vesting conditions at target levels and 85,864.5 shares of Company Common Stock were underlying outstanding Company PSUs assuming satisfaction of any performance vesting conditions at maximum levels, and (iv)&nbsp;no shares of Company Preferred Stock were issued and outstanding. Except for Company RSUs, Company RSAs and Company PSUs, there are no options, warrants, equity-based compensation awards or other rights, agreements, arrangements or commitments of any character to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound relating to the issued or unissued capital stock or other Equity Interests of the Company, or securities convertible into or exchangeable for such capital stock or other Equity Interests, or obligating the Company or any of its Subsidiaries to issue or sell any shares of its capital stock or other Equity Interests, or securities convertible into or exchangeable for such capital stock of, or other Equity Interests in, the Company. Since the Capitalization Date, the Company has not issued any shares of its capital stock or other Equity Interests, or securities convertible into or exchangeable for such capital stock or other Equity Interests, other than those shares of capital stock reserved for issuance described in this <u>Section </u><u>&#8206;</u><u>3.2(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section </u><u>&#8206;</u><u>3.2(b)(i)</u> of the Company Disclosure Schedule sets forth a true and complete list, as of the Capitalization Date, of each outstanding Company RSU, Company RSA, and Company PSU. All shares of Company Common Stock subject to issuance under the Company Stock Plans, upon issuance prior to the Effective Time on the terms and conditions specified in the instruments pursuant to which they are issuable, will be duly authorized, validly issued, fully paid, nonassessable and free of preemptive rights. There are no bonds, debentures, notes or other indebtedness of the Company having the right to vote on any matters on which shareholders of the Company may vote. Neither the Company nor any of its Subsidiaries is a party to any voting agreement with respect to the voting of any Equity Interests of the Company. All Company RSUs, Company RSAs, and Company PSUs were granted under and in compliance in all material respects with the terms of the Company Stock Plan (including any sub-plans subject to the terms of the Company Stock Plan) and applicable Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section 3.2(c)</u> of the Company Disclosure Schedule sets forth a true and complete list of (i)&nbsp;all of the Subsidiaries of the Company, (ii)&nbsp;the jurisdiction of organization of each such Subsidiary and (iii)&nbsp;if not wholly owned by the Company or one of its Subsidiaries, the number of Equity Interests owned by the Company or its Subsidiaries and the corresponding ownership percentage of the Company or its Subsidiaries of such entity. None of the Company or any of its Subsidiaries holds any Equity Interests in any other Person (other than other Subsidiaries of the Company). Except as would reasonably be expected to be a Company Material Adverse Effect, each outstanding share of capital stock of or other Equity Interests in each Subsidiary of the Company is duly authorized, validly issued, fully paid, nonassessable and free of preemptive rights and is owned, beneficially and of record, by Company or one or more of its wholly owned Subsidiaries free and clear of all Liens, other than Permitted Liens.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority; Execution and Delivery; Enforceability</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company has all necessary power and authority to execute and deliver this Agreement, to perform and comply with its obligations under this Agreement and, subject to the receipt of the adoption of this Agreement by the holders of a majority of the shares of the Company Common Stock outstanding and entitled to vote thereon at the Company Shareholders Meeting (the &#8220;<u>Company Shareholder Approval</u>&#8221;) and the satisfaction of the closing conditions, to consummate the Transactions. The execution and delivery by the Company of this Agreement, the performance and compliance by the Company with each of its obligations herein and the consummation by the Company of the Transactions have been duly authorized by all necessary corporate action on the part of the Company, subject to the receipt of the Company Shareholder Approval, and no other corporate proceedings on the part of the Company and no other shareholder votes are necessary to authorize this Agreement or the consummation by the Company of the Transactions. The Company has duly and validly executed and delivered this Agreement and, assuming the due authorization, execution and delivery by Parent and Merger Sub of this Agreement, this Agreement constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except as limited by Laws affecting the enforcement of creditors&#8217; rights generally, by general equitable principles or by the discretion of any Governmental Entity before which any Proceeding seeking enforcement may be brought.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company Board, at a meeting duly called and held, unanimously adopted resolutions (i)&nbsp;determining that the Transactions, including the Merger, are advisable, fair to and in the best interests of the Company and its shareholders, (ii)&nbsp;approving, adopting and declaring advisable this Agreement and the Transactions, including the Merger, and (iii) recommending that the Company&#8217;s shareholders adopt this Agreement (such recommendation the &#8220;<u>Company Board Recommendation</u>&#8221;) and directing that such matter be submitted for consideration of the Company&#8217;s shareholders at the Company Shareholders Meeting.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the accuracy of the representations and warranties set forth in <u>&#8206;</u><u>Article 4</u>, no state &#8220;fair price,&#8221; &#8220;moratorium,&#8221; &#8220;control share acquisition,&#8221; &#8220;supermajority,&#8221; &#8220;affiliate transactions&#8221; or &#8220;business combination statute or regulation&#8221; or other anti-takeover or similar Laws, including Section 1701.831 of the OGCL and Chapter 1704 of the OGCL (each such Law, a&nbsp;&#8220;<u>Takeover Statute</u>&#8221;) is applicable to this Agreement, the Merger or the Transactions. The Company Board has taken all actions necessary to render all potentially applicable Takeover Statutes inapplicable to this Agreement, the Merger and the other Transactions. The only vote of holders of any class or series of Equity Interests of the Company necessary to approve the Transactions is the Company Shareholder Approval. No other vote of the holders of Company Common Stock or any other Equity Interests of the Company is necessary to consummate the Transactions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.4&nbsp;&nbsp;&nbsp;&nbsp;<u>No Conflicts</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery of this Agreement by the Company does not and will not, and the performance of this Agreement by the Company and the consummation of the Transactions will not, (i)&nbsp;assuming the Company Shareholder Approval is obtained, conflict with or violate any provision of the Company Charter, Company Code of Regulations or any equivalent organizational documents of any Subsidiary of the Company, (ii)&nbsp;assuming that all consents, approvals, authorizations and permits described in <u>Section </u><u>&#8206;</u><u>3.4(b)</u> have been obtained and all filings and notifications described in <u>Section </u><u>&#8206;</u><u>3.4(b)</u> have been made and any waiting periods thereunder have terminated or expired, conflict with or violate any Law applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected or (iii)&nbsp;require any consent or approval under, result in any breach of or any loss or impairment of any benefit under, constitute a change of control or default (or an event which with notice or lapse of time or both would become a default) under or give to others any right of termination, vesting, amendment, acceleration or cancellation of, or result in the creation of a Lien on any property or asset of the Company or any of its Subsidiaries pursuant to, any Company Material Contract or material Permit, except, with respect to <u>clauses (ii)</u> and <u>(iii)</u>, for any such conflicts, violations, breaches, defaults or other occurrences which would not, individually or in the aggregate, reasonably be expected to (A)&nbsp;prevent or materially delay consummation of the Merger or other Transactions or (B)&nbsp;have a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery of this Agreement by the Company does not, and the consummation by the Company of the Transactions and compliance by the Company with any of the terms or provisions hereof will not, require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity or any other Person, except (i)&nbsp;under the Exchange Act, Securities Act, any applicable blue sky Law, and the rules and regulations of NASDAQ, (ii)&nbsp;under the HSR Act or other applicable antitrust Laws or foreign investment Laws, (iii)&nbsp;the filing of the Certificate of Merger as required by the OGCL and (iv)&nbsp;where failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications, would not, individually or in the aggregate, reasonably be expected to (A)&nbsp;prevent or materially delay consummation of the Merger or other Transactions or (B)&nbsp;have a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.5&nbsp;&nbsp;&nbsp;&nbsp;<u>SEC Documents; Financial Statements; Undisclosed Liabilities</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company has filed or furnished on a timely basis all reports, schedules, forms, statements, registration statements, prospectuses and other documents required to be filed or furnished by the Company with the SEC under the Securities Act or the Exchange Act since the Applicable Date (the &#8220;<u>Company SEC Documents</u>&#8221;). None of the Subsidiaries of the Company is subject to the periodic reporting requirements of the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;As of its respective filing date, and, if amended, as of the date of the last amendment prior to the date of this Agreement, each Company SEC Document complied in all material respects with the requirements of the Exchange Act, the Securities Act, and the Sarbanes-Oxley Act of 2002, as amended (the &#8220;<u>Sarbanes-Oxley Act</u>&#8221;) as the case may be, and the rules and regulations of the SEC promulgated thereunder applicable to such Company SEC Document and did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of the Company and its Subsidiaries included or incorporated by reference in the Company SEC Documents (including, in each case, any notes or schedules thereto) (the &#8220;<u>Company SEC Financial Statements</u>&#8221;), comply as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. The Company SEC Financial Statements fairly present, in all material respects, the financial condition and the results of operations, cash flows and changes in shareholders&#8217; equity of the Company and its Subsidiaries (on a consolidated basis) as of the respective dates of and for the periods referred to in the Company SEC Financial Statements, and were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto), subject, in the case of interim Company SEC Financial Statements, to normal year-end adjustments (which are not material in significance or amount) and the absence of notes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this Agreement, no more than $300,000,000 of indebtedness is outstanding in the aggregate pursuant to the Company Credit Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from the SEC staff with respect to any Company SEC Documents and none of the Company SEC Documents is, to the Knowledge of the Company, the subject of ongoing SEC review or investigation. To the Knowledge of the Company, there are no SEC inquiries or investigations pending or threatened, in each case, regarding any accounting practices of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Company has established and maintains disclosure controls and procedures and internal control over financial reporting (as such terms are defined in paragraphs (e)&nbsp;and (f), respectively, of Rule&nbsp;13a-15 and paragraph (e)&nbsp;of Rule&nbsp;15d-15 under the Exchange Act) as required by Rules&nbsp;13a-15 and 15d-15 under the Exchange Act. The Company&#8217;s disclosure controls and procedures are designed to ensure that all information (both financial and non-financial) required to be disclosed by the Company in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such information is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections&nbsp;302 and 906 of the Sarbanes-Oxley Act. The Company&#8217;s management has completed an assessment of the effectiveness of the Company&#8217;s disclosure controls and procedures for the fiscal year ended December 31, 2024 and, to the extent required by applicable Law, presented in any applicable Company SEC Document that is a report on Form 10-K or Form 10-Q, or any amendment thereto, its conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by such report or amendment based on such evaluation. Since January 1, 2024 (the &#8220;<u>Applicable Date</u>&#8221;), the Company has had no significant deficiencies or material weaknesses in the design or operation of its internal control over financial reporting that would reasonably be expected to adversely affect in any material respect the Company&#8217;s ability to record, process, summarize and report financial information and the Company does not have Knowledge of any fraud that involves management or other employees who have a significant role in the Company&#8217;s internal control over financial reporting (except, in each case, as would not be material to the Company and its Subsidiaries on a consolidated basis). The Company has timely filed all certifications and statements required by (i)&nbsp;Rule 13a-14 or Rule 15d-14 under the Exchange Act; or (ii)&nbsp;18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act) with respect to all applicable Company SEC Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries do not have any liabilities or obligations of any nature whether absolute or contingent, asserted or unasserted, known or unknown, primary or secondary, direct or indirect, and whether or not accrued that are required to be reflected in the Company&#8217;s consolidated balance sheets in accordance with GAAP, except (i)&nbsp;as disclosed, reflected or reserved against in the most recent unaudited consolidated balance sheet included in the Company SEC Financial Statements or the notes thereto, (ii)&nbsp;for liabilities and obligations incurred in the ordinary course of business since the date of the most recent unaudited consolidated balance sheet included in the Company SEC Financial Statements, (iii)&nbsp;for liabilities and obligations arising out of or in connection with this Agreement, the Merger or the Transactions and (iv)&nbsp;for liabilities and obligations that, individually or in the aggregate, have not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off-balance sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between or among the Company and any of its Subsidiaries, on the one hand, and any unconsolidated affiliate, including any structured finance, special purpose or limited purpose entity or Person, on the other hand, or any &#8220;off-balance-sheet arrangements&#8221; (as defined in Item 303(a) of Regulation S-K under the Exchange Act)), where the result, purpose or intended effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, the Company or any of its Subsidiaries in the Company&#8217;s published financial statements or other Company SEC Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Absence of Certain Changes or Events</u>. Since December 31, 2024 through the date of this Agreement, except as otherwise contemplated by this Agreement, the Company and its Subsidiaries have conducted their businesses in all material respects only in the ordinary course and in a manner consistent with past practice and there has not been any Effect that, individually or in the aggregate, has had or would reasonably be expected to have a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Information Supplied</u>. None of the information supplied or to be supplied by the Company for inclusion or incorporation by reference in (a)&nbsp;the registration statement on Form&nbsp;S&#8209;4 to be filed with the SEC by Parent in connection with the Merger (the &#8220;<u>Form</u><u>&nbsp;</u><u>S-4</u>&nbsp;&#8221;) will, at the time the Form S-4 is filed with the SEC, and at any time it is amended or supplemented or at the time it becomes effective under the Securities Act, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and (b)&nbsp;the Joint Proxy Statement will, at the date it or any amendment or supplement is mailed to each of the holders of Parent Common Stock and Company Common Stock and at the time of each of the Company Shareholders Meeting and the Parent Stockholders Meeting, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances in which they are made, not misleading (except, in the case of both <u>clause</u><u>&nbsp;</u><u>(a)</u> and <u>(b)</u> that no representation or warranty is made by the Company to such portions thereof that relate expressly to Parent or any of its Subsidiaries, including Merger Sub, or to statements made therein based on information supplied by or on behalf of Parent for inclusion or incorporation by reference therein). The Form S-4 and the Joint Proxy Statement will comply as to form in all material respects with the requirements of the Securities Act or Exchange Act, as applicable, and other applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Proceedings</u>. There are no Proceedings pending or to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries or any of their respective assets, rights or properties or any of the officers or directors of the Company, except, in each case, for those that, individually or in the aggregate, would not, and would not reasonably be expected to, (a)&nbsp;prevent or materially delay the consummation of the Transactions or (b)&nbsp;have a Company Material Adverse Effect. Neither the Company nor any of its Subsidiaries nor any of their respective properties, rights or assets is or are subject to any Order, except, in each case, for those that, individually or in the aggregate, have not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Compliance with Laws</u>.&nbsp; (a)&nbsp;The Company and its Subsidiaries are in compliance, and since the Applicable Date have been in compliance, with all Laws and Orders applicable to the Company or any of its Subsidiaries or any assets owned or used by any of them (except for such past noncompliance as has been remedied and imposes no undue continuing obligations or costs on the Company or its Subsidiaries), and (b)&nbsp;neither the Company nor any of its Subsidiaries has, since the Applicable Date, received any written communication from a Governmental Entity that alleges that the Company or any of its Subsidiaries is not in compliance with any such Law or Order, except, in each case, where non-compliance, individually or in the aggregate, has not had and would not reasonably be expected to have, a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Permits</u>. The Company and each of its Subsidiaries have all required governmental permits, licenses, franchises, certificates, registrations, approvals, exemptions, clearances, billings and authorizations and similar rights (&#8220;<u>Permits</u>&#8221;) necessary for the conduct of their business and the use of their properties and assets, as presently conducted and used, and each of the Permits is valid, subsisting and in full force and effect, in each case except where the failure to have or maintain such Permit, individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse Effect. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (a)&nbsp;the operation of the business of the Company and its Subsidiaries as currently conducted is not, and has not been, in violation of, nor is the Company or any of its Subsidiaries in default or violation under, any Permit (except for such past violation or default as has been remedied and imposes no continuing obligations or costs on the Company or its Subsidiaries), and (b)&nbsp;to the Knowledge of the Company, no event has occurred which, with notice or the lapse of time or both, would constitute a default or violation of any term, condition or provision of any Permit. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;there are no actions pending or, to the Knowledge of the Company, threatened, that seek the revocation, cancellation or modification of any Permit and (ii)&nbsp;neither the Company nor its Subsidiaries have, since the Applicable Date, received written notice of any charge, claim or assertion from any Governmental Entity alleging any violations of or noncompliance with any Permit, nor to the Knowledge of the Company, has any charge, claim or assertion been threatened.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee Benefit Plans</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, &#8220;<u>Company Benefit Plan</u>&#8221; means any &#8220;employee benefit plan&#8221; as defined in Section 3(3) of ERISA, whether or not subject to ERISA, and any other plan, policy, program, Contract, or arrangement (whether written or unwritten, insured or self-insured) providing compensation or other benefits, in each case, that is established, maintained, sponsored or contributed to (or required to be contributed to) by the Company or any of its Subsidiaries, or under which the Company or any of its Subsidiaries has any obligation or liability, whether actual or contingent, including each employment, incentive, bonus, deferred compensation, profit-sharing, pension, retirement, vacation, holiday, sick pay, cafeteria, fringe benefit, medical, health, welfare, disability, retention, severance, termination, change in control, stock purchase, stock option, stock appreciation, phantom stock, restricted stock, restricted stock unit or other equity-based compensation plans, policies, programs, practices or arrangements, in each case, which is not sponsored and administered by a Governmental Entity and which is not a Multiemployer Plan. <u>Section </u><u>&#8206;</u><u>3.11(a)</u> of the Company Disclosure Schedule contains a true and complete list, as of the date of this Agreement, of each material Company Benefit Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has delivered or made available to Parent true and complete written copies of (i)&nbsp;the Company Stock Plan and each of the forms of award agreements for the Company RSUs, Company RSAs, Company PSUs, Company Phantom Awards, and Company Cash Awards, and (ii) each Company Benefit Plan that provides for any material severance benefits applicable to any current or former employee, director, or other service provider of the Company and its Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Company Benefit Plan, and to the Knowledge of the Company, each Multiemployer Plan, has been established, maintained and administered in accordance and in compliance with its terms and all applicable Laws, including ERISA and the Code, and all contributions required to be made under the terms of any Company Benefit Plans have been timely made or, if not yet due, have been properly reflected on the most recent consolidated balance sheet filed or incorporated by reference in Company SEC Documents prior to the date of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="21" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: (i)&nbsp;each Company Benefit Plan, and to the Knowledge of the Company, each Multiemployer Plan which is intended to qualify under Section 401(a) of the Code is so qualified and has either received a currently effective favorable determination letter or is entitled to rely on an opinion or advisory letter from the IRS as to its qualified status, and each trust established in connection with any Company Benefit Plan which is intended to be exempt from federal income taxation under Section&nbsp;501(a) of the Code is so exempt, and, to the Knowledge of the Company, no fact or event has occurred that could reasonably be expected to adversely affect the qualified status of any such Company Benefit Plan or the exempt status of any such trust, (ii)&nbsp;there has been no prohibited transaction (within the meaning of Section 406 of ERISA or Section&nbsp;4975 of the Code), other than a transaction that is exempt under a statutory or administrative exemption, with respect to any Company Benefit Plan, and (iii)&nbsp;no Proceeding or claim (other than for routine benefits claims) has been brought, or to the Knowledge of the Company is threatened, against or with respect to any Company Benefit Plan, including any audit or inquiry by any Governmental Entity.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Section </u><u>&#8206;</u><u>3.11(e)</u> of the Company Disclosure Schedule, no Company Benefit Plan is and, in the past six years, none of Company, any of its Subsidiaries or any of their respective ERISA Affiliates has sponsored, maintained, contributed to (or been required to contribute to), or had any liability or obligation, whether fixed or contingent, with respect to, (i)&nbsp;a multiemployer plan (as defined in Section&nbsp;4001(a)(3) of ERISA) (a&nbsp;&#8220;<u>Multiemployer Plan</u>&#8221;), (ii)&nbsp;a voluntary employees&#8217; beneficiary association (VEBA) maintained under Section 501(c)(9) of the Code, (iii)&nbsp;a multiple employer plan maintained under Section 413(c) of the Code; (iv)&nbsp;a &#8220;multiple employer welfare arrangement&#8221; within the meaning of Section 3(40) of ERISA or (v)&nbsp;any other plan subject to Title IV of ERISA or the minimum funding requirements of Section 302 of ERISA or Section 412 of the Code (any such plan, a &#8220;<u>Company Pension Plan</u>&#8221;). No material liability under Title IV of ERISA has been incurred by the Company, any of its Subsidiaries or any of their respective ERISA Affiliates that has not been satisfied in full, and no condition exists that would reasonably be expected to result in liability under Title IV of ERISA (whether primarily, jointly or secondarily) and have a Company Material Adverse Effect. With respect to each Company Pension Plan: (i) no such pension plan is in &#8220;at risk&#8221; status, within the meaning of Section 430 of the Code or Section 303 of ERISA; (ii) no &#8220;reportable event&#8221; within the meaning of Section 4043 of ERISA (for which the thirty (30) day notice requirement has not been waived by the Pension Benefit Guaranty Corporation (PBGC)) has occurred within the last twenty-four (24) months (disregarding any &#8220;reportable event&#8221; triggered by the execution of this Agreement or the transactions contemplated herein); and (iii) no such pension plan has failed to satisfy the &#8220;minimum funding standard&#8221; (as defined in Section 412 of the Code).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section </u><u>&#8206;</u><u>3.11(f)</u> of the Company Disclosure Schedule sets forth a true and complete list of each Multiemployer Plan to which the Company, its Subsidiaries, or any of their ERISA Affiliates contributes, has ever contributed (or been obligated to contribute) in the last three years, or has any liability or potential liability.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="22" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">22</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (A) neither the Company, its Subsidiaries, nor any of their ERISA Affiliates has received any notification, nor has any reason to believe, that any Multiemployer Plan is in reorganization, has been terminated, is insolvent, or may reasonably be expected to be in reorganization, to be insolvent, or to be terminated and (B) neither the Company, its Subsidiaries, nor any of their ERISA Affiliates has incurred or, to the Knowledge of the Company, are there any circumstances that exist that would reasonably expected to result in, (i)&nbsp;a complete or partial withdrawal, within the meaning of Section 4203 or 4205 of ERISA from any Multiemployer Plan; or (ii)&nbsp;any direct, indirect, contingent or secondary liability for withdrawal liability with respect to a Multiemployer Plan in which the Company, its Subsidiaries, or any ERISA Affiliates, participates or has participated in (or to which the Company, its Subsidiaries, or any ERISA Affiliates makes or is obligated to make, or made or was obligated to make, contributions).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;No Company Benefit Plan provides or is obligated to provide any material post-employment or post-service medical, disability, life insurance or other welfare benefits to any former director, employee or their respective dependents (other than health care continuation coverage as required by Section B of Subtitle B of Title I of ERISA or Section 4980B of the Code or any similar state law (&#8220;<u>COBRA</u>&#8221;) at the participant&#8217;s sole cost or coverage through the end of the calendar month in which a termination of employment occurs).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Merger or other Transactions (either alone or in combination with another event) will (i)&nbsp;entitle any current or former employee or director of the Company or its Subsidiaries to any compensation, (ii)&nbsp;accelerate the time of payment or vesting or trigger any payment or funding obligation (through a grantor trust or otherwise) of compensation or benefits, (iii)&nbsp;increase the amount payable or trigger any other obligation pursuant to any Company Benefit Plan or (iv)&nbsp;result in any breach or violation of, or default under, any Company Benefit Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;No amount that has been or could be received (whether in cash or property or the vesting of property) by any current or former employee, officer, director or other service provider of the Company or any of its Subsidiaries could, as a result of or in connection with the consummation of the Merger or other Transactions (either alone or in combination with another event), reasonably be characterized as an &#8220;excess parachute payment&#8221; (within the meaning of Section 280G(b)(1) of the Code).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Company Benefit Plan that is subject to Section 409A of the Code has been operated and maintained in operational and documentary compliance with Section 409A of the Code and all IRS guidance promulgated thereunder. There is no material agreement, plan, Contract or other arrangement to which the Company or any of its Subsidiaries is a party, or by which any of them is otherwise bound to compensate any Person in respect of Taxes, including Taxes under Sections 409A or 4999 of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">23</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, with respect to each Company Benefit Plan that is subject to the Laws of a jurisdiction other than the United States (whether or not United States law also applies) (a &#8220;Company Non-U.S. Plan&#8221;): (i) all employer and employee contributions to each Company Non-U.S. Plan required by Law or by the terms of such Company Non-U.S. Plan have been timely made, or, if applicable, accrued in accordance with normal accounting practices, (ii) each Company Non-U.S. Plan required to be registered has been registered and has been maintained in good standing with applicable regulatory authorities, and (iii) there are no unfunded or underfunded liabilities with respect to any Company Non-U.S. Plan. No Company Non-U.S. Plan is a defined benefit plan (as defined in ERISA, whether or not subject to ERISA) or termination indemnity, long-service award, jubilee payment or similar program in any jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section </u><u>&#8206;</u><u>3.11(m)(i)</u> of the Company Disclosure Schedule sets forth a true and complete list, as of the Capitalization Date, of each Person who holds a Company RSU, Company RSA, Company PSU, Company Phantom Award, and Company Cash Award, which schedule shows for each such award, the type of award (including whether the Company RSU is held through the Company&#8217;s Supplemental Executive Retirement Plan and whether the holder has a right to make an election to receive cash in lieu of shares), the date of grant, the number of shares or units subject thereto or cash value (for cash-based awards, if applicable), and the vesting date. All Company Phantom Awards and Company Cash Awards were granted under and in compliance in all material respects with the terms of the Company Stock Plan and applicable Laws. <u>Section 3.11(m)(ii)</u> of the Company Disclosure Schedule sets forth each Contract, Company Benefit Plan or other type of letter or agreement that legally obligates the Company to provide a grant of, or a right to purchase or receive equity or equity-based awards with respect to, Company Common Stock or other equity of the Company or any of its Subsidiaries that has not been issued or granted as of the date of this Agreement, together with the number of such equity awards and any promised terms thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee and Labor Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Section </u><u>&#8206;</u><u>3.12(a)</u> of the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries is a party to or bound by any material collective bargaining agreement, agreement with any works council, neutrality agreement, or other similar labor Contract with any union, employee association, works council, or any other labor organization (collectively, a &#8220;<u>Union</u>&#8221;); to the Knowledge of the Company, no Union has made a pending demand for recognition or certification as the bargaining unit representative of any employee employed, or individual engaged on an independent contractor basis, by the Company or any of its Subsidiaries (collectively, the &#8220;<u>Company Business Personnel</u>&#8221;); to the Knowledge of the Company, there are no representation or certification proceedings or petitions seeking a representation or decertification proceeding presently pending or threatened in writing to be brought or filed with the National Labor Relations Board or any other labor relations tribunal or authority; and to the Knowledge of the Company, there are no material organizing or decertification activities by or with respect to any Company Business Personnel. Neither the Company nor any of its Subsidiaries has in the past three years engaged in any unfair labor practice with respect to any Company Business Personnel, and there is no unfair labor practice complaint or grievance or other administrative or judicial complaint, action or investigation pending or threatened in writing against the Company or any of its Subsidiaries by the National Labor Relations Board or any other Governmental Entity with respect to any present or former Company Business Personnel which would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. There is no labor strike, dispute, lockout, slowdown, stoppage, or other material labor dispute pending or, to the Knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries. Each of the Company and its Subsidiaries, as applicable, have complied in all material respects with all of its obligations under each collective bargaining agreement and each other agreement or arrangement with any Union.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="24" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">24</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries will incur any notice, consultation or consent obligations with respect to any labor union, works council or other employee representative body in connection with the execution of this Agreement or the consummation of the Transactions, in each case, except as would not, individually or in the aggregate, reasonably be expected to (i) prevent or materially delay consummation of the Merger or other Transactions or (ii) have a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries are and have since the Applicable Date been in compliance with all applicable Laws respecting employment and employment practices, including, without limitation, all Laws respecting terms and conditions of employment, health and safety, wage payment, wages and hours, pay equity, child labor, fair labor standards, collective bargaining, immigration and work authorizations, background checks, employment discrimination, retaliation, harassment, notices, privacy, record retention, whistleblowing, civil rights, veterans&#8217; rights, disability rights or benefits, equal opportunity, plant closures and layoffs, affirmative action, workers&#8217; compensation, labor relations, social welfare obligations, proper classification of employees as exempt and non-exempt and as employees and independent contractors, termination, family and medical leave and other leaves of absence, sick time, unemployment insurance and the collection and payment of withholding and/or social security Taxes and any similar Tax, except for noncompliance as, individually or in the aggregate, has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, no Company Business Personnel at the level of Vice President or above is in any material respect in violation of any term of any employment agreement, nondisclosure agreement, common law nondisclosure obligation, fiduciary duty, noncompetition agreement, restrictive covenant or other obligation to the Company or any of its Subsidiaries or to a former employer of any such employee relating (i)&nbsp;to the right of any such individual to be employed by or provide services for the Company or its Subsidiaries or (ii)&nbsp;to the confidentiality or use of trade secrets or other confidential or proprietary information.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries are not delinquent in payments to any current or former Company Business Personnel for any services or amounts required to be reimbursed or otherwise paid except as does not have and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Since the Applicable Date, the Company and its Subsidiaries have investigated all material allegations of sexual harassment or discriminatory harassment of which they had or have Knowledge and have taken all reasonable and necessary corrective actions with respect to such allegations. No such allegation of sexual or discriminatory harassment would reasonably be expected to result in any material liability to the Company or any of its Subsidiaries and no such allegations have been made that, if known to the public, would reasonably be expected to bring the Company or any of its Subsidiaries into material disrepute.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="25" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">25</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;Since the Applicable Date, neither the Company nor its Subsidiaries have implemented any &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; (in each case, as defined under the Worker Adjustment and Retraining Notification Act of 1988 or any similar applicable state or local Laws).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.13&nbsp;&nbsp;&nbsp;&nbsp;<u>Environmental Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as is not, and would not reasonably be expected to be, a Company Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Company and each of its Subsidiaries (A)&nbsp;have been since the Applicable Date, and are, in compliance with all, and are not subject to any liability with respect to noncompliance with any, applicable Environmental Laws, (B)&nbsp;have held and hold, or have applied for, all Environmental Permits necessary for the conduct of their business and the use of their properties and assets, as currently conducted and used, and (C)&nbsp;have been since the Applicable Date, and are in compliance with their respective Environmental Permits;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;there are no Environmental Claims pending, or to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any written notification of any allegation of actual or potential liability or other responsibility for any Release or threatened Release of any Hazardous Materials with respect to any location;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;there has been no Release, transport, storage, arrangement for disposal of, or exposure of any Person to Hazardous Materials, and there has been no Release of Hazardous Materials at any Company Real Property (as defined below), or to the Knowledge of the Company, at properties that were formerly owned, operated, leased or used by the Company or any of its Subsidiaries during the time that the Company or any of its Subsidiaries owned or operated such property, that are reasonably likely to cause the Company or any of its Subsidiaries to incur liability pursuant to applicable Environmental Law; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;none of the Company nor any of its Subsidiaries (A)&nbsp;has entered into or agreed to any consent decree or consent order or is otherwise subject to any judgment, decree, or judicial or administrative Order relating to compliance with Environmental Laws or Environmental Permits, the investigation, sampling, monitoring, treatment, remediation, response, removal or cleanup of Hazardous Materials, or personal or bodily injury, wrongful death, property damage or natural resource damages in connection with a Release of or exposure to Hazardous Materials, and no Proceeding is pending, or to the Knowledge of the Company, is threatened with respect thereto, or (B)&nbsp;is an indemnitor by contract or otherwise in connection with any claim, demand, suit or action threatened or asserted by any third party for any liability under any Environmental Law or otherwise relating to any Release of or exposure to Hazardous Materials.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="26" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">26</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as may be set forth in the Company Real Property Leases or other Contracts entered into in the ordinary course of business or as has not had or would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries has assumed by contract, or provided an outstanding indemnity with respect to, any liability (contingent or otherwise) of another Person arising under Environmental Laws or relating to the Release of Hazardous Materials for which the Company and its Subsidiaries would not otherwise be liable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither this Agreement nor the consummation of the transactions contemplated hereby will result in any obligations for site investigation or cleanup, or notification to or consent of any Governmental Entity or third party pursuant to any transaction-triggered Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.14&nbsp;&nbsp;&nbsp;&nbsp;<u>Real Property</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company or its Subsidiaries, as the case may be, holds good and marketable fee title to all real property and interest in real property owned in fee by the Company or any of its Subsidiaries (collectively, the &#8220;<u>Company Owned Real Property</u>&#8221;), free and clear of all Liens, except for Permitted Liens. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, all buildings and other structures, facilities, building systems, fixtures or improvements located on each parcel of Company Owned Real Property are in good working order and repair for the sufficient operation of the business as currently conducted (ordinary wear and tear excepted). <u>Section </u><u>&#8206;</u><u>3.14(a)</u> of the Company Disclosure Schedule lists the address of each Company Owned Real Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company or its Subsidiaries, as the case may be, has a good and valid leasehold or subleasehold interest, as applicable, in all real property leased, subleased or otherwise used or occupied by the Company or any of its Subsidiaries (collectively the &#8220;<u>Company Leased Real Property</u>&#8221;), free and clear of all Liens, except for Permitted Liens. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries has received any notice of default under any Company Real Property Lease which is outstanding and remains uncured beyond any applicable period of cure, nor does the Company or any of its Subsidiaries have Knowledge of the existence of, any default, or event or circumstance that, with notice or lapse of time, or both, would constitute a default or permit the termination, modification or acceleration of rent under such Company Real Property Lease by the party that is the lessee or lessor of such Company Leased Real Property. <u>Section </u><u>&#8206;</u><u>3.14(b)</u> of the Company Disclosure Schedule lists the address of each material Company Leased Real Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="27" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">27</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company Owned Real Property and Company Leased Real Property are referred to collectively herein as the &#8220;<u>Company Real Property</u>.&#8221; The Company Real Property constitutes all of the real property used or necessary for use in connection with the conduct of the business of the Company and its Subsidiaries as presently conducted. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect and, in the case of the Company Leased Real Property, to the Knowledge of the Company, (i)&nbsp; there are no Proceedings in eminent domain, condemnation or other similar Proceedings that are pending and, to the Company&#8217;s Knowledge, there are no such Proceedings threatened in writing, affecting any portion of the Company Real Property, and (ii)&nbsp;no casualty event has occurred with respect to any Company Real Property that has not been remedied (including in compliance with any applicable Company Real Property Lease). Other than in connection with Permitted Liens, or with respect to the Company Leased Real Property as set forth on <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>3.14(c)</u> of the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries has leased, subleased, licensed or otherwise granted any Person a right to use or occupy any of the Company Real Property or any material portion thereof, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Neither the Company nor any of its Subsidiaries has granted any option or other right to any third party to purchase any of the Company Real Property or any material portion thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.15&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had and would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;All Tax Returns that are required to be filed by or with respect to the Company or any of its Subsidiaries have been timely filed (taking into account any extension of time within which to file) in accordance with applicable Law, (B)&nbsp;all such Tax Returns are true, complete and accurate, (C)&nbsp;the Company and its Subsidiaries have timely paid in full to the appropriate Governmental Entity all Taxes due and owing by any of them (whether or not shown on any Tax Return), except, in the case of <u>clauses (A)</u>, <u>(B)</u> and <u>(C)</u>, with respect to matters contested in good faith and for which adequate reserves have been established in accordance with GAAP, (D)&nbsp;the Company and its Subsidiaries have established adequate accruals and reserves, in accordance with GAAP, on the financial statements included in the Company SEC Documents for all Taxes payable by the Company and its Subsidiaries for all taxable periods and portions thereof through the date of such financial statements and (E)&nbsp;the Company and its Subsidiaries have timely deducted, withheld and collected all amounts required to be deducted, withheld or collected by any of them with respect to any amounts paid or owing to any employee, independent contractor, creditor, shareholder or other third party, and all such deducted, withheld and collected amounts were either timely paid or remitted to the appropriate Governmental Entity or properly set aside in accounts for such purpose and were reported to the appropriate Governmental Entity and to each such employee, independent contractor, creditor, shareholder or other third party as required under applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="28" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">28</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;No written agreement or other written document waiving or extending, or having the effect of waiving or extending, the statute of limitations or the period of assessment or collection of any Taxes relating to the Company or any of its Subsidiaries has been filed or entered into with any Taxing Authority, which the applicable statute of limitations or period of assessment or collection (including any waivers or extensions) has not yet expired. Neither the Company nor any of its Subsidiaries has (A)&nbsp;filed any extension of time within which to file any Tax Returns that have not been filed, except in the ordinary course of business, (B)&nbsp;has applied for a ruling from any Taxing Authority relating to any Taxes that has not been granted or has proposed to enter into an agreement with a Taxing Authority that is pending or (C)&nbsp;has been issued any private letter rulings, technical advice memoranda or similar written agreement or rulings by any Taxing Authority.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is the subject of any currently ongoing or pending audit or other proceeding with respect to any Taxes or Tax Return nor has any audit or other proceeding with respect to Taxes been threatened or proposed against any of them in writing. No deficiencies for any amount of Taxes have been asserted or assessed in writing against the Company or any of its Subsidiaries that have not been paid in full or otherwise completely resolved by any of them or are being contested in good faith for which adequate accruals or reserves for such deficiency have been established, in accordance with GAAP, on the financial statements included in the Company SEC Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;No claim has ever been made in writing by a Taxing Authority in a jurisdiction where the Company or any of its Subsidiaries has not filed a Tax Return of a particular type that the Company or its applicable Subsidiary, as the case may be, is or may be subject to Tax by, or required to file Tax Returns in, such jurisdiction with respect to Taxes that are the subject to such Tax Return, which claim has not been completely resolved.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries (A)&nbsp;is a party to or bound by or has any obligation under any Tax indemnification, separation, sharing or similar agreement or arrangement (other than such an agreement or arrangement (I)&nbsp;entered into in the ordinary course of business which does not relate primarily to Taxes or (II)&nbsp;solely between or among the Company and/or any of its Subsidiaries), (B)&nbsp;is or has been a member of any consolidated, combined, affiliated, unitary or similar group for purposes of filing Tax Returns or paying Taxes (other than a group comprised solely of (I)&nbsp;Subsidiaries of the Company or (II)&nbsp;the Company and any of its Subsidiaries), and (C)&nbsp;has any liability for Taxes of any Person (other than the Company or any of its Subsidiaries) under Treasury Regulations Section 1.1502-6 (or any comparable, analogous or similar provision of U.S. state or local, or non-U.S. Law) or as transferee or successor.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="29" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">29</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;There are no Liens for Taxes upon any property or assets of the Company or any of its Subsidiaries, except for Permitted Liens.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has entered into, or participated in, any &#8220;listed transaction&#8221; within the meaning of Section 6707A(c)(2) of the Code and Treasury Regulations Section 1.6011-4(b)(2) (or any comparable, analogous or similar provision of U.S. state or local or non-U.S. Law).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(viii)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries conducts a trade or business, has a permanent establishment (within the meaning of an applicable Tax treaty), operates or conducts business through any branch or is otherwise subject to taxation, in each case, in any country other than the country of its formation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has constituted, in the two years prior to the date of this Agreement, a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of stock intended to qualify for tax-free treatment under Section 355 of the Code (or any comparable, analogous or similar provision of U.S. state or local, or non-U.S. Law) or otherwise as part of a plan (or series of related transactions), within the meaning of Section 355(e) of the Code, that includes the Merger.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is aware of any facts, agreements, plans or other circumstances or has taken or agreed to take any action that would reasonably be expected to prevent or impede the Merger from qualifying for the Intended Tax Treatment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.16&nbsp;&nbsp;&nbsp;&nbsp;<u>Material Contracts</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section </u><u>&#8206;</u><u>3.16(a)</u> of the Company Disclosure Schedule sets forth a true and complete list, as of the date hereof, of each of the following Contracts (excluding any Company Benefit Plans) (other than with respect to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>3.16(a)(vi)</u>) to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or any of their material assets or businesses are bound (and any amendments thereto) (the &#8220;<u>Company Material Contracts</u>&#8221;):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;any Contract that is a &#8220;material contract&#8221; (as such term is defined in Item 601(b)(10) of Regulation&nbsp;S-K of the Exchange Act);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract relating to indebtedness for borrowed money (or guarantee thereof), in excess of $5,000,000, other than Contracts solely among the Company and its Subsidiaries;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract that relates to the purchase, acquisition, sale, transfer or disposition of a business or assets by the Company or any of its Subsidiaries pursuant to which the Company or any of its Subsidiaries has any continuing &#8220;earnout&#8221; or other contingent or deferred payment obligations in excess of $5,000,000 in the aggregate, for each such purchase, acquisition, sale, transfer or disposition;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="30" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">30</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;any Contract that by its terms prevents or materially restricts the payment of dividends or other distributions by the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;any Contract for any material joint venture, partnership or similar arrangement, or any Contract involving a sharing of material revenues, profits, losses, costs, or liabilities by the Company with any other Person or any of its Subsidiaries (other than Contracts solely among the Company and its Subsidiaries);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;any collective bargaining agreement or other agreement or arrangement with any Union; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract pursuant to which the Company or any of its Subsidiaries grants or is granted a license or other right (including a covenant not to sue or assert) to any material Intellectual Property (other than Contracts (A)&nbsp;in which grants of Intellectual Property are incidental to the primary purpose of such Contracts, (B)&nbsp;granting non-exclusive licenses or rights to customers in the ordinary course of business, (C)&nbsp;non-disclosure agreements, or (D)&nbsp;granting rights to use commercially available, off-the-shelf, non-customized software pursuant to shrink wrap, click through or similar nonexclusive, royalty-free licenses on standard non-discriminatory terms).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has heretofore made available to Parent true, correct and complete copies of Company Material Contracts not filed as exhibits to the Company SEC Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, all Company Material Contracts are valid, binding and in full force and effect and are enforceable by the Company or its applicable Subsidiary in accordance with their terms, except as limited by Laws affecting the enforcement of creditors&#8217; rights generally, by general equitable principles or by the discretion of any Governmental Entity before which any Proceeding seeking enforcement may be brought. Neither the Company nor any of its Subsidiaries has Knowledge of, or has received written notice of, any breach or default under (with or without notice or lapse of time, or both) any Company Material Contract and, to the Knowledge of the Company, no other party to any Company Material Contract is (with or without notice or lapse of time, or both) in breach or default thereunder, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries has Knowledge of, or has received written notice of, any actual, alleged, possible or potential violation of, or failure to comply with, any term or requirement of any Company Material Contract, or any intention of any party to cancel, terminate, materially change the scope of rights under or fail to renew any Company Material Contract.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="31" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">31</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.17&nbsp;&nbsp;&nbsp;&nbsp;<u>Intellectual Property</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;the Company and its Subsidiaries exclusively own the Company Owned Intellectual Property and have the valid right to use all other Company Intellectual Property, in each case, free and clear of all Liens other than Permitted Liens, (ii)&nbsp;each of the Company and its Subsidiaries has the right to use all Intellectual Property that is necessary for or used or held for use in the conduct of the businesses of the Company and its Subsidiaries as presently conducted or previously conducted since the Applicable Date, and (iii)&nbsp;neither the execution and delivery of this Agreement by the Company, nor the performance of this Agreement by the Company, will result in the loss, forfeiture, termination, or impairment of, or give rise to a right of any Person to limit, terminate, or consent to or require additional consideration for the continued use of, any rights of the Company or any of its Subsidiaries in any Company Intellectual Property. <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>3.17(a)</u> of the Company Disclosure Schedule sets forth a correct and complete list, as of the date hereof, of (x)&nbsp;the Company Registered Intellectual Property (together with identification of the jurisdiction and the relevant registration number or similar identifier for each such item of Company Registered Intellectual Property), and (y)&nbsp;all material Company Proprietary Software. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, all of the registrations, patents and applications included in the Company Registered Intellectual Property are and remain subsisting, are in compliance with all formal legal requirements, with all fees, payments and filings due through the date of this Agreement duly made, and, with respect to the registrations and patents included in the Company Registered Intellectual Property, valid and enforceable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;neither the Company nor any of its Subsidiaries nor the conduct of their businesses as presently conducted or previously conducted since the Applicable Date is infringing, misappropriating, diluting, or otherwise violating, nor has, since the Applicable Date, infringed, misappropriated, diluted, or otherwise violated, the Intellectual Property rights of any Person, (ii)&nbsp;neither the Company nor any of its Subsidiaries has received, since the Applicable Date, any written charge, complaint, claim, demand, or notice alleging that it has infringed, misappropriated, diluted or otherwise violated any Intellectual Property rights of any Person, and there are no pending written charges, complaints claims, demands or notices alleging any such infringement, misappropriation, dilution or other violation of the Intellectual Property rights of any Person, (iii)&nbsp;to the Knowledge of the Company, no Person is infringing, misappropriating, diluting or otherwise violating any Company Owned Intellectual Property, and (iv)&nbsp;neither the Company nor any of its Subsidiaries has made or asserted any written charge, complaint, claim, demand or notice since the Applicable Date alleging any such infringement, misappropriation, dilution, or violation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, there are no Proceedings pending against the Company or any of its Subsidiaries, and since the Applicable Date neither the Company nor any of its Subsidiaries have received notice of any pending Proceedings, challenging the ownership, use, validity or enforceability of any Company Owned Intellectual Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="32" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">32</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;All Trade Secrets and other material confidential information of the Company and its Subsidiaries have been maintained in confidence by the Company and its Subsidiaries in accordance with commercially reasonable security and protection measures consistent with those customarily used in the industry to protect the secrecy, confidentiality and value of the same. To the Knowledge of the Company, there has been no unauthorized access to or use or disclosure of any Trade Secrets or material confidential information that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, none of the Company nor any of its Subsidiaries&#8217; current and former employees, consultants, founders or contractors have any right, title or interest in any Company Owned Intellectual Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The IT Assets owned, leased or licensed by the Company and its Subsidiaries and used by them in the operation of their businesses as presently conducted operate as required by the Company and its Subsidiaries and have not, since the Applicable Date, malfunctioned or failed, in each case, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. The Company and its Subsidiaries have implemented and maintained commercially reasonable and appropriate measures with respect to technical, administrative and physical safeguards to preserve and protect the confidentiality, availability, integrity and security of the Company IT Assets and all information stored or contained therein or transmitted thereby against any unauthorized use, access, interruption or corruption where such unauthorized use, access, interruption or corruption has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.18&nbsp;&nbsp;&nbsp;&nbsp;<u>Data Privacy</u>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, since the Applicable Date, (a)&nbsp;the Company and its Subsidiaries, have been in compliance with (i) all applicable Laws, including, but not limited to, those pertaining to data protection, data privacy, data security, cybersecurity, data breach notification, cross-border data transfer, and general consumer laws as applied in the context of data privacy and security, electronic communication, telephone and text message communications, marketing by email or other channels, and other similar Laws (&#8220;<u>Privacy Laws</u>&#8221;), (ii) public facing policies, procedures, and notices related to the collection, use, storage, disclosure, or other processing of Personal Information, and (iii) contractual commitments, or binding codes of conduct or industry standards, in each case, related to privacy, security, or the processing of Personal Information ((i)-(iii) collectively, &#8220;<u>Privacy Requirements</u>&#8221;); (b)&nbsp;the Company and its Subsidiaries have implemented and maintain commercially reasonable organizational, physical, and technical security measures and policies, materially compliant with applicable Privacy Requirements, designed to protect all Personal Information in its possession or control, or collected by or on behalf of the Company or its Subsidiaries, against unauthorized or unlawful access, acquisition, interruption, alteration, modification, encryption, exfiltration, loss, destruction, disclosure, use, and/or other processing or misuse (&#8220;<u>Security Incident</u>&#8221;); and (c)&nbsp;the Company or any Subsidiary of the Company has not (i)&nbsp;experienced any Security Incident that required or would require notification of any Person pursuant to any applicable Privacy Law, or (ii)&nbsp;notified or been required to notify any Person of a Security Incident pursuant to any applicable Privacy Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="33" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">33</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.19&nbsp;&nbsp;&nbsp;&nbsp;<u>Anti-Corruption and Trade Sanctions</u>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries (i)&nbsp;are in compliance, and for the last five years have been in compliance, in all respects with the United States Foreign Corrupt Practices Act of 1977 (the &#8220;<u>FCPA</u>&#8221;) and any other applicable Anti-corruption Laws; and (ii)&nbsp;during the past five years have not been investigated, to the Knowledge of the Company, by any Governmental Entity with respect to, or been given notice by a Governmental Entity or any other Person of, any actual, alleged, or possible violation by the Company or any of its Subsidiaries of the FCPA or any other applicable Anti-corruption Laws;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor its Subsidiaries, nor any of their directors, officers, nor, to the Knowledge of the Company and its Subsidiaries, any of their employees, agents, other Representatives, or any Person authorized to act on their behalf (including any distributor, agent, sales intermediary or other third party), in each case, when acting on behalf of the Company or any of its Subsidiaries, has, directly or knowingly indirectly, offered, promised, paid, authorized or given money or anything of value to any Person for the purpose of: (i)&nbsp;influencing any act or decision of any Government Official or Other Covered Party; (ii)&nbsp;inducing any Government Official or Other Covered Party to do or omit to do an act in violation of a lawful duty; (iii)&nbsp;securing any improper advantage; or (iv)&nbsp;inducing any Government Official or Other Covered Party to influence the act or decision of a government or Governmental Entity, in order to obtain or retain business, or direct business to, any Person or entity, in any way;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Since April 24, 2019, neither the Company, its Subsidiaries nor any of their directors, officers, respective employees or, to the Knowledge of the Company and its Subsidiaries, any other Persons acting for or on behalf of the Company or its Subsidiaries is or has been a Person that is (i)&nbsp;any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;<u>OFAC</u>&#8221;) or the U.S. Department of State, the United Nations Security Council, the European Union, any Member State of the European Union or His Majesty&#8217;s Treasury of the United Kingdom; (ii)&nbsp;any Person located, organized, or resident in a country that is the subject of comprehensive Sanctions (currently, Cuba, Iran, North Korea, the Crimea region of Ukraine, the so-called Donetsk People&#8217;s Republic, and the so-called Luhansk People&#8217;s Republic) (a &#8220;<u>Sanctioned Country</u>&#8221;); or (iii)&nbsp;any Person 50% or more owned or, where applicable, controlled by any such Person or Persons or acting for or on behalf of such Person or Persons (collectively, &#8220;<u>Sanctioned Persons</u>&#8221;);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Since April 24, 2019, none of the Company or its Subsidiaries nor any of their directors, officers, or, to the Knowledge of the Company and its Subsidiaries, employees has had a customer or supplier or other business relationship with, is a party to any Contract with, or has engaged in any transaction with or involving a Sanctioned Country or Sanctioned Person in violation of Sanctions;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="34" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">34</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Since April 24, 2019, the Company has been in compliance with (i)&nbsp;applicable economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by the U.S. government, including OFAC, the United Nations Security Council, the European Union, any European Union member state or His Majesty&#8217;s Treasury of the United Kingdom (&#8220;<u>Sanctions</u>&#8221;) and (ii)&nbsp;applicable trade, export control, import, and antiboycott laws and regulations imposed, administered, or enforced by the U.S. government, including the Arms Export Control Act (22 U.S.C. &#167; 1778), the International Emergency Economic Powers Act (50 U.S.C. &#167;&#167; 1701&#8211;1706), Section 999 of the Internal Revenue Code, the U.S. customs laws at Title 19 of the U.S. Code, the Export Control Reform Act of 2018 (50 U.S.C. &#167;&#167; 4801-4861), the International Traffic in Arms Regulations (22 C.F.R. Parts 120&#8211;130), the Export Administration Regulations (15 C.F.R. Parts 730-774), the U.S. customs regulations at 19 C.F.R. Chapter 1, and the Foreign Trade Regulations (15 C.F.R. Part 30) (&#8220;<u>Trade Control Laws</u>&#8221;); and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, there is no current investigation, allegation, request for information, or other inquiry by any Governmental Entity regarding the violation of Sanctions or Trade Control Laws by the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.20&nbsp;&nbsp;&nbsp;&nbsp;<u>Broker</u><u>&#8217;</u><u>s Fees</u>. Except for the financial advisors&#8217; fees set forth in <u>Section </u><u>&#8206;</u><u>3.20</u> of the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries nor any of their respective officers or directors on behalf of the Company or such Subsidiaries has employed any financial advisor, broker or finder or incurred any liability for any financial advisory fee, broker&#8217;s fees, commissions or finder&#8217;s fees in connection with any of the Transactions. The Company will promptly after the date of this Agreement make available to Parent (on an outside counsel basis only) complete and correct copies of all engagement letters with its financial advisors.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.21&nbsp;&nbsp;&nbsp;&nbsp;<u>Opinion of Financial Advisors</u>. KeyBanc Capital Markets Inc. and Houlihan Lokey Capital, Inc., the Company&#8217;s financial advisors, have each delivered to the Company Board their respective separate opinions in writing or orally, in which case, such opinion will be subsequently confirmed in writing, to the effect that, based upon and subject to the assumptions, qualifications, limitations and other matters considered as set forth therein, as of the date thereof the Exchange Ratio pursuant to this Agreement is fair from a financial point of view to the holders of the shares of Company Common Stock (other than Parent or Merger Sub or any direct or indirect wholly owned subsidiaries of the Company, Parent or Merger Sub). The Company will make available to Parent copies of such opinions as soon as practicable following the execution of this Agreement for informational purposes only.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.22&nbsp;&nbsp;&nbsp;&nbsp;<u>Insurance</u>. The Company and its Subsidiaries maintain insurance in such amounts and against such risks as the management of the Company has in good faith determined to be prudent and appropriate in all material respects. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (a)&nbsp;all insurance policies maintained by or on behalf of the Company or any of its Subsidiaries are in full force and effect, (b)&nbsp;all premiums and other payments due on such policies have been paid by the Company or its Subsidiaries and all claims thereunder have been filed in due and timely fashion, (c)&nbsp;neither the Company nor any of its Subsidiaries is in breach or default under, has received any written notice of, or has taken any action that could permit cancellation, termination or modification of, any such insurance policies and (d)&nbsp;neither the Company nor any of its Subsidiaries has received any written notice of cancellation, invalidation or non-renewal of any such policy.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="35" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">35</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.23&nbsp;&nbsp;&nbsp;&nbsp;<u>Ownership of Parent Common Stock</u>. Neither the Company nor any of its affiliates or associates is, nor at any time during the last three years has the Company or any of its affiliates or associates been, an &#8220;interested shareholder&#8221; of Parent as defined in Section 1704 of the OGCL. The Company and its Subsidiaries, affiliates and associates do not beneficially own any shares of Parent Common Stock or other securities of Parent or any options, warrants or other rights to acquire Parent Common Stock or other securities of, or any other economic interest (through derivative securities or otherwise) in, Parent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.24&nbsp;&nbsp;&nbsp;&nbsp;<u>Related Party Transactions</u>. From the Applicable Date through the date of this Agreement, there have been no transactions or contracts between the Company or any of its Subsidiaries, on the one hand, and any affiliates (other than the Company Subsidiaries) of the Company or other Persons, on the other hand, that would be required to be reported by the Company pursuant to Item 404 of Regulation S-K promulgated by the SEC that have not been so reported.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.25&nbsp;&nbsp;&nbsp;&nbsp;<u>Company Material Customers and Company Material Suppliers</u>. <u>Section</u><u>&nbsp;</u><u>3.25</u> of the Company Disclosure Schedule lists (a) the 10 largest suppliers of the Company and its Subsidiaries measured by dollar volume of spend for the fiscal year ended December 31, 2024 (each such supplier, a &#8220;<u>Company Material Supplier</u>&#8221;) and (b) the 10 largest customers of the Company and its Subsidiaries measured by dollar volume of revenue for the fiscal year ended December 31, 2024 (each such customer, a &#8220;<u>Company Material Customer</u>&#8221;). Except as would not, individually or in the aggregate, have or reasonably be expected to have a Company Material Adverse Effect, between the Applicable Date and the date of this Agreement, no Company Material Customer or Company Material Supplier has terminated or adversely modified its business relationship with the Company or any of its Subsidiaries, or notified the Company or the applicable Subsidiary (whether in writing or, to the Knowledge of the Company, orally) of its intention to terminate or adversely modify its business relationship with the Company or the applicable Subsidiary in any way, other than the expiration of such relationship in accordance with its terms.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">3.26&nbsp;&nbsp;&nbsp;&nbsp;<u>No Other Representations or Warranties</u>. The Company hereby acknowledges and agrees that, except for the representations and warranties set forth in <u>Article </u><u>&#8206;</u><u>4</u>, (a) none of Parent, or any of its affiliates, stockholders or Representatives, or any other Person, has made or is making any express or implied representation or warranty with respect to Parent or its business or operations, including with respect to any information provided or made available to the Company or any of its affiliates, shareholders or Representatives, or any other Person, or, except as otherwise expressly set forth in this Agreement, had or has any duty or obligation to provide any information to the Company or any of its affiliates, shareholders or Representatives, or any other Person, in connection with this Agreement, the Transactions or otherwise, and (b) to the fullest extent permitted by Law, none of Parent, nor any of its affiliates, stockholders or Representatives, or any other Person, will have or be subject to any liability or indemnification or other obligation of any kind or nature to the Company, or any of its affiliates, shareholders or Representatives, or any other Person, resulting from the delivery, dissemination or any other distribution to the Company or any of its affiliates, shareholders or Representatives, or any other Person, or the use by the Company or any of its affiliates, shareholders or Representatives, or any other Person, of any such information provided or made available to any of them by Parent, or any of its affiliates, stockholders or Representatives, or any other Person, and (subject to the express representations and warranties of Parent set forth in Article &#8206;4) the Company and its Subsidiaries, affiliates, shareholders and Representatives, or any other Person, expressly disclaim reliance on any such information (including the accuracy or completeness thereof) or any representations or warranties or other statements or omissions that may have been made by Parent or any Person with respect to Parent other than the representations and warranties set forth in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="36" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">36</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE 4</b><br>
<b>REPRESENTATIONS AND WARRANTIES OF PARENT</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">Except (a)&nbsp;as set forth in the Parent Disclosure Schedule (subject to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>8.13</u>) and (b)&nbsp;as otherwise disclosed or identified in the Parent SEC Documents publicly filed, or furnished, prior to the date hereof (other than any forward-looking disclosures contained in the &#8220;Forward Looking Statements&#8221; and &#8220;Risk Factors&#8221; sections of the Parent SEC Documents and any other disclosures included therein to the extent they are primarily predictive, cautionary or forward-looking in nature), Parent hereby represents and warrants to the Company as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Corporate Organization</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent is a corporation duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization and has the requisite corporate power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted and is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to have such power and authority or to be so licensed or qualified, individually or in the aggregate, has not had and would not reasonably be expected to have, a Parent Material Adverse Effect. Parent has made available to the Company true, complete and correct copies of the Third Amended and Restated Certificate of Incorporation (the &#8220;<u>Parent</u><u>&nbsp;</u><u>Charter</u>&nbsp;&#8221;), and the Second Amended and Restated Bylaws (the &#8220;<u>Parent</u><u>&nbsp;</u><u>Bylaws</u>&nbsp;&#8221;) of Parent as in effect as of the date of this Agreement. Parent is not in violation in any material respect of any of the provisions of the Parent Charter or Parent Bylaws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Subsidiary of Parent is a corporation or other entity duly organized, validly existing and, to the extent applicable, in good standing under the Laws of the jurisdiction of its incorporation or organization and has the requisite corporate or organizational, as the case may be, power and authority to own or lease its properties and assets and to carry on its business as it is now being conducted, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Each Subsidiary of Parent is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed or qualified, individually or in the aggregate, has not had and would not reasonably be expected to have a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="37" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">37</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Parent Capitalization</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The authorized capital stock of Parent consists of 100,000,000 shares of Parent Common Stock and 7,000,000 shares of undesignated preferred stock, par value $0.01 per share (the &#8220;<u>Parent Preferred Stock</u>&#8221;). As of the Capitalization Date, (i)&nbsp;32,209,364 shares of Parent Common Stock (other than treasury shares) were issued and outstanding, all of which were validly issued and fully paid, nonassessable and free of preemptive rights, (ii)&nbsp;8,164,148 shares of Parent Common Stock were held in the treasury of Parent or by its Subsidiaries, (iii)&nbsp;2,549,318 shares of Parent Common Stock were reserved for issuance pursuant to the Parent Stock Plan, of which amount (A)&nbsp;101,700 shares of Parent Common Stock were underlying outstanding options to acquire shares of Parent Common Stock (&#8220;<u>Parent Stock Options</u>&#8221;), (B)&nbsp;1,004,444 shares of Parent Common Stock were underlying outstanding time-based restricted stock units with respect to Parent Common Stock (&#8220;<u>Parent RSUs</u>&#8221;) and (C)&nbsp;403,000 shares of Parent Common Stock were underlying outstanding awards of performance restricted stock units (&#8220;<u>Parent PSUs</u>&#8221;) assuming satisfaction of any performance vesting conditions at target levels and 806,000 shares of Parent Common Stock were underlying outstanding Parent PSUs assuming satisfaction of any performance vesting conditions at maximum levels, and (iv)&nbsp;no shares of Parent Preferred Stock were issued and outstanding. Except for Parent Stock Options, Parent RSUs, and Parent PSUs, there are no options, warrants, equity-based compensation awards or other rights, agreements, arrangements or commitments of any character to which Parent or any of its Subsidiaries is a party or by which Parent or any of its Subsidiaries is bound relating to the issued or unissued capital stock or other Equity Interests of Parent, or securities convertible into or exchangeable for such capital stock or other Equity Interests, or obligating Parent or any of its Subsidiaries to issue or sell any shares of its capital stock or other Equity Interests, or securities convertible into or exchangeable for such capital stock of, or other Equity Interests in, Parent. Since the Capitalization Date, Parent has not issued any shares of its capital stock or other Equity Interests, or securities convertible into or exchangeable for such capital stock or other Equity Interests, other than those shares of capital stock reserved for issuance described in this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.2(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.2(b)</u> of the Parent Disclosure Schedule sets forth a true and complete list, as of the Capitalization Date, of each outstanding Parent Stock Option, Parent RSU and Parent PSU. All shares of Parent Common Stock subject to issuance under the Parent Stock Plan, upon issuance prior to the Effective Time on the terms and conditions specified in the instruments pursuant to which they are issuable, will be duly authorized, validly issued, fully paid, nonassessable and free of preemptive rights. There are no bonds, debentures, notes or other indebtedness of Parent having the right to vote on any matters on which stockholders of Parent may vote. Neither Parent nor any of its Subsidiaries is a party to any voting agreement with respect to the voting of any Equity Interests of Parent. All Parent Stock Options, Parent RSUs, and Parent PSUs were granted under and in compliance in all material respects with the terms of a Parent Stock Plan and applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section </u><u>&#8206;</u><u>4.2(c)</u> of the Parent Disclosure Schedule sets forth a true and complete list of (i)&nbsp;all of the Subsidiaries of Parent, (ii)&nbsp;the jurisdiction of organization of each such Subsidiary and (iii)&nbsp;if not wholly owned by Parent or one of its Subsidiaries, the number of Equity Interests owned by Parent or its Subsidiaries and the corresponding ownership percentage of Parent or its Subsidiaries of such entity. None of Parent or any of its Subsidiaries holds any Equity Interests in any other Person (other than other Subsidiaries of Parent). Except as would reasonably be expected to be a Parent Material Adverse Effect, each outstanding share of capital stock of or other Equity Interests in each Subsidiary of Parent is duly authorized, validly issued, fully paid, nonassessable and free of preemptive rights and is owned, beneficially and of record, by Parent or one or more of its wholly owned Subsidiaries free and clear of all Liens, other than Permitted Liens.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="38" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">38</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority; Execution and Delivery; Enforceability</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent has all necessary power and authority to execute and deliver this Agreement, to perform and comply with its obligations under this Agreement and, subject to the receipt of the adoption of this Agreement (i)&nbsp;by Parent as the sole shareholder of Merger Sub and (ii)&nbsp;by the holders of a majority of the shares of Parent Common Stock outstanding and entitled to vote thereon at the Parent Stockholders Meeting (the &#8220;<u>Parent Stockholder Approval</u>&#8221;) and the satisfaction of the closing conditions, to consummate the Transactions applicable to such party. The execution and delivery by Parent of this Agreement, the performance and compliance by Parent with its obligations herein and the consummation by Parent of the Transactions have been duly authorized by all necessary corporate action on the part of Parent, subject to the receipt of the Parent Stockholder Approval and to the adoption of this Agreement by Parent as the sole shareholder of Merger Sub, and no other corporate proceedings on the part of Parent and no other stockholder votes are necessary to authorize this Agreement or the consummation by Parent of the Transactions to which it is a party. Parent has duly and validly executed and delivered this Agreement and, assuming the due authorization, execution and delivery by the Company of this Agreement, this Agreement constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except as limited by Laws affecting the enforcement of creditors&#8217; rights generally, by general equitable principles or by the discretion of any Governmental Entity before which any Proceeding seeking enforcement may be brought.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Parent Board, at a meeting duly called and held, adopted resolutions (i)&nbsp;determining that the Transactions, including the Merger and the issuance of shares of Parent Common Stock in connection with the Merger (the &#8220;<u>Parent Common Stock Issuance</u>&#8221;), are advisable, fair to and in the best interests of Parent and its stockholders, (ii)&nbsp;approving, adopting and declaring advisable this Agreement and the Transactions, including the Merger and the Parent Common Stock Issuance, (iii)&nbsp;directing that the Parent Common Stock Issuance be submitted to the stockholders of Parent for approval, and (iv)&nbsp;recommending that the Parent stockholders approve the Parent Common Stock Issuance (the &#8220;<u>Parent Board Recommendation</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the accuracy of the representations and warranties in <u>&#8206;</u><u>Article 3</u>, the Parent Board has taken all necessary actions&nbsp;so that the restrictions on business combinations set forth in Section 203 of the Delaware General Corporation Law and any other similar Law are not applicable to this Agreement and the Transactions. The only vote of holders of any class or series of Equity Interests of Parent necessary to approve the Transactions is the Parent Stockholder Approval. No other vote of the holders of Parent Common Stock or any other Equity Interests of Parent is necessary to consummate the Transactions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="39" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">39</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.4&nbsp;&nbsp;&nbsp;&nbsp;<u>No Conflicts</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery of this Agreement by Parent does not and will not, and the performance of this Agreement by Parent and the consummation of the Transactions will not, (i)&nbsp;assuming Parent Stockholder Approval is obtained, conflict with or violate any provision of the Parent Charter, Parent Bylaws, or any equivalent organizational documents of any Subsidiary of Parent, (ii)&nbsp;assuming that all consents, approvals, authorizations and permits described in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.4(b)</u> have been obtained and all filings and notifications described in <u>Section </u><u>&#8206;</u><u>4.4(b)</u> have been made and any waiting periods thereunder have terminated or expired, conflict with or violate any Law applicable to Parent or any of its Subsidiaries or by which any property or asset of Parent or any of its Subsidiaries is bound or affected or (iii)&nbsp;require any consent or approval under, result in any breach of or any loss or impairment of any benefit under, constitute a change of control or default (or an event which with notice or lapse of time or both would become a default) under or give to others any right of termination, vesting, amendment, acceleration or cancellation of, or result in the creation of a Lien on any property or asset of Parent or any of its Subsidiaries pursuant to, any Parent Material Contract or Permit, except, with respect to <u>clauses (ii)</u> and <u>(iii)</u>, for any such conflicts, violations, breaches, defaults or other occurrences which would not, individually or in the aggregate, reasonably be expected to (A)&nbsp;prevent or materially delay consummation of the Merger or other Transactions or (B)&nbsp;have a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery of this Agreement by Parent does not, and the consummation by Parent of the Transactions and compliance by Parent with any of the terms or provisions hereof will not, require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity or any other Person, except (i)&nbsp;under the Exchange Act, Securities Act, any applicable blue sky Law, and the rules and regulations of the NYSE, (ii)&nbsp;under the HSR Act or other applicable antitrust Laws or foreign investment Laws, (iii)&nbsp;the filing of the Certificate of Merger as required by the OGCL and (iv)&nbsp;where failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications, would not, individually or in the aggregate, reasonably be expected to (A)&nbsp;prevent or materially delay consummation of the Merger or other Transactions or (B)&nbsp;have a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.5&nbsp;&nbsp;&nbsp;&nbsp;<u>SEC Documents; Financial Statements; Undisclosed Liabilities</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent has filed or furnished on a timely basis all reports, schedules, forms, statements, registration statements, prospectuses and other documents required to be filed or furnished by Parent with the SEC under the Securities Act or the Exchange Act since the Applicable Date (the &#8220;<u>Parent SEC Documents</u>&#8221;). None of the Subsidiaries of Parent is subject to the periodic reporting requirements of the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;As of its respective filing date, and, if amended, as of the date of the last amendment prior to the date of this Agreement, each Parent SEC Document complied in all material respects with the requirements of the Exchange Act, the Securities Act, and the Sarbanes-Oxley Act as the case may be, and the rules and regulations of the SEC promulgated thereunder applicable to such Parent SEC Document and did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="40" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">40</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of Parent and its Subsidiaries included or incorporated by reference in the Parent SEC Documents (including, in each case, any notes or schedules thereto) (the &#8220;<u>Parent SEC Financial Statements</u>&#8221;), comply as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. The Parent SEC Financial Statements fairly present, in all material respects, the financial condition and the results of operations, cash flows and changes in stockholders&#8217; equity of Parent and its Subsidiaries (on a consolidated basis) as of the respective dates of and for the periods referred to in the Parent SEC Financial Statements, and were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto), subject, in the case of interim Parent SEC Financial Statements, to normal year-end adjustments (which are not material in significance or amount) and the absence of notes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from the SEC staff with respect to any Parent SEC Documents and none of the Parent SEC Documents is, to the Knowledge of Parent, the subject of ongoing SEC review or investigation. To the Knowledge of Parent, there are no SEC inquiries or investigations pending or threatened, in each case, regarding any accounting practices of Parent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Parent has established and maintains disclosure controls and procedures and internal control over financial reporting (as such terms are defined in paragraphs (e)&nbsp;and (f), respectively, of Rule&nbsp;13a-15 and paragraph (e)&nbsp;of Rule&nbsp;15d-15 under the Exchange Act) as required by Rules&nbsp;13a-15 and 15d-15 under the Exchange Act. Parent&#8217;s disclosure controls and procedures are designed to ensure that all information (both financial and non-financial) required to be disclosed by Parent in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such information is accumulated and communicated to Parent&#8217;s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections&nbsp;302 and 906 of the Sarbanes-Oxley Act. Parent&#8217;s management has completed an assessment of the effectiveness of Parent&#8217;s disclosure controls and procedures for the fiscal year ended December 31, 2024 and, to the extent required by applicable Law, presented in any applicable Parent SEC Document that is a report on Form 10-K or Form 10-Q, or any amendment thereto, its conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by such report or amendment based on such evaluation. Since the Applicable Date, Parent has had no significant deficiencies or material weaknesses in the design or operation of its internal control over financial reporting that would reasonably be expected to adversely affect in any material respect Parent&#8217;s ability to record, process, summarize and report financial information and Parent does not have Knowledge of any fraud that involves management or other employees who have a significant role in Parent&#8217;s internal control over financial reporting (except, in each case, as would not be material to Parent and its Subsidiaries on a consolidated basis). Parent has timely filed all certifications and statements required by (i)&nbsp;Rule 13a-14 or Rule 15d-14 under the Exchange Act; or (ii)&nbsp;18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act) with respect to all applicable Parent SEC Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="41" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">41</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Parent and its Subsidiaries do not have any liabilities or obligations of any nature whether absolute or contingent, asserted or unasserted, known or unknown, primary or secondary, direct or indirect, and whether or not accrued that are required to be reflected in Parent&#8217;s consolidated balance sheets in accordance with GAAP, except (i)&nbsp;as disclosed, reflected or reserved against in the most recent unaudited consolidated balance sheet included in the Parent SEC Financial Statements or the notes thereto, (ii)&nbsp;for liabilities and obligations incurred in the ordinary course of business since the date of the most recent unaudited consolidated balance sheet included in the Parent SEC Financial Statements, (iii)&nbsp;for liabilities and obligations arising out of or in connection with this Agreement, the Merger or the Transactions and (iv)&nbsp;for liabilities and obligations that, individually or in the aggregate, have not had, and would not reasonably be expected to have, a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off-balance sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between or among Parent and any of its Subsidiaries, on the one hand, and any unconsolidated affiliate, including any structured finance, special purpose or limited purpose entity or Person, on the other hand, or any &#8220;off-balance-sheet arrangements&#8221; (as defined in Item 303(a) of Regulation S-K under the Exchange Act)), where the result, purpose or intended effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, Parent or any of its Subsidiaries in Parent&#8217;s published financial statements or other Parent SEC Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Absence of Certain Changes or Events</u>. Since December 31, 2024 through the date of this Agreement, except as otherwise contemplated by this Agreement, Parent and its Subsidiaries have conducted their businesses in all material respects only in the ordinary course and in a manner consistent with past practice and there has not been any Effect that, individually or in the aggregate, has had or would reasonably be expected to have a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Information Supplied</u>. None of the information supplied or to be supplied by Parent for inclusion or incorporation by reference in (a)&nbsp;the Form S-4 will, at the time the Form S-4 is filed with the SEC, and at any time it is amended or supplemented or at the time it becomes effective under the Securities Act, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and (b)&nbsp;the Joint Proxy Statement will, at the date it or any amendment or supplement is mailed to each of the holders of Parent Common Stock and Company Common Stock and at the time of each of the Company Shareholders Meeting and the Parent Stockholders Meeting, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances in which they are made, not misleading (except, in the case of both <u>clause (a)</u> and <u>(b)</u> that no representation or warranty is made by Parent to such portions thereof that relate expressly to the Company or to statements made therein based on information supplied by or on behalf of the Company for inclusion or incorporation by reference therein). The Form S-4 and the Joint Proxy Statement will comply as to form in all material respects with the requirements of the Securities Act or Exchange Act, as applicable, and other applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Proceedings</u>. There are no Proceedings pending or, to the Knowledge of Parent, threatened against Parent or any of its Subsidiaries or any of their respective assets, rights or properties or any of the officers or directors of Parent, except, in each case, for those that, individually or in the aggregate, would not, and would not reasonably be expected to, (a)&nbsp;prevent or materially delay the consummation of the Transactions or (b)&nbsp;have a Parent Material Adverse Effect. Neither Parent nor any of its Subsidiaries nor any of their respective properties, rights or assets is or are subject to any Order, except, in each case, for those that, individually or in the aggregate, have not had, and would not reasonably be expected to have, a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="42" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">42</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Compliance with Laws</u>. (a)&nbsp;Parent and its Subsidiaries are in compliance, and since the Applicable Date have been in compliance, with all Laws and Orders applicable to Parent or any of its Subsidiaries or any assets owned or used by any of them (except for such past noncompliance as has been remedied and imposes no undue continuing obligations or costs on Parent or its Subsidiaries), and&nbsp;(b)&nbsp;neither Parent nor any of its Subsidiaries has, since the Applicable Date, received any written communication from a Governmental Entity that alleges that Parent or any of its Subsidiaries is not in compliance with any such Law or Order, except, in each case, where non-compliance, individually or in the aggregate, has not had and would not reasonably be expected to have, a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Permits</u>. Parent and each of its Subsidiaries have all required governmental Permits necessary for the conduct of their business and the use of their properties and assets, as presently conducted and used, and each of the Permits is valid, subsisting and in full force and effect, in each case except where the failure to have or maintain such Permit, individually or in the aggregate, has not had and would not reasonably be expected to have a Parent Material Adverse Effect. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, (a)&nbsp;the operation of the business of Parent and its Subsidiaries as currently conducted is not, and has not been, in violation of, nor is Parent or any of its Subsidiaries in default or violation under, any Permit (except for such past violation or default as has been remedied and imposes no continuing obligations or costs on Parent or its Subsidiaries), and (b)&nbsp;to the Knowledge of Parent, no event has occurred which, with notice or the lapse of time or both, would constitute a default or violation of any term, condition or provision of any Permit. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, (x)&nbsp;there are no actions pending or, to the Knowledge of Parent, threatened in writing, that seek the revocation, cancellation or modification of any Permit and (y)&nbsp;neither Parent nor its Subsidiaries have, since the Applicable Date, received written notice of any charge, claim or assertion from any Governmental Entity alleging any violations of or noncompliance with any Permit, nor to the Knowledge of Parent, has any charge, claim or assertion been threatened.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee Benefit Plans</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, &#8220;<u>Parent Benefit Plan</u>&#8221; means any &#8220;employee benefit plan&#8221; as defined in Section 3(3) of ERISA, whether or not subject to ERISA, and any other plan, policy, program, Contract, or arrangement (whether written or unwritten, insured or self-insured) providing compensation or other benefits, in each case, that is established, maintained, sponsored or contributed to (or required to be contributed to) by Parent or any of its Subsidiaries, or under which Parent or any of its Subsidiaries has any obligation or liability, whether actual or contingent, including each employment, incentive, bonus, deferred compensation, profit-sharing, pension, retirement, vacation, holiday, sick pay, cafeteria, fringe benefit, medical, health, welfare, disability, retention, severance, termination, change in control, stock purchase, stock option, stock appreciation, phantom stock, restricted stock, restricted stock unit or other equity-based compensation plans, policies, programs, practices or arrangements, in each case, which is not sponsored and administered by a Governmental Entity and which is not a Multiemployer Plan. <u>Section 4.11(a)</u> of the Parent Disclosure Schedule contains a true and complete list, as of the date of this Agreement, of each material Parent Benefit Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="43" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">43</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent has delivered or made available to the Company true and complete written copies of (i)&nbsp;the Parent Stock Plan and each of the forms of award agreements for the Parent RSUs, Parent PSUs, and Parent Stock Options, and (ii) each Parent Benefit Plan that provides for any material severance benefits applicable to any current or former employee, director, or other service provider of Parent and its Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, each Parent Benefit Plan, and to the Knowledge of Parent, each Multiemployer Plan, has been established, maintained and administered in accordance and in compliance with its terms and all applicable Laws, including ERISA and the Code, and all contributions required to be made under the terms of any Parent Benefit Plans have been timely made or, if not yet due, have been properly reflected on the most recent consolidated balance sheet filed or incorporated by reference in Parent SEC Documents prior to the date of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect: (i)&nbsp;each Parent Benefit Plan, and to the Knowledge of Parent, each Multiemployer Plan, which is intended to qualify under Section 401(a) of the Code is so qualified and has either received a currently effective favorable determination letter or is entitled to rely on an opinion or advisory letter from the IRS as to its qualified status, and each trust established in connection with any Parent Benefit Plan which is intended to be exempt from federal income taxation under Section&nbsp;501(a) of the Code is so exempt, and, to the Knowledge of Parent, no fact or event has occurred that could reasonably be expected to adversely affect the qualified status of any such Parent Benefit Plan or the exempt status of any such trust, (ii)&nbsp;there has been no prohibited transaction (within the meaning of Section 406 of ERISA or Section&nbsp;4975 of the Code), other than a transaction that is exempt under a statutory or administrative exemption, with respect to any Parent Benefit Plan, and (iii)&nbsp;no Proceeding or claim (other than for routine benefits claims) has been brought, or to the Knowledge of Parent is threatened, against or with respect to any Parent Benefit Plan, including any audit or inquiry by any Governmental Entity.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Section 4.11(d)</u> of the Parent Disclosure Schedule, no Parent Benefit Plan is and, in the past six years, none of Parent, any of its Subsidiaries or any of their respective ERISA Affiliates has sponsored, maintained, contributed to (or been required to contribute to), or had any liability or obligation, whether fixed or contingent, with respect to, (i)&nbsp;a Multiemployer Plan, (ii)&nbsp;a voluntary employees&#8217; beneficiary association (VEBA) maintained under Section 501(c)(9) of the Code, (iii)&nbsp;a multiple employer plan maintained under Section 413(c) of the Code; (iv)&nbsp;a &#8220;multiple employer welfare arrangement&#8221; within the meaning of Section 3(40) of ERISA or (v)&nbsp;any other plan subject to Title IV of ERISA or the minimum funding requirements of Section 302 of ERISA or Section 412 of the Code (any such plan, a &#8220;<u>Parent Pension Plan</u>&#8221;). No material liability under Title IV of ERISA has been incurred by Parent, any of its Subsidiaries or any of their respective ERISA Affiliates that has not been satisfied in full, and no condition exists that would reasonably be expected to result in liability under Title IV of ERISA (whether primarily, jointly or secondarily) and have a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="44" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">44</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section 4.11(e)</u> of the Parent Disclosure Schedule sets forth a true and complete list of each Multiemployer Plan to which Parent, its Subsidiaries, or any of their ERISA Affiliates contributes, has ever contributed (or been obligated to contribute) in the last three years, or has any liability or potential liability.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, (A) neither Parent, its Subsidiaries, nor any of their ERISA Affiliates has received any notification, nor has any reason to believe, that any Multiemployer Plan is in reorganization, has been terminated, is insolvent, or may reasonably be expected to be in reorganization, to be insolvent, or to be terminated, and (B) neither Parent, its Subsidiaries, nor any of their ERISA Affiliates has incurred or, to the Knowledge of the Parent, are there any circumstances that exist that would reasonably be expected to result in, (i)&nbsp;a complete or partial withdrawal, within the meaning of Section 4203 or 4205 of ERISA from any Multiemployer Plan; or (ii)&nbsp;any direct, indirect, contingent or secondary liability for withdrawal liability with respect to a Multiemployer Plan in which Parent, its Subsidiaries, or any ERISA Affiliates, participates or has participated in (or to which Parent, its Subsidiaries, or any ERISA Affiliates makes or is obligated to make, or made or was obligated to make, contributions).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;No Parent Benefit Plan provides or is obligated to provide any material post-employment or post-service medical, disability, life insurance, or other welfare benefits to any former director, employee or their respective dependents (other than health care continuation coverage as required by COBRA at the participant&#8217;s sole cost or coverage through the end of the calendar month in which a termination of employment occurs).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Merger or other Transactions (either alone or in combination with another event) will (i)&nbsp;entitle any current or former employee or director of Parent or its Subsidiaries to any compensation, (ii)&nbsp;accelerate the time of payment or vesting or trigger any payment or funding obligation (through a grantor trust or otherwise) of compensation or benefits, (iii)&nbsp;increase the amount payable or trigger any other obligation pursuant to any Parent Benefit Plan or (iv)&nbsp;result in any breach or violation of, or default under any Parent Benefit Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;No amount that has been or could be received (whether in cash or property or the vesting of property) by any current or former employee, officer, director or other service provider of Parent or any of its Subsidiaries could, as a result of or in connection with the consummation of the Merger or other Transactions (either alone or in combination with another event), reasonably be characterized as an &#8220;excess parachute payment&#8221; (within the meaning of Section 280G(b)(1) of the Code).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, each Parent Benefit Plan that is subject to Section 409A of the Code has been operated and maintained in operational and documentary compliance with Section 409A of the Code and all IRS guidance promulgated thereunder. There is no material agreement, plan, Contract or other arrangement to which Parent or any of its Subsidiaries is a party or by which any of them is otherwise bound to compensate any Person in respect of Taxes, including Taxes under Sections 409A or 4999 of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="45" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">45</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;Except as would not have, individually or in the aggregate, a Parent Material Adverse Effect, with respect to each Parent Benefit Plan that is subject to the Laws of a jurisdiction other than the United States (whether or not United States law also applies) (a&nbsp;&#8220;Parent Non-U.S. Plan&#8221;): (i) all employer and employee contributions to each Parent Non-U.S. Plan required by Law or by the terms of such Parent Non-U.S. Plan have been timely made, or, if applicable, accrued in accordance with normal accounting practices, (ii) each Parent Non-U.S. Plan required to be registered has been registered and has been maintained in good standing with applicable regulatory authorities, and (iii) there are no unfunded or underfunded liabilities with respect to any Parent Non-U.S. Plan. No Parent Non-U.S. Plan is a defined benefit plan (as defined in ERISA, whether or not subject to ERISA) or termination indemnity, long-service award, jubilee payment or similar program in any jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee and Labor Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.12(a)</u> of the Parent Disclosure Schedule, neither Parent nor any of its Subsidiaries is a party to or bound by any material collective bargaining agreement, agreement with any works council, neutrality agreement, or other similar labor Contract with any Union; to the Knowledge of Parent, no Union has made a pending demand for recognition or certification as the bargaining unit representative of any employee employed, or individual engaged on an independent contractor basis, by Parent or any of its Subsidiaries (collectively, the &#8220;<u>Parent Business Personnel</u>&#8221;); to the Knowledge of Parent, there are no representation or certification proceedings or petitions seeking a representation or decertification proceeding presently pending or threatened in writing to be brought or filed with the National Labor Relations Board or any other labor relations tribunal or authority; and to the Knowledge of Parent, there are no material organizing or decertification activities by or with respect to any Parent Business Personnel. Neither Parent nor any of its Subsidiaries has in the past three years engaged in any unfair labor practice with respect to any Parent Business Personnel, and there is no unfair labor practice complaint or grievance or other administrative or judicial complaint, action or investigation pending or threatened in writing against Parent or any of its Subsidiaries by the National Labor Relations Board or any other Governmental Entity with respect to any present or former Parent Business Personnel which would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. There is no labor strike, dispute, lockout, slowdown, stoppage, or other material labor dispute pending or, to the Knowledge of Parent, threatened against or affecting Parent or any of its Subsidiaries. Each of Parent and its Subsidiaries, as applicable, have complied in all material respects with all of its obligations under each collective bargaining agreement and each other agreement or arrangement with any Union.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries will incur any notice, consultation or consent obligations with respect to any labor union, works council or other employee representative body in connection with the execution of this Agreement or the consummation of the Transactions, in each case, except as would not, individually or in the aggregate, reasonably be expected to (i) prevent or materially delay consummation of the Merger or other Transactions or (ii) have a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="46" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">46</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Parent and its Subsidiaries are and have since the Applicable Date been in compliance with all applicable Laws respecting employment and employment practices, including, without limitation, all Laws respecting terms and conditions of employment, health and safety, wage payment, wages and hours, pay equity, child labor, fair labor standards, collective bargaining, immigration and work authorizations, background checks, employment discrimination, retaliation, harassment, notices, privacy, record retention, whistleblowing, civil rights, veterans&#8217; rights, disability rights or benefits, equal opportunity, plant closures and layoffs, affirmative action, workers&#8217; compensation, labor relations, social welfare obligations, proper classification of employees as exempt and non-exempt and as employees and independent contractors, termination, family and medical leave and other leaves of absence, sick time, unemployment insurance and the collection and payment of withholding and/or social security Taxes and any similar Tax, except for noncompliance as, individually or in the aggregate, has not had and would not reasonably be expected to have, a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of Parent, no Parent Business Personnel at the level of Vice President or above is in any material respect in violation of any term of any employment agreement, nondisclosure agreement, common law nondisclosure obligation, fiduciary duty, noncompetition agreement, restrictive covenant or other obligation to Parent or any of its Subsidiaries or to a former employer of any such employee relating (i)&nbsp;to the right of any such individual to be employed by or provide services for Parent or its Subsidiaries or (ii)&nbsp;to the confidentiality or use of trade secrets or other confidential or proprietary information.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Parent and its Subsidiaries are not delinquent in payments to any current or former Parent Business Personnel for any services or amounts required to be reimbursed or otherwise paid except as does not have and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Since the Applicable Date, Parent and its Subsidiaries have investigated all material allegations of sexual harassment or discriminatory harassment of which they had or have Knowledge and have taken all reasonable and necessary corrective actions with respect to such allegations. No such allegation of sexual or discriminatory harassment would reasonably be expected to result in any material liability to Parent or any of its Subsidiaries and no such allegations have been made that, if known to the public, would reasonably be expected to bring Parent or any of its Subsidiaries into material disrepute.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Since the Applicable Date, neither Parent nor its Subsidiaries have implemented any &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; (in each case, as defined under the Worker Adjustment and Retraining Notification Act of 1988 or any similar applicable state or local Laws).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.13&nbsp;&nbsp;&nbsp;&nbsp;<u>Environmental Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as is not, and would not reasonably be expected to be, a Parent Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries (A)&nbsp;have been since the Applicable Date, and are, in compliance with all, and are not subject to any liability with respect to noncompliance with any, applicable Environmental Laws, (B)&nbsp;have held and hold, or have applied for, all Environmental Permits necessary for the conduct of their business and the use of their properties and assets, as currently conducted and used, and (C)&nbsp;have been since the Applicable Date, and are in compliance with their respective Environmental Permits;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="47" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">47</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;there are no Environmental Claims pending, or to the Knowledge of Parent, threatened against Parent or any of its Subsidiaries, and none of Parent or any of its Subsidiaries has received any written notification of any allegation of actual or potential liability or other responsibility for any Release or threatened Release of any Hazardous Materials with respect to any location;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;there has been no Release, transport, storage, arrangement for disposal of, or exposure of any Person to Hazardous Materials, and there has been no Release of Hazardous Materials at any Parent Real Property (as defined below), or to the Knowledge of Parent, at properties that were formerly owned, operated, leased or used by Parent or any of its Subsidiaries during the time that Parent or any of its Subsidiaries owned or operated such property, that are reasonably likely to cause Parent or any of its Subsidiaries to incur liability pursuant to applicable Environmental Law; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;none of Parent nor any of its Subsidiaries (A)&nbsp;has entered into or agreed to any consent decree or consent order or is otherwise subject to any judgment, decree, or judicial or administrative Order relating to compliance with Environmental Laws or Environmental Permits, the investigation, sampling, monitoring, treatment, remediation, response, removal or cleanup of Hazardous Materials, or personal or bodily injury, wrongful death, property damage or natural resource damages in connection with a Release of or exposure to Hazardous Materials, and no Proceeding is pending, or to the Knowledge of Parent, is threatened with respect thereto, or (B)&nbsp;is an indemnitor by contract or otherwise in connection with any claim, demand, suit or action threatened or asserted by any third party for any liability under any Environmental Law or otherwise relating to any Release of or exposure to Hazardous Materials.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as may be set forth in the Parent Real Property Leases or other Contracts entered into in the ordinary course of business or as has not had or would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, neither Parent nor any of its Subsidiaries has assumed by contract, or provided an outstanding indemnity with respect to, any liability (contingent or otherwise) of another Person arising under Environmental Laws or relating to the Release of Hazardous Materials for which Parent and its Subsidiaries would not otherwise be liable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had or would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, neither this Agreement nor the consummation of the transactions contemplated hereby will result in any obligations for site investigation or cleanup, or notification to or consent of any Governmental Entity or third party pursuant to any transaction-triggered Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="48" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">48</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.14&nbsp;&nbsp;&nbsp;&nbsp;<u>Real Property</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent or its Subsidiaries, as the case may be, holds good and marketable fee title to all real property and interest in real property owned in fee by Parent or any of its Subsidiaries (collectively, the &#8220;<u>Parent Owned Real Property</u>&#8221;), free and clear of all Liens, except for Permitted Liens. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, all buildings and other structures, facilities, building systems, fixtures or improvements located on each parcel of Parent Owned Real Property are in good working order and repair for the sufficient operation of the business as currently conducted (ordinary wear and tear excepted). <u>Section </u><u>&#8206;</u><u>4.15(a)</u> of the Parent Disclosure Schedule lists the address of each Parent Owned Real Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent or its Subsidiaries, as the case may be, has a good and valid leasehold or subleasehold interest, as applicable, in all real property leased, subleased or otherwise used or occupied by Parent or any of its Subsidiaries (collectively the &#8220;<u>Parent Leased Real Property</u>&#8221;), free and clear of all Liens, except for Permitted Liens. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, neither Parent nor any of its Subsidiaries has received any notice of default under any Parent Real Property Lease which is outstanding and remains uncured beyond any applicable period of cure, nor does Parent or any of its Subsidiaries have Knowledge of the existence of, any default, or event or circumstance that, with notice or lapse of time, or both, would constitute a default or permit the termination, modification or acceleration of rent under such Parent Real Property Lease by the party that is the lessee or lessor of such Parent Leased Real Property. <u>Section </u><u>&#8206;</u><u>4.15(b)</u>of the Parent Disclosure Schedule lists the address of each material Parent Leased Real Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Parent Owned Real Property and Parent Leased Real Property are referred to collectively herein as the &#8220;<u>Parent Real Property</u>.&#8221; The Parent Real Property constitutes all of the real property used or necessary for use in connection with the conduct of the business of Parent and its Subsidiaries as presently conducted. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect and, in the case of the Parent Leased Real Property, to the Knowledge of Parent, (i)&nbsp; there are no Proceedings in eminent domain, condemnation or other similar Proceedings that are pending and, to Parent&#8217;s Knowledge, there are no such Proceedings threatened in writing, affecting any portion of the Parent Real Property, and (ii)&nbsp;no casualty event has occurred with respect to any Parent Real Property that has not been remedied (including in compliance with any applicable Parent Real Property Lease). Other than in connection with Permitted Liens, or with respect to the Parent Leased Real Property as set forth on <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.14(c)</u> of the Parent Disclosure Schedule, neither Parent nor any of its Subsidiaries has leased, subleased, licensed or otherwise granted any Person a right to use or occupy any of the Parent Real Property or any material portion thereof, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Neither Parent nor any of its Subsidiaries has granted any option or other right to any third party to purchase any of the Parent Real Property or any material portion thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="49" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">49</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.15&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had and would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;All Tax Returns that are required to be filed by or with respect to Parent or any of its Subsidiaries have been timely filed (taking into account any extension of time within which to file) in accordance with applicable Law, (B)&nbsp;all such Tax Returns are true, complete and accurate, (C)&nbsp;Parent and its Subsidiaries have timely paid in full to the appropriate Governmental Entity all Taxes due and owing by any of them (whether or not shown on any Tax Return), except, in the case of clauses (A), (B) and (C), with respect to matters contested in good faith and for which adequate reserves have been established in accordance with GAAP, (D)&nbsp;Parent and its Subsidiaries have established adequate accruals and reserves, in accordance with GAAP, on the financial statements included in the Parent SEC Documents for all Taxes payable by Parent and its Subsidiaries for all taxable periods and portions thereof through the date of such financial statements and (E)&nbsp;Parent and its Subsidiaries have timely deducted, withheld and collected all amounts required to be deducted, withheld or collected by any of them with respect to any amounts paid or owing to any employee, independent contractor, creditor, stockholder or other third party, and all such deducted, withheld and collected amounts were either timely paid or remitted to the appropriate Governmental Entity or properly set aside in accounts for such purpose and were reported to the appropriate Governmental Entity and to each such employee, independent contractor, creditor, stockholder or other third party as required under applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;No written agreement or other written document waiving or extending, or having the effect of waiving or extending, the statute of limitations or the period of assessment or collection of any Taxes relating to Parent or any of its Subsidiaries has been filed or entered into with any Taxing Authority, which the applicable statute of limitations or period of assessment or collection (including any waivers or extensions) has not yet expired. Neither Parent nor any of its Subsidiaries has (A)&nbsp;filed any extension of time within which to file any Tax Returns that have not been filed, except in the ordinary course of business, (B)&nbsp;has applied for a ruling from any Taxing Authority relating to any Taxes that has not been granted or has proposed to enter into an agreement with a Taxing Authority that is pending or (C)&nbsp;has been issued any private letter rulings, technical advice memoranda or similar written agreement or rulings by any Taxing Authority.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is the subject of any currently ongoing or pending audit or other proceeding with respect to any Taxes or Tax Return nor has any audit or other proceeding with respect to Taxes been threatened or proposed against any of them in writing. No deficiencies for any amount of Taxes have been asserted or assessed in writing against Parent or any of its Subsidiaries that have not been paid in full or otherwise completely resolved by any of them or are being contested in good faith for which adequate accruals or reserves for such deficiency have been established, in accordance with GAAP, on the financial statements included in the Parent SEC Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="50" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">50</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;No claim has ever been made in writing by a Taxing Authority in a jurisdiction where Parent or any of its Subsidiaries has not filed a Tax Return of a particular type that Parent or its applicable Subsidiary, as the case may be, is or may be subject to Tax by, or required to file Tax Returns in, such jurisdiction with respect to Taxes that are the subject to such Tax Return, which claim has not been completely resolved.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries (A)&nbsp;is a party to or bound by or has any obligation under any Tax indemnification, separation, sharing or similar agreement or arrangement (other than such an agreement or arrangement (I)&nbsp;entered into in the ordinary course of business which does not relate primarily to Taxes or (II)&nbsp;solely between or among Parent and/or any of its Subsidiaries), (B)&nbsp;is or has been a member of any consolidated, combined, affiliated, unitary or similar group for purposes of filing Tax Returns or paying Taxes (other than a group comprised solely of (I)&nbsp;Subsidiaries of Parent or (II)&nbsp;Parent and any of its Subsidiaries), and (C)&nbsp;has any liability for Taxes of any Person (other than Parent or any of its Subsidiaries) under Treasury Regulations Section 1.1502-6 (or any comparable, analogous or similar provision of U.S. state or local, or non-U.S. Law) or as transferee or successor.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;There are no Liens for Taxes upon any property or assets of Parent or any of its Subsidiaries, except for Permitted Liens.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 63pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has entered into, or participated in, any &#8220;listed transaction&#8221; within the meaning of Section 6707A(c)(2) of the Code and Treasury Regulations Section 1.6011-4(b)(2) (or any comparable, analogous or similar provision of U.S. state or local or non-U.S. Law).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(viii)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries conducts a trade or business, has a permanent establishment (within the meaning of an applicable Tax treaty), operates or conducts business through any branch or is otherwise subject to taxation, in each case, in any country other than the country of its formation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has constituted, in the two years prior to the date of this Agreement, a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of stock intended to qualify for tax-free treatment under Section 355 of the Code (or any comparable, analogous or similar provision of U.S. state or local, or non-U.S. Law) or otherwise as part of a plan (or series of related transactions), within the meaning of Section 355(e) of the Code, that includes the Merger.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="51" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">51</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is aware of any facts, agreements, plans or other circumstances or has taken or agreed to take any action that would reasonably be expected to prevent or impede the Merger from qualifying for the Intended Tax Treatment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.16&nbsp;&nbsp;&nbsp;&nbsp;<u>Material Contracts</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section </u><u>&#8206;</u><u>4.16(a)</u> of the Parent Disclosure Schedule sets forth a true and complete list, as of the date hereof, of each of the following Contracts (excluding any Parent Benefit Plans) (other than with respect to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>3.16(a)(vi)</u>) to which Parent or any of its Subsidiaries is a party or by which Parent or any of its Subsidiaries or any of their material assets or businesses are bound (and any amendments thereto) (the &#8220;<u>Parent Material Contracts</u>&#8221;):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;any Contract that is a &#8220;material contract&#8221; (as such term is defined in Item 601(b)(10) of Regulation&nbsp;S-K of the Exchange Act);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract relating to indebtedness for borrowed money (or guarantee thereof), in excess of $5,000,000, other than Contracts solely among Parent and its Subsidiaries;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract that relates to the purchase, acquisition, sale, transfer or disposition of a business or assets by Parent or any of its Subsidiaries pursuant to which Parent or any of its Subsidiaries has any continuing &#8220;earnout&#8221; or other contingent or deferred payment obligations in excess of $5,000,000 in the aggregate, for each such purchase, acquisition, sale, transfer or disposition;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;any Contract that by its terms prevents or materially restricts the payment of dividends or other distributions by Parent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;any Contract for any material joint venture, partnership or similar arrangement, or any Contract involving a sharing of material revenues, profits, losses, costs, or liabilities by Parent with any other Person or any of its Subsidiaries (other than Contracts solely among Parent and its Subsidiaries);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;any collective bargaining agreement or other agreement or arrangement with any Union; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 63pt; text-align: justify;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract pursuant to which Parent or any of its Subsidiaries grants or is granted a license or other right (including a covenant not to sue or assert) to any material Intellectual Property (other than Contracts (A)&nbsp;in which grants of Intellectual Property are incidental to the primary purpose of such Contracts, (B)&nbsp;granting non-exclusive licenses or rights to customers in the ordinary course of business, (C)&nbsp;non-disclosure agreements, or (D)&nbsp;granting rights to use commercially available, off-the-shelf, non-customized software pursuant to shrink wrap, click through or similar nonexclusive, royalty-free licenses on standard non-discriminatory terms).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="52" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">52</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent has heretofore made available to the Company true, correct and complete copies of the Parent Material Contracts not filed as exhibits to the Company SEC Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, all Parent Material Contracts are valid, binding and in full force and effect and are enforceable by Parent or its applicable Subsidiary in accordance with their terms, except as limited by Laws affecting the enforcement of creditors&#8217; rights generally, by general equitable principles or by the discretion of any Governmental Entity before which any Proceeding seeking enforcement may be brought. Neither Parent nor any of its Subsidiaries has Knowledge of, or has received written notice of, any breach or default under (with or without notice or lapse of time, or both) any Parent Material Contract and, to the Knowledge of Parent, no other party to any Parent Material Contract is (with or without notice or lapse of time, or both) in breach or default thereunder, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, neither the Company nor any of its Subsidiaries has Knowledge of, or has received written notice of, any actual, alleged, possible or potential violation of, or failure to comply with, any term or requirement of any Parent Material Contract, or any intention of any party to cancel, terminate, materially change the scope of rights under or fail to renew any Parent Material Contract.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.17&nbsp;&nbsp;&nbsp;&nbsp;<u>Intellectual Property</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, (i)&nbsp;Parent and its Subsidiaries exclusively own the Parent Owned Intellectual Property and have the valid right to use all other Parent Intellectual Property, in each case, free and clear of all Liens other than Permitted Liens, (ii)&nbsp;each of Parent and its Subsidiaries has the right to use all Intellectual Property that is necessary for or used or held for use in the conduct of the businesses of Parent and its Subsidiaries as presently conducted or previously conducted since the Applicable Date, and (iii)&nbsp;neither the execution and delivery of this Agreement by Parent, nor the performance of this Agreement by Parent, will result in the loss, forfeiture, termination, or impairment of, or give rise to a right of any Person to limit, terminate, or consent to or require additional consideration for the continued use of, any rights of Parent or any of its Subsidiaries in any Parent Intellectual Property. <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>3.17(a)</u> of the Parent Disclosure Schedule sets forth a correct and complete list, as of the date hereof, of (x)&nbsp;the Parent Registered Intellectual Property (together with identification of the jurisdiction and the relevant registration number or similar identifier for each such item of Parent Registered Intellectual Property), and (y)&nbsp;all material Parent Proprietary Software. Except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, all of the registrations, patents and applications included in the Parent Registered Intellectual Property are and remain subsisting, are in compliance with all formal legal requirements, with all fees, payments and filings due through the date of this Agreement duly made, and, with respect to the registrations and patents included in the Parent Registered Intellectual Property, valid and enforceable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="53" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">53</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, (i)&nbsp;neither Parent nor any of its Subsidiaries nor the conduct of their businesses as presently conducted or previously conducted since the Applicable Date is infringing, misappropriating, diluting, or otherwise violating, nor has, since the Applicable Date, infringed, misappropriated, diluted, or otherwise violated, the Intellectual Property rights of any Person, (ii)&nbsp;neither Parent nor any of its Subsidiaries has received, since the Applicable Date, any written charge, complaint, claim, demand, or notice alleging that it has infringed, misappropriated, diluted or otherwise violated any Intellectual Property rights of any Person, and there are no pending written charges, complaints claims, demands or notices alleging any such infringement, misappropriation, dilution or other violation of the Intellectual Property rights of any Person, (iii)&nbsp;to the Knowledge of Parent, no Person is infringing, misappropriating, diluting or otherwise violating any Parent Owned Intellectual Property, and (iv)&nbsp;neither Parent nor any of its Subsidiaries has made or asserted any written charge, complaint, claim, demand or notice since the Applicable Date alleging any such infringement, misappropriation, dilution, or violation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, there are no Proceedings pending against Parent or any of its Subsidiaries, and since the Applicable Date neither Parent nor any of its Subsidiaries have received notice of any pending Proceedings, challenging the ownership, use, validity or enforceability of any Parent Owned Intellectual Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;All Trade Secrets and other material confidential information of Parent and its Subsidiaries have been maintained in confidence by Parent and its Subsidiaries in accordance with commercially reasonable security and protection measures consistent with those customarily used in the industry to protect the secrecy, confidentiality and value of the same. To the Knowledge of Parent, there has been no unauthorized access to or use or disclosure of any Trade Secrets or material confidential information that has had or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, none of Parent nor any of its Subsidiaries&#8217; current and former employees, consultants, founders or contractors have any right, title or interest in any Parent Owned Intellectual Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The IT Assets owned, leased or licensed by Parent and its Subsidiaries and used by them in the operation of their businesses as presently conducted operate as required by Parent and its Subsidiaries and have not, since the Applicable Date, malfunctioned or failed, in each case, except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Parent and its Subsidiaries have implemented and maintained commercially reasonable and appropriate measures with respect to technical, administrative and physical safeguards to preserve and protect the confidentiality, availability, integrity and security of the Parent IT Assets and all information stored or contained therein or transmitted thereby against any unauthorized use, access, interruption or corruption where such unauthorized use, access, interruption or corruption has had or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="54" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">54</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.18&nbsp;&nbsp;&nbsp;&nbsp;<u>Data Privacy</u>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, since the Applicable Date, (a)&nbsp;Parent and its Subsidiaries have been in compliance with all applicable Privacy Requirements; (b)&nbsp; Parent and its Subsidiaries have implemented and maintain commercially reasonable organizational, physical, and technical security measures and policies, materially compliant with applicable Privacy Requirements, designed to protect all Personal Information in its possession or control, or collected by or on behalf of Parent or its Subsidiaries, against Security Incidents, and (c)&nbsp;Parent or any Subsidiary of Parent has not (i)&nbsp;experienced any Security Incident that required or would require notification of any Person pursuant to any applicable Privacy Law, or (ii)&nbsp;notified or been required to notify any Person of a Security Incident pursuant to any applicable Privacy Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.19&nbsp;&nbsp;&nbsp;&nbsp;<u>Anti-Corruption and Trade Sanctions</u>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries (i)&nbsp;are in compliance, and for the last five years have been in compliance, in all respects with the FCPA and any other applicable Anti-corruption Laws; and (ii)&nbsp;during the past five years have not been investigated, to the Knowledge of Parent, by any Governmental Entity with respect to, or been given notice by a Governmental Entity or any other Person of, any actual, alleged, or possible violation by Parent or any of its Subsidiaries of the FCPA or any other applicable Anti-corruption Laws;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither Parent nor its Subsidiaries, nor any of their directors, officers, nor, to the Knowledge of Parent and its Subsidiaries, any of their employees, agents, other Representatives, or any Person authorized to act on their behalf (including any distributor, agent, sales intermediary or other third party), in each case, when acting on behalf of Parent or any of its Subsidiaries, has, directly or knowingly indirectly, offered, promised, paid, authorized or given money or anything of value to any Person for the purpose of: (i)&nbsp;influencing any act or decision of any Government Official or Other Covered Party; (ii)&nbsp;inducing any Government Official or Other Covered Party to do or omit to do an act in violation of a lawful duty; (iii)&nbsp;securing any improper advantage; or (iv)&nbsp;inducing any Government Official or Other Covered Party to influence the act or decision of a government or Governmental Entity, in order to obtain or retain business, or direct business to, any Person or entity, in any way;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Since April 24, 2019, neither Parent, its Subsidiaries nor any of their directors, officers, or, to the Knowledge of Parent and its Subsidiaries, any of their respective employees or any other Persons acting for or on behalf of Parent or its Subsidiaries is or has been a Person that is (i)&nbsp;any Person listed in any Sanctions-related list of designated Persons maintained by OFAC or the U.S. Department of State, the United Nations Security Council, the European Union, any Member State of the European Union or His Majesty&#8217;s Treasury of the United Kingdom; (ii)&nbsp;any Person located, organized, or resident in a Sanctioned Country; or (iii)&nbsp;any Sanctioned Person;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Since April 24, 2019, none of Parent or its Subsidiaries nor any of their directors, officers, or, to the Knowledge of Parent and its Subsidiaries, employees has had a customer or supplier or other business relationship with, is a party to any Contract with, or has engaged in any transaction with or involving a Sanctioned Country or Sanctioned Person in violation of Sanctions;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Since April 24, 2019, Parent has been in compliance with (i)&nbsp;applicable Sanctions and (ii)&nbsp;applicable Trade Control Laws; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="55" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">55</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of Parent, there is no current investigation, allegation, request for information, or other inquiry by any Governmental Entity regarding the violation of Sanctions or Trade Control Laws by Parent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.20&nbsp;&nbsp;&nbsp;&nbsp;<u>Broker</u><u>&#8217;</u><u>s Fees</u>. Except for the financial advisors&#8217; fees set forth in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.20</u> of the Parent Disclosure Schedule, neither Parent nor any of its Subsidiaries nor any of their respective officers or directors on behalf of Parent or such Subsidiaries has employed any financial advisor, broker or finder or incurred any liability for any financial advisory fee, broker&#8217;s fees, commissions or finder&#8217;s fees in connection with any of the Transactions. Parent will promptly after the date of this Agreement make available to the Company (on an outside counsel basis only) complete and correct copies of all engagement letters with its financial advisors.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.21&nbsp;&nbsp;&nbsp;&nbsp;<u>Opinion of Financial Advisor</u>. J.P. Morgan Securities LLC, Parent&#8217;s financial advisor, has delivered to the Parent Board its opinion in writing or orally, in which case, such opinion will be subsequently confirmed in writing, to the effect that, based upon and subject to the various qualifications, assumptions, limitations and other matters set forth therein, as of the date thereof, the Exchange Ratio pursuant to this Agreement is fair, from a financial point of view, to Parent. Parent will make available to the Company a copy of such opinion as soon as practicable following the execution of this Agreement for informational purposes only.<sup style="vertical-align:top;line-height:120%;"> </sup></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.22&nbsp;&nbsp;&nbsp;&nbsp;<u>Insurance</u>. Parent and its Subsidiaries maintain insurance in such amounts and against such risks as the management of Parent has in good faith determined to be prudent and appropriate in all material respects. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, (a)&nbsp;all insurance policies maintained by or on behalf of Parent or any of its Subsidiaries are in full force and effect, (b)&nbsp;all premiums and other payments due on such policies have been paid by Parent or its Subsidiaries and all claims thereunder have been filed in due and timely fashion, (c)&nbsp;neither Parent nor any of its Subsidiaries is in breach or default under, has received any written notice of, or has taken any action that could permit cancellation, termination or modification of, any such insurance policies and (d)&nbsp;neither Parent nor any of its Subsidiaries has received any written notice of cancellation, invalidation or non-renewal of any such policy.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.23&nbsp;&nbsp;&nbsp;&nbsp;<u>Ownership of Company Common Stock</u>. Neither Parent nor any of its affiliates or associates is, nor at any time during the last three years has Parent or any of its affiliates or associates been, an &#8220;interested shareholder&#8221; of the Company as defined in Section 203 of the Delaware General Corporation Law. Parent and its Subsidiaries, affiliates and associates do not beneficially own any shares of the Company Common Stock or other securities of the Company or any options, warrants or other rights to acquire the Company Common Stock or other securities of, or any other economic interest (through derivative securities or otherwise) in, the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.24&nbsp;&nbsp;&nbsp;&nbsp;<u>Related Party Transactions</u>. From the Applicable Date through the date of this Agreement, there have been no transactions or contracts between Parent or any of its Subsidiaries, on the one hand, and any affiliates (other than Parent Subsidiaries) of Parent or other Persons, on the other hand, that would be required to be reported by Parent pursuant to Item 404 of Regulation S-K promulgated by the SEC that have not been so reported.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="56" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">56</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.25&nbsp;&nbsp;&nbsp;&nbsp;<u>Merger Sub</u>. Merger Sub was formed solely for purposes of consummating the Merger. Since its date of incorporation, Merger Sub has not carried on any business or conducted any operations other than the execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto. The authorized capital stock of Merger Sub consists of 1,000 shares of Merger Sub Common Stock, all of which have been validly issued, are fully paid and nonassessable and are owned directly by Parent free and clear of any Liens. Merger Sub has no assets or liabilities other than those necessary for corporate existence.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.26&nbsp;&nbsp;&nbsp;&nbsp;<u>Financing</u>. Subject to the accuracy of <u>Section </u><u>&#8206;</u><u>3.5(d)</u> and the compliance by the Company in all material respects with its obligations under <u>Section </u><u>&#8206;</u><u>5.1</u>, Parent will have sufficient funds available to it for Parent and, after the Effective Time, the Surviving Corporation, to complete the Merger and refinance in full all amounts outstanding under the Company Credit Agreement for which payment is required to be made at or immediately after the Effective Time, to pay cash in lieu of fractional shares in accordance with <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>2.3</u>, and to satisfy the respective obligations of Parent and Merger Sub as and when contemplated by this Agreement and to pay or otherwise perform such obligations of Parent and Merger Sub under any agreement or documents entered into in connection with the Merger. Notwithstanding anything to the contrary in this Agreement, each of Parent and Merger Sub acknowledges that its obligation to consummate the Merger as set forth in this Agreement is not contingent on Parent&#8217;s ability to obtain any financing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.27&nbsp;&nbsp;&nbsp;&nbsp;<u>Parent Material Customers and Parent Material Suppliers</u>. <u>Section </u><u>&#8206;</u><u>4.27</u> of the Parent Disclosure Schedule lists (a) the 10 largest suppliers of Parent and its Subsidiaries measured by dollar volume of spend for the fiscal year ended December 31, 2024 (each such supplier, a &#8220;Parent Material Supplier&#8221;) and (b) the 10 largest customers of Parent and its Subsidiaries measured by dollar volume of revenue for the fiscal year ended December 31, 2024 (each such customer, a &#8220;Parent Material Customer&#8221;). Except as would not, individually or in the aggregate, have or reasonably be expected to have a Parent Material Adverse Effect, between the Applicable Date and the date of this Agreement, no Parent Material Customer or Parent Material Supplier has terminated or adversely modified its business relationship with Parent or any of its Subsidiaries, or notified Parent or the applicable Subsidiary (whether in writing or, to the Knowledge of Parent, orally) of its intention to terminate or adversely modify its business relationship with Parent or the applicable Subsidiary in any way, other than the expiration of such relationship in accordance with its terms.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">4.28&nbsp;&nbsp;&nbsp;&nbsp;<u>No Other Representations or Warranties</u>. Parent hereby acknowledges and agrees that, except for the representations and warranties set forth in Article &#8206;3, (a) none of the Company, or any of its affiliates, shareholders or Representatives, or any other Person, has made or is making any express or implied representation or warranty with respect to the Company or its business or operations, including with respect to any information provided or made available to Parent or any of its affiliates, stockholders or Representatives, or any other Person, or, except as otherwise expressly set forth in this Agreement, had or has any duty or obligation to provide any information to Parent or any of its affiliates, stockholders or Representatives, or any other Person, in connection with this Agreement, the Transactions or otherwise, and (b) to the fullest extent permitted by Law, none of the Company, nor any of its affiliates, shareholders or Representatives, or any other Person, will have or be subject to any liability or indemnification or other obligation of any kind or nature to Parent, or any of its affiliates, stockholders or Representatives, or any other Person, resulting from the delivery, dissemination or any other distribution to Parent or any of its affiliates, stockholders or Representatives, or any other Person, or the use by Parent or any of its affiliates, stockholders or Representatives, or any other Person, of any such information provided or made available to any of them by the Company, or any of its affiliates, shareholders or Representatives, or any other Person, and (subject to the express representations and warranties of the Company set forth in Article &#8206;3) Parent and its Subsidiaries, affiliates, stockholders and Representatives, or any other Person, expressly disclaim reliance on any such information (including the accuracy or completeness thereof) or any representations or warranties or other statements or omissions that may have been made by the Company or any Person with respect to the Company other than the representations and warranties set forth in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="57" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">57</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE 5</b><br>
<b>COVENANTS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Conduct of Business by the Company and its Subsidiaries Pending the Effective Time</u>. The Company agrees that, between the date of this Agreement and the earlier of the Effective Time or the valid termination of this Agreement in accordance with <u>&#8206;</u><u>Article 7</u>, except as set forth in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.1</u> of the Company Disclosure Schedule, as required by Law or as otherwise expressly required or contemplated by this Agreement, unless Parent shall otherwise consent in writing (including via email specifically referencing this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.1</u>) (such consent not to be unreasonably withheld, conditioned or delayed), the Company shall, and shall cause each of its Subsidiaries to, (x)&nbsp;use its commercially reasonable efforts to conduct its operations in the ordinary course of business consistent with past practice in all material respects and (y)&nbsp;use its commercially reasonable efforts to preserve intact its business organization and comply with all applicable Laws in all material respects, including, in each case, continuing to use commercially reasonable efforts to prepare audited financial statements for the fiscal year ended December 31, 2025 irrespective of the anticipated Closing Date. Without limiting the foregoing, except as set forth in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.1</u> of the Company Disclosure Schedule, as required by applicable Law or as otherwise expressly required by this Agreement, the Company shall not, and shall not permit any of its Subsidiaries to, between the date of this Agreement and the Effective Time, directly or indirectly, take any of the following actions without the prior written consent (including via email specifically referencing this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.1</u>) of Parent (such consent not to be unreasonably withheld, conditioned or delayed):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;amend the Company Charter or Company Code of Regulations or the organizational documents of any &#8220;significant&#8221; Subsidiary of the Company (as defined in Rule 1-02(w) of Regulation&nbsp;S&#8209;X) (other than ministerial changes or such amendments as may be necessary to effect the Transactions) or adopt any shareholder rights plan, &#8220;poison pill&#8221; antitakeover plan or similar device, in each case, to the extent that it would apply to the Transactions;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;issue, sell, pledge, dispose of, grant, transfer or encumber, or authorize the issuance, sale, pledge, disposition, grant, transfer, or encumbrance of, any shares of capital stock of, or other Equity Interests in, the Company or any of its Subsidiaries, or securities convertible into, or exchangeable or exercisable for, any shares of such capital stock or other Equity Interests, or any options, warrants or other rights of any kind to acquire any shares of such capital stock or other Equity Interests or such convertible or exchangeable securities, or any other ownership interest (including any such interest represented by Contract right), or any &#8220;phantom&#8221; stock, &#8220;phantom&#8221; stock rights, stock appreciation rights or stock based performance rights, of the Company or any of its Subsidiaries, other than (i)&nbsp;the issuance of Company Common Stock in connection with the vesting of Company RSAs and settlement of Company RSUs or Company PSUs or the payment of cash in respect of the settlement of Company Phantom Awards or Company Cash Awards, in each case, outstanding as of the date hereof (or issued as permitted by this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.1</u>) and as required in accordance with their terms or (ii)&nbsp;as may be required pursuant to the Company Credit Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="58" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">58</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;sell, pledge, dispose of, transfer, lease, license, guarantee or encumber any property or assets of the Company or any of its Subsidiaries (excluding Company Owned Intellectual Property which instead is the subject of <u>Section </u><u>&#8206;</u><u>5.1(d)</u> below), including, without limitation, the Company Real Property, in each case with value in excess of $5,000,000, except pursuant to existing Contracts, the sale or purchase of goods in the ordinary course of business consistent with past practice and Permitted Liens;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;sell, assign, pledge or otherwise encumber, transfer, license, abandon, permit to enter the public domain, permit to lapse or otherwise dispose of any material Company Owned Intellectual Property, except for (i)&nbsp;non-exclusive licenses granted in the ordinary course of business consistent with past practice and (ii)&nbsp;disclosure of non-public material Company Owned Intellectual Property or Trade Secrets to any Person, other than (A)&nbsp;to the Company or any of its Subsidiaries or (B)&nbsp;pursuant to a valid and binding confidentiality agreement or other binding obligation of confidentiality that the Company or a Subsidiary entered into in the ordinary course of business;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;declare, set aside, make or pay any dividend or other distribution (whether payable in cash, shares, property or a combination thereof) with respect to any of its capital stock or other Equity Interests (other than (i)&nbsp;Permitted Dividends consistent with past practice and the terms and conditions of <u>Section </u><u>&#8206;</u><u>5.17</u> and (ii)&nbsp;dividends paid by any direct or indirect wholly owned Subsidiary of the Company to the Company or to any other direct or indirect wholly owned Subsidiary of the Company that are made in compliance with the Company Credit Agreement and the other contractual obligations of the Company and its Subsidiaries) or enter into any agreement with respect to the voting or registration of its capital stock or other Equity Interests;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;reclassify, combine, split, subdivide or amend the terms of, or redeem, purchase or otherwise acquire, directly or indirectly, any of the capital stock or other Equity Interests of the Company or any material Subsidiary of the Company or to satisfy any withholding obligations;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;merge or consolidate the Company or any of its Subsidiaries with any Person or adopt a plan of complete or partial liquidation or resolutions providing for a complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization of the Company or any of its Subsidiaries, except with respect to internal reorganizations solely among Subsidiaries of the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;acquire (including by merger, consolidation, or acquisition of shares or assets) any interest in any Person or any assets thereof in each case with value in excess of $5,000,000, other than the purchase of goods, equipment and other operating assets in the ordinary course of business consistent with past practice;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="59" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">59</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;other than in accordance with <u>Section </u><u>&#8206;</u><u>5.16</u>, incur any indebtedness for borrowed money or guarantee any such indebtedness of another Person, or issue or sell any debt securities or warrants or other rights to acquire any of its debt securities or the debt securities of any of its Subsidiaries, except for (A) indebtedness for borrowed money incurred in the ordinary course of business pursuant to the revolving, swingline or letter of credit facilities of the Company Credit Agreement so long as the aggregate amount of indebtedness outstanding thereunder does not exceed $350,000,000, (B) guarantees by the Company or any wholly owned Subsidiary of the Company of indebtedness for borrowed money of the Company or any other wholly owned Subsidiary of the Company, and (C) interest and commodity swaps, futures, forward contracts and similar derivatives (1) not entered for speculative purposes and (2) entered into on customary commercial terms in the ordinary course of business and in compliance with its risk management and hedging policies in effect on the date of this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;make any loans, advances or capital contributions to, or investments in, any other Person (other than trade credit and similar loans and routine travel and business expense advances made to directors or employees in the ordinary course of business or any wholly owned Subsidiary of the Company);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;other than in accordance with <u>Section </u><u>&#8206;</u><u>5.16</u>, terminate, cancel, renew, or request or agree to any material change in or waiver under any Company Material Contract, or enter into or amend any Contract that, if existing on the date hereof, would be a Company Material Contract, in each case other than in the ordinary course of business consistent with past practice;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;except to the extent required by applicable Law or the existing terms of any Company Benefit Plan set forth on <u>Section </u><u>&#8206;</u><u>3.11(a)</u> of the Company Disclosure Schedule as in effect on the date of this Agreement, (A)&nbsp;grant or announce any increase in the compensation or benefits payable or to become payable to any current or former director, officer, employee or other service provider of the Company or any of its Subsidiaries; (B)&nbsp;grant any new or additional rights to severance or termination pay or transaction or retention bonus payments to, or enter into any severance agreement with, any current or former director, officer, employee or other service provider of the Company or any of its Subsidiaries; (C)&nbsp;establish, adopt, enter (or commit to enter) into, amend, terminate or extend (or enter into negotiations to do any of the foregoing) (x)&nbsp;any collective bargaining agreement or other Contract with any Union or (y)&nbsp;any Company Benefit Plan or other plan, agreement, trust, fund, policy or arrangement that would be a Company Benefit Plan if it were in existence on the date hereof (other than any such changes associated with annual renewals of Company Benefit Plans that are health and welfare plans in the ordinary course of business consistent with past practice that do not materially increase the costs to the Company or any of its Subsidiaries under such plans) or grant, amend or terminate any awards thereunder; (D)&nbsp;take any action to amend or waive any performance or vesting criteria or accelerate vesting, exercisability or funding of any compensation or benefit under any Company Benefit Plan; (E)&nbsp;fund any payments or benefits that are payable or to be provided under any Company Benefit Plan (other than ordinary course contributions, accruals and/or payments made in accordance with the terms of such Company Benefit Plans); (F)&nbsp;terminate without &#8220;cause&#8221; (as determined consistent with past practice) or change the title of any director, officer, employee or other service provider of the Company or any of its Subsidiaries or hire, promote or engage any director, officer, employee or any service provider of the Company or any of its Subsidiaries, in each case, other than terminations, changes in title, new hires, promotions or engagements of individuals in the ordinary course of business consistent with past practices at or below the level of Vice President; (G)&nbsp;make or forgive any loan to any current or former director, officer, employee or other service provider of the Company or its Subsidiaries (other than advancement of expenses in the ordinary course of business consistent with past practices); (H)&nbsp;recognize or certify any labor union, works council, bargaining representative, or any other similar organization as the bargaining representative for any employees of the Company or its Subsidiaries; (I)&nbsp;implement or announce any employee layoffs, furloughs, reductions in force, reductions in compensation, hour or benefits, work schedule changes or similar actions that could implicate the Worker Adjustment and Retraining Notification Act of 1988 or any similar state Law; (J)&nbsp;waive or release any noncompetition, nonsolicitation, nondisclosure, noninterference, nondisparagement, or other restrictive covenant obligation of any current or former director, officer, employee or any service provider of the Company or its Subsidiaries; and (K)&nbsp;enter into, commit to enter into or otherwise provide for any agreement or arrangement providing for a Tax gross-up or other payment from the Company or its Subsidiaries as a result of the imposition of the excise Taxes required by Section 4999 of the Code;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="60" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">60</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;make any material change in accounting policies, practices, principles, methods or procedures, other than as required by GAAP or by a Governmental Entity;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;compromise, settle or agree to settle any Proceeding other than compromises, settlements or agreements that (i)&nbsp;involve only the payment of monetary damages by the Company or its Subsidiaries not in excess of $500,000 individually or $2,000,000 in the aggregate, and (ii)&nbsp;does not impose material restrictions on the future activities or conduct of, or the admission of a violation of Law by, the Company or any of its Subsidiaries; <u>provided</u>, that any Proceeding described in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.12</u> shall be compromised, settled or agreed in accordance with <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.12</u>;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;other than consistent with past practice, (i)&nbsp;make (other than in the ordinary course of business), change or revoke any material Tax election, (ii)&nbsp;change or adopt any Tax accounting period or material method of Tax accounting, (iii)&nbsp;amend or refile any material Tax Return, (iv)&nbsp;file any material Tax Return prepared in a manner materially inconsistent with past practice, (v)&nbsp;request any written ruling from any Governmental Entity relating to material Taxes, (vi)&nbsp;settle or compromise any material liability for Taxes or any audit or other proceeding relating to a material amount of Taxes, (vii)&nbsp;other than in the ordinary course of business, agree to an extension or waiver of the statute of limitations with respect to a material amount of Taxes or (viii)&nbsp;enter into any &#8220;closing agreement&#8221; within the meaning of Section 7121 of the Code (or any comparable, analogous or similar provision of U.S. state or local, or non-U.S. Law), in each case, if such action would, individually or in the aggregate with other actions described in this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.1(o)</u> and taken after the date hereof, reasonably be expected to result in a material increase in the Tax liability of the Company and its Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(p)&nbsp;&nbsp;&nbsp;&nbsp;take any action or knowingly fail to take any action, which action or failure to act would reasonably be expected to prevent or impede the Merger from qualifying for the Intended Tax Treatment; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="61" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">61</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(q)&nbsp;&nbsp;&nbsp;&nbsp;authorize or enter into any Contract to do any of the foregoing or otherwise make any commitment to do any of the foregoing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Conduct of Business by Parent and its Subsidiaries Pending the Effective Time</u>. Parent agrees that, between the date of this Agreement and the earlier of the Effective Time or the valid termination of this Agreement in accordance with <u>Article</u><u>&nbsp;</u><u>7</u>, except as set forth in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.2</u> of the Parent Disclosure Schedule, as required by Law or as otherwise expressly required or contemplated by this Agreement, unless the Company shall otherwise consent in writing (including via email specifically referencing this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.2</u>) (such consent not to be unreasonably withheld, conditioned or delayed), Parent shall, and shall cause each of its Subsidiaries to, (x)&nbsp;use its commercially reasonable efforts to conduct its operations in the ordinary course of business consistent with past practice in all material respects and (y)&nbsp;use its commercially reasonable efforts to preserve intact its business organization and comply with all applicable Laws in all material respects. Without limiting the foregoing, except as set forth in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.2</u> of the Parent Disclosure Schedule, as required by applicable Law or as otherwise expressly required by this Agreement, Parent shall not, and shall not permit any of its Subsidiaries to, between the date of this Agreement and the Effective Time, directly or indirectly, take any of the following actions without the prior written consent (including via email specifically referencing this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.2</u>) of the Company (such consent not to be unreasonably withheld, conditioned or delayed):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;amend the Parent Charter or Parent Bylaws or the organizational documents of any &#8220;significant&#8221; Subsidiary of Parent (as defined in Rule 1-02(w) of Regulation S&#8209;X) (other than ministerial changes or such amendments as may be necessary to effect the Transactions) or adopt any stockholder rights plan, &#8220;poison pill&#8221; antitakeover plan or similar device, in each case, to the extent that it would apply to the Transactions;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;issue, sell, pledge, dispose of, grant, transfer or encumber, or authorize the issuance, sale, pledge, disposition, grant, transfer, or encumbrance of, any shares of capital stock of, or other Equity Interests in, Parent or any of its Subsidiaries, or securities convertible into, or exchangeable or exercisable for, any shares of such capital stock or other Equity Interests, or any options, warrants or other rights of any kind to acquire any shares of such capital stock or other Equity Interests or such convertible or exchangeable securities, or any other ownership interest (including any such interest represented by Contract right), or any &#8220;phantom&#8221; stock, &#8220;phantom&#8221; stock rights, stock appreciation rights or stock based performance rights, of Parent or any of its Subsidiaries, other than (i)&nbsp;the issuance of Parent Common Stock or other Equity Interests in connection with the exercise of Parent Stock Options or settlement or distribution of Parent PSUs or Parent RSUs (including issuances of dividend equivalents in connection therewith), in each case, outstanding as of the date hereof (or issued as permitted hereunder) and as required in accordance with their terms, (ii)&nbsp;in the ordinary course consistent with past practice, the grant of equity awards to Parent&#8217;s employees, directors or service providers (including newly hired, newly engaged, or newly promoted employees, directors or service providers or in accordance with Parent&#8217;s equity award grant practices), pursuant to the terms of the Parent Stock Plan and an applicable award agreement, and (iii)&nbsp;as may be required pursuant to any credit agreements of Parent or its Subsidiaries;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="62" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">62</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;other than in accordance with <u>Section </u><u>&#8206;</u><u>5.16</u>, sell, pledge, dispose of, transfer, lease, license, guarantee or encumber any property or assets of Parent or any of its Subsidiaries (excluding Parent Owned Intellectual Property which instead is the subject of <u>Section </u><u>&#8206;</u><u>5.1(d)</u> below), including, without limitation, the Parent Real Property, in each case with value in excess of $15,000,000, except pursuant to existing Contracts, the sale or purchase of goods in the ordinary course of business consistent with past practice and Permitted Liens;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;sell, assign, pledge or otherwise encumber, transfer, license, abandon, permit to enter the public domain, permit to lapse or otherwise dispose of any material Parent Owned Intellectual Property, except for (i)&nbsp;non-exclusive licenses granted in the ordinary course of business consistent with past practice and (ii)&nbsp;disclosure of non-public material Parent Owned Intellectual Property or Trade Secrets to any Person, other than (A)&nbsp;to Parent or any of its Subsidiaries or (B)&nbsp;pursuant to a valid and binding confidentiality agreement or other binding obligation of confidentiality that Parent or a Subsidiary entered into in the ordinary course of business;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;declare, set aside, make or pay any dividend or other distribution (whether payable in cash, shares, property or a combination thereof) with respect to any of its capital stock or other Equity Interests (other than (i)&nbsp;Permitted Dividends consistent with past practice and the terms and conditions of <u>Section </u><u>&#8206;</u><u>5.17</u> and (ii)&nbsp;dividends paid by any direct or indirect wholly owned Subsidiary of Parent to Parent or to any other direct or indirect wholly owned Subsidiary of Parent that are made in compliance with any credit agreement of Parent or its Subsidiaries and the other contractual obligations of Parent and its Subsidiaries) or enter into any agreement with respect to the voting or registration of its capital stock or other Equity Interests;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;reclassify, combine, split, subdivide or amend the terms of, or redeem, purchase or otherwise acquire, directly or indirectly, any of the capital stock or other Equity Interests of Parent or any material Subsidiary of Parent or to satisfy any withholding obligations or the payment of option exercise prices in connection with awards made pursuant to the Parent Stock Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;merge or consolidate Parent or any of its Subsidiaries with any Person or adopt a plan of complete or partial liquidation or resolutions providing for a complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization of Parent or any of its Subsidiaries, except with respect to internal reorganizations solely among Subsidiaries of Parent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;acquire (including by merger, consolidation, or acquisition of shares or assets) any interest in any Person or any assets thereof in each case with value in excess of $15,000,000, other than the purchase of goods, equipment and other operating assets in the ordinary course of business consistent with past practice;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;other than in accordance with <u>Section </u><u>&#8206;</u><u>5.16</u>, incur any indebtedness for borrowed money or guarantee any such indebtedness of another Person, or issue or sell any debt securities or warrants or other rights to acquire any of its debt securities or the debt securities of any of its Subsidiaries, except for (A)&nbsp;indebtedness for borrowed money incurred in the ordinary course of business pursuant to the revolving, swingline or letter of credit facilities of any credit agreement of Parent or its Subsidiaries in an aggregate amount not to exceed $700,000,000, (B)&nbsp;guarantees by Parent or any wholly owned Subsidiary of Parent of indebtedness for borrowed money of Parent or any other wholly owned Subsidiary of Parent, and (C)&nbsp;interest and commodity swaps, futures, forward contracts and similar derivatives (1)&nbsp;not entered for speculative purposes and (2)&nbsp;entered into on customary commercial terms in the ordinary course of business and in compliance with its risk management and hedging policies in effect on the date of this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="63" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">63</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;make any loans, advances or capital contributions to, or investments in, any other Person (other than trade credit and similar loans and routine travel and business expense advances made to directors or employees in the ordinary course of business or any wholly owned Subsidiary of Parent);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;other than in accordance with <u>Section </u><u>&#8206;</u><u>5.16</u>, terminate, cancel, renew, or request or agree to any material change in or waiver under any Parent Material Contract, or enter into or amend any Contract that, if existing on the date hereof, would be a Parent Material Contract, in each case other than in the ordinary course of business consistent with past practice;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;make any material change in accounting policies, practices, principles, methods or procedures, other than as required by GAAP or by a Governmental Entity;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;compromise, settle or agree to settle any Proceeding other than compromises, settlements or agreements that (i)&nbsp;involve only the payment of monetary damages by Parent or its Subsidiaries not in excess of $1,000,000 individually or $5,000,000 in the aggregate, and (ii)&nbsp;does not impose material restrictions on the future activities or conduct of, or the admission of a violation of Law by, Parent or any of its Subsidiaries; <u>provided</u>, that any Proceeding described in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.12</u> shall be compromised, settled or agreed in accordance with <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.12</u>;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;other than consistent with past practice, (i)&nbsp;make (other than in the ordinary course of business), change or revoke any material Tax election, (ii)&nbsp;change or adopt any Tax accounting period or material method of Tax accounting, (iii)&nbsp;amend or refile any material Tax Return, (iv)&nbsp;file any material Tax Return prepared in a manner materially inconsistent with past practice, (v)&nbsp;request any written ruling from any Governmental Entity relating to material Taxes, (vi)&nbsp;settle or compromise any material liability for Taxes or any audit or other proceeding relating to a material amount of Taxes, (vii)&nbsp;other than in the ordinary course of business, agree to an extension or waiver of the statute of limitations with respect to a material amount of Taxes or (viii)&nbsp;enter into any &#8220;closing agreement&#8221; within the meaning of Section 7121 of the Code (or any comparable, analogous or similar provision of U.S. state or local, or non-U.S. Law), in each case, if such action would, individually or in the aggregate with other actions described in this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.2(n) </u>and taken after the date hereof, reasonably be expected to result in a material increase in the Tax liability of Parent and its Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;take any action or knowingly fail to take any action, which action or failure to act would reasonably be expected to prevent or impede the Merger from qualifying for the Intended Tax Treatment; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(p)&nbsp;&nbsp;&nbsp;&nbsp;authorize or enter into any Contract to do any of the foregoing or otherwise make any commitment to do any of the foregoing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="64" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">64</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Preparation of the Joint Proxy Statement and Form S-4; Stockholder and Shareholder Meetings.</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;As promptly as practicable after the execution of this Agreement (i)&nbsp;Parent and the Company shall jointly prepare and cause to be filed with the SEC, the Joint Proxy Statement to be sent to the stockholders of Parent and the shareholders of the Company, as applicable, and (ii)&nbsp;Parent and the Company shall jointly prepare and Parent shall file with the SEC the Form S-4, in which the Joint Proxy Statement will be included as a prospectus, in connection with the registration under the Securities Act of the shares of Parent Common Stock to be issued in the Merger. Each of Parent and the Company shall use its reasonable best efforts to have the Form S-4 declared effective as promptly as practicable after such filing (including by responding to comments of the SEC) and Parent shall use reasonable best efforts to keep the Form S-4 effective as long as is necessary to consummate the Merger. Each of Parent and the Company shall furnish all information as may be reasonably requested by the other Party in connection with any such action and the preparation, filing and distribution of the Form S-4 and the Joint Proxy Statement. As promptly as practicable after the Form S-4 shall have become effective, each of Parent and the Company shall use its reasonable best efforts to cause the Joint Proxy Statement to be sent to its respective stockholders and shareholders. Parent and the Company shall jointly prepare any response to requests or comments from the SEC and each of Parent and the Company agrees to permit the other and their respective counsels to participate in all substantive meetings and conferences with the SEC. No filing of, or amendment or supplement to, the Form S-4 will be made by Parent, and no filing of, or amendment or supplement to, the Joint Proxy Statement will be made by Parent or the Company, in each case, without providing the other Party with a reasonable opportunity to review and comment thereon and receiving the approval of the other Party (e-mail being sufficient) (such approval shall not be unreasonably withheld, conditioned or delayed); <u>provided</u>, <u>however</u>, that in the event of a Company Adverse Recommendation Change in the case of the Company or a Parent Adverse Recommendation Change in the case of Parent, in each case, that is expressly permitted to be made pursuant to <u>Section </u><u>&#8206;</u><u>5.4</u>, such Party may communicate the Company Adverse Recommendation Change or the Parent Adverse Recommendation Change, as applicable, and such Party&#8217;s basis for its lack of a recommendation to its stockholders or shareholders, as applicable, in the Joint Proxy Statement or an appropriate amendment or supplement thereto without the consent or approval of the other Party. If at any time prior to the Effective Time any information relating to Parent or the Company, or any of their respective affiliates, directors or officers, should be discovered by Parent or the Company which should be set forth in an amendment or supplement to either the Form S-4 or the Joint Proxy Statement, so that either such document would not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, the Party that discovers such information shall promptly notify the other Party and an appropriate amendment or supplement describing such information shall be promptly filed with the SEC and, to the extent required by Law, disseminated to the stockholders of Parent and the shareholders of the Company. Parent shall notify the Company promptly of the time when the Form S-4 has become effective, and of the issuance of any stop order or suspension of the qualification of the shares of Parent Common Stock issuable in connection with the Merger for offering or sale in any jurisdiction. In addition, each Party agrees to provide the other Party and its legal counsel with copies of any written comments, and shall inform the other Party of any oral comments, that such Party or its counsel may receive from time to time from the SEC or its staff with respect to the Form S-4 or the Joint Proxy Statement promptly after receipt of such comments, and any written or oral responses thereto. Each Party and their respective counsel shall be given a reasonable opportunity to review any such written responses and each Party shall give due consideration to the additions, deletions or changes suggested thereto by the other Party and their respective counsel. Neither Party shall submit any such written responses without receiving the approval of the other Party (e-mail being sufficient) (such approval shall not be unreasonably withheld, conditioned or delayed).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Company Shareholders Meeting.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 54pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall, promptly following the date on which the Form&nbsp;S-4 has been filed with the SEC and the Parties otherwise mutually determine to be appropriate, establish a record date for, and, as soon as practicable following the effectiveness of the Form S-4, duly call and give notice of and convene and hold a meeting of its shareholders (the &#8220;<u>Company Shareholders Meeting</u>&#8221;), in accordance with applicable Law and the Company Charter and Company Code of Regulations, for the purpose of seeking the Company Shareholder Approval and other ancillary matters with respect thereto. The Company shall not, without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed), adjourn, postpone or otherwise delay the Company Shareholders Meeting; <u>provided</u>, <u>however</u>, that the Company may postpone or adjourn the Company Shareholders Meeting (A)&nbsp;if a quorum has not been established, (B)&nbsp;to allow reasonable additional time for the filing and dissemination of any supplemental or amended disclosure which the Company Board has determined in good faith after consultation with outside counsel is necessary under applicable Law and for such supplemental or amended disclosure to be disseminated and reviewed by the Company&#8217;s shareholders prior to the Company Shareholders Meeting, (C)&nbsp;to allow reasonable additional time to solicit additional proxies, if and to the extent the requisite Company Shareholder Approval would not otherwise be obtained, or (D)&nbsp;if required by applicable Law; <u>provided</u>, <u>however</u>, that in each case the Company Shareholders Meeting shall not be postponed or adjourned for more than ten Business Days in the aggregate from the originally scheduled date of the Company Shareholders Meeting without the prior written consent of Parent. The Company shall, upon the reasonable request of Parent, advise Parent with reasonable frequency prior to the date of the Company Shareholders Meeting as to the aggregate tally of proxies received by the Company with respect to the Company Shareholder Approval.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 54pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 54pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall, through the Company Board, unless the Company Board has made a Company Adverse Recommendation Change in compliance with <u>Section </u><u>&#8206;</u><u>5.4</u>, (A)&nbsp;make the Company Board Recommendation and include such Company Board Recommendation in the Joint Proxy Statement, (B)&nbsp;use its reasonable best efforts to solicit from its shareholders proxies in favor of the adoption of this Agreement and the Transactions, including the Merger, (C)&nbsp;use its reasonable best efforts to take all other action necessary or advisable to secure the Company Shareholder Approval and (D)&nbsp;otherwise comply in all material respects with applicable Law with respect to the Company Shareholders Meeting.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 54pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="65" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">65</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 54pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly permitted in <u>Section </u><u>&#8206;</u><u>5.4</u>, neither the Company Board nor any committee thereof shall (A)&nbsp;withhold, withdraw, amend, modify or qualify, or propose publicly to withhold, withdraw, modify or qualify, in a manner adverse to Parent, the Company Board Recommendation, (B)&nbsp;fail to include the Company Board Recommendation in the Joint Proxy Statement, (C)&nbsp;approve, adopt, or recommend, or announce publicly an intent to approve, determine to be advisable, or recommend, any Competing Proposal, or (D)&nbsp;if requested by Parent, fail to issue, within ten Business Days after a Competing Proposal is publicly announced (and in no event later than one Business Day prior to the date of the Company Shareholders Meeting, as it may be postponed or adjourned pursuant to this Agreement), a press release reaffirming the Company Board Recommendation which request may not be made more than two times in respect of any specific Competing Proposal (the actions specified in the foregoing <u>clauses (A)</u> through <u>(D)</u>&nbsp;being referred to as a &#8220;<u>Company Adverse Recommendation Change</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Parent Stockholders Meeting.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 54pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall, promptly following the date on which the Form&nbsp;S-4 has been filed with the SEC and the Parties otherwise mutually determine to be appropriate, establish a record date for, and, as soon as practicable following the effectiveness of the Form S-4, duly call and give notice of and convene and hold a meeting of its stockholders (the &#8220;<u>Parent Stockholders Meeting</u>&#8221;), in accordance with applicable Law and the Parent Charter and Parent Bylaws, for the purpose of seeking the Parent Stockholder Approval. At such Parent Stockholders Meeting, Parent may seek approval for other ancillary matters, including certain changes to the Parent Charter and Parent Bylaws in respect of officer exculpation. Parent shall not, without the prior written consent of the Company (such consent not to be unreasonably withheld, conditioned or delayed), adjourn, postpone or otherwise delay the Parent Stockholders Meeting; <u>provided</u>, <u>however</u>, that Parent may postpone or adjourn the Parent Stockholders Meeting (A)&nbsp;if a quorum has not been established, (B)&nbsp;to allow reasonable additional time for the filing and dissemination of any supplemental or amended disclosure which the Parent Board has determined in good faith after consultation with outside counsel is necessary under applicable Law and for such supplemental or amended disclosure to be disseminated and reviewed by Parent&#8217;s stockholders prior to the Parent Stockholders Meeting, (C)&nbsp;to allow reasonable additional time to solicit additional proxies, if and to the extent the requisite Parent Stockholder Approval would not otherwise be obtained, or (D)&nbsp;if required by applicable Law; <u>provided</u>, <u>however</u>, that, in each case the Parent Stockholders Meeting shall not be postponed or adjourned for more than ten Business Days in the aggregate from the originally scheduled date of the Parent Stockholders Meeting without the prior written consent of the Company. Parent shall, upon the reasonable request of the Company, advise the Company with reasonable frequency prior to the date of the Parent Stockholders Meeting as to the aggregate tally of proxies received by Parent with respect to the Parent Stockholder Approval.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="66" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">66</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 54pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall, through the Parent Board, unless the Parent Board has made a Parent Adverse Recommendation Change in compliance with <u>Section </u><u>&#8206;</u><u>5.4</u>, (A)&nbsp;make the Parent Board Recommendation and include such Parent Board Recommendation in the Joint Proxy Statement, (B)&nbsp;use its reasonable best efforts to solicit from its stockholders proxies in favor of the Parent Common Stock Issuance, (C)&nbsp;use its reasonable best efforts to take all other action necessary or advisable to secure the Parent Stockholder Approval and (D)&nbsp;otherwise comply in all material respects with applicable Law with respect to the Parent Stockholders Meeting.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 54pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly permitted in <u>Section 5.4</u>, neither the Parent Board nor any committee thereof shall (A)&nbsp;withhold, withdraw, amend, modify or qualify, or propose publicly to withhold, withdraw, modify or qualify, in a manner adverse to the Company, the Parent Board Recommendation, (B)&nbsp;fail to include the Parent Board Recommendation in the Joint Proxy Statement, (C)&nbsp;approve, adopt, or recommend, or announce publicly an intent to approve, determine to be advisable, or recommend, any Competing Proposal, or (D)&nbsp;if requested by the Company, fail to issue, within ten Business Days after a Competing Proposal is publicly announced (and in no event later than one Business Day prior to the date of the Parent Stockholders Meeting, as it may be postponed or adjourned pursuant to this Agreement), a press release reaffirming the Parent Board Recommendation which request may not be made more than two times in respect of any Competing Proposal (the actions specified in the foregoing <u>clauses (A)</u>&nbsp;through <u>(D)</u>&nbsp;being referred to as a &#8220;<u>Parent Adverse Recommendation Change</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company and Parent shall use their respective reasonable best efforts to set the record dates for, and to hold the Company Shareholders Meeting and the Parent Stockholders Meeting on the same date and at the same time; <u>provided</u>, that, in furtherance of the foregoing, in the event that either the Company shall have postponed or adjourned the Company Shareholders Meeting in accordance with <u>Section </u><u>&#8206;</u><u>5.3(b)(i)</u> or Parent shall have postponed or adjourned the Parent Stockholders Meeting in accordance with <u>Section </u><u>&#8206;</u><u>5.3(c)(i)</u>, the other Party shall be entitled to delay its meeting for the same number of days or otherwise until the same date as such adjourned or postponed meeting.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Merger Sub Consent</u>. Promptly following the execution of this Agreement (but no later than 24 hours following the execution of this Agreement), Parent shall execute and deliver, in accordance with Section 1701 of the OGCL, a written consent adopting this Agreement in its capacity as the sole shareholder of Merger Sub and shall promptly deliver a copy of such written consent to the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="67" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">67</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.4&nbsp;&nbsp;&nbsp;&nbsp;<u>No Solicitation of Transactions</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly provided in this <u>Section </u><u>&#8206;</u><u>5.4</u>, each of Parent and the Company shall immediately cease, and each shall cause its respective Subsidiaries to, and direct their Representatives to, immediately cease, any discussions or negotiations with any Person that may be ongoing with respect to a Competing Proposal, or any proposal that would reasonably be expected to lead to a Competing Proposal, and shall immediately request (and in any case within two Business Days following the execution of this Agreement) to have promptly returned or destroyed to Parent or the Company, as applicable, any confidential information that has been provided in any such discussions or negotiations. From the date hereof until the earlier of the Effective Time or the date of valid termination of this Agreement in accordance with <u>Article</u><u>&nbsp;</u><u>&#8206;</u><u>7</u>, each of Parent and the Company shall not, and shall cause its respective Subsidiaries not to, and direct and use reasonable best efforts to cause its respective Representatives not to, directly or indirectly, (i)&nbsp;solicit, initiate, endorse, or knowingly encourage or induce (including by way of furnishing information), or take any other action intentionally designed to facilitate, any inquiries regarding the making of any proposal which constitutes, or could reasonably be expected to lead to, any Competing Proposal, or (ii)&nbsp;participate in or engage in any discussions or negotiations with any Person regarding any Competing Proposal; <u>provided</u>, <u>however</u>, that if, prior to obtaining the Parent Stockholder Approval (in the case of Parent) or the Company Shareholder Approval (in the case of the Company) and following the receipt of a bona fide written Competing Proposal made after the date hereof that the Parent Board or the Company Board, as applicable, determines in good faith (after consulting with its financial advisor as to financial matters and with its outside legal counsel) is or would reasonably be expected to lead to a Superior Proposal and that did not result from a breach of this <u>Section </u><u>&#8206;</u><u>5.4</u>, the Parent Board or the Company Board, as applicable, determines in good faith, after consultation with outside legal counsel, that a failure to take action with respect to such Competing Proposal would reasonably be expected to be inconsistent with such directors&#8217; fiduciary duties under applicable Law, Parent or the Company, as applicable, may, in response to such Competing Proposal, and subject to compliance with <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4(c)</u>, (A)&nbsp;furnish information with respect to Parent or the Company, as applicable, to the Person making such Competing Proposal pursuant to an Acceptable Confidentiality Agreement, and (B)&nbsp;engage in discussions or negotiations with such Person regarding such Competing Proposal (so long as such Person has executed an Acceptable Confidentiality Agreement); <u>provided</u>, <u>however</u>, that any such information that is material and non-public or access has previously been made available to Parent or the Company, as applicable, or shall be made available to Parent or the Company, as applicable, prior to, or substantially concurrently with, the time such information is made available to such Person (subject to applicable Law). Except as expressly permitted by this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4</u>, each of Parent and the Company shall not, and shall cause its respective Subsidiaries not to, and direct its Representatives not to, from and after the date of this Agreement until the earlier of the Effective Time or the date, if any, on which this Agreement is validly terminated pursuant to <u>Article </u><u>&#8206;</u><u>7</u>, directly or indirectly (1)&nbsp;approve, endorse, recommend or enter into, or publicly propose to approve, endorse, recommend or enter into, any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or similar definitive agreement (other than an Acceptable Confidentiality Agreement) with respect to any Competing Proposal or any offer or proposal that could lead to a Competing Proposal; (2)&nbsp;take any action to make the provisions of any takeover statute inapplicable to any transactions contemplated by a Competing Proposal; or (3)&nbsp;terminate, amend, release, modify or fail to enforce any provision of, or grant any permission, waiver or request under, any standstill, confidentiality or similar agreement entered into by the applicable Party in respect of or in contemplation of a Competing Proposal (other than to the extent the Parent Board or the Company Board, as applicable, determines in good faith after consultation with its outside legal counsel, that failure to take any of such actions under clause (3)&nbsp;would reasonably be expected to be inconsistent with such directors&#8217; fiduciary duties under applicable Law), or (4)&nbsp;propose to do any of the foregoing. Notwithstanding the foregoing, each of Parent and the Company and each of their respective Subsidiaries and Representatives may in any event (x)&nbsp;seek to clarify and understand the terms and conditions of any proposal, offer, written inquiry or indication of interest from a third party solely to determine whether such proposal, offer, written inquiry or indication of interest constitutes or would reasonably be expected to lead to a Superior Proposal and (y)&nbsp;inform such third party that has made or, to the Knowledge of Parent or Knowledge of the Company, as applicable, is considering making a Competing Proposal of the provisions of this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="68" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">68</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision of this Agreement, but subject to compliance with this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4</u>, prior to receipt of the Parent Stockholder Approval, the Parent Board may, or, prior to receipt of the Company Shareholder Approval, the Company Board may, in each case in response to any Competing Proposal that was not a result of a breach of this <u>Section </u><u>&#8206;</u><u>5.4</u>, effect a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change, as applicable, or, in the case of the Company only, terminate this Agreement to enter into a definitive written agreement providing for the consummation of a Superior Proposal pursuant to <u>Section </u><u>&#8206;</u><u>&#8206;</u><u>7.1(c)(iii)</u> if and only if (i)&nbsp;the Parent Board or the Company Board, as applicable, concludes in good faith, after consultation with its outside financial advisors as to financial matters and outside legal counsel, that such Competing Proposal constitutes a Superior Proposal; (ii)&nbsp;the Parent Board or the Company Board, as applicable, provides the other Party five Business Days&#8217; prior written notice of its intention to take such action (a &#8220;<u>Competing Proposal Notice</u>&#8221;), which notice shall include the information with respect to such Competing Proposal that is specified in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4(c)</u>, as well as a copy of such Competing Proposal, it being agreed that neither the delivery of such notice by Parent or the Company, as applicable, nor any public announcement thereof that such Party determines it is required to make under applicable Law shall constitute a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change, as applicable, unless and until such Party shall have failed at or prior to the end of the period referred to in <u>clause (iii)</u>&nbsp;below (and, upon the occurrence of such failure, such notice and such public announcement shall constitute a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change, as applicable) to publicly announce that it (A)&nbsp;is recommending the Transactions and (B)&nbsp;has determined that such other Competing Proposal (taking into account (x)&nbsp;any modifications or adjustments made to the Transactions proposed or agreed to by the other Party in writing and (y)&nbsp;any modifications or adjustments made to such other Competing Proposal) is not a Superior Proposal and has publicly rejected such Competing Proposal; (iii)&nbsp;during the five Business Days following the Competing Proposal Notice (the &#8220;<u>Negotiation Period</u>&#8221;), if requested by the other Party, the board of directors effecting the recommendation change and its Representatives have negotiated in good faith with the other Party and its Representatives regarding any revisions to the terms of the Transactions proposed by the other Party in response to such Competing Proposal; and (iv)&nbsp;at the end of such five Business Day period, the Parent Board or the Company Board, as applicable, concludes in good faith, after consultation with its outside legal counsel and, as to financial matters, its outside financial advisors (and taking into account any adjustment or modification of the terms of this Agreement to which the other Party has irrevocably and in writing agreed to make to the terms of the Transactions), that the Competing Proposal continues to be a Superior Proposal and, after consultation with its outside legal counsel, that the failure to make a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change, as applicable, would be inconsistent with the directors&#8217; fiduciary duties to the stockholders of Parent or the stockholders of the Company, as applicable, under applicable Law. Any material amendment or modification to any Competing Proposal shall require a new Competing Proposal Notice and the Negotiation Period shall be extended by an additional two Business Days from the date of receipt of such new Competing Proposal Notice.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="69" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">69</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;In addition to the obligations of Parent and the Company set forth in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4(a)</u> and <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4(b)</u>, Parent or the Company shall promptly, and in any event no later than twenty-four (24) hours, after it receives (x)&nbsp;a Competing Proposal, (y)&nbsp;any request for non-public information relating to Parent or the Company or its respective Subsidiaries, other than requests unrelated to a Competing Proposal, or (z)&nbsp;any inquiry or request for discussions or negotiations regarding any potential Competing Proposal, notify the other Party orally and in writing of any of the foregoing occurrences, the identity of the Person making such request, inquiry or proposal and provide an unredacted copy of such request, inquiry or Competing Proposal (or where no such copy is available, a reasonably detailed description of such request, inquiry or Competing Proposal, including the identity of the Person making such request, inquiry or Competing Proposal) and any material modifications to such request, inquiry or Competing Proposal. Each Party shall keep the other Party reasonably informed (and in any event, at the other Party&#8217;s reasonable request) of the status of any request, inquiry or Competing Proposal (including the material terms and conditions thereof and of any material modification thereto), and any material developments, discussions and negotiations, including furnishing unredacted copies of any written material correspondence related to the terms and conditions of the Competing Proposal and draft documentation. Without limiting the foregoing, each Party shall promptly (and in any event within twenty-four (24) hours) notify the other Party orally and in writing if it determines to begin providing information or to engage in discussions or negotiations concerning a Competing Proposal pursuant to this <u>Section </u><u>&#8206;</u><u>5.4</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in this <u>Section </u><u>&#8206;</u><u>5.4</u> to the contrary, at any time prior to obtaining the Parent Stockholder Approval or the Company Shareholder Approval, the Parent Board or the Company Board, respectively, may make a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change, as applicable, if (i)&nbsp;such board of directors determines that an Intervening Event has occurred and (ii)&nbsp;such board of directors determines in good faith (after consultation with outside counsel) that the failure to make a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change, as applicable, in response to such Intervening Event would reasonably be expected to be inconsistent with such directors&#8217; fiduciary duties to the stockholders of Parent or the shareholders of the Company, as applicable, under applicable Law; <u>provided</u> that (x)&nbsp;the Parent Board or the Company Board has given the other Party at least five Business Days&#8217; prior written notice of its intention to take such action and specifying in reasonable detail the circumstances related to such determination and (y)&nbsp;prior to effecting a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change, the applicable Party has negotiated in good faith with the other Party and its Representatives during such notice period (to the extent such other Party wishes to negotiate) to enable such other Party to revise the terms of this Agreement, such that the failure to make a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change, as applicable, would reasonably be expected to be inconsistent with such directors&#8217; fiduciary duties to its stockholders under applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="70" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">70</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Nothing contained in this Agreement shall prohibit the Parent Board or the Company Board from taking and disclosing to its shareholders a position contemplated by Rule 14d-9 or Rule&nbsp;14e-2(a) promulgated under the Exchange Act regarding a Competing Proposal, or from issuing a &#8220;stop, look and listen&#8221; statement pending disclosure of its position thereunder; <u>provided</u>, <u>however</u>, that no such communication or statement that would constitute a Parent Adverse Recommendation Change or a Company Adverse Recommendation Change shall be permitted, made or taken except in accordance with <u>Section </u><u>&#8206;</u><u>5.4(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Any violation of the restrictions contained in this <u>Section </u><u>&#8206;</u><u>5.4</u> by any of the Subsidiaries of Parent or the Company, or any action taken by any Representatives of Parent or the Company or any of their respective Subsidiaries acting at Parent&#8217;s or the Company&#8217;s respective direction or on its respective behalf that would have constituted a breach of this <u>Section </u><u>&#8206;</u><u>5.4</u> if such action had been taken by Parent or the Company shall, in each case, be deemed to be a breach of this <u>Section </u><u>&#8206;</u><u>5.4</u> by Parent or the Company (as applicable).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 54pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&#8220;<u>Competing Proposal</u>&#8221; shall mean, other than the Transactions, any <i>bona fide</i> written proposal, offer, written inquiry or indication of interest from a third party relating to (A)&nbsp;a merger, reorganization, sale of assets, share exchange, consolidation, business combination, recapitalization, dissolution, liquidation, joint venture or similar transaction involving Parent or the Company or any of its respective Subsidiaries, as applicable; (B)&nbsp;the acquisition (whether by merger, consolidation, equity investment, joint venture, lease, or otherwise) by any Person (or group of Persons) of any business or assets of Parent or the Company and their respective Subsidiaries that generated 20% or more of the consolidated revenues, net income or assets of Parent or the Company and its respective Subsidiaries, as determined on a book-value or fair-market-value basis in good faith by the Parent Board or the Company Board, as applicable; (C)&nbsp;the purchase or acquisition, in any manner, directly or indirectly, by any Person (or group of Persons) of 20%&nbsp;or more of the issued and outstanding shares of Parent Common Stock or Company Common Stock or any other Equity Interests in Parent or the Company, (D)&nbsp;any purchase, acquisition, tender offer or exchange offer that, if consummated, would result in any Person (or group of Persons) beneficially owning 20%&nbsp;or more of the shares of Parent Common Stock or Company Common Stock or any other Equity Interests of Parent or the Company or any of its respective Subsidiaries, (E)&nbsp;any sale, lease, exchange, transfer, license (other than licenses in the ordinary course of business), acquisition or disposition of 20% or more of the consolidated assets of Parent or the Company or any of their respective Subsidiaries (measured by the fair market value thereof), or (F)&nbsp;any combination of the foregoing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="71" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">71</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 54pt; text-align: justify;">(ii)&nbsp; &nbsp;&nbsp;&#8220;<u>Intervening Event</u>&#8221; means any material event, development or change in circumstances that first occurs, arises or becomes known to Parent or the Company, as applicable, or its respective board of directors after the date of this Agreement that (A)&nbsp;was not known or reasonably foreseeable as of the date of this Agreement (or, if known or reasonably foreseeable, the magnitude or consequences of which were not known or reasonably foreseeable as of the date of this Agreement), (B)&nbsp;did not arise out of a material breach of this Agreement, and (C)&nbsp;does not relate to a Competing Proposal or a Superior Proposal or any inquiry or communications or matters related thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 54pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&#8220;<u>Superior Proposal</u>&#8221; means a Competing Proposal (except the references therein to &#8220;20%&#8221; shall be replaced by &#8220;50%&#8221;) made by a third party that did not otherwise result from a breach of this <u>Section </u><u>&#8206;</u><u>5.4</u> and which, in the good faith judgment of the Parent Board or the Company Board, as applicable, and after consultation with its outside financial advisors as to financial matters and outside legal counsel, taking into account the various legal, financial and regulatory aspects of the Competing Proposal, including the financing terms thereof, the conditionality, the timing and likelihood of the consummation of such Competing Proposal and the third party making such Competing Proposal in addition to such other factors as the Parent Board or the Company Board, as applicable, considers appropriate, (x) if consummated, would result in a transaction that is more favorable to the stockholders of Parent or the shareholders of the Company (in each case, in their capacities as such), as applicable, than the Merger and the other Transactions contemplated hereby (after giving effect to all adjustments or modifications to the terms thereof which may be agreed in writing to be made by the other Party (including pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4(b)</u>) and taking into account any applicable Parent Termination Fee or Company Termination Fee) and (y) if a cash transaction (in whole or in part), financing for which is then fully committed or reasonably determined to be available.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Access to Information; Confidentiality</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Upon reasonable notice, each of Parent and the Company shall (and shall cause their respective Subsidiaries and direct their Representatives to) afford to the other Party and its Representatives reasonable access during normal business hours upon reasonable advance notice, during the period prior to the Effective Time, to all its properties, books, Contracts and records and its officers, key employees and Representatives and, during such period, each of Parent and the Company shall (and shall cause its Subsidiaries and direct its Representatives to) furnish promptly to the other Party consistent with its obligations under applicable Law, all other information concerning its business, properties and personnel as the other Party may reasonably request, in each case, solely to the extent required for the consummation of the Transactions (including the Merger) and integration planning purposes; <u>provided</u>, <u>however</u>, none of Parent or the Company or any of their respective Subsidiaries or Representatives shall be required to provide access to or disclose information where such information or access would, in the reasonable judgment of such Party, (x)&nbsp;breach any agreement with any third party, (y)&nbsp;constitute a waiver of the attorney-client or other privilege held by such Party or (z)&nbsp;otherwise violate any applicable Law; <u>provided</u>, <u>further</u>, that none of Parent or the Company or any of their respective Subsidiaries or Representatives shall be allowed access for the purpose of conducting any Phase II environmental site assessment or other sampling or intrusive investigation with respect to their respective properties without the prior consent of the other Party; and, <u>provided</u>, <u>further</u>, that in no event shall either Parent or the Company be required pursuant to this <u>Section </u><u>&#8206;</u><u>5.5</u> or any other provision of this Agreement to provide the other Party or its Representatives any data or information in any format other than in the form that it then exists, or to otherwise manipulate or reconfigure any data or information regarding such Party and its Subsidiaries or any of its or their assets, financial performance or conditions or operations. In the event any of the restrictions in <u>clauses (x)</u> through <u>(z)</u> of the foregoing sentence shall apply, each Party shall advise the other Party of the subject matter of any such information that cannot be disclosed and the Parties shall use their reasonable best efforts to make appropriate alternate disclosure arrangements, including adopting additional specific procedures to protect the confidentiality of sensitive material and to ensure compliance with applicable Laws. Any such information provided pursuant to this <u>Section </u><u>&#8206;</u><u>5.5</u> shall be held in confidence to the extent required by, and in accordance with, the provisions of that certain Confidentiality Agreement, dated September 18, 2025, as such agreement may be amended from time to time in accordance with its terms (the &#8220;<u>Confidentiality Agreement</u>&#8221;), between Parent and the Company, which Confidentiality Agreement shall remain in full force and effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Parties hereby agree that no investigation by any of the Parties or their respective Representatives or information provided, made available or delivered pursuant to this Agreement shall affect the representations, warranties, covenants or agreements of any other Party set forth herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Appropriate Action</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company, Parent and Merger Sub shall use their reasonable best efforts to take or cause to be taken all appropriate action, and to do, or cause to be done, all things necessary, proper and advisable to consummate and make effective the Transactions, including using their reasonable best efforts to obtain, or cause to be obtained, all waivers, permits, consents, approvals, authorizations, qualifications and Orders of all Governmental Entities and parties to Contracts with the Company, Parent or any of their respective Subsidiaries that may be or become necessary for the performance of obligations pursuant to this Agreement and the consummation of the Transactions. The Parties shall cooperate and assist one another in good faith (i)&nbsp;in connection with all actions to be taken pursuant to this <u>Section </u><u>&#8206;</u><u>5.6(a)</u>, including the preparation and making of the filings referred to herein and, if requested, amending or furnishing additional information thereunder, and (ii)&nbsp;in seeking, as promptly as practicable, to obtain all such waivers, permits, consents, approvals, authorizations, qualifications and Orders. Upon the terms and subject to the conditions set forth in this Agreement, each Party agrees to make any filings required to be made pursuant to the HSR Act or other applicable antitrust Laws, foreign investment Laws, or foreign subsidies Laws with respect to the Transactions as promptly as practicable (and, in the case of the required Notification and Report Forms pursuant to the HSR Act, in any event, no later than 20&nbsp; Business Days after the date hereof) and to supply as promptly as practicable to the appropriate Governmental Entities any additional information and documentary material that may be requested by such Governmental Entities pursuant to the HSR Act or such other applicable antitrust Laws or foreign investment Laws. All such antitrust or foreign investment filings to be made shall be made in substantial compliance with the requirements of the HSR Act and such other applicable antitrust Laws, foreign investment Laws, or foreign subsidies Laws, as applicable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="72" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">72</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;In furtherance, and without limiting the generality of the foregoing, the Parties shall use their reasonable best efforts to cooperate with and assist each other in good faith to (i)&nbsp;provide or cause to be provided promptly to the other Party all necessary information and reasonable assistance as any Governmental Entity may from time to time require of such Party in connection with obtaining the relevant waivers, permits, consents, approvals, authorizations, qualifications, Orders or expiration of waiting periods in relation to such filings or in connection with any other review or investigation of the Transactions by a Governmental Entity pursuant to the HSR Act or other applicable antitrust Laws, foreign investment Laws or foreign subsidies Laws and (ii)&nbsp;provide or cause to be provided promptly all commercially reasonable assistance and cooperation to allow the other Party to prepare and submit any such filings or submissions required to be submitted under the HSR Act or other applicable antitrust Laws, foreign investment Laws, or foreign subsidies Laws, including providing to the other Party any information that the other Party may from time to time reasonably require for the purpose of any filing with, notification to, application with, or request for further information made by, any Governmental Entity in respect of any such filing. To the extent permitted by applicable Law, each Party shall (x)&nbsp;keep the other apprised of the content and status of any substantive communications with, and substantive communications from, any Governmental Entity with respect to the Transactions, including notifying the other Party promptly of any substantive communication it receives from any Governmental Entity relating to any review or investigation of the Transactions under the HSR Act or other applicable antitrust Laws, foreign investment Laws, or foreign subsidies Laws, and (y)&nbsp;provide advance notice of, and permit representatives of the other Party to be present and participate at, each substantive meeting or teleconference relating to any review or investigation of the Transactions under the HSR Act or other applicable antitrust Laws, foreign investment Laws or foreign subsidies Laws; <u>provided,</u> <u>further,</u> that each Party shall consult with the other Party in advance in connection with any argument, opinion or proposal to be made or submitted to any Governmental Entity in such meetings or teleconferences. To the extent permitted by applicable Law, the Parties shall, and shall use their reasonable best efforts to cause their respective Representatives to, provide each other with copies of all correspondence, filings or communications between them or any of their respective Representatives, on the one hand, and any Governmental Entity or members of its staff, on the other hand, with respect to this Agreement and the Transactions; <u>provided</u>, <u>however</u>, that materials may be redacted (1)&nbsp;as necessary to comply with any Contract or Laws; and (2)&nbsp;as necessary to address reasonable attorney-client or other privilege or confidentiality concerns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the penultimate sentence of this <u>Section </u><u>&#8206;</u><u>5.6(c)</u>, Parent and the Company shall, and shall cause each of their respective Subsidiaries to, use reasonable best efforts to take any and all steps necessary to obtain approval of the consummation of the Transactions by any Governmental Entity, including taking all steps necessary to avoid or eliminate each and every legal impediment under any applicable state, federal, foreign or supranational antitrust, competition, fair trade or similar Law that may be asserted by any Governmental Entity so as to enable the Parties to close the Transactions as promptly as practicable, and in any event prior to the Outside Date to obtain such approvals and to avoid the entry of, or to effect the dissolution of, any injunction, temporary restraining order or other Law in any suit or other action, arbitration, or litigation, which could otherwise have the effect of delaying beyond the Outside Date or preventing the consummation of any of the Transactions. Notwithstanding the foregoing or any other provision of this Agreement, neither Parent nor the Company nor any of their respective Subsidiaries shall be required to (or permitted to without the written consent of the other Party) agree to any sale, transfer, license, separate holding, divestiture or other disposition of, or to any prohibition of or any limitation on the acquisition, ownership, operation, effective control or exercise of full rights of ownership, or other modification of rights in respect of, any assets or businesses, or otherwise modify any business practice or contractual relationship (such consent to be granted or withheld in such other Party&#8217;s sole discretion) (each a &#8220;<u>Remedial Action</u>&#8221;) unless such Remedial Action, individually or in the aggregate with all Remedial Actions, would be immaterial to Parent and its Subsidiaries (including the Surviving Corporation), taken as a whole. In the event of any conflict between <u>subsections (a)</u>, <u>(b)</u> or <u>(c)</u> of this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.6</u>, the provisions of this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.6(c)</u> shall, with respect to the matters addressed in this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.6(c)</u>, supersede the provisions of <u>subsections (a)</u> and <u>(b)</u> of this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.6</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="73" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">73</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Parent and the Company shall not, and each of Parent and the Company shall cause their respective Subsidiaries to not, acquire or agree to acquire any other Person or business or any assets or properties of any other Person if such acquisition would reasonably be expected to materially impede or prevent the expiration or termination of the waiting period under the HSR Act, receipt of any approval or clearance under any other applicable antitrust Laws, foreign investment Laws, or foreign subsidies Laws, or the Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Notices</u>. Subject to applicable Law, each Party shall give prompt notice to the other Parties if any of the following occur after the date of this Agreement: (a)&nbsp;receipt of any notice or other communication in writing from any Person alleging that the consent or approval of such Person is or may be required in connection with the Transactions, but, with respect to Persons other than any Governmental Entity, only if the failure to obtain such consent or approval would or would reasonably be expected to&nbsp;materially impair or delay the consummation of the Transactions or be material to the Party receiving such notice or communication and its Subsidiaries, taken as a whole; (b)&nbsp;receipt of any notice or other communication from any Governmental Entity, the NYSE or NASDAQ (or any other securities market) in connection with the Transactions; or (c)&nbsp;such Party becoming aware of the occurrence of an event that would reasonably be expected to prevent or delay beyond the Initial Outside Date the consummation of the Transactions or that would reasonably be expected to result in any of the conditions to the Merger set forth in <u>Article </u><u>&#8206;</u><u>6</u> not being satisfied; <u>provided</u>, <u>however</u>, that the delivery of any notice pursuant to this <u>Section </u><u>&#8206;</u><u>5.7</u> shall not cure any breach of any representation, warranty, covenant or agreement contained in this Agreement or otherwise limit or affect the remedies available hereunder to the Party receiving such notice.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Public Announcements</u>. Each Party agrees that no public release or announcement concerning the Transactions shall be issued by any Party without the prior written consent of the other Party (which consent shall not be unreasonably withheld, conditioned or delayed), except to the extent such release or announcement is required by applicable Law or the rules or regulations of any applicable securities exchange or regulatory or governmental body to which the relevant Party is subject, in which case the Party required to make the release or announcement shall use its reasonable best efforts to allow each other Party reasonable time to comment on such release or announcement in advance of such issuance; <u>provided</u>, that each Party may make public statements or disclosures with respect to the Transactions that are substantially similar with prior releases, public disclosures or statements made by either Party in compliance with this <u>Section </u><u>&#8206;</u><u>5.8</u>. Notwithstanding the foregoing, the restrictions in this <u>Section </u><u>&#8206;</u><u>5.8</u> shall not apply to any public release or announcement (a)&nbsp;made or proposed to be made by Parent or the Company, as applicable, in connection with a Competing Proposal, a Superior Proposal, a Company Adverse Recommendation Change, a Parent Adverse Recommendation Change or an Intervening Event or any action taken pursuant thereto, in each case, that does not violate <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4</u> or (b)&nbsp;in connection with any disputes between the Parties regarding this Agreement or the Transactions. Parent and the Company agree that the press release announcing the execution and delivery of this Agreement shall be a joint release in the form heretofore agreed by the Parties.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="74" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">74</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Director and Officer Indemnification</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;From and after the Effective Time, Parent shall, and shall cause the Surviving Corporation to, and the Surviving Corporation shall, indemnify, defend and hold harmless, and shall advance expenses as incurred, to the fullest extent permitted under (i)&nbsp;applicable Law, (ii)&nbsp;the Company&#8217;s (or its Subsidiaries&#8217;) organizational documents in effect as of the date of this Agreement, and (iii)&nbsp;any Contract of the Company in effect as of the date of this Agreement, each person who is now, or has been at any time prior to the Effective Time (A)&nbsp;a director or officer of the Company or its Subsidiaries or (B)&nbsp;serving at the request of the Company as an officer or director of another corporation, joint venture or other enterprise or general partner of any partnership or a trustee of a trust, in each case, in which the Company or any of its Subsidiaries owns any Equity Interests, properties or assets (each person in <u>clauses (A)</u> and <u>(B)</u>, an &#8220;<u>Indemnitee</u>&#8221; and, collectively, the &#8220;<u>Indemnitees</u>&#8221;) against any costs or expenses (including reasonable attorneys&#8217; fees), judgments, settlements, fines, losses, claims, damages or liabilities incurred in connection with any Proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or pertaining to matters existing or occurring at or prior to the Effective Time, including in connection with this Agreement or the Transactions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent agrees that all rights to exculpation, indemnification or advancement of expenses arising from, relating to, or otherwise in respect of, acts or omissions occurring prior to the Effective Time (including in connection with this Agreement or the Transactions) now existing in favor of an Indemnitee as provided in the Company&#8217;s or its respective Subsidiaries&#8217; articles of incorporation, code of regulations or other organizational documents shall survive the Merger and shall continue in full force and effect in accordance with their terms. For a period of no less than six&nbsp;years from the Effective Time, Parent shall cause the Surviving Corporation and its Subsidiaries to, and the Surviving Corporation shall and shall cause its Subsidiaries to, maintain in effect the exculpation, indemnification and advancement of expenses provisions of the organizational documents of the Company or such Subsidiary, in effect as of the date of this Agreement, and shall not amend, repeal or otherwise modify any such provisions in any manner that would adversely affect the rights thereunder of any Indemnitee; <u>provided</u>, <u>however</u>, that all rights to exculpation, indemnification and expenses in respect of any Proceeding pending or asserted or any claim within such period shall continue until the final disposition of such Proceeding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="75" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">75</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;For six years from and after the Effective Time, Parent shall maintain for the benefit of the Indemnitees, director&#8217;s and officer&#8217;s insurance policies that provide coverage for events occurring prior to the Closing Date (the &#8220;<u>D&amp;O Insurance</u>&#8221;) that is substantially equivalent to and in any event not less favorable in the aggregate than the existing policies of the Company, or, if substantially equivalent insurance coverage is unavailable, the best available coverage; <u>provided</u>, <u>however</u>, that Parent shall not be required to pay an annual premium for the D&amp;O Insurance in excess of 300% of the last annual premium paid by the Company prior to the date of this Agreement (it being understood and agreed that, in the event that the requisite coverage is not available for an annual premium less than or equal to 300% of such last annual premium, Parent shall nevertheless be obligated to provide such coverage as may be obtained for 300% of such last annual premium). The provisions of the immediately preceding sentence shall be deemed to have been satisfied if prepaid &#8220;tail&#8221; policies have been obtained by the Company prior to the Effective Time, which policies provide such directors and officers with coverage for an aggregate period of six years with respect to claims arising from facts or events that occurred on or before the Effective Time, including in respect of the Transactions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;With respect to any indemnification obligations of Parent and the Surviving Corporation pursuant to this <u>&#8206;</u><u>&#8206;</u><u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.9</u>, Parent and the Surviving Corporation hereby acknowledge and agree that: (i)&nbsp;Parent and the Surviving Corporation shall be the indemnitors of first resort with respect to all indemnification obligations of Parent and the Surviving Corporation pursuant to this &#8206;&#8206;<u>&#8206;</u><u>&#8206;</u><u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.9</u> (i.e., their obligations to an applicable Indemnitee are primary, and any obligation of any other Person to advance expenses or to provide indemnification and/or insurance for the same expenses or liabilities incurred by such Indemnitee are secondary) and (ii)&nbsp;Parent and the Surviving Corporation irrevocably waive, relinquish and release any such other Person from any and all claims for contribution, subrogation or any other recovery of any kind in respect thereof; <u>provided</u> that nothing in this Agreement is intended to relieve, or shall be construed as relieving, any insurer of its obligations under any insurance policy.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;If either Parent or the Surviving Corporation or any of their respective successors or assigns (i)&nbsp;consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger, or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any Person or consummates any division transaction, then, and in each such case, to the extent necessary, proper provision shall be made so that the successors and assigns of Parent or the Surviving Corporation (as applicable) shall assume the obligations set forth in this &#8206;&#8206;<u>Section </u><u>&#8206;</u><u>5.9</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;The provisions of this &#8206;&#8206;<u>Section </u><u>&#8206;</u><u>5.9</u> shall survive the consummation of the Merger for a period of six years and are expressly intended to benefit each of the Indemnitees; <u>provided</u>, <u>however</u>, that in the event that any claim or claims for indemnification are asserted or made within such six-year period, all rights to indemnification in respect of any such claim or claims shall continue until disposition of any and all such claims.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="76" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">76</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Stock Exchange Listing</u>. Parent shall use its reasonable best efforts to cause the shares of Parent Common Stock to be issued in connection with the Merger (including shares of Parent Common Stock to be reserved upon exercise of Parent Stock Options) to be approved for listing on the NYSE, subject to official notice of issuance, prior to the Effective Time. Prior to the Closing, Parent shall submit a listing application with NYSE (the &#8220;<u>NYSE Listing Application</u>&#8221;) with respect to such shares of Parent Common Stock. Parent shall use its reasonable best efforts to have the NYSE Listing Application approved (subject to official notice of issuance) as promptly as practicable after such submission (including by responding to comments of NYSE). Each of Parent and the Company shall furnish all information as may be reasonably requested by the other Party in connection with any such action and the preparation and submission of the NYSE Listing Application. No submission of, or amendment or supplement to, the NYSE Listing Application will be made by any Party without providing the other Parties with a reasonable opportunity to review and comment thereon and Parent giving due consideration to the reasonable additions, deletions or changes suggested by the Company and its legal counsel. In addition, each Party agrees to provide the other Party and its legal counsel with copies of any written comments or requests, and shall inform the other Party of any oral comments or requests, that such Party or its counsel may receive from time to time from NYSE or its staff with respect to the NYSE Listing Application promptly after receipt of such comments or requests, and any written or oral responses thereto. Each Party and their respective counsel shall be given a reasonable opportunity to review any such written responses and each Party shall give due consideration to the additions, deletions or changes suggested thereto by the other Party and their respective counsel.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Section</u><u>&nbsp;</u><u>16 Matters</u>. Prior to the Effective Time, Parent and the Company shall take all such steps as may be required to cause any dispositions of Company Common Stock (including derivative securities with respect to Company Common Stock) or acquisitions of Parent Common Stock (including derivative securities with respect to Parent Common Stock) resulting from the Transactions by each individual who is subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to the Company to be exempt under Rule&nbsp;16b-3 promulgated under the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Stockholder and Shareholder Litigation</u>. Subject to entry into a customary joint defense agreement, each of Parent and the Company shall provide the other Party the opportunity to participate, at its own cost and expense, in the defense of any litigation brought by stockholders of Parent or shareholders of the Company or in the name of Parent or the Company against Parent or the Company, as applicable, and/or their respective directors relating to the Transactions contemplated by this Agreement, including the Merger; <u>provided</u>, <u>however</u>, that no Party shall compromise, settle, come to an arrangement regarding or agree to compromise, settle or come to an arrangement regarding any litigation arising or resulting from the Transactions contemplated by this Agreement, or consent to the same, without the prior written consent of the other Party (not to be unreasonably withheld, conditioned or delayed) <u>provided</u> that either Parent or the Company may compromise, settle or come to an agreement regarding any litigation brought by stockholders of Parent or stockholders of the Company or in the name of Parent or the Company against Parent or the Company, as applicable, and/or their respective directors relating to the Transactions contemplated by this Agreement, including the Merger, if each of the following conditions are met: (a) the resolution of such litigation requires payments from Parent or the Company, as applicable, in an amount not to exceed the amount set forth on <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.12</u> of the<u> </u>Parent Disclosure Schedule or the Company Disclosure Schedule, as applicable, or the provision of disclosures to the stockholders of Parent or the Company as applicable (which disclosure shall be subject to the other Party&#8217;s review and comments, which reasonable comments Parent or the Company, as applicable, shall consider in good faith); (b)&nbsp;the settlement provides for no injunctive relief; (c)&nbsp;the settlement provides that the applicable Party is released from all liability in connection therewith; and (d)&nbsp;none of Parent, Merger Sub and the Company, and their respective Subsidiaries and Representatives are required to admit any wrongdoing as part of the settlement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="77" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">77</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.13&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Intended Tax Treatment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 45pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;For U.S. federal income Tax purposes, the Parties (A)&nbsp;intend that the Merger qualify for the Intended Tax Treatment and (B)&nbsp;hereby adopt this Agreement as a &#8220;plan of reorganization&#8221; for purposes of Sections 354, 361 and the 368 of the Code and within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3(a) to which Parent, Merger Sub and the Company are parties under Section 368(b) of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 45pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 45pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything herein to the contrary, both prior to and following the Effective Time, the Company, Parent and Merger Sub shall use their reasonable best efforts, and shall cause their respective Subsidiaries to use their reasonable best efforts, to take or cause to be taken, and not knowingly fail to take, any action necessary for the Merger to qualify for the Intended Tax Treatment, including (A)&nbsp;by using reasonable best efforts to refrain from any action that such Party knows, or is reasonably expected to know, is reasonably likely to prevent the Merger from qualifying for the Intended Tax Treatment and (B)&nbsp;by not taking any Tax reporting position inconsistent with the Intended Tax Treatment for U.S. federal (and applicable U.S. state and local and non-U.S.) income Tax purposes, unless otherwise required by a change in applicable Tax Law after the date of this Agreement or a &#8220;determination&#8221; within the meaning of Section 1313(a) of the Code (or any comparable, analogous or similar provision of U.S. state or local or non-U.S. Law).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 45pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 45pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Parent, on the one hand, and the Company, on the other hand, shall use reasonable best efforts to promptly notify the other Party if, at any time before the Effective Time, it has Knowledge of any facts, agreements, plans or other circumstances that would reasonably be expected to prevent, cause a failure of, or impede the Merger from qualifying for the Intended Tax Treatment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Opinions</u>. Parent, Merger Sub and the Company shall each reasonably cooperate with one another and their respective counsel and use reasonable best efforts to cause the delivery of each of the Company Tax Opinion and the Parent Tax Opinion. Each of Parent and the Company shall execute and deliver to each of Company Tax Counsel and Parent Tax Counsel a Tax representation letter (i)&nbsp;substantially in the form of <u>Exhibit</u><u>&nbsp;</u><u>C</u> and <u>Exhibit D</u> attached hereto, (ii)&nbsp;dated as of the date of such opinion and (iii)&nbsp;signed by an officer of the Company or Parent and Merger Sub, as applicable. Parent and the Company shall provide such other information as reasonably requested by each of Company Tax Counsel and Parent Tax Counsel for purposes of rendering the Company Tax Opinion or Parent Tax Opinion, as applicable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="78" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">78</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>FIRPTA Certificate</u>. At the Closing, the Company shall deliver to Parent a certificate and notice prepared in accordance with the requirements of Treasury Regulations Section 1.897-2(h)(2) and 1.1445-2(c)(3) and dated as of the Closing Date, along with written authorization for Parent to deliver such certificate and notice to the IRS on behalf of the Company upon the Closing; <u>provided</u>, that the only remedy for any failure to deliver the documentation described in this paragraph shall be to make an appropriate withholding (to the extent required by applicable Law) from consideration deliverable in connection with this Agreement consistent with the terms of <u>Section </u><u>&#8206;</u><u>2.5(i)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.14&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall, or shall cause a Subsidiary to, provide each employee of the Company and its Subsidiaries immediately prior to the Effective Time who does not provide services pursuant to a collective bargaining agreement or other Contract with any Union and who continues employment with Parent or its Subsidiaries (including the Surviving Corporation and its Subsidiaries) following the Effective Time (each, a &#8220;<u>Continuing Employee</u>&#8221;), subject to continued employment, with the following: (i)&nbsp;during the period beginning on the Closing Date and ending on the first anniversary of the Closing Date, (A)&nbsp;an annual base salary or hourly wage rate that is not less than the annual base salary or hourly wage rate for which such Continuing Employee was eligible immediately prior to the Effective Time, and (B)&nbsp;a short-term annual cash incentive opportunity that is not less than the short-term annual cash incentive opportunity (including annual cash bonus programs and commissions) for which such Continuing Employee was eligible immediately prior to the Effective Time, and (ii)&nbsp; except to the extent otherwise agreed to with Parent or one of its Subsidiaries and the applicable Continuing Employee, if the Effective Time occurs after January 1, 2026, but prior to the grant of any phantom stock awards to such Continuing Employee as permitted pursuant to <u>Section 5.1(b)</u>, during the period beginning on the Closing Date and ending on December 31, 2026, a long-term incentive opportunity with a grant date fair value that is substantially comparable to the grant date fair value of the phantom stock awards for which such Continuing Employee was eligible immediately prior to the Effective Time, as applicable (excluding any change-of-control, transaction or one-time special bonus opportunities (including any retention agreements)), (iii)&nbsp;during the period beginning on the Closing Date and ending on the earlier of the first anniversary of the Closing Date and December 31, 2026, retirement, health and welfare and other benefits (excluding equity or equity-based compensation, cash-based incentive compensation (such as cash bonuses or commissions), specific performance goals for any cash-based compensation program, long-term incentive, defined benefit arrangements, nonqualified deferred compensation, change-of-control, transaction or one-time special bonus opportunities (including any retention agreements) and post-retirement or retiree health and welfare arrangements (together, the &#8220;<u>Excluded Benefits</u>&#8221;)) that are, in Parent&#8217;s sole discretion, substantially comparable in the aggregate, to either those provided to similarly situated employees of Parent and its Subsidiaries or those provided to such Continuing Employee immediately prior to the Closing Date (in each case, excluding the Excluded Benefits).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="79" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">79</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent will and will cause its Subsidiaries (including the Surviving Corporation and its Subsidiaries) to use commercially reasonable efforts to give credit to Continuing Employees under each of their respective employee benefit plans, programs and arrangements (the &#8220;<u>Post-Closing Plans</u>&#8221;) offered to Continuing Employees for all service prior to the Effective Time with the Company or its Subsidiaries, as applicable, or any predecessor employer (to the extent that such credit was given by the Company or any of its Subsidiaries, as applicable) for purposes of vesting, level of benefit accrual and eligibility to participate under each applicable Parent benefit plan made available to Continuing Employees on or after the Closing to the same extent and for the same purpose such service was recognized immediately prior to the Closing Date by the Company and its Subsidiaries under an analogous plan, as if such service had been performed with Parent except for (i)&nbsp;benefit accrual under defined benefit pension plans, any non-qualified deferred compensation plan, for purposes of qualifying for subsidized early retirement benefits or for purposes of any retiree health or welfare plans or arrangements, (ii)&nbsp;to the extent it would result in a duplication of benefits, (iii)&nbsp;to the extent that such service is not recognized under such Parent benefit plan for other employees of Parent or its Subsidiaries, and (iv)&nbsp;for purposes of any new equity or equity-based compensation plan, program, agreement or arrangement, in either case.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;To the extent that Continuing Employees do not continue to participate in Company Benefit Plans as in place immediately prior to the Closing, in addition, for purposes of each Post-Closing Plan providing medical, dental, pharmaceutical, vision and/or other health or welfare benefits to any Continuing Employee and his or her dependents, for the plan year in which the Effective Time occurs, Parent will use commercially reasonable efforts to and to cause its Subsidiaries (including the Surviving Corporation and its Subsidiaries) to use commercially reasonable efforts to, (i)&nbsp;cause all waiting periods, pre-existing condition exclusions, evidence of insurability requirements and actively-at-work requirements of such Post-Closing Plan to be waived for such Continuing Employee and his or her covered dependents, to the extent any such waiting periods, pre-existing condition exclusions, evidence of insurability requirements and actively-at-work requirements were satisfied, waived or were inapplicable under the comparable Company Benefit Plan as of immediately prior to the Effective Time, and (ii)&nbsp;credit each Continuing Employee with all deductible payments, co-payments and other out-of-pocket expenses incurred by such Continuing Employee and his or her covered dependents prior to the Effective Time under a Company Benefit Plan during the plan year in which the Effective Time occurs for the purpose of determining the extent to which such Continuing Employee has satisfied the deductible, co-payments, or maximum out-of-pocket requirements applicable to such Continuing Employee and his or her covered dependents for such plan year under any Post-Closing Plan, as if such amounts had been paid in accordance with such plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall take all action necessary to amend each Company Benefit Plan that is intended to qualify as a cash deferred arrangement under Section&nbsp;401(k) of the Code, effective as of the Closing, to the extent necessary to limit participation to employees of the Company and to exclude all employees of Parent and its Subsidiaries (other than the Company and its Subsidiaries) from participation in such plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Company and Parent shall reasonably cooperate in satisfying all legal or contractual requirements to provide notice to, or carry out any information and/or consultation procedure with, any employee or groups of employees of the Company, Parent or any of their respective Subsidiaries, or any Union which is representing any employee of the Company, Parent or any of their respective Subsidiaries in connection with the transactions contemplated by this Agreement (the &#8220;<u>Labor Consultations</u>&#8221;). In connection with the Labor Consultations, the Company and Parent shall (i)&nbsp;keep the other fully informed of the status of the Labor Consultations process and shall promptly provide the other with a true and certified copy of any opinion or statement delivered by an applicable labor or trade union, works council, labor organization or other employee representative, (ii)&nbsp;provide the other with a reasonable opportunity to review, prior to distribution, any communications delivered to any Union and consider in good faith the other&#8217;s reasonable comments thereon and (iii)&nbsp;use commercially reasonable efforts to, and to cause its affiliates to use commercially reasonable efforts to, complete any of the Labor Consultations expeditiously.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="80" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">80</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Prior to the Effective Time, each of Parent and the Company shall provide to the other Party copies of any written or pre-recorded oral, broad-based communications with employees of the Company or its Subsidiaries regarding the impact of the Merger on such employee&#8217;s employment, compensation or benefits for the Company&#8217;s or Parent&#8217;s prior approval, as applicable, which shall not be unreasonably withheld, conditioned or delayed; <u>provided</u>, that no such prior approval shall be required in the event (i)&nbsp;the other Party has previously approved the information contained in such communication or (ii)&nbsp;the information contained in such communication was previously publicly disclosed as long as no such communication creates a legally binding right to any compensation or benefits.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each material Company Benefit Plan, the Company shall, within 30 days following the date of this Agreement, deliver or make available to Parent copies, to the extent applicable, of (i)&nbsp;the plan and trust documents and the most recent summary plan description, (ii)&nbsp;the most recent favorable determination letter from the IRS with respect to each Company Benefit Plan intended to qualify under Section 401(a) of the Code; and (iii)&nbsp;the most recent nondiscrimination testing results.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each Multiemployer Plan set forth in <u>Section</u><u>&nbsp;</u><u>3.11(f)</u> of the Company Disclosure Schedule, the Company shall, within 30 days following the date of this Agreement, deliver true and complete copies of (i)&nbsp;contribution reports for the last three years; (ii)&nbsp;all participation agreements; (iii)&nbsp;any notices of endangered or critical status received by the Company; (iv)&nbsp;any notices of funding improvement or rehabilitation plans received by the Company; (v)&nbsp;any estimates of withdrawal liability received by the Company in the last 2 years or any notices of a complete or partial withdrawal received by the Company; and (vi)&nbsp;any notices of monetary assessments, insolvency or termination received by the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each material Parent Benefit Plan, Parent shall, within 30 days following the date of this Agreement, deliver or make available to the Company copies, to the extent applicable, of (i)&nbsp;the plan and trust documents and the most recent summary plan description, (ii)&nbsp;the most recent favorable determination letter from the IRS with respect to each Parent Benefit Plan intended to qualify under Section 401(a) of the Code; and (iii)&nbsp;the most recent nondiscrimination testing results.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each Multiemployer Plan set forth in <u>Section</u><u>&nbsp;</u><u>4.11(f)</u> of the Parent Disclosure Schedule, Parent shall, within 30 days following the date of this Agreement, deliver true and complete copies of (i)&nbsp;contribution reports for the last three years; (ii)&nbsp;all participation agreements; (iii)&nbsp;any notices of endangered or critical status received by Parent; (iv)&nbsp;any notices of funding improvement or rehabilitation plans received by Parent; (v)&nbsp;any estimates of withdrawal liability received by Parent in the last 2 years or any notices of a complete or partial withdrawal received by Parent; and (vi)&nbsp;any notices of monetary assessments, insolvency or termination received by Parent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="81" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">81</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;Without limiting the generality of <u>Section </u><u>&#8206;</u><u>8.8</u>, this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.14</u> shall be binding upon and inure solely to the benefit of the Parties, and nothing in this <u>Section </u><u>&#8206;</u><u>5.14</u>, express or implied, shall confer upon any other Person any rights or remedies of any nature whatsoever under or by reason of this <u>Section </u><u>&#8206;</u><u>5.14</u>. Nothing in this Agreement, express or implied, is or shall be construed to (i)&nbsp;establish, amend or modify any Company Benefit Plan or other employee or director compensation or benefit plan or (ii)&nbsp;prevent Parent or its Subsidiaries from amending, modifying, suspending, revoking or terminating any Company Benefit Plan. The Parties acknowledge and agree that the terms set forth in this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.14</u> shall not create or confer any right in any employee of the Company or its Subsidiaries or any other Person, including continued employment with the Company, Parent, the Surviving Corporation or their respective Subsidiaries or compensation or benefits, or any rights or remedies of any nature or kind whatsoever under or by reason of this <u>Section </u><u>&#8206;</u><u>5.14</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.15&nbsp;&nbsp;&nbsp;&nbsp;<u>Cooperation as to Integration</u>. Each of Parent and the Company will, and will cause each of its respective Representatives to, use its reasonable best efforts, subject to applicable Laws and <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.5</u> (which it is hereby acknowledged is not amended, modified or superseded by this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.15</u>), to cooperate with the other Party in connection with planning the integration of the business operations of Parent and the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.16&nbsp;&nbsp;&nbsp;&nbsp;<u>Financing Matters</u>. Between the date hereof and the Closing Date, each of Parent and the Company shall, and shall cause its Subsidiaries to, reasonably cooperate to mutually develop and determine an optimal global financing structure for Parent and its Subsidiaries from and after the Closing (assuming the consummation of the Merger), and to use reasonable best efforts to implement any necessary, appropriate or desirable arrangements, in anticipation of the consummation of the Merger and taking into account the expected post-Closing operations and characteristics and terms of the existing indebtedness, regarding each Party&#8217;s and its Subsidiaries&#8217; credit agreements or other documents governing or relating to indebtedness of the Parties and their Subsidiaries, including arrangements by way of amendments, consents, payoff (or similar action), new financing or otherwise with respect to refinancing or retaining a Party&#8217;s or its Subsidiaries&#8217; credit facilities (or similar indebtedness).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.17&nbsp;&nbsp;&nbsp;&nbsp;<u>Dividends</u>. From and after the date of this Agreement until the earlier of the Effective Time and termination of this Agreement in accordance with <u>Article </u><u>&#8206;</u><u>7</u>, none of the Company or Parent shall make, declare or set aside any dividend or other distribution to its stockholders or shareholders, as applicable, without the prior written consent of Parent (in the case of the Company) or the Company (in the case of Parent);&nbsp;<u>provided</u>,&nbsp;<u>however</u>, that the written consent of the other Party shall not be required for (a)&nbsp;in the case of the Company, subject to the terms of this&nbsp;<u>Section </u><u>&#8206;</u><u>5.17</u>, the authorization and payment of regular quarterly dividends on Company Common Stock at a rate not in excess of $0.16 per share, per calendar quarter consistent with past practice and made solely out of the Company&#8217;s cash on hand prior to the Effective Time and (b)&nbsp;in the case of Parent, subject to the terms of this&nbsp;<u>Section </u><u>&#8206;</u><u>5.17</u>, the authorization and payment of regular quarterly dividends on shares of Parent Common Stock at a rate not in excess of $0.1875 per share, per calendar quarter in accordance with past practice and made solely out of Parent&#8217;s cash on hand prior to the Effective Time (any dividend permitted under the preceding <u>clauses (a)</u> and <u>(b)</u>, a &#8220;<u>Permitted Dividend</u>&#8221;);&nbsp;<u>provided</u>,&nbsp;<u>further</u>, that (i)&nbsp;any Permitted Dividend authorized by a Party shall be deemed to relate to the calendar quarter in which the record date for such Permitted Dividend occurs, even if the payment date for such Permitted Dividend occurs in a subsequent calendar quarter; (ii)&nbsp;it is agreed that the Parties shall take such actions as are necessary to ensure that if either the holders of Company Common Stock or the holders of Parent Common Stock are entitled to receive a dividend for a particular calendar quarter prior to the Closing Date, then the holders of Parent Common Stock and the holders of Company Common Stock, respectively, shall also receive a dividend for such calendar quarter, as necessary to result in the holders of Company Common Stock and the holders of Parent Common Stock receiving dividends covering the same periods prior to the Closing Date; and (iii)&#8239;the Parties will cooperate such that, and Parent will ensure that, any Permitted Dividend authorized by Parent having a record date in the calendar quarter in which the Closing occurs will have the same record date as the Company&#8217;s Permitted Dividend for such calendar quarter in order to ensure that the shareholders of the Company and stockholders of Parent are entitled to receive the same number of such dividends between the date hereof and the Effective Time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="82" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">82</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.18&nbsp;&nbsp;&nbsp;&nbsp;<u>Stock Exchange Delisting and Deregistration</u>. Parent and the Company will cooperate and use their respective reasonable best efforts to cause the delisting of shares of Company Common Stock from NASDAQ and the deregistration of such shares under the Exchange Act as promptly as practicable following the Closing in compliance with applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.19&nbsp;&nbsp;&nbsp;&nbsp;<u>Section 280G</u>. As soon as practicable following the date hereof, the Company shall use reasonable best efforts to provide Parent with calculations and reasonable back up information relating to Sections 280G and 4999 of the Code relating to the Transactions, and shall provide Parent with an update to such calculations within a reasonable time prior to the Effective Time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.20&nbsp;&nbsp;&nbsp;&nbsp;<u>Takeover Statutes</u>. If any Takeover Statute may become, or may purport to be, applicable to this Agreement, the Merger or any of the Transactions, each of the Company and Parent and their respective boards of directors shall grant such approvals and take such actions as are reasonably necessary so that the transactions contemplated hereby may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to eliminate or minimize the effects of such Takeover Statute on the transactions contemplated hereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">5.21&nbsp;&nbsp;&nbsp;&nbsp;<u>Obligations of Merger Sub </u>. Parent shall cause Merger Sub to comply in all respects with each of the representations, warranties, covenants, obligations, agreements and undertakings made or required to be performed by Merger Sub in accordance with the terms of this Agreement, the Merger and the other Transactions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE 6</b><br>
<b>CONDITIONS TO CONSUMMATION OF THE MERGER</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">6.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions to Obligations of Each Party Under This Agreement</u>. The obligations of Parent, the Company and Merger Sub to consummate the Merger are subject to the satisfaction or waiver (to the extent permitted by applicable Law), at or prior to the Closing, of the following conditions:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Stockholder Approvals</u>. The Company Shareholder Approval and the Parent Stockholder Approval shall have been obtained.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="83" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">83</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>NYSE Listing</u>. The shares of Parent Common Stock issuable to the shareholders of the Company pursuant to this Agreement shall have been approved for listing on the NYSE, subject to official notice of issuance.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Statutes and Injunctions</u>. No Law or Order shall have been promulgated, entered, enforced, enacted or issued by any Governmental Entity of competent jurisdiction in which the Company and its Subsidiaries (taken as a whole) or Parent and its Subsidiaries (taken as a whole) have material assets or material business operations which prohibits, restrains or makes illegal the consummation of the Merger and is in effect (it being understood and agreed that, for clarity, any communication or notification from a Governmental Entity that an investigation of the Transactions under antitrust or foreign investment Laws may be conducted or continue following the expiration of the waiting period under the HSR Act, or similar period under other applicable antitrust, foreign investment or foreign subsidies Law, and the consummation of the Merger shall not constitute such a Law or Order).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Form S-4</u>. The Form S-4 shall have become effective under the Securities Act and shall not be the subject of any stop order.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>HSR Act</u>. Any applicable waiting period, together with any voluntary extensions thereof pursuant to any agreement with any Governmental Entity, under the HSR Act shall have expired or been terminated.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">6.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions to Obligations of Parent and Merger Sub Under This Agreement</u>. The obligations of Parent and Merger Sub to consummate the Merger are subject to the satisfaction or waiver (to the extent permitted by applicable Law), at or prior to the Closing, of the following conditions:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The representations and warranties of the Company set forth in this Agreement (except those representations and warranties set forth in the proviso below) shall be true and correct in all respects (without giving effect to any qualifications as to materiality or Company Material Adverse Effect or other similar qualifications contained therein) as of the Closing Date as though made on and as of such date (or, in the case of representations and warranties that address matters only as of a particular date or time, as of such date or time), except to the extent that any failures of such representations and warranties to be so true and correct, individually or in the aggregate, have not had and would not reasonably be expected to have a Company Material Adverse Effect; <u>provided</u>, that (i)&nbsp;the representations and warranties set forth in <u>Section </u><u>&#8206;</u><u>3.1(a)</u> (Corporate Organization), <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>3.3</u> (Authority; Execution and Delivery; Enforceability), and <u>Section </u><u>&#8206;</u><u>3.20 </u>(Broker&#8217;s Fees) shall be true and correct in all material respects (without giving effect to any qualifications as to materiality or Company Material Adverse Effect or other similar qualifications contained therein) as of the Closing Date as though made on and as of such date (or, in the case of representations and warranties that address matters only as of a particular date or time, as of such date or time), (ii)&nbsp;the representations and warranties set forth in <u>Section </u><u>&#8206;</u><u>3.2(a)</u> (Company Capitalization) shall be true and correct in all respects as of the Closing Date as though made on and as of such date (or, in the case of representations and warranties that address matters only as of a particular date or time, as of such date or time), except for <i>de minimis</i> inaccuracies and (iii)&nbsp;the representation and warranty set forth in <u>clause (b)</u> of <u>Section </u><u>&#8206;</u><u>3.6</u> (Absence of Certain Changes or Events) shall be true and correct in all respects as of the Closing Date as though made on and as of such date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="84" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">84</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have performed or complied with, as applicable, all of the covenants and agreements required by this Agreement to be performed or complied with by it in all material respects; <u>provided</u>, <u>however</u>, that with respect to the covenant set forth in <u>Section</u><u>&nbsp;</u><u>5.1(i)</u>, the Company shall have performed or complied with such covenant in all respects.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;No Effect shall have occurred since the date of this Agreement that has had, or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have delivered to Parent a certificate, dated as of the Closing Date and signed by an executive officer of the Company, certifying to the effect that the conditions set forth in <u>Sections </u><u>&#8206;</u><u>6.2(a)</u>, <u>&#8206;</u><u>6.2(b)</u> and <u>6.2(c)</u> have been satisfied.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall have received the Parent Tax Opinion from Parent Tax Counsel, and such opinion shall not have been withdrawn or adversely modified.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">6.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions to Obligations of the Company Under This Agreement</u>. The obligation of the Company to consummate the Merger is subject to the satisfaction or waiver (to the extent permitted by applicable Law), at or prior to the Closing, of the following conditions:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The representations and warranties of Parent set forth in this Agreement (except those representations and warranties set forth in the proviso below) shall be true and correct in all respects (without giving effect to any qualifications as to materiality or Parent Material Adverse Effect or other similar qualifications contained therein) as of the Closing Date as though made on and as of such date (or, in the case of representations and warranties that address matters only as of a particular date or time, as of such date or time), except to the extent that any failures of such representations and warranties to be so true and correct, individually or in the aggregate, have not had, and would not reasonably be expected to have, a Parent Material Adverse Effect; <u>provided</u>, that (i)&nbsp;the representations and warranties set forth in <u>Section </u><u>&#8206;</u><u>4.1(a)</u> (Corporate Organization), <u>Section 4.3</u> (Authority; Execution and Delivery; Enforceability), <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.20</u> (Broker&#8217;s Fees) and <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.25</u> (Merger Sub) shall be true and correct in all material respects (without giving effect to any qualifications as to materiality or Parent Material Adverse Effect or other similar qualifications contained therein) as of the Closing Date as though made on and as of such date (or, in the case of representations and warranties that address matters only as of a particular date or time, as of such date or time), (ii)&nbsp;the representations and warranties set forth in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>4.2(a)</u> (Parent Capitalization) shall be true and correct in all respects as of the Closing Date (or, in the case of representations and warranties that address matters only as of a particular date or time, as of such date or time), except for <i>de minimis </i>inaccuracies, and (iii)&nbsp;the representation and warranty set forth in <u>clause</u><u>&nbsp;</u><u>(b)</u> of <u>Section </u><u>&#8206;</u><u>4.6</u> (Absence of Certain Changes or Events) shall be true and correct in all respects as of the Closing Date as though made on and as of such date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="85" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">85</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each of Parent and Merger Sub shall have performed or complied with, as applicable, all of the covenants and agreements required by this Agreement to be performed or complied with by it in all material respects.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;No Effect shall have occurred since the date of this Agreement that has had, or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall have delivered to the Company a certificate, dated as of the Closing Date and signed by an executive officer of Parent, certifying to the effect that the conditions set forth in <u>Sections </u><u>&#8206;</u><u>6.3(a),</u> <u>&#8206;</u><u>6.3(b)</u> and <u>6.3(c)</u> have been satisfied.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have received the Company Tax Opinion from Company Tax Counsel, and such opinion shall not have been withdrawn or adversely modified.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE 7</b><br>
<b>TERMINATION, AMENDMENT AND WAIVER</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">7.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination</u>. This Agreement may be terminated, and the Merger and the other Transactions contemplated hereby may be abandoned:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;By mutual written consent of Parent and the Company at any time prior to the Effective Time, whether before or after the Parent Stockholder Approval or Company Shareholder Approval have been obtained;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;By either Parent or the Company:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 45pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;if, whether before or after the Parent Stockholder Approval or Company Shareholder Approval have been obtained, any Law or final and non-appealable Order shall have been promulgated, entered, enforced, enacted or issued by any Governmental Entity of competent jurisdiction in which the Company and its Subsidiaries (taken as a whole) or Parent and its Subsidiaries (taken as a whole) have material assets or material business operations (or any other Governmental Entity whose approval is required as a condition to Closing pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>6.1(e)</u>) which is in effect and permanently prohibits, restrains, enjoins or makes illegal the consummation of the Merger; <u>provided</u>, that the right to terminate this Agreement pursuant to this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1(b)(i)</u> shall not be available to any Party whose material breach of any of its obligations under this Agreement is the primary cause of, or resulted in, the enactment or issuance of any such Law or Order;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: -18pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="86" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">86</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 45pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;if, whether before or after the Parent Stockholder Approval or Company Shareholder Approval have been obtained, the Transactions shall not have been consummated by April 28, 2026 (the &#8220;<u>Initial Outside Date</u>&#8221;); <u>provided</u>, that in the event that at the Initial Outside Date, all of the conditions to Closing set forth in <u>&#8206;</u><u>Article 6</u> other than <u>Section </u><u>&#8206;</u><u>6.1(a)</u>, <u>Section </u><u>&#8206;</u><u>6.1(c)</u> (solely with respect to Laws or Orders related to the HSR Act or other Laws or Orders relating to any other regulatory approval required to be obtained pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>6.1(e)</u>) or <u>Section </u><u>&#8206;</u><u>6.1(e)</u> have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub or the Company, as applicable, then the Initial Outside Date shall automatically be extended to July 28, 2026 (the &#8220;<u>Extended Outside Date</u>&#8221; and together with the Initial Outside Date, the &#8220;<u>Outside Date</u>&#8221;) unless Parent and the Company mutually agree in writing to an earlier Extended Outside Date; <u>provided</u>, <u>however</u>, that the right to terminate this Agreement pursuant to this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1(b)(ii)</u> shall not be available to any Party whose material breach of any of its obligations under this Agreement is the primary cause of, or resulted in, the failure of the Closing to have occurred prior to the Initial Outside Date or the Extended Outside Date, as the case may be;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 45pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;if the Company Shareholder Approval shall not have been obtained upon a vote taken thereon at the Company Shareholders Meeting duly convened therefor or at any adjournment or postponement thereof; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: 45pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 45pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;if the Parent Stockholder Approval shall not have been obtained upon a vote taken thereon at the Parent Stockholders Meeting duly convened therefor or at any adjournment or postponement thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;By the Company:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 45pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;if, whether before or after the Parent Stockholder Approval or Company Shareholder Approval have been obtained, Parent shall have breached or failed to perform any of its representations, warranties or covenants contained in this Agreement, which breach or failure to perform (A)&nbsp;is incapable of being cured by Parent prior to the Outside Date or otherwise is not cured by the earlier of (x)&nbsp;30 days following written notice to Parent by the Company of such breach or (y)&nbsp;the Business Day prior to the Outside Date and (B)&nbsp;would result in a failure of any condition set forth in <u>Section </u><u>&#8206;</u><u>6.3(a)</u> or <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>6.3(b)</u>;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 45pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;prior to the receipt of the Parent Stockholder Approval, if (A)&nbsp;the Parent Board or a committee thereof shall have effected a Parent Adverse Recommendation Change or (B)&nbsp;Parent shall have committed a Willful and Material Breach of any of its obligations under <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4</u>; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 45pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;prior to receipt of the Company Shareholder Approval but not thereafter in connection with the Company or any of its Subsidiaries entering into a definitive written agreement providing for the consummation of a Superior Proposal in accordance with <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4; </u>provided, that the Company shall not have the right to terminate this Agreement pursuant to this <u>Section </u><u>&#8206;</u><u>7.1(c)(iii)</u> unless the Company has complied in all material respects with <u>Section </u><u>&#8206;</u><u>5.4</u> (including <u>Section </u><u>&#8206;</u><u>5.4(d)</u>).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="87" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">87</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;By Parent:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 45pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;if, whether before or after the Parent Stockholder Approval or Company Shareholder Approval have been obtained, the Company shall have breached or failed to perform any of its representations, warranties or covenants contained in this Agreement, which breach or failure to perform (A)&nbsp;is incapable of being cured by the Company prior to the Outside Date or otherwise is not cured by the earlier of (x)&nbsp;30 days following written notice to the Company by Parent of such breach or (y)&nbsp;the Business Day prior to the Outside Date and (B)&nbsp;would result in a failure of any condition set forth in <u>Section </u><u>&#8206;</u><u>6.2(a)</u> or <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>6.2(b)</u>; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 99pt; text-indent: 45pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;prior to the receipt of the Company Shareholder Approval, if (A)&nbsp;the Company Board or a committee thereof shall have effected a Company Adverse Recommendation Change or (B)&nbsp;the Company shall have committed a Willful and Material Breach of any of its obligations under <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">7.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Effect of Termination</u>. In the event of the valid termination of this Agreement by either Parent or the Company as provided in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1</u>, written notice thereof shall forthwith be given by the terminating Party to the other Party or Parties, specifying the provision hereof pursuant to which such termination is made and the basis therefor described in reasonable detail. In the event of the valid termination of this Agreement pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1</u>, this Agreement shall be terminated and this Agreement shall forthwith become void and have no effect, without any liability or obligation on the part of Parent, the Company or Merger Sub or their respective Subsidiaries, officers, directors or Representatives, except with respect to this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.2</u>, <u>Section </u><u>&#8206;</u><u>7.3</u> and <u>Article </u><u>&#8206;</u><u>8</u>, which provisions shall survive such termination; <u>provided</u>, that nothing herein shall relieve any Party for liabilities or damages incurred or suffered (including the loss to the shareholders of the Company or the stockholders of Parent, as applicable, of the benefits of the Transaction) as a result of a Willful and Material Breach or fraud by the Company, on the one hand, or Parent or Merger Sub, on the other hand, of any of their respective representations, warranties, covenants or other agreements set forth in this Agreement. For the avoidance of doubt, (a)&nbsp;only the Company or Parent, as applicable (and not their respective stockholders or shareholders, as applicable) may bring an action pursuing liability for such damages and (b)&nbsp;the Company or Parent, as applicable, may retain, without distribution to its stockholders or shareholders, as applicable, any such damages received. No termination of this Agreement shall affect the obligations of the Parties contained in the Confidentiality Agreement, all of which obligations shall survive the termination of this Agreement in accordance with their terms.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="88" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">88</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">7.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Expenses; Termination Fees</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.3</u> and except for (i)&nbsp;the expenses in connection with printing and mailing the Joint Proxy Statement and the Form S-4 required in connection with the actions specified in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.3</u>, (ii)&nbsp;all SEC filing fees relating to the Transactions and (iii)&nbsp;the filing fees in connection with the approvals required under <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>6.1(e)</u> related to the Transactions (each of which fees and expenses shall be borne, in each case, equally by Parent and the Company), all fees and expenses incurred by the Parties shall be borne solely by the Party that has incurred such fees and expenses and all such fees and expenses shall be paid by the applicable responsible Party concurrently with the Closing. All transfer, documentary, sales, use, stamp, registration and other similar Taxes and fees imposed with respect to, or as a result of, the Merger shall be borne by Parent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If this Agreement is terminated (i)&nbsp;pursuant to <u>Section 7.1(d)(ii)</u> (or pursuant to any other provision of <u>Section </u><u>&#8206;</u><u>7.1</u> at a time when Parent would have been&nbsp;entitled to terminate this Agreement pursuant to <u>Section 7.1(d)(ii)</u>) or (ii)&nbsp;pursuant to <u>Section </u><u>&#8206;</u><u>7.1(c)(iii)</u>, then the Company shall pay to Parent $15,000,000<b> </b>(the &#8220;<u>Company Termination Fee</u>&#8221;) no later than three Business Days (x)&nbsp;following such termination in the case of a termination pursuant to <u>clause</u><u>&nbsp;</u><u>(i)</u> above or (y)&nbsp;following consummation of the transaction in respect of such Competing Proposal in which the Company has terminated this Agreement pursuant to <u>Section 7.1(d)(ii)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;If this Agreement is terminated (A)&nbsp;pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1(b)(iii)</u> or (B)&nbsp;pursuant to <u>Section </u><u>&#8206;</u><u>7.1(d)(i)</u>, and (ii)&nbsp;in any such case a Competing Proposal shall have been publicly announced (and not publicly withdrawn) after the date of this Agreement and prior to the date of the Company Shareholders Meeting, in the case of <u>clause (A)</u>, or the date of termination, in the case of <u>clause (B)</u>, and (iii)&nbsp;if within 12 months after the date of such termination, a transaction in respect of a Competing Proposal is consummated or the Company enters into a definitive agreement in respect of a Competing Proposal, then the Company shall pay to Parent the Company Termination Fee, less any Expenses previously paid, no later than three Business Days following the consummation of such transaction; <u>provided</u>, that, solely for purposes of this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.3(c)</u>, the term &#8220;Competing Proposal&#8221; shall have the meaning ascribed thereto in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4(g)(i)</u>, except that all references to 15% shall be changed to 50%.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;If this Agreement is terminated pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1(c)(ii)</u> (or pursuant to any other provision of <u>Section </u><u>&#8206;</u><u>7.1</u> at a time when the Company would have been entitled to terminate this Agreement pursuant to <u>Section </u><u>&#8206;</u><u>7.1(c)(ii)</u>), then Parent shall pay to the Company $15,000,000 (the &#8220;<u>Parent Termination Fee</u>&#8221;) no later than three Business Days following such termination.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;If this Agreement is terminated (A)&nbsp;pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1(b)(iv)</u> or (B)&nbsp;pursuant to <u>Section </u><u>&#8206;</u><u>7.1(c)(i)</u>, and (ii)&nbsp;in any such case a Competing Proposal shall have been publicly announced (and not publicly withdrawn) after the date of this Agreement and prior to the date of the Parent Stockholders Meeting, in the case of <u>clause (A)</u>, or the date of termination, in the case of <u>clause (B)</u>, and (iii)&nbsp;if within 12 months after the date of such termination, a transaction in respect of a Competing Proposal is consummated or Parent enters into a definitive agreement in respect of a Competing Proposal, then Parent shall pay to the Company the Parent Termination Fee, less any Expenses previously paid, no later than three Business Days following the consummation of such transaction; <u>provided</u> that, solely for purposes of this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.3(e)</u>, the term &#8220;Competing Proposal&#8221; shall have the meaning ascribed thereto in <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.4(g)(i)</u>, except that all references to 15% shall be changed to 50%.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="89" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">89</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;If this Agreement is terminated pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1(b)(iii)</u> and as of the date of such termination (x) the Parent Stockholders Meeting has been held and the Parent Stockholder Approval was obtained and (y) neither the Parent Board nor a committee thereof shall have effected a Parent Adverse Recommendation Change, then the Company shall pay or cause to be paid to Parent the Expenses of Parent no later than three Business Days after such termination.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;If this Agreement is terminated pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.1(b)(iv)</u> and as of the date of such termination (x) the Company Shareholders Meeting has been held and the Company Shareholder Approval was obtained and (y) neither the Parent Board nor a committee thereof shall have effected a Parent Adverse Recommendation Change, then Parent shall pay or cause to be paid to the Company the Expenses of the Company no later than three Business Days after such termination.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Any Company Termination Fee, Parent Termination Fee or Expenses due under this <u>Section </u><u>&#8206;</u><u>7.3</u> shall be paid by wire transfer of immediately available funds.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 90pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Parties each agree that the agreements contained in this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.3</u> are an integral part of the Transactions, and that, without these agreements, the Parties would not enter into this Agreement. Accordingly, if a Party fails to pay any amounts due under this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.3</u> and, in order to obtain such payment, the Company or Parent, as the case may be, commences a suit that results in a judgment against such Party for such amounts, such Party shall pay interest on such amounts from the date payment of such amounts were due to the date of actual payment at the rate equal to the prime rate published in The Wall Street Journal for the relevant period, together with the costs and expenses of the other Party (including reasonable legal fees and expenses) in connection with such suit. For the avoidance of doubt, in no event shall the Company be required to pay the Company Termination Fee, nor shall Parent be required to pay the Parent Termination Fee, on more than one occasion. Notwithstanding anything to the contrary in this Agreement, in the event that the Parent Termination Fee or Company Termination Fee is payable and actually paid to Parent or the Company in accordance with this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.3</u>, payment of such Parent Termination Fee or Company Termination Fee, as applicable, shall be the sole and exclusive remedy of the non-terminating Party and its respective affiliates against any other Party or such other Party&#8217;s stockholders or shareholders, as applicable, directors, officers, affiliates and other Representatives, for any loss or damage based upon, arising out of or relating to this Agreement or the negotiation, execution or performance hereof or the Transactions contemplated hereby, except in the case of Willful and Material Breach or fraud. Solely for purposes of establishing the basis for the amount thereof, and without in any way increasing the amount of the Parent Termination Fee or Company Termination Fee, expanding the circumstances in which the Parent Termination Fee or Company Termination Fee are to be paid or restricting or modifying the other rights of any Party hereunder, in the event of the valid termination of this Agreement under circumstances in which the Parent Termination Fee or Company Termination Fee are payable pursuant to this <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>7.3</u>, it is agreed that each of such amount is liquidated damages, and not a penalty, and the payment thereof in such circumstances is supported by due and sufficient consideration; <u>provided</u>, that no payment of the Parent Termination Fee or Company Termination Fee shall be considered in lieu of, or a replacement or substitution for, damages incurred in the event of Willful and Material Breach or fraud.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="90" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">90</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">7.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment or Supplement</u>. This Agreement may be amended, modified or supplemented by the Parties by action taken or authorized by their respective Boards of Directors at any time prior to the Effective Time, whether before or after the Parent Stockholder Approval or Company Shareholder Approval has been obtained; <u>provided</u>, that after the Parent Stockholder Approval or Company Shareholder Approval has been obtained, no amendment shall be made that pursuant to applicable Law requires further approval or adoption by the stockholders of Parent or shareholders of the Company, as applicable, without such further approval or adoption. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing specifically designated as an amendment hereto, signed on behalf of each of the Parties in interest at the time of the amendment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">7.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Extension of Time; Waiver</u>. At any time prior to the Effective Time, the Parties may, by action taken or authorized by their respective Boards of Directors, to the extent permitted by applicable Law, (a)&nbsp;extend the time for the performance of any of the obligations or acts of the other Parties, (b)&nbsp;waive any inaccuracies in the representations and warranties of the other Parties set forth in this Agreement or any document delivered pursuant hereto, or (c)&nbsp;waive compliance with any of the agreements or conditions of the other Parties contained herein; <u>provided</u>, that after the Parent Stockholder Approval or Company Shareholder Approval, as applicable, has been obtained, no waiver may be made that pursuant to applicable Law requires further approval or adoption by the stockholders of Parent or shareholders of the Company, as applicable, without such further approval or adoption. Any agreement on the part of a Party to any such waiver shall be valid only if set forth in a written instrument executed and delivered by a duly authorized officer on behalf of such Party. No failure or delay of any Party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise have hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE 8</b><br>
<b>GENERAL PROVISIONS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Survival</u>. This &#8206;<u>Article 8</u> and the agreements of the Company, Parent and Merger Sub contained in &#8206;&#8206;<u>Article 2</u>, <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.9</u> (Director and Officer Indemnification), <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.10</u> (Stock Exchange Listing), and <u>Section </u><u>&#8206;</u><u>5.14</u> (Employee Matters) shall survive the consummation of the Merger. No other representations, warranties, covenants or agreements in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Effective Time, except for those covenants or agreements of the Parties which by their terms apply, or are to be performed in whole or in part, after the Effective Time, which shall survive to the extent expressly provided for therein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="91" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">91</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>. Any notices or other communications to any Party required or permitted under, or otherwise given in connection with, this Agreement shall be in writing and shall be deemed to have been duly given (a)&nbsp;when delivered or sent if delivered in person, (b)&nbsp;on the fifth Business Day after dispatch by registered or certified mail, (c)&nbsp;on the next Business Day if transmitted by national overnight courier or (d)&nbsp;on the date delivered if sent by email (provided the sender does not receive an automatic bounce back of non-delivery), in each case, as follows (or to such other Persons or addressees as may be designated in writing by the Party to receive such notice):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">If to the Company, addressed to it at:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-align: justify;">Olympic Steel, Inc.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-align: justify;">22901 Millcreek Boulevard, Suite 650</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-align: justify;">Highland Hills, Ohio 44122<br>
Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Richard Manson<br>
Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;rmanson@olysteel.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">with a copy (which shall not constitute notice) to:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">Jones Day</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">901 Lakeside Avenue</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">Cleveland, Ohio 44114</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benjamin L. Stulberg; Jared P. Hasson</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-align: justify;">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;blstulberg@jonesday.com; jhasson@jonesday.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">If to Parent or Merger Sub, addressed to it at:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">Ryerson Holding Corporation</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-align: justify;">227 W. Monroe St. &#8211; 27th Floor</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-align: justify;">Chicago, Illinois 60606<br>
Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General Counsel<br>
Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mark.Silver@ryerson.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">with a copy (which shall not constitute notice) to:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">Willkie Farr &amp; Gallagher LLP</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">787 Seventh Avenue</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">New York, New York 10019</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-align: justify;">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cristopher Greer; Adam Turteltaub; Brian Hamilton; Thomas Sharkey</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 180pt; text-indent: -72pt; text-align: justify;">Email:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;CGreer@willkie.com;&nbsp;ATurteltaub@willkie.com; BHamilton@willkie.com; TSharkey@willkie.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Definitions</u>. For purposes of this Agreement, the term:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Acceptable Confidentiality Agreement</u>&#8221; means a confidentiality agreement between Parent or the Company, on the one hand, and a counterparty, on the other hand, that contains confidentiality provisions that are no less favorable in the aggregate to such counterparty than those contained in the Confidentiality Agreement with respect to Parent or the Company, as applicable; <u>provided</u> that such confidentiality agreement shall not include any provision calling for an exclusive right to negotiate with any Party; <u>provided</u>, <u>however</u>, that such confidentiality agreement shall not contain any &#8220;standstill&#8221; or similar provision that would prohibit making or amending a Competing Proposal to Parent or the Company, as applicable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="92" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">92</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>affiliate</u>&#8221; means a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, the first-mentioned Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Anti-corruption Laws</u>&#8221; means Laws relating to anti-bribery or anti-corruption (governmental or commercial) which apply to the Company, Parent, or their respective Subsidiaries, including Laws that prohibit the corrupt payment, offer, promise or authorization of the payment or transfer of anything of value (including gifts or entertainment), directly or indirectly, to any foreign Government Official or other Person to obtain a business advantage, including the FCPA, the U.K. Bribery Act of 2010 and all national and international Laws enacted to implement the OECD Convention on Combating Bribery of Foreign Officials in International Business Transactions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>associate</u>&#8221; has the meaning set forth in Chapter 1704.01 of the OGCL.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>beneficial ownership</u>&#8221; (and related terms such as &#8220;beneficially owned&#8221; or &#8220;beneficial owner&#8221;) has the meaning set forth in Rule 13d-3 under the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Business Day</u>&#8221; means any date except Saturday or Sunday on which commercial banks are not required or authorized to close in New York, New York, United States.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Credit Agreement</u>&#8221; means that certain Third Amended and Restated Loan and Security Agreement, dated as of December 8, 2017, by and among the Lenders (as defined therein), Bank of America, N.A., as administrative agent, and the other parties party thereto, as amended, restated, amended and restated, supplemented or otherwise modified from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Disclosure Schedule</u>&#8221; means the disclosure schedule delivered by the Company to Parent and Merger Sub prior to the execution of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Intellectual Property</u>&#8221; means all Company Owned Intellectual Property together with all third party Intellectual Property used, held for use in or necessary to conduct the business of the Company and its Subsidiaries as currently conducted.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="93" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">93</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Material Adverse Effect</u>&#8221; means any Effect that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole; <u>provided</u>, <u>however</u>, that Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to <u>clauses (a)</u>, <u>(b)</u>, <u>(c)</u> and <u>(d)</u> of the below shall be so considered to the extent such Effect disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industries in the same geographic regions: (a)&nbsp;changes or proposed changes in Law or other legal or regulatory conditions (or the interpretation or enforcement thereof) or changes or proposed changes in GAAP or other accounting standards (or the interpretation or enforcement thereof), including the adoption, implementation, repeal, modification, reinterpretation or proposal of any Law (or the enforcement thereof) by any Governmental Entity, or any panel or advisory body empowered or appointed thereby, (b)&nbsp;changes in general economic, business or labor conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in the United States or globally, or changes generally affecting the industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in the United States or globally, (c)&nbsp;changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action, sabotage, acts of terrorism, government shutdown, lapse in appropriation or funding hiatus (or similar event), or civil unrest), changes due to natural or man-made disasters or any other national or international calamity, crisis or disaster or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis, (d)&nbsp;any Tariff Event, (e)&nbsp;actions expressly required of the Company under this Agreement (or expressly permitted in <u>Section 5.1</u> of the Company Disclosure Schedule) or taken at the written request of Parent (including any action taken in accordance with and subject to the terms of <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.6(c)</u>), (f)&nbsp;the negotiation, execution, delivery, announcement, performance, pendency or consummation of this Agreement and the Merger, including (i)&nbsp;the identity of, or the effect of any fact or circumstance relating to, Parent, and (ii)&nbsp;any termination of, reduction in or similar negative impact on relationships, contractual or otherwise, with any customers, suppliers, distributors, partners or employees due to the public announcement of this Agreement and the Merger, (g)&nbsp;any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to this Agreement or the Transactions, (h)&nbsp;changes in the trading price or trading volume of shares of Company Common Stock or any downgrade in the ratings of any indebtedness or debt securities of the Company or its Subsidiaries (provided that the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred to the extent not otherwise excluded hereunder), and (i)&nbsp;any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (including any analysts&#8217; estimates or expectations) (provided that the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred to the extent not otherwise excluded hereunder).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Owned Intellectual Property</u>&#8221; means all Intellectual Property owned or purported to be owned by the Company and its Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Proprietary Software</u>&#8221; means all Software included in the Company Owned Intellectual Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Real Property Lease</u>&#8221; means any lease, sublease, occupancy agreement or other agreement governing any Company Leased Real Property and any amendment, modification, guaranties and side letters relating thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Registered Intellectual Property</u>&#8221; means any and all Company Owned Intellectual Property which consists of (a)&nbsp;applications or registrations of Patents, (b)&nbsp;applications or registrations of Trademarks, (c)&nbsp;applications or registrations of Copyrights and (d)&nbsp;Internet Domain Names.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="94" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">94</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Stock Plan</u>&#8221; means the Olympic Steel, Inc. Amended and Restated 2007 Omnibus Incentive Plan, as amended and/or restated from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Tax Counsel</u>&#8221; means Jones Day or such other nationally recognized Tax counsel reasonably acceptable to the Company and Parent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Company Tax Opinion</u>&#8221; means a written opinion from Company Tax Counsel delivered to the Company in connection with the consummation of the Merger pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.13(b)</u>, dated as of the Closing Date, based on the facts, representations, assumptions and exclusions set forth or described in such opinion, to the effect that the Merger will qualify for the Intended Tax Treatment. In rendering such opinion, Company Tax Counsel shall be entitled to rely upon customary assumptions, representations, warranties and covenants reasonably satisfactory to it, including representations and covenants set forth in the customary Tax representation letters obtained from Parent, Merger Sub and the Company pursuant to <u>Section </u><u>&#8206;</u><u>5.13(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Contract</u>&#8221; means any legally binding agreements, arrangements, commitments, contracts, leases (whether for real or personal property), notes, bonds, mortgages, indentures, deeds of trust, loans, evidences of indebtedness, purchase orders, letters of credit, settlement agreements, employment agreements, licenses and other obligations to which a Person is a party or to which any of the assets of such Person or its Subsidiaries are subject, whether oral or written, express or implied, including all amendments or modifications thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>control</u>&#8221; (including the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly or as trustee or executor, of the power to direct or cause the direction of the management or policies of a Person, whether through the ownership of stock or shares or as trustee or executor, by Contract or otherwise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Disclosure Schedules</u>&#8221; means the Parent Disclosure Schedule and the Company Disclosure Schedule.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Effect</u>&#8221; means any change, event, occurrence or development.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Environmental Claim</u>&#8221; means any written notice of Proceeding, investigation, order, demand, or claim by any Person or entity alleging actual or potential liability (including actual or potential liability for investigatory costs, cleanup costs, response costs, natural resources damages, property damages, personal injuries, attorneys&#8217; fees or penalties) arising out of, based on, resulting from or relating to (a)&nbsp;the Release or threat of Release of or exposure of any Person to any Hazardous Materials, (b)&nbsp;circumstances forming the basis of any violation or alleged violation of any applicable Environmental Law, or (c)&nbsp;any other matters for which liability is imposed under Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Environmental Laws</u>&#8221; means any and all applicable Laws, regulating or relating to pollution, protection of the environment (including ambient air, surface water, ground water, land surface, subsurface strata, wildlife, plants or other natural resources), and/or the protection of health and safety of persons from exposures to Hazardous Materials in the environment, including those relating to the manufacture, distribution or labeling of Hazardous Materials or products containing Hazardous Materials, or the handling, use, presence, generation, treatment, transportation, storage, disposal, Release or threatened Release of or human exposure to any Hazardous Material.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="95" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">95</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Environmental Permits</u>&#8221; means any permit, certificate, approval, identification number, license or other authorization required under an Environmental Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Equity Interest</u>&#8221; means any share, capital stock, partnership, member, membership, limited liability company or similar interest in any Person, and any option, warrant, right or security (including debt securities) convertible, exchangeable or exercisable thereto or therefor.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>ERISA</u>&#8221; means the United States Employee Retirement Income Security Act of 1974, as amended.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>ERISA Affiliate</u>&#8221; means, with respect to any Person, any trade or business or Person (whether or not incorporated) that, together with such Person, is, or was at the relevant time, considered under common control and treated as one employer under Section 414(b), (c), (m) or (o) of the Code or Section 4001 of ERISA.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Expenses</u>&#8221; means an amount in cash equal to the aggregate amount of all out-of-pocket fees, costs and other expenses (including legal fees, financial advisory fees, consultant fees, filing fees and travel expenses) that Parent or the Company as applicable has directly or indirectly paid or otherwise borne, in connection with this Agreement and the Transactions, up to a maximum of $10,000,000.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>GAAP</u>&#8221; means generally accepted accounting principles as applied in the United States.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Government Official</u>&#8221; means (a)&nbsp;any official, officer, employee, representative or any person acting in an official capacity for or on behalf of any Governmental Entity; (b)&nbsp;any political party or party official or candidate for political office; (c)&nbsp;any public international organization or any department or agency thereof; or (d)&nbsp;any Person or other entity owned in whole or in part, or controlled by any Person described in the foregoing <u>clauses (a)</u>, <u>(b)</u> or <u>(c)</u> of this definition.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Governmental Entity</u>&#8221; means (a)&nbsp;any transnational, national, federal, state, county, municipal, local or foreign government, or subdivision thereof (including any governmental agency, branch, department, division, official, or entity, and any court or tribunal); (b)&nbsp;any entity owned in whole or in part by any transnational, national, federal, state, county, municipal, local or foreign government, or subdivision thereof; (c)&nbsp;any entity exercising or entitled to exercise executive, legislative, judicial, regulatory, taxing or administrative functions of or pertaining to government, and (d)&nbsp;any arbitrator or arbitral body or panel of competent jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>group</u>&#8221; has the meaning ascribed to it in the Exchange Act, except where the context otherwise requires.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="96" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">96</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Hazardous Materials</u>&#8221; means any chemicals, materials, wastes or substances defined as or included in the definition of &#8220;hazardous substances,&#8221; &#8220;hazardous wastes,&#8221; &#8220;hazardous materials,&#8221; &#8220;hazardous constituents,&#8221; &#8220;restricted hazardous materials,&#8221; &#8220;extremely hazardous substances,&#8221; &#8220;toxic substances,&#8221; &#8220;contaminants,&#8221; &#8220;pollutants,&#8221; or &#8220;toxic pollutants,&#8221; under, or for which liability or standards of conduct are imposed pursuant to, any Environmental Law, including petroleum or petroleum by-products, asbestos or asbestos-containing materials or products, per- and polyfluoroalkyl substances, polychlorinated biphenyls (PCBs) radioactive materials, lead-based paints and radon.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>HSR Act</u>&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Intellectual Property</u>&#8221; means all domestic and foreign intellectual property rights, including all (a)&nbsp;patents, utility models and industrial design registrations and applications (including any continuations, divisionals, continuations-in-part, provisionals, renewals, reissues, re-examinations and applications for any of the foregoing) (&#8220;<u>Patents</u>&#8221;), (b)&nbsp;trademarks, service marks, trade names, trade dress, logos, slogans, corporate names, brand names and other source or origin indicators, in each case together with all goodwill associated with any of the foregoing, and all applications and registrations in connection therewith (&#8220;<u>Trademarks</u>&#8221;), (c)&nbsp;rights associated with the registration, ownership, or use of any internet domain name, together with any rights in such internet domain name and any account associated therewith (&#8220;<u>Internet Domain Names</u>&#8221;), (d)&nbsp;rights associated with the registration, ownership, or use of an account with a proprietor of an internet-based application or Web site that facilitates the creation and exchange of user-generated content, such as Facebook, X, Pinterest, TikTok, or Instagram, (e)&nbsp;copyrights, works of authorship, mask works, and all renewals, registrations and applications in connection therewith, Software, and moral rights (&#8220;<u>Copyrights</u>&#8221;), (f)&nbsp;trade secrets and other intellectual property rights in confidential and proprietary information (including ideas, know-how, formulas, compositions, processes and techniques, research and development information, data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, pricing and cost information, business and marketing plans and proposals and customer and supplier lists and information) (&#8220;<u>Trade Secrets</u>&#8221;), (g)&nbsp;all other intellectual property rights or proprietary rights which subsist in any part of the world; and (h)&nbsp;all tangible embodiments of the foregoing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>IRS</u>&#8221; means the United States Internal Revenue Service.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>IT Assets</u>&#8221; means (a)&nbsp;all computer hardware (including peripherals and ancillary equipment and network and telecommunications equipment), Software, servers, workstations, routers, hubs, switches, databases, circuits, networks, data communications lines and all other information technology equipment and infrastructure and (b)&nbsp;associated user manuals and other related documentation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Joint Proxy Statement</u>&#8221; means a proxy statement or similar disclosure document or circular relating to the Company Shareholders Meeting and the Parent Stockholders Meeting.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="97" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">97</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Knowledge</u>&#8221; and &#8220;<u>known</u>&#8221; means the actual knowledge of the officers of the Company set forth in <u>Section </u><u>&#8206;</u><u>8.3(a)</u> of Company Disclosure Schedule or of the officers of Parent set forth in <u>Section </u><u>&#8206;</u><u>8.3(a)</u> of the Parent Disclosure Schedule, as the case may be.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Law</u>&#8221; means any federal, state, provincial, municipal, local or foreign law, common law, statute, code, ordinance, rule, regulation, and any legally-binding order, judgment, writ, stipulation, award, injunction, decree or arbitration award of any applicable Governmental Entity having the effect of law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Lien</u>&#8221; means any lien, mortgage, pledge, conditional or installment sale (or lease in the nature thereof) agreement, encumbrance, defect in title, covenant, condition, restriction, charge, option, right of first refusal, right of first offer, lease, sublease, easement, security interest, deed of trust, right-of-way, encroachment, community property interest or other claim or restriction of any nature, whether voluntarily incurred or arising by operation of Law (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset). For the avoidance of doubt, Liens shall not include non-exclusive licenses of Intellectual Property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>NASDAQ</u>&#8221; means the NASDAQ Stock Market LLC.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>NYSE</u>&#8221; means the New York Stock Exchange.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Order</u>&#8221; means any order, writ, injunction, decree, circular, judgment, award, settlement or stipulation issued, promulgated, made, rendered, of, by or with any Governmental Entity (in each case, whether temporary, preliminary or permanent).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Other Covered Party</u>&#8221; means any political party or party official, or any candidate for political office.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Parent Disclosure Schedule</u>&#8221; means the disclosure schedule delivered by Parent to the Company prior to the execution of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">&#8220;<u>Parent Intellectual Property</u>&#8221; means all Parent Owned Intellectual Property together with all third party Intellectual Property used, held for use in or necessary to conduct the business of Parent and its Subsidiaries as currently conducted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="98" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">98</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Parent Material Adverse Effect</u>&#8221; means any Effect that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of Parent and its Subsidiaries, taken as a whole; <u>provided</u>, <u>however</u>, that Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Parent Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Parent Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b), (c) and (d) of the below shall be so considered to the extent such Effect disproportionately impacts Parent and its Subsidiaries, taken as a whole, relative to other companies operating in the same industries in the same geographic regions: (a)&nbsp;changes or proposed changes in Law or other legal or regulatory conditions (or the interpretation or enforcement thereof) or changes or proposed changes in GAAP or other accounting standards (or the interpretation or enforcement thereof), including the adoption, implementation, repeal, modification, reinterpretation or proposal of any Law (or the enforcement thereof) by any Governmental Entity, or any panel or advisory body empowered or appointed thereby, (b)&nbsp;changes in general economic, business or labor conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in the United States or globally, or changes generally affecting the industries (including seasonal fluctuations) in which Parent or its Subsidiaries operate in the United States or globally, (c)&nbsp;changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action, sabotage, acts of terrorism, government shutdown, lapse in appropriations or funding hiatus (or similar event), or civil unrest), changes due to natural or man-made disasters or any other national or international calamity, crisis or disaster or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis, (d)&nbsp;any Tariff Event, (e)&nbsp;actions expressly required of Parent (or expressly permitted in <u>Section </u><u>&#8206;</u><u>5.2</u> of the Parent Disclosure Schedule) under this Agreement or taken at the written request of the Company (including any action taken in accordance with and subject to the terms of <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.6(c)</u>), (f)&nbsp;the negotiation, execution, delivery, announcement, performance, pendency or consummation of this Agreement and the Merger, including (i)&nbsp;the identity of, or the effect of any fact or circumstance relating to, the Company, and (ii)&nbsp;any termination of, reduction in or similar negative impact on relationships, contractual or otherwise, with any customers, suppliers, distributors, partners or employees due to the public announcement of this Agreement and the Merger, (g)&nbsp;any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to this Agreement or the Transactions, (h)&nbsp;changes in the trading price or trading volume of shares of Parent Common Stock or any downgrade in the ratings of any indebtedness or debt securities of Parent or its Subsidiaries (provided that the underlying cause of such failure may be taken into account in determining whether a Parent Material Adverse Effect has occurred to the extent not otherwise excluded hereunder), and (i)&nbsp;any failure by Parent or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (including any analysts&#8217; estimates or expectations) (provided that the underlying cause of such failure may be taken into account in determining whether a Parent Material Adverse Effect has occurred to the extent not otherwise excluded hereunder).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Parent Owned Intellectual Property</u>&#8221; means all Intellectual Property owned or purported to be owned by Parent and its Subsidiaries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Parent Proprietary Software</u>&#8221; means all Software included in the Parent Owned Intellectual Property.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Parent Real Property Lease</u>&#8221; means any lease, sublease, occupancy agreement or other agreement governing any Parent Leased Real Property and any amendment, modification, guaranties and side letters relating thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Parent Registered Intellectual Property</u>&#8221; means any and all Parent Owned Intellectual Property which consists of (a)&nbsp;applications or registrations of Patents, (b)&nbsp;applications or registrations of Trademarks, (c)&nbsp;applications or registrations of Copyrights and (d)&nbsp;Internet Domain Names.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="99" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">99</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Parent Stock Plan</u>&#8221; means the Second Amended and Restated Parent Omnibus Incentive Plan, as amended from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Parent Tax Counsel</u>&#8221; means Willkie Farr &amp; Gallagher LLP or such other nationally recognized Tax counsel reasonably acceptable to the Company and Parent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Parent Tax Opinion</u>&#8221; means a written opinion from Parent Tax Counsel delivered to Parent in connection with the consummation of the Merger pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.13(b)</u>, dated as of the Closing Date, based on the facts, representations, assumptions and exclusions set forth or described in such opinion, to the effect that the Merger will qualify for the Intended Tax Treatment. In rendering such opinion, Parent Tax Counsel shall be entitled to rely upon customary assumptions, representations, warranties and covenants reasonably satisfactory to it, including representations and covenants set forth in the customary Tax representation letters obtained from Parent, Merger Sub and the Company pursuant to <u>Section</u><u>&nbsp;</u><u>&#8206;</u><u>5.13(b).</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Party</u>&#8221; and &#8220;<u>Parties</u>&#8221; means Parent, Merger Sub and the Company, collectively or individually as the context may require.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Permitted Liens</u>&#8221; means (a)&nbsp;Liens for current Taxes, or governmental assessments, charges or claims of payment not yet past due, or the amount or validity of which is being contested in good faith by appropriate Proceedings and for which adequate reserves in accordance with GAAP have been established in the latest financial statements of Parent included in the Parent SEC Documents or the Company included in Company SEC Documents, as the case may be, (b)&nbsp;mechanics&#8217;, workmen&#8217;s, repairmen&#8217;s, warehousemen&#8217;s and carriers&#8217; Liens arising in the ordinary course of business consistent with past practice for sums not yet due and payable, (c)&nbsp;matters of record, matters that would be revealed by a current, accurate survey of real property or a physical inspection thereof, Liens and other imperfections of title that do not secure or evidence indebtedness and do not and would not reasonably be expected to, individually or in the aggregate, materially impair the value or continued ownership, use and operation of the assets to which they relate, (d)&nbsp;restrictions on transfers under applicable securities Laws, (e)&nbsp;zoning, building codes and other land use Laws regulating the use or occupancy of the applicable real property or the activities conducted thereon, which are imposed by any governmental authority having jurisdiction over such real property, which are not violated in any material respect by the current use or occupancy of such real property or the operation of the business thereon, (f)&nbsp;with respect to any leased real property, statutory or contractual landlord&#8217;s or lessor&#8217;s liens and (g)&nbsp; Liens incurred pursuant to the Company Credit Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Person</u>&#8221; means an individual, corporation (including not-for profit), limited company, limited liability company, partnership, association, estate, trust, unincorporated organization, Governmental Entity, or other entity or group of any kind or nature.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Personal Information</u>&#8221; means any information that relates, describes, is reasonably capable of being associated with, or could reasonably be linked, directly or indirectly, to an identified or identifiable individual or that constitutes &#8220;personal information,&#8221; &#8220;personal data,&#8221; &#8220;personally identifiable information,&#8221; or any similar term under any applicable Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="100" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">100</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Proceeding</u>&#8221; means any claim, complaint, charge, demand, assessment, litigation, injunction, suit, action, proceeding, arbitration, mediation, audit, hearing, inquiry or administrative proceeding (in each case, whether civil, criminal, administrative, investigative, formal or informal) commenced, brought, conducted or heard by or before or otherwise involving, any Governmental Entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Release</u>&#8221; means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, dumping, disposing or other release into, or migrating through, soil, air, water, groundwater, wetland or any other environmental medium.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Representatives</u>&#8221; means, with respect to any Person, such Person&#8217;s officers, directors, employees, accountants, legal counsel, financial advisors, consultants and other advisors and representatives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>SEC</u>&#8221; means the Securities and Exchange Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Software</u>&#8221; means all (a)&nbsp;computer programs (including any and all software, firmware, or implementation of algorithms, models and methodologies whether in source code, executable code, or object code), (b)&nbsp;APIs; (c)&nbsp;assemblers and compilers; (d)&nbsp;data files, (e)&nbsp;software libraries; (f)&nbsp;device drivers; (g)&nbsp;databases and database schema and compilations (including any and all data and collections of data, whether machine readable or otherwise), (h)&nbsp;all programming notes, flow-charts and other work product used to design and develop any of the foregoing, and (i)&nbsp;documentation (including user manuals and training materials) relating to any of the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Subsidiary</u>&#8221; means, with respect to any Person, any corporation, partnership, joint venture or other legal entity of which such Person (either alone or through or together with any other Subsidiary), owns, directly or indirectly, a majority of the stock or other Equity Interests, the holders of which are generally entitled to vote for the election of the board of directors or other governing body of such corporation, partnership, joint venture or other legal entity, or any Person that would otherwise be deemed a &#8220;subsidiary&#8221; under Rule 12b-2 promulgated under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Tariff Event</u>&#8221; means changes in interest, currency or exchange rates, commodity prices, tariffs, anti-dumping or countervailing duties, surtaxes or any trade wars or worsening of the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Tax Return</u>&#8221; means any report, return (including information return), claim for refund, election, estimated filing, declaration, forms, statements or similar documents filed or required to be filed with any Governmental Entity with respect to Taxes, including any schedules or attachments thereto and any amendments thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Taxes</u>&#8221; means any and all U.S. federal, state and local and non-U.S. taxes, assessments, levies, duties, tariffs, imposts and other charges and fees of any kind whatsoever similar to, or in the nature of, a tax (together with any and all interest, penalties, additions to tax and additional amounts imposed with respect thereto) imposed by any Governmental Entity, including any income, franchise, windfall or other profits, gross receipts, occupation, severance, disability, property, sales, use, net worth, capital stock, payroll, employment, social security, workers&#8217; compensation, unemployment compensation, excise, withholding, ad valorem, stamp, transfer, value-added, and license, registration documentation fees, alternative or add-on minimum or estimated taxes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="101" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">101</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Taxing Authority</u>&#8221; means any Governmental Entity responsible for the administration or the imposition of any Tax.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">&#8220;<u>Willful and Material Breach</u>&#8221; means (a)&nbsp;with respect to any material breach of a representation and warranty, that the breaching Party had Knowledge of such breach as of the date of this Agreement and (b)&nbsp;with respect to any material breach of a covenant or other agreement, that the breaching Party took or failed to take action with Knowledge that the action so taken or omitted to be taken constituted a material breach of such covenant or agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Headings</u>. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>. If any term or other provision (or part thereof) of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other conditions and provisions (or part thereof) of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the Transactions is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision (or part thereof) is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in an acceptable manner to the end that the Transactions are fulfilled to the extent possible.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u>. This Agreement (together with the Exhibits, the Parent Disclosure Schedules, the Company Disclosure Schedules and the other documents delivered pursuant hereto) and the Confidentiality Agreement constitute the entire agreement of the Parties and supersede all prior agreements and undertakings, both written and oral, among the Parties, or any of them, with respect to the subject matter hereof. Notwithstanding anything to the contrary in this Agreement, the Parent Disclosure Schedules, the Company Disclosure Schedules, schedules and similar documents and instruments delivered pursuant to this Agreement shall not be deemed part of this Agreement for purposes of the OGCL, but shall have the effects provided in this Agreement otherwise (including with respect to this <u>Section </u><u>&#8206;</u><u>8.6</u>).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Assignment</u>. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the Parties, in whole or in part (whether by operation of law or otherwise), without the prior written consent of the other Parties, and any attempt to make any such assignment without such consent shall be null and void. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and assigns.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="102" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">102</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.8&nbsp;&nbsp;&nbsp;&nbsp;<u>No Third Party Beneficiaries</u>. Parent, Merger Sub and the Company hereby agree that their respective representations, warranties and covenants set forth herein shall be binding upon and inure solely to the benefit of the Parties and their respective successors and assigns, and nothing in this Agreement, express or implied, other than <u>Section </u><u>&#8206;</u><u>5.9</u>, is intended to or shall confer upon any other Person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement, including the right to rely upon the representations and warranties set forth herein. The Parties further agree that the rights of third-party beneficiaries under <u>Section </u><u>&#8206;</u><u>5.9</u> shall not arise unless and until the Effective Time occurs. The representations and warranties in this Agreement are the product of negotiations among the Parties and are for the sole benefit of the Parties. In some instances, the representations and warranties in this Agreement may represent an allocation among the Parties of risks associated with particular matters regardless of the Knowledge of any of the Parties. Consequently, Persons other than the Parties may not rely upon the representations and warranties in this Agreement as characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Mutual Drafting; Interpretation</u>. Each Party has participated in the drafting of this Agreement, which each Party acknowledges is the result of extensive negotiations between the Parties. If an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision. For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders. As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221; The words &#8220;made available to Parent&#8221; or &#8220;made available to the Company&#8221;, as applicable, and words of similar import refer to documents (a)&nbsp;posted to the data room maintained by Parent or the Company or their respective Representatives, as applicable in connection with the Transactions, (b)&nbsp;delivered in person or electronically to Parent and Merger Sub or the Company or any of their respective Representatives, as applicable, or (c)&nbsp;that are publicly available in the Electronic Data Gathering, Analysis and Retrieval (EDGAR) database of the SEC, in each case, at least one Business Day prior to the date of this Agreement. Except as otherwise indicated, all references in this Agreement to &#8220;Sections,&#8221; &#8220;Exhibits,&#8221; &#8220;Annexes&#8221; and &#8220;Schedules&#8221; are intended to refer to Sections of this Agreement and Exhibits, Annexes and Schedules to this Agreement. All references in this Agreement to &#8220;$&#8221; are intended to refer to U.S. dollars. Unless otherwise specifically provided for herein, the term &#8220;or&#8221; shall not be deemed to be exclusive. In this Agreement, when determining whether an item is &#8220;material&#8221; to Parent or the Company, the term &#8220;material&#8221; shall be interpreted to mean, as applicable, &#8220;material to the business of Parent and its Subsidiaries, taken as a whole&#8221; or &#8220;material to the business of the Company and its Subsidiaries, taken as a whole.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="103" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">103</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">8.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall be deemed to be made in and in all respects shall be interpreted, construed and governed by and in accordance with the Law of the State of Delaware without regard to the conflict of law principles thereof. Notwithstanding the foregoing (i)&nbsp;the matters contained in <u>&#8206;</u><u>Article 1</u> and <u>&#8206;</u><u>Article 2</u> shall be governed by the OGCL, including matters relating to the filing of the Certificate of Merger and the effects of the Merger, and (ii)&nbsp;all matters relating to the fiduciary duties of the Company Board (<u>clauses (i)</u> and <u>(ii)</u> together, the &#8220;<u>Ohio Law Matters</u>&#8221;) shall be governed and construed in accordance with the laws of the State of Ohio, in each case without regard to the conflict of law principles thereof to the extent that such principles would direct a matter to another jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Parties hereby irrevocably and unconditionally submits, for itself and its property, (i)&nbsp;for all matters other than the Ohio Law Matters, to the exclusive jurisdiction of the Court of Chancery of the State of Delaware, or, in the event such court does not have jurisdiction, Federal court of the United States of America, sitting in Delaware, and any appellate court from any thereof, and (ii)&nbsp;for the Ohio Law Matters, to the court of Common Pleas, Commercial Docket, Cuyahoga County, Ohio, or in the event such court does not have jurisdiction, a Federal Court of the United States sitting in Cuyahoga County, Ohio, in each case in any Proceeding arising out of or relating to this Agreement or the Transactions, and each of the Parties hereby irrevocably and unconditionally (A)&nbsp;agrees not to commence any such Proceeding except in such courts, (B)&nbsp;agrees that any claim in respect of any such Proceeding may be heard and determined in such Delaware or Ohio State court (as applicable) or, to the extent permitted by Law, in such Federal court, (C)&nbsp;waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Proceeding in any such Delaware or Ohio State or Federal court (as applicable), and (D)&nbsp;waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such Proceeding in any such Delaware or Ohio State or Federal court (as applicable). Each of the Parties agrees that a final judgment in any such Proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each Party irrevocably consents to service of process in the manner provided for notices in <u>Section </u><u>&#8206;</u><u>8.2</u>. Nothing in this Agreement will affect the right of any Party to this Agreement to serve process in any other manner permitted by Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (ii)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (iii)&nbsp;IT MAKES SUCH WAIVERS VOLUNTARILY, AND (iv)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <u>SECTION</u><u>&nbsp;</u><u>&#8206;</u><u>8.10(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="104" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">104</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u>. This Agreement may be executed in one or more counterparts, and by the different Parties in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. This Agreement shall become effective when each Party hereto shall have received a counterpart hereof signed by all of the other Parties. Until and unless each Party has received a counterpart hereof signed by the other Party, this Agreement shall have no effect and no Party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement or other communication). The exchange of a fully executed Agreement (in counterparts or otherwise) by portable document format (.PDF) or other electronic transmission shall be sufficient to bind the Parties to the terms and conditions of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Specific Performance</u>. The Parties agree that if any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached (including failing to take such actions as are required by the Parties hereunder to consummate the Transactions), irreparable damage would occur, no adequate remedy at Law would exist and damages would be difficult to determine, and accordingly, (a)&nbsp;the Parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity, (b)&nbsp;the Parties waive any requirement for the securing or posting of any bond in connection with the obtaining of any specific performance or injunctive relief and (c)&nbsp;the Parties will waive, in any action for specific performance, the defense of adequacy of a remedy at Law. The Company&#8217;s or Parent&#8217;s pursuit of specific performance at any time will not be deemed an election of remedies or waiver of the right to pursue any other right or remedy to which such Party may be entitled, including the right to pursue remedies for liabilities or damages incurred or suffered by the other Party in the case of a breach of this Agreement involving a Willful and Material Breach.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">8.13&nbsp;&nbsp;&nbsp;&nbsp;<u>Disclosure Schedules</u>. The Parties acknowledge and agree that (a)&nbsp;the inclusion of any items or information in the Disclosure Schedules that are not required by this Agreement to be so included is solely for the convenience of Parties, (b)&nbsp;the disclosure by the Parties of any matter in the Disclosure Schedules shall not be deemed to constitute an acknowledgement by any Party that the matter is required to be disclosed by the terms of this Agreement or that the matter is material or significant or that such item has had or would reasonably be expected to have a Company Material Adverse Effect or Parent Material Adverse Effect, and the disclosure therein of any allegations with respect to any alleged breach, violation or default under any contractual or other obligation, or any law, is not an admission that such breach, violation or default has occurred, (c)&nbsp;if any section of the Disclosure Schedules lists an item or information in such a way as to make its relevance to the disclosure required by or provided in another section of the Disclosure Schedules or the statements contained in any Section of this Agreement reasonably apparent on the face of such disclosure, the matter shall be deemed to have been disclosed in or with respect to such other section, notwithstanding the omission of an appropriate cross-reference to such other section or the omission of a reference in the particular representation and warranty to such section of the Disclosure Schedules, (d)&nbsp;except as provided in <u>clause (c)</u> above, headings have been inserted in the Disclosure Schedules for convenience of reference only, (e)&nbsp;the Disclosure Schedules are qualified in their entirety by reference to specific provisions of this Agreement (f)&nbsp;the Disclosure Schedules and the information and statements contained therein are not intended to constitute, and shall not be construed as constituting, representations or warranties of the Parties except as and to the extent provided in this Agreement, and (g)&nbsp;in disclosing such information, the disclosing Party does not waive, and expressly reserves any rights under, any attorney-client privilege associated with such information or any protection afforded by the work-product doctrine with respect to any of the matters disclosed or discussed therein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[<i>Remainder of page intentionally left blank.</i>]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="105" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">105</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">IN WITNESS WHEREOF, each of the Parties hereto has caused this Agreement to be executed as of the date first written above by their respective officers thereunto duly authorized.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><b>OLYMPIC STEEL, INC.</b></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Richard T. Marabito</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" rowspan="1" valign="top" width="3%">Name:&nbsp; &nbsp; &nbsp;Richard T. Marabito</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" rowspan="1" valign="top" width="3%">Title:&nbsp; &nbsp; &nbsp; &nbsp;Chief Executive Officer</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">[<i>Signature Page to Agreement and Plan of Merger</i>]</p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" rowspan="1" valign="top" width="3%"><b>RYERSON HOLDING CORPORATION</b></td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">By:</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="35%">/s/ Edward Lehner</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" rowspan="1" valign="top" width="3%">Name:&nbsp; &nbsp; &nbsp; Edward Lehner<br>
			Title:&nbsp; &nbsp; &nbsp; &nbsp; President and Chief Executive Officer</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">[<i>Signature Page to Agreement and Plan of Merger</i>]</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" rowspan="1" valign="top" width="3%"><b>CRIMSON MS CORP.</b></td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">By:</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="35%">/s/ Edward Lehner</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">Name:&nbsp; &nbsp; &nbsp;Edward Lehner<br>
			Title:&nbsp; &nbsp; &nbsp; &nbsp;President and Chief Executive Officer</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center;">[<i>Signature Page to Agreement and Plan of Merger</i>]</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>zeus-20251028.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/30/2025 12:51:59 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:zeus="http://www.zeus.com/20251028" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.zeus.com/20251028">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/cyd-8k-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zeus-20251028_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zeus-20251028_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zeus-20251028_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.zeus.com/20251028/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="zeus_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>zeus-20251028_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/30/2025 12:51:59 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.zeus.com/20251028/role/statement-document-and-entity-information" xlink:href="zeus-20251028.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.zeus.com/20251028/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>zeus-20251028_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/30/2025 12:51:59 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>zeus-20251028_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/30/2025 12:51:59 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.zeus.com/20251028/role/statement-document-and-entity-information" xlink:href="zeus-20251028.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.zeus.com/20251028/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">OLYMPIC STEEL, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Oct. 28,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">000-23320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">34-1245650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">22901 Millcreek Boulevard, Suite 650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Highland Hills<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">44112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">292-3800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZEUS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000917470<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="zeus20251029_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zeus.com/20251028/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>zeus-20251028.xsd</File>
    <File>zeus-20251028_def.xml</File>
    <File>zeus-20251028_lab.xml</File>
    <File>zeus-20251028_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="zeus20251029_8k.htm">zeus20251029_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zeus20251029_8k.htm": {
   "nsprefix": "zeus",
   "nsuri": "http://www.zeus.com/20251028",
   "dts": {
    "schema": {
     "local": [
      "zeus-20251028.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-cr-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "zeus-20251028_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "zeus-20251028_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zeus-20251028_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "zeus20251029_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 36,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.zeus.com/20251028/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zeus20251029_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zeus20251029_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Axis]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentDomain",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Domain]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r8"
     ]
    },
    "cyd_MaterialCybersecurityIncidentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Table]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.zeus.com/20251028/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001437749-25-032436-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-25-032436-xbrl.zip
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M$DMKPRQ?=)@0+Q*1BF@DO"#R3D-Q*T*,YJPXJ96DT]/RO)6TV.O.6.^<50?
M5".8=HH: 3#<*S'*DR +8!YP!K*>.K*.'N;(VAR+510]!YUV9-4=PU4_;<\L
M?9Z1VCKMUH+'^\#@3\9_YFDV%5&V\H16,G#6AJUUV<7U(?$I"=0/O:L;/UE]
M?O8 ,EMQ?M9E+]?9]]&-'UV3+PMY6S"!R62"'0KOXOC;SEF4)?,-#:XXJ^NR
M%^LJBT??=MZ!B34FLOL41]<[7T4R]4[]],8[N?.3\<J3WNNU97]=]EO](\AN
M;N(0\[N\2]RIE:>S_0?8#9L\D[Y[K0Z]2S$C7VTF@U;(</_A)W C^:YDZ. T
MGL*[SOOEO-I_H/=J<SQ640 ==MQ[Q9$YX9TGUWX4_+L70;KG%D+/2&R==EXQ
M5P>U>A9@SG]/B&U=/0N'G79@G>3939P$V?R-=_9=C'*=.O->A ',#;^/0%<9
M"7\8A'#=RM-AR=!9&Z;790_7EQ@CM9,P&/7 N'NYMJRNTPZLLU/O?3S**1ST
MQOL01'XT"M!S#U:6D-_^$8V#=!3&Z.7Z%##/ZT&8<O_5VG*]+CNV3H:<CR7=
M^ABR/"5'/YCXB7=VVX? Y?ZZ^E0/=TMRH$.D]S%B(!O4]Z[RV2P,Q,JG A[L
MK2V7*_'W#I':)W$-4O8BB4="H ]_Y5G:0^ALQ5E:B9EWB,[0<1+"KR!0[X+L
MQOODWZTUJ:TX2^NR0_A")--@]76S-69D^UTFKS-@9/%<".^=B,0DR+R+T(]6
MG]I*2[X^O*S+ 0=-;936XP_!]/SL9YE(5I_BUC4]&RBNRU&'L^@V2.((?6Y@
M&?2%V-8WLE".)'>(V"X%6Y\SF,;*AZ\.UC>V4(X@=XC(OOK?>\/'UC=64 X.
M=XC$@+Q$@O&J4[@2ZTY6GM(.U]C\['9L(!-A*$99WB/)>;BN #Y ;%V.#KSW
M,Q^(++CU1ZM/8P_ /5EUAM;ER,!)E 4[IW&2Y#.=X/8U\<?"N_(C*N!<?5FZ
MQLF\)36B0Z3W+HF_B>0O__7J8/_EF]3[(%8_F>AP?5-YRR[L#I':^2R(),"&
M26X[&=\&:;SZ5NE#B&[5^5N7@P<?HS1/,.:^S@2VZERMR[&"\[M().E-,$.^
M=N$G(LJP\'&*>6M8DK[R=+>^88-R>*Y#='<I0FI9!227S=%:B%*_)Z9"'<7]
M)_R+O55J6NX]L+E>#_H^Z88^0^P\$]1U\S&]>QHF\I"EW JV-[VG.M=[JL-]
MB7JNOW0Y,JC*>4WX)D^S>"HD''3I9YF,WP.+;8T5FR['$;_$WGEV(Y(2R$B<
M6!@CZTQ]&P#<OB/L'+5 V&%;LU_@.H<O-]#0ZP<-?=3I6HI^@NL<KFNBWE&G
MP764 [%7V#J'ZYJQ=[3!UND4':YKJ?_1!EMG!4ALQ5E=EYU<ZXRM<[2N6<Q'
M&VR=YR:]=<UI/MI@ZZP0J:TXE^MR]GSOL'76F*5U.8.^C]@Z1^M:K7&TN]_E
ME/F>@.L\A+Q6G)-MP'56BMI6G9EU.>#07W"=HW7-[SG:@.L\/;&M;SAU Z[S
M9$2VOL&%#;A.]TELU?E8EZ,%_0/7.5Y?1]H&7.?)B6V-K<\NAP?Z!*YSO*X(
M)T<;<)WG)KUUQ08XVH#K/#6IK:]7;67!==:9YE:=O74Y=M ;;)UU9FI=#A4X
MV#JZ[W2/P'76F;-U.VS05W"==69U78XA?!;)M4B\JWRX\A2VOJ'03N-J2+,@
MNEYG EMU%M;ER(&L7:X!$BK^VAL<H77F=UV.+:P'CM!S,\.51$NI.W:]PQ$Z
M!FOY5H#<QWR!/@$%';]Z&%#0AO174>(<=QPH*!KGHPQ]5>_R-(A$FGK#N0<R
M2/NN4!$*LA3-O#08!S 8//%"1%@:1Q>>329BE 6W@H _5_V@'J\K\,MQIT&&
M:@A5:NAK1J,OUK5P^+C3X$07B9CY"=>H YTBW?TM#H \+Y+X^]S@=A"Y?H !
MO*N=HS<<%;B)PS'H_?C+U0T0M?S\68@,2Y!W5YYDU[77R''7<8RNXC 8!9DF
MVSY%#EZL:VKX<:>AC4Y&(Y3?6>Q9L!YO"%$K& .##/P^0+>]7-=L\>-N@QC-
M9DD\@]\SX9V,^H!5^1!"6W$NU^78@H+(^A+#+%;?:_MR77/%CSN-5G21#T%_
M\TZB"%9]Q+B ZTQJ*\[0NER5\#Y(Q"B+V4H]GTR JR6@P8W%- K@0R]PGU_6
MV:F;1E[+-?)ZSDY>FU9>FU9>FU9>.O[4Y7(C<GYZ9]]'A"/K?0K2K ?I7B_7
M-=WKN-LX95>"#'[F2_LO^H* \1!R6W7FUN6@95-DYU.0!=?]4)G7F-EU.1S9
M(XB?EP](REAU!M?E\*%&8NP+G:TK6MEQM]'*3F/$].$0M2\#AYFX3GHA/U^M
M;_BFT_AENOBH+]SM(82VZMRMRX'"]\$MICV,UYK 5IV3=3E&6'"R8:]$<K/)
MSHF)N(;//1&FZ]HAX+C;B&;2\^8=O-K[?9UI;,797*>AR[[ZWT1\BX@$F9_E
MV>JGW*PQ,^LV<-DPE+[;%#.F^X.#\2,XFUV@N@SQ/4^M8=VQZ5V9[0M,MQX'
M3,09M3-.\^G4J5YAPNY7%2Z2^$.J</M-YBLA'5YTOJ36'*N"J#CS1S<2H>N/
M",. 7V^"U#NY3@1E;J[Z^5I;S?A%YXMG:TG2*J$UBDP_J7-=,]A?=+ILMI$Z
M;22"7M+D#X!![X<JTCN-^Z7W%;NP1D3< ^\$R'>LR\'_X0>WO5.U7VQ4[167
M'"\[K6I;YVG5C\NK=455?MEIS9EQ8P@6H4>TMJX01R\[K0>??9^)*!7I&YO6
M>M& Y=6ZPG"\[#3XB]% XX2Q;7MA4KTNJ2QKP]ZZG,-Y]CT#]J9 AF"P-]KH
M65]ZZ[>)TSL3_I7WNXA$PEU&;X.4,;+Z9+,C,6]L]I46 Z\Z;;-?Y<EM<.N'
MJWY6?@377Q'RZK+!WA.PI=?KFJK_JM,FNH+T>B\F013T B+S(92VXGRLR[;Y
M7X6/P"@K3U[[>^O+R;ILC5\)F( _#/H M/H@&EMQ'M;E LJS* L2T9]<C77F
M95VNGSQ)4WCLVE/8BG.R+A=0?HDQ[2Q1S77?B0@,@!'W&5E]FEO7*J-7G49;
M_9QGN1]Z[Q-_@K6Z;PCR(IDE(NM%$L*#R&[%65VG$1E_QQ+*"*O#/_EWU)0!
M^U!B:N[?\B1(Q\&(NS5P\(X[AF!SU.$<+^B!,;&N6>*ONHW=> JKC0P0)' /
M9.X/2/M>%2+K<OC@:B9&B&7N78B$.M-$HY7O%O<@8EMUCM;E:,+[(!V%<9HG
MPKL:W8AQ'O;!FE@*0-^>8 E^?.D%?12\<0?QG5XQB+ I%;[T=UIA]^ 4=R6+
M9^5S(@=]>4#S=#>I$41=;D2+/5P$UHX96#?!,,B\DR8BDS/5".G/,E-JC@B:
MI<R[H4JPC]$H3F:QVU^1LPE063TU/[8@P UQU!''NY4ACM-X+/#?2W&=AV[%
MX(8L'ILL3E>&+&0],Z(?7XI9(M!Z99[Q22",XX8,'D &[U>&#%31\$/HH*'/
MS[V4JJ?J\U/5CN=A_7B<*57KBJV;\^CN/"O8CZ>JN<[3J+./98%8+R@WURVI
M/+O\?.6]/_OP\<O9>^_\CZ]7']^?>><?O%_SMU=GIU\_GG_Q?OTY?PL?__)?
MKP[V7KR1GRAQ*W_[M+-]] 9#2QI)-C4:]K[(;D,VKXVVO1^<Y)Z_I60U,::J
M,KU%+4W,'SQ5:WO9@"S.7<)&5DW;\F$L_Q;MT\H7W?M4?KL?32B/DJ6Q8(Y/
MXX*X2(0_!5;P7$ZO'[Y3LUD(CT=F]][/'N2>[,1^*6C8P]WCK<GV<_G%?_BN
MI6D^!2Y\>?5';W;L ';,W]X*'K!IW3YJI_XLR.#1_V;#H6?'[0 VKZ_'#3/U
MN2FM,!"MO=F[_7*51&^.7!BG#^P V;&M>K:4OB?:JGZQQ0?M5\>/UOF[R\;8
MSTIMU.'N_O[6S;;E NCC$8O'JW^T+L4(M:A2;+LWYRJ>3H$@N<N*Q%#%M+E@
M+![>5*43.V@4_OVM87]U1@X9K/QN]=T!HD([)V.82"H\X"]P D4T9BOME+H<
MK?PNJC-WO'L(9T[&37I]\&1=1>9=A'Y_>";I*0\QM%?C,+Z+_62\\IOV<%5E
M14X:[E:!<:[\YID3=_@@+655#ES\;><LRI(Y]Y5_4.IHI_8/M<Q1_X5=G@:1
M2%-,-4_C*!(/@D3JU :"R'N8;WDU3N"IG]YX)W? 27MS]@YZ'8/3&V>" WW9
MN <SS94X<NSL P,OJ4C@6]FM W;9YTB<.G3E=.W-#J[2X?-L/^?*;]VZ6'J?
MA)]BVHE@T-H9S&KU/9S6N3M: U/O,R@J5&-_"G<D_NAA!=!=V\$7:R#\S [F
M:19/>Z6\'#Q;>?&3[QXU20@VN[=29^_\+NJW .R_YGDA.T?T+S D>B_Z+"2-
MG7>DBQJ_66_VDOUF_3^'B9B()($][(<1N":YT&KW>E9ZT'_#K\=*2_\#?)=7
M_4FVA>.&Y;X'^V_@G\,71P](N%V1D]<S7ME_Z79U=NJ]CT<YUK#VR3_VL+U;
MC=.&>_<AB,!&("]+YF>B?]O8?XE'>4@W<3@6B7<RFR7Q _M\=6P+UR&KS-K"
MU/LL1-:G6CR52MW[@UAH(-V;#7S9^S-(!XY,OCCM$?,\WCW:NL:3-_#LO>RW
M2'3WTN/6A+W:TCZ?Q6@2('8?**1!-G^<)D8=V[\&RZ(E"MX]0>">!@7OP]=J
M6+<*3+O"O3>3G22^*W^) &)>);S>[8/0]1ZREEO![;:+1[>ZZ'KM-^'K^>FG
M(/I6#<C7"I[/*^'S+<*6K#]:^"I=!:-[5"DJ&1H_Z?!H]^4/9\(@0G.4HF?3
M61C/EU)EEYSL4W/?)PW</_'&O?^+/YV].?<^1FF>+-E#H>/;]OH)E=8GWK6S
MR01?\U80(^S+ECTA5M)3[]?W$96Z@W*ZG&+:Z?TZV'T88^SV$5-;]@&FO=FQ
M53IDE^A.Z\^6/260R]-O69B/Q5CA22P31NKTKO5;:=3;1C&(ONS9P9,6]SWY
MEF4BPBT[SS.$NUH6"K#3._>2>.36@W!W.GW@/IQ>+).AU.G-.MS=?]W?<X9-
M3=B]=+53:D^ZNEM6:BK?EX.%-7KPBIC+0M L,N5]BBU,^[)]!P^QJSM]VCZ"
M2)M&0=8G;^/#F&.G3YO9KAXI^CT69A]AKS#-;Z,SKN1ADQH_]E7[F@@_6S(H
MWLGM>VHPB&?8M.161!1(N^W!?A73BGI[W#[YPYC!I/,P6QHTI^-[MW_TA.6O
M3[QQ2S<<Z>1>/35R^[-LTKVQVCNY96OAX9<;=Y4/5WV[GAJK_=DVZK[H89W<
M-7G(V"6')VW<VY,&>D<@./DJ619_H\M[]W#XC4X?O"_B.@8KF][T0B1!W)ML
M@X?FG7?ZN'WYY]69]RE(J7) -OKLDU8"2O]>3T_<^8>3T[YL$T73>IOG>/[[
MZ:=5WZF>6V8;W_ *GJL+/^F!;['G%AEOTJ/USNKD%MKUWJ.G;9WU/+MYS\99
MG=Z\HZ?MF_5,&[=DUZQ.[EC/HV?V5MV_958G=\Z<M:?$57BF_7M(OZ4N[][1
M0[LMK<#I8T_KNWGHW_4F 'KTI$U#GG';EN_7LP+[]K1]QY^'9?8P9//@N.@*
MG#IGW[R/:9KWJ03[H;K**AR\!S;MZ?C^[3\E=//S;."#.O9T??N>LF'/<V_?
M\NUZ.KY[!WTMNBENW3UZ]?1XZU;AU#VL44_'-Z_/E=MR_^[9I:?K&_>437J>
M:>/NW=:EXWOWE%W(GVGKKO[HD6K9L%\;1,JE$"F?$9!R@T>YP:.<]1*/4O+<
M7FJH#V[*M K2\G)=I&5/3MI]>_IT?..>LJ7/\VW< QOZ='X/>YL?K?:0PD?G
MLUY5':^#34@;=_\V3!W?O\/^2SVS?_?IP=3I_5,IN3T_@O=OP-3IW<.>/;TM
M=;W />N/BG+8WU([WJE,C+WWP2UVZ5GY%&JK/K*W0;XXS79.PSBEIEBAWQ^=
MLM^PS!=)<.N/YMZG'J7> F]\U=-C=@F&]AB-[I-1CRH4V)=]O/NBOR[**S^B
M5P6I=HHXL4F?7,L]KB:W]HTK2_K$)1^V;RMQWOJU7;U-5;GRDZ$?B73G_'LH
MYBC=^K-O/<Z'AI?,$VR@^C$:43_5_NQ:;U7(J[/+B[YLTP$%VQX( =#M$P:[
MA8'M?O88>(3=Z_99RV>(SI;<I^5[I[=.0S/W]^#ER6UPB]ZLTSB9Q?V"C]WO
M<]NJK_XW$=\B+FGF9WE_$*8.*;C6T^/V-?''@NOIXK!OWL@>&VZP;U'J]\/4
M[CGJWA]1CR388:]A4?X19#>8(D(XL7UJ__R7_WIUL/?BC?SG8/?%,O4@]K1+
M^?1+KW'_BD*"9ZP*"39E(<UE(71_C/V5,C$.B+B!HD':"+E+?I[%.[-KV,W?
M?A+1N##JTQR#QV)FUA)+\G*>^>OP[<GOEV=GG\^^?/5.OKSW+CZ=?/'./WB?
MSRY_/[O\]>?AVZ8)=?^E_\S3+)C,[8?2KT&$3M)?7AZP[O37CU=>TT)X6]E-
MD!+3/-A[\VO^]N0Z$8);<N5OZ>O]-]L>7 (4),:>GWKQQ#L?93$P!.\ A=O>
M 6@CP[GG1_#S- 9Y<A[.I[-@!-:1$.$ /;>[ _C9.[\)8J!0;>OBPP4OE)G
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M:0ZR\S9(LEP45##RZ,D$+.*++*O=J&EEJ$;J#GQL&8F%69EOO57@O%5!Q\9
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MO0HC-4Z:]%RC1JAZ$&:\H*),"/O"=F^H!R7.[T1_J'QPA$KYPA-!/[ B2F5
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M48)NA)A;&_BN7XH9:EX0QE6G"\01)=@XKUW9>ULF;U<N6Z%KC,\5I>P+JM-
MB6&IJB)2I);,B+=$G!NJ>U)SX[Y*?N_<%2^>R5WQ8N.N6$]WQ?W-ZT;[NB*@
M&33E.1:R&IOZ*@[0W"[G"Y6>:"/#&;F@?,_5U@(V9RDTM*[PF9<?17D<V0T0
M\_4-.87?<W *XVV%&)\?&=6[4C^O,W#;L/.'*;>- 2)"R+,3MTIU2,8%@?GU
M(%ZG<2(>8]&D9K@@E^9.) \L#ZNJBZ\! ZO-!+-24V3=$O55J?;E<!!G; (B
M<?,Z8)%[EC(FGU FZE(NJ\$3V4D+8XW/;!N5J%$ZD!JO*;@JK$H3;1T]MA<Q
MNXOOZ41LHKN%/L3:)5C6C]CL@;NW[XT'7\;[]F:!^RT169Z8]D75G+FMMTNZ
MIVRKJW[4RG+$3)?0+;AWD2]G25=.@W^F0<!VS$G33^93Z9:H+(!T6=)%"V]-
MT8.W:,]59SSEW*EUY"QX)\8'4+Z%'V>LEYZL+'8U^-*6>W%$71#=G.NKU)VL
M2<ROLR>@.X''Q\%"P/;:RF^'--,,,Z:S#8VS#\OG2VT*C.8!G%SR_<P S="?
MYB)0+"9Y0LXS/FQ6"R?YF-3-GJHNPE"^0!15Q2FU[I!;E8-43(>M9Q@.NL&B
M^=Z[>+@EUD#L8"M(Q &$;="N8'VH)@06UM3C"NRI^H6K7*EEU@(9DQ%()E]<
MRN1JT$>5N<1Z%FW?O*STTHXI43_V^A.+*40 "Y4,$J*]",)&A>;.]OI#>#PA
M69N&SR(=W0B?EE^Y\($*NI#BL1Y982^?R<WZ<N-F74\WZ^,@<: R025Y6GYC
MSND;[T2SF O)8K26H15'@R.*WCGL@F#)&[=IL.-'*)EW9$76.!8L1U; SUY8
M3TZYS8SJH@O>BTFU9&8L2*&6*!Z9!119D_%LRU"KH+W&*K/4*DM2U1B_(8PA
ME6\M8K>L9AX+9($;U$6)L(U2"%X/M'102^"E FKK(EVP)7TD:U$2WFPQ9=2U
M:>FUDD@_8#(%I5)7F;]XCRP:Z7<&U<A4>P??B7C3&NJEA!\K%E^E]YF&P6CZ
MDK<*7TK%WBT<4;7,5%"G-@I&B%5W8?6.M)<*K>#W&.@OPK%@T\Z0/.:."G-_
M!6%[4  *7GZC;F0%(V^6W>WZP5M5M#,742)<OE2-:3O(@V5'M?>[,2>I<5EE
M 83;(F2&S#J3+B!7XQ_4$9#R@DY4@^Q1B+P:20LMD] /IBFCW4H_B20ZZ7X!
MC>8VB/.4TE048V)0M'+X#9\-^KJXCJDA3T1QFXGCB*VV#*2.7PQ127OA4ADF
M/IDP,@,OQ&-H@D>:?\+WDJD7,+!K(G0-FS QN,LN33@RP8?#.(2M\*B?!];1
M/<KA7 GEO7/*CFA2=C[%"!$-JD(HB.;> [TGU&/'S=^6T4DZ>:9_5TVV6[FS
M84B/2?5CQNHQ@_K8 Q4@E0("[*FO&ZXF,T^'&*<,(D 'VDU:I??!#"E5P2V/
MB3Y-RPC^,D[V(^!C5/1R@R]NXCN$X[%ZN[E^AW)*]4 U:-/!';M-FVIK79W@
M)YEO(3UQP;(,')46@=@3*^BRU%:Z^04C('(X1]1M:BRF$6H!/B(%I$R:Q,IY
M462J+ZNY\I)[,N%:5[[K9 M#<2TUY,7'8,/9[L/9)DV<[7T9M//2[-D?D?&G
M5;GS-"[/0CA0C2F%Z1A$7G7Q@R+=5*)?E(&I:L<S:;,88I%'T^UPD4>+<GP;
MI'UIPHNM33LFEZFH3I5O,(H]1)^Q\ &:/86E=]6XN_*%[\]?)>I/'H6JLZ/!
M<EN<2-^X@++21UM_]QJDH2R^#<3MKG>BH)075S)76;LM*^*5U?>8!+@8$]>E
M"U._4>_ L+(F) )VI4/$T(!CO-]K!YLK9*2&L&WWY&B"<5@%4=$'#_:K9_)@
MO]IXL#<>[$6JSW6;#C)DK3':8SQI:7(/L!3$Z#KH$AO8';*<>L"HOA[J1XJT
M03'\7LW\W3J:46U@MTT<U8 MEE*N#&:U<AA96#0J59&MC&54GI+*I(S+DE;6
M&FZPTF]G!X0?J$3I7$*9.033N ^:?GT"#GO9T)_&6UZ9+-!F.PNP_YDR8^$T
M).1$4X)X3.&:Y=YIL-1+86JJY3=7QXO,<&<:LCLS)?7+8(F\N)XVVBY(!Y2*
M#G#<9NBYXP9CDQ9QYYVO,H4^Q='U#@82Y8F^\Y/Q.B/./4Y?0<KT AFE5&0E
M7RZO_E!)7[4=71[>7E*%)=WB# QR[0QIXY'U)P&"-L@,LSP*RMZB!6E$UXFO
M,EK5[]0L$&%IRVU=X,T=;#CR=0%'?U!7!VS"F'&6)@O^=>V&:2JW:D$1ZX!1
M&DCX!%0)S#DU5'MFI[W"U\7:X*NSRPNZ'!V&(Y SK(DH54G*8N!0<':H+SSL
M(FR;5:TM'^GB&]2V\:BA9!^Y6 ,]5^I-"S6]-MH%O]BVM5J.VHE+YE/ZMGI1
MV15'OI5,.8Q1W<MUUN' 70230R"31#&YNK+'CNJPQM[=TDS:GK<MTL4&.IV/
MD&@59NPXSH>4^48^BK0B!\X*@J8B8RP!Y<I R.*$@:35S'@[+D*?//P_HT>"
MMM,WP,'[V[A7(D1' [S;K:R:Q[?76),I4T<>FJZ[G!K ZBJ6WVT=;,N<1G+Z
MTWT2MY?6?XP6V6V@R*%0>:7CF#(Y9.MPV^*^&KM$9UTS]A\L3BA/@Q4A5Q"+
M&IN;296;KUK'4-5"ZMH4-5BA_:JZY4IDH"[3BYVIQQ8X\;;NCT7;2V2DW6!!
MA$87AVY+0 )?3:\#VT_GCZ<P04XLYH@O?P;C%O-6R"1)"X#B#I8)FG8+&I[=
MXU 1%$0UNQAAC@;'P)VNFVWT\T;,=6N ;1?"$_3W<<[6[M;_M6#%J^ K*Z6O
ME4A46@P)SQ[PVF[]TQJ_T/MARTIF&NE>V#7$5""<;H,"O#A\IK#0_45Q*UE<
M<Z(Q71C,VH^8*F'[M;T%]Q%70E:)VB&(@;L$<U2JF93L-I":D=QL&4X7LY6&
MA=5L?(OM[W%9?5/(DX_UEL9=X2)'F;;B,FAXBVU98*NL8Y@9O<U6T25B'=2%
M)[.RZT7A8"[<@/K#JKHF<+\$W:VW-H$RJLC?E*$B)X\E\[_37B"A4)+!$.C3
MEQX!77U&R^-7!;5D QKX/\Q3HF8*R*;XN:O'%OH0 GC]3"& UYL0P'J& !X@
MYAKEG+(@49RE%08G-[6099GDR)2)?!@)3?EOA"0GER1BL0=P:Z:U<=6/9>B'
M))*D&2*?H"^[RH%;"I6U^UUUDKD4F;(3R#XI0.'CW"NZU1;KHTI&K,UIM]SA
MZ)UK^J!8@NIDNT*K]!Y+H1R4A9175B9+5[WCJQXNQ78M(\ 8!JZ<L[T/U?D8
MG#%OD,84*=@@9&2.FK&4P5N-<\9V1QJ/ K)"2;NAI:N:QT#Z[QQ,4MG -G4#
M81J8+ICB^UG6J6UFV3H4/7%-';9-+4+V]U[="W&YSGU[H13M-5_JU^6E)O9>
MM]+U'/_IW># @!"8@;C_$B[#12YPFS$TN,$OJMS@*,[44(X?CH)I,BV7X#P>
MZ"]WQ-!RKM9, P@XJ^O8AR7CR@BHH"R@3AY)0,&2>EOT,N0#'-T$XI9E- <[
M,%-XE.%$[*U'UFZOI7W$]6; >QSL'1Q*7";"7\C@.(@,U*Y;$=)<[SGH$0T*
M?QQOUPG.!>(U"!Y1OKK@/Z7UE14MTO [W--&7UD06TD.];8[%6956>K;52X#
M3@&_SK&X H1C$B-<.*,I"=V3U&A098O>:GM2EXE9S.I 5SYGL^_"M]Z&Z2_/
M]+O$]6UB5J%'=2!-SE 5SWT0P_V1X:P6"$1-++-%9I-U!BIB61>=B65=+!/+
MLOI#MP_]F$J5@F.10DY& LCXN@I(6=,O1;XL?UQ%Y*L<]>I0G&:@2F]:AVC:
MT0J%:.I7LY/!F\?48MJH <N%;"Z>,6332H3UP?>ZO_=,SM?]O8WW=3V]KX^(
M1U:9I7;R;%EJ)2;_(PQSN0@526HGE4EJ:+ZVT@,MY=%4M5-I/PHQ%-1MU92R
M"^%#CAC$?^=QZF8, Y)AN%BWK=#_./2GY=,RF4_'NOBWYKWM_J 5S4R+1B>2
M8$$>FNSQ@1*YJ/+$4MICMGB0%H0Q-WH/_1DUO!;9'=:V_LV/<BS%W=<)]WX(
MBA08EX2$$R@<$/R)UM%*:DY-OYUB>WA:8$%XS)6SXA<MS*VL#"IM!_2@("X0
M?GF)ZBCZ(HDY-ZJ:7@:28'CBI4ZH=:26%GN?5ESB=D ELZ%\5;O(R&*?4[G?
M4(F)+&4@E6<ZJ"]OJP-NM+$&:),8@2 1QLEG.1Y OF'> IU:^9I<Q4XY7J@E
M4%=WZKT6RV:B=+(:MMA")'(1S)W5!C5[(H),XO1%L=NOOGNZ8N<D:S,X5V4
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MP!9O**4LC5MIL,O#"A.ZH^42X>YZ^)=*B,8^A!%)%9J$;IG'KA-F:$;QQ+<
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M*(  )I[,4L UCR1EJ10==3'\%A34&-ENW",>/PK(QLFQ\UGYD>671S6(=8V
MW9;HNITK4(321L5)U3Z1 51J?6YRK!6HNFBQ&WP4P.X!EE%L5DL?4S\4EJ\4
MG@XSUPVIBNY&=^<B3*!*XI$0X]0=T*R5;B_W.Y:^1@H)&0_F7!6_F6=QZ &G
M7S^V+#@UJZA5?WG(G(Y!L(K*=^Q3CM&V:=OB)B[M>E\=C8[M#75PL?=B7'-2
MN5U, ";CK4@JZ*3JU:M0,\P=<,P'-K&4GBBG58JCJ1PVX$^S.!72$>;P)Z#Y
M&Y^8/447[$[:S+.VTJ(KTVJA6,]E[LAQ->Y@W=0SS$0J@3^]_77X]N3RZ\?3
M3V<>Z'1#^)R &C-\>WEV<7EV=?;EZ\G7C^=?KKR3+^^]?YQ<7IY\^?KQ[,H[
M_^!]_>N9=WK^^>+DRS_IQG5>U3;JT!F'/33O\BNP\I1O[GV08IU@#J?Z:G0#
M)(U\Y9Z(-:]V]ZD5Z+;+SA#53DNQ,3^/O4K821/[LAKAJIW,9Z?>>^T"F^5#
MX <@/M!8'0_PUDF>1 0P/JA/4]ZR6JGAH+  Z#W8">/X&Y[3L7[W5'6!,C.1
M&M<'OL?[).^Y4J9Q:N.]R(LO@_2;]P',_3C1/Z="6O\J=%/YAJY.:$],=RHG
M;W80%:QM^'-./!E6 :@EH-"<& >D=@ZP@PLUATVH%*6X #!:Y&?PF&W782O5
M%MTHE^<'MV)Z0VI!,*Q]E\ E3N7A[GZCAYW-#>&=)]=^%/S;5V=NO:7( [N&
M?K6H.J# I142!6:'QX*6&QG)+8P\AJ_$]\!TOX,S<AW'")U6RIG!_MCJ6/^9
M)T%*QXZU0@R@QM9.TE@W?FJ"WBD6B(STML_B.]7YEZV%C)1PA%&!DQL*T'(Y
M)Y_'EKV[ Y6'F0*'ETA:H&S#29VC_H]7#O,4^%I*)E<@ 1/N0.-1"9I&J8*?
M:$F UXI(LFA,#6$.C99C;$93)8[.BSM 7\Q:U +I&\TS@<4$E+!#*?8W/L:7
M42''[*J1;^O7U6\+:\.3I-51XW'[+5+1^$7(<ZO?1 ZL+1V=)7!';<4IPN('
M(<Y<YO,J6ZV\/RQVAJ005RX:6BG4,3HG#VR<:'2R:]!"KREZCT2!X9@;7ZJV
M5&."WUCN?33AOZ,2RAM!TS*9[)]]F81P,D;4&>48YK0#S=2E5FI\LA8CSQ),
M]%'Y-3(7)$E0"1C%LT!H.C^1D5B\XE*0HWCLG6!7F) O^AC91ZQ8>,MSJ5(E
M3F'_X2W(FV%RN#4R2.5S3^,QT=<E92JPF*U^8M6E+LJ?*YU])G!VY!M87D:M
M*QH2[CI+1!*X_3:(^5&>#'5/U3Y9%@5)?4WEMT%:I2S(Q4$":GBA[DF*7KB^
MCY[+]7VT<7UO7-^+=)_ZECODW]8)L/,B3RFI0RHOF9W%\U;J43'X9SN?'Z Y
M!5%Q8LNH4H7K_9#<FQG7\0F94S1HI7'] %5+*QSD?KJ?[&^C5[10#Q93R$8?
M=/7![NIZG9/]W;._#UIDN)WZLR"#>S?V]Z/9WU;T:\2K*U%$"^R&L'+3C 3#
MP=X = [\;Q$N.1ZCXXJ+4SXEJ+2)!$-^],R!KC69^8FJ;RC,H\:"N- CT8/=
MFE%.M#T?93$6%AP<#:@/56DHA[@H>]O%0-19F/O[@_W7+P<O#O87O;_MY,38
M1YHG<WG/MG>'+$R&+PMUR@/E36 &35<J"6_=,2'<:@R-#%"71$X+;'(H0V43
ML( (4Q4MH1E%NDEI3P>>J<B.%F++T\,IG"-9IGZ1PM8 4R6F[A;VT,/TR@V.
MVA$./91SOF2X2.=\%4MI*O*K!V;I5!K\B9S!B[W#P=&K=L\GE2B<DTBJZ'+&
M>7A;[^3(!X>#PQ>'CS/P"8O.K5,Y]O'+P<'1HXQ-K=DTZD0*M)Y.?*W>%2J&
MJQK[^%FA)QQ.]-7QX-6+H]WCKLQPZG\/IOE43E'"EP:W331?X"!-IW/7.S.U
M*RXUE+;0?JL!APDH(@!SB&>R!;GRW0]D'K7,ID2'#V@R4JV6]8'*#% G61<5
MXM\XS+7LG$HUX]-ID,F/O'1&<8/38[0_ZPA+ET>I/H\L$JSX4P=]V;N':+>6
M$J;E"L.M>23_+L@A]<9GG&/^4=:Q%-TP%'A*Q0@T7%(])<(,U?X1Q@S\+&0R
M$+%(W#R9H]#J>?0 U3I>9J6V>',LS<+WXNEAHG TM\@/KU]F H_QAI-!PZH&
M;D;5KG<5R'(-KT)"%D)34H/6Q^:YW[3A 99@OHE3.]O5':-:"#G)&ZW@8T##
ME:D=W=-9>^$)/'XN3^#QQA.X\03>WQ/8AG$,M\'XH/2Z@LY=E2%"[A;.)_$I
M=B0C1C)\A/42 [NO?!57QYHNRL"MUGL=16=05'08BJ%]8T#-59N0&8 P\AEZ
MK;0=T%#D+"O0*VNG4\9>,,DD093"*JED%F-<: 6'<SA4P<. N]IC0BSZWXP!
M/2B8:(/[VF<4LC)ZXA#F#F\_%D.8(J:=X&"(\:/%&U+@,!-C<MD5*$0FT9$[
M5B'LW<89K9$,>V4(W! K;R#MFX)S* R&WEF\>1>.3R EJ/DU:J<^RLQC&(=S
MJ57&7U4-BKQ(:J\+5$"FNWJ%O$2H*6OY+C"(S"N@\Q(0I6& $ 8N!@C3&@"0
M*HAC%]P):'^'BVD+%?\+QN'<+3<!LX.!Q<XQW\:6@(KY(I\=/2:3I4X!RO,A
M_3E<QF"=BZ(18SPS5>$7)]*B>#0IOE:@0*)8J'&"">GDV+L'/=]WD2CU":R'
M9=$H(A*2HWP":\8K,0 % $*9"^DL9IF"MR?I33!#HQZU,?]:%)>_:C25:LW1
M,&!'<OXMC3)D;VDU2Y'9 ,Q8.=/8<>/QGPU[N*W= R!C.890'S\8MH@>#,JB
M6#>**/ELFPP['F=Q2.D'B#2-2HOD@J 8D<"R!0K&D'=E@K"O,>($#N<ENDR\
M:9QH^G0HV=D(>CR=PQ [&Z+4@&/W*1"1:_%=($Q!AEM OVTXZ.+PS&$#!SU1
M$=HW0/E@M>LX\'LNA<'OL51_!,9Z$,)UW;2".R>VVF5.HM/%16ZHB9T+VAL^
M(+)(J9 K10D#TKMJY-G<H,XH]Q?JT1:X@U6U@5D'!:6&\)QG&FS&'\=6X;MS
MMQ0CEO+IP]K]*?/Y)H6J9"<'RRG+*N KV?5UI/J2&Q9I-',5+5OS_2P$J9XU
M 2?K6N]$ C>4L*1HO@4'-LE B1!DK)(!EV%%:3Y%-9.NLI&..(M-.*=+[N&\
M)'V+Z\I"W/::Z[UE!;<P &VWD 68Q6V7B>Y&G,LYXZRJ)E) ;#)X80510^AE
M#AF;G)%ZV#FM-S737-.NL56 _G@2$%;2+]=UP4:E#8]V[[:,)R(U+LER*O?T
M*Q>I7^56++>BY3Q27MAH;.4$T<$?VU1#-0OEHZOC+I10F9OXL*RUK:= JU&E
MJ<&MID7GL?BZ<#QS7"NDM5!<XY[0W&FT82!514V$, TE3E#ON/;1@J><GFJL
M++*J[,R>,)@&,J>%DIU\]A[(UY:#:]0SK-A012/[+]\HC>8:=)B$ 1QA'/F)
M(SA<A9B T1?,0C;4Y49B\4@B[&!65=7=4"".C(I@4G!*D2(8'H+*0^Q92B"F
M(8&Q;;)-'N*-LP_3NYB J[&^TIM*<4"'"W$[Y7%B0)X\ K-L&N<IGCR4;V+L
M0 =I,U !T.GFJL7C7,0]T5A?Z \:WP8INZ F?I"P(T6[L8:,;EGM&N$+N113
MRSC;VF3P(4X]( $M9>=8C$*?>L'JIU<PCO:OH6Q34O>GF#?N+(6<KH9(<IQ1
M-+'BTQD[28_&;+-:9M-^>I?.I269/0X2S0M\"9C"/C()YB0M!PG*;1?B3UJ\
MPF*-HWO'MQ?AH1?/%1YZL0D/;<)#]_=07KF*+>@W>>*/M"JHRT!] U(G\TG0
M(^*4%I="2[(TR#MBQ"W,B\':'<4Z2<A0@]*!*IB5OTQC A4.\FGQ%RS536(9
M_8'9<@(X*FV%"],<#!)EW!5_U(@L#D:7N@@XK[S.RE.>#A%X4@%DY9QIGNCZ
M&^M>B90""[2#Z&V$AH#Y Z 4(J(J:H2V^%+^X?V7>_N[KP[WU<J?_W[ZB0,*
M-_X,Q0-<<.3\N&7<LX244.I<^%4]_HJG[ BC("T@'%<9=5+5EJ9#O5W HH_R
M\N&9D8-8YU@G#,++X PQ@8:SC\[&=W$GC9[%UA-5N@+O07F^<13.97AJXO@!
M,'<)F0QGABBWZX* 4,'P(A6G;%LK^.DF(Q$]S'+2:G8%3T6U)\+&YEDTV2+$
M2Y,[H',Z0O<\ED<-'DO8S-,XF@#-9NO<L._QG)$U?H%:%Y^B>0VESC M# (T
MT&S"]EDM'*O2)57E@S+/,>$YV^_1Q @HB#%D- H"8B4B8E\#G':N*A6<IJHJ
M1FL*1@<6SRB7RDK6@?X$>"S[A^RR*0N$5O+'VL".8^>9%_4911>72^:/RG?$
M/VVW#VL5,PJ:E'&+%B2O'(&Q34%5X_E3Z\<N:I@""GOTLK$K+=.%/X_Q,*ZJ
ME@@>=WY IAV#T,OV#NS(ICLL_&I*,9PA'MF";0;17A+4K8*0=AJMI!>LF^)[
ML&AJB8"FSJ_%:\B;Q:]@Q8$E;)>GJCFDRU&C#M,R#-!MD8>9"H,.$^4'E@\/
M8Y;! 4PI2)2/C"ZEF%ZFQC%^/:QD9 R^F'L(H'Y(0&D3'Q_%T*42)TX6/. Z
M(R6,2(T+_5G*#("2>V#=0*+J?H^@^^$SY'#;,C !5UUC_#&3<IO#O9P"@R/)
MG29WHDPB'S"4.2LMH&B+T,+8X_:5H>(J U8OU5H1WT%P*^79H\BBRK%YR,Y:
M&4G<*:84+3[%)?5'M)LZ1X5#G,KI609XU8!C*3$'.C1X2N![HAFV""8&5?9&
MGP)@#[IX'OYF$A&4H40[8"4FQ6BM@$J)?0GDSJJBNC85>?5Q<UW/ =;/K:1D
M]>YP-2%B5PH"HS"755 Z,*J<8U/9]R2^UH<J#H-JL=\B$M4B!F;=*C.S$AL'
M0B)9&76B@L4:J5H0JC06'5+%35@*:AEC"T)]^*NB!8Z1H? \9;!#*S@FM=(@
MHF)JR97)LJ?/I$@9:38,<^&EW^;2@)5+G>2AS.A);(UEXGTYN7I_\G]L?<,\
M]Z]7E_@(RP(WCT%C/$N 9F3Q.:%A": D8 K(G(D"V#"W)!J.*A=-\5.L$J!%
M(W&AC,[48(O*;=;&NZD*XI)BJYR8U13-^Q8J27I#N7Z!6FE\DP U2L,I["L6
M_VP8XL9[O=![_?*YO-<O-][KC?=ZH:_EN"F_UL92?.-] *T[PLP_"ZWQC?='
M9+ G/P6<)@8R:>.;>>1$,<+H=" ZR48APPJ%BI\&G$V6"$111H*5&<\I60.8
M1Z$;4*2#FLX4*>)^QF1KD(51W3G'0?NNF%B51D;YTT!01JUP%1CE";>5'"_5
M%8PG1N6@KH1UR5TVR;I8 G:B<4,2,!KDA90D]CD$([FT121M-8 ]\PWI/\"Z
M.-%5IQ;4OU07QPS"@QE/B++-\'6#2BPYV=A0>P8J$&TKDIS(:U)%3M+DD+UD
MFZM*%I''H.( &"7]RD^&?B32G?/OH9CSX4#LCKT#>E'5M:UP!,IW%5L8D*UE
M0S4MM K4H06>,,W#:W*O69ZWBCZ>E2O'V1F,R",1@<E<R2.JO[#ZXG#>J%S7
MB72-Q%,&N^<09_&" CN2&(:9S'9$M5V'9NCS6!@-G](\->]3-PV4_AYJGQ.N
M7)# ZV!Z*OI$> &L0C.J1T*7)=5X>=,@#84_[F162.=807T,_:MT#\1A,&;\
M>:V$6/M6DS'E^ED5X#.99SI7=,Q]2B>"?%W->-EV U95D\%M$KB&3E;V:;G+
M])3%VTW2JDJK<M%K9"JWSWVEJ -4(P.RK?/1"$%42A)+1VD0 9Q$]D(6X+HA
M^<7<2'7=VU#*&P-HLU^E;OK,%<T.ZR1KPZC(;4OSDHUFR1*GSH43Q,MFWY#L
M&1M$3@J7R@*5+0_;$,T6J5@. 9*BM6T)'$M&X14RJ#/672-4Q$*CE&#=;)G,
MJE:..31Q%FZ!6-W(_/>3DPO=55C/&%OHHO>-%,-QGJ@8F9I/$-W&(<(C;)GT
M6IF.BNZ,D6J;CO<P;2MRUCG;FE&25$&9C79K,&WQ8K (S#2\N?"3'8%A'MVG
M$A9>!E>HCC8SI();"MR#W# 1AQ@8)\BD[?O#5,BH(TU[PW\7\M_Q E6L25^*
M8B[QHO*L_W6X9Q#&B!ZL\F:,OUKU'44?62T\U"FE<5NXP)L-7;2AX@$;FCE(
M1]:&$=(/Y4;?,L81'U6NN";U+11<D4XU'+?"ZG^%C  &FDQ*X2P[,%9NWA!5
M5(>Z5P6I!DO]GRB^ UNT5(?*<D49=2@[(N[TBB,EXC: S2&M@**)7*F@F_4T
M#FH6"H<*(A2Q,D#LC)8"U]6+F-U0+YV(L2UM-0(/0J)KS2WA;7J$%^KF.W<4
M>N&S??5</MM7&Y_MQF>[B+E/6OL,$=!?*?C(356#^-1JA:/R.F2J$)8KC:E#
M#A>H $U'K(IS\@>FCQH-W3C$MGP)!BR16Q)$VIJHSC_8O?LZ\6<WV(1>Y3-A
M#&^R/; 4:*S(PF0JL$4DZN2AO[-_S#-30Y@1W$N/QWAI=;1TNQA)Q/O2TC,:
MQW",'5TCTF8A:2U0;67E7T1TN4[CLINA;U%^C%E@*0-W]#?;I=Z.VOM>\+I*
M_4JZ@_EQH$:ANS:UW;5IS?NBOL:5_=P-*D8OBJ BX2FV1/JW)"I^@.!>;0IH
M%+-]E*%1@NTQMB;YI2TK4[FDY,H00=G+@R[N$4C^G)L]RT2 :1Y)<\75'/4F
MP='TKW5S.KMI("H@V&A)N='',%5.$3"R6"^XM=<2IEP[D48Z?"UOEK?8.JW,
M@)-D=[AW0*.\WGNA%Z#DP:NF.>MU\)0KZ!)<#X]A'90S#4<5"F"I F-H&3)6
M]NP$+I5FF\>.R/>@[A',R.$^ ?0>>140]O;I*S8BE)X!:=VZ>0R5#D4FYI0:
M;"/UZ8;:^WL[_X/$K3[\GX%*LC!N8&G&#AC7,$:?#F^Y/T0$X]HU:W/4]<6"
MH3&,P0WW</'N4"9EJ9DGUM08/C26J0L"@92E-LI8CG_SHQP=F6J="WZE0I#$
M=2-E!>& 8.E8-Z+-Z8PX-G8D'4D=5IO==\+_ADO!3A5:#&)HY)V=665TW&6@
MK="@;5P$M.)SE@)ZP+AO3%W7ERJZEK 57!_!*"62DUE\S&)CUC1MOJ-\"Z7D
M9TJM<$P$_'F2^+ED8]++XAQ:TQ$"#FX\%Y1BIQ'I[0V!U2OZ)/6K+2&;52IA
MP6F96D#YU+97+FC!_J[TC-4YQLI%[9*S<IB0TI9=7HG#6[Y<FT_H'"@4UQX)
MZB-</?Z(POJH1GB]D2FT"KWZE??'[M7NZ:ZI"3H\WO.VU*=&)KQ=MEFQ!J>9
M177![52A4W9=M[UNI=M64N0X-B>2\IU-,H*-_RO=VN2QY\X9=S>"L]J&5/8M
M&("9#&]. P2^EV0*ZEA]&GC?(MG3)(_HSX%L%CF7&+AQ-*;&%UR7S#X!_EOZ
M=>5S.;,,%9LD%TK[*3?Q!ELT9*98PQ *IS$D!RDH>$)B8U5XC<O9AGYJ-,J!
M]4S.F68\78W;P/.8QFE&+I\(4\B!\Q%"0_UL3"BFI1M<I08X7F@[51%5$WN[
M*6O!VF]X8)XDYH$Q*G8,5)(G[+G6]8@FY<".)/_P=W32(Q>]#Q!\*D'898(_
M.>&B2+(S&8=>INBPD%*Y: :J5_CBSBRW0K5FD53?NA?/"F8L=HZ?WM3RTP?!
M@))63?!5E"^MP.J94\FJ#G,M7O1G#/J*=\LXJ&CE3W;< X.7*T1!5;L@ZWIU
MF40!C-,NG[ 0]!VD>KS.JD1F/B;#F_BHH<CNJ+*) DF%,C)5?%0)KRC!*M!!
M?<,(//+J/'+X@JZ(MDN3Z?6R)!_A<JBH-EQ!MK*OVZM3"8V$O%%?"9T[KC+&
MU4QH/WDN<@6E:6"M]@ZOMMUP0!58HPO'\ME\!,[D'>X=;OG;;H6;=P4V5HV?
M!>P,T^")H[4#^V50:26;4?: 5&B0>BL#BG+[MW'@V-M28AL5U=I25K$I*F_;
M+([\G[CV3Q.=5PM7$RFOSD!0*GU7=<$.,*KF1-0733"%)J2+=0*8/G0J8_RP
M\&>W*F="F<EEAT1V0PA+S9E?.@QN^JJC'HA6FLH4J1*JC5HI"4#3BPVN#Q*M
M;#"Y5:=R4#U]C;XBL8,P$PID?F*'^TGTSS#O3<6,E/&*O8!DEP<JK\0ILQQ=
M0IJSVP!^7&2U;VH.GC%^]?JYXE>O-_&K3?QJ(:M_V<#J/UI>MZN<<YJ8M=OY
MV[9O+LU5YI-N&ZZ^*41$)ISZQ^Y>-P]05AXZB8 Z.9]UF:IT>>5WEH _5-3^
M^LV1DQGO9+\;N,5*BTU;: 7'+CZCJKOWU<Y1N;,WE34.%& 9A6+P#W*)PPVH
M8I5G)M77C!5FO(<[K:ID8VK3 \M*K\V?[0<$F53\4^,[KTWU'SQ"$K"M#"Z;
M!MR<_5M(WY7(=T.+%OY&MLQ%$G^?&PO>7772,;CKJAM\<-81%WCJ!Q+@5M7K
MX_T6/(VDE]-B=\9*V!JYB7I?%-)\/9JJP<M53F[Y0!JP<,UC[%SA@K;;TB8I
MV^Z+RZT_JA*R'7^XG;U(L5==7E]UWF0?*%UO+S$KR&47Q05(+U*3&-!KSCL]
M+A4KJ[1Y<M6S8X5+DVE(LE1)KX)A$:$2+I>[4V_!V&:FP7-5A:W6PM)\%-'K
MR%,E:QU*1'<X63=^.+'(<AF>*I\E8P2:'RFZJS]62Z= 9S4U&.62([<JPT^=
M5MNF^LF-6'9/;>V>D'_5(.0_(5*P!8TKC;>O=D*=]:N3/+<X*T]EUVD_=4O+
MW_S$5IJ5V,V=L <*0)C!!%2K;.<^]&R!T970U^SMCTO=> RXAQN1XQ [NDK:
M6F16#7I+Y^K Z#5-!>?930LX)HRQ#9<K,E^Z_5#4L"UF$^RMD6W+ _Z0"+N<
M#T<Z3PCFYK&V8./B?F9.\[J!TYP:F! 2#(A$0<R&KS!G86%XD1J)V<VE>*_K
M*U0-D%7A-B[2P?8FOBQ8(8HL@T8NP[4DT7-K%8Q)RHPP<W2FNM!#]]PD/Q'8
MVQ:8"GEX4IXW"L]Q(/.L@BGZ</$\HEZ?"QDBS5V =]F]EC 2H^(K%.>^7="M
MHR59 TQT4+\! Y.&3D7(":(_1U:^&'(U2E#W*\%95!::N!8R>ZZM!UFV4G4Z
MD6E4&@4JBB,T<B+VHV/RGTT\[9QTDAWUGQOUP5UWL/=,[KJ#O8V[;N.N6RA?
M]_<:!"RCU1D%WA&B=B>:<E2$P2JDU^;:YL :C GXN8A20K  O7-T$]#?)H%,
M%( L7)0G\9U:F7&)*/85(R_!P!N"2:E1*ROP,E7<6:J46\8/9[VM]K89!X;*
MD)7A'J.RZN029>KFJ3"_6J8$34C:&L#&I3<AG%L1)+PDI^0<>X7);R-A/D'^
M4 \6*M/$N)!R[H"LP"9P'K4?X=MEFSI;\J@XF(GC6LA:M'%D+W E 8LS!5GX
MXX13&\O"].Z[OPA<_ 8MFOXYCF,G/1:_T,30I@ 9T[L)A]$E@L!"T+.#>K23
M&N*1PMZH0!5@LINCWPK<,TZLD20T*-[&FUVC3%K/-C"A;73*Q]<F%WH*X*EL
M_^+D)-[EF!V(@R*.*3D>J[!,E0GN@*96+J%,8<#ZF(%5VFX#$ZIK>(F[1-$6
M<)]QT2@W@''/M"K%--6/W*=%B&_287<;CR2NJXO9BETDQP92T5DEF;@6++ A
M*D50.^M!60Z*&B2F_0V(4X&"Q0^FRNV06$9%#>8C610J!<B@L<H\/M<8TT:#
M8K!1&P^8SLNJGR$=1;,3W=/K.Z@%[3=H06<RD=][)Z&4J>_Y!@/M@1AH'Y Y
M<O)86I6Q4]$HREI_2TOSIL*/4CLE3I5>:/!K[.JMKG83X72;Z:U#RH0[N_QX
M=3(HIF];3D9Y@<X>I,MP_($WBX')S*D(Y3KQIP.=^#8H)C%NJ?$5^Z%$<_D!
MV7I*F8.4:AY.=N3G;18F8^Y1.07.G&H>RO.0[YL6W0VJI,JJ&1UH-8_*_F:8
MU2B?234GP3!7&*:45ND$8-TKMBL:3==G5B9%>*56G:$EVS/J@V<E,<_-AL%J
M@S0L9OF;H!DM"M/'5/V$29<H+X9QE#->-F.YV&M,NPI+NX.@,Q0LQ9_H!VP<
MF$BBO?65D+NA'%%L@1F,OH'^-$>Y-Q$D@]'BP:FI_8*]$ C*$L)MP@])\8!]
M]S&9=HS=W>1+PI-PKCA\"MI-PEXC!S-=!KPX 0$KAP:R"34<-?@-B4$VI9[)
M@3BT#(85)J?*5X5!,A!S]!O5\,)ND^91\PUL:6"7/A$(SPZ''1U*Q8.2RI-"
MY"#/"OVE81"<PU(B9B8<Z8@SA$LG<HQ-_-),U>)5._^X/L,:Q/<^@T872+:1
M$(/9;='78']?Q8P+ZGY5:WH97$]K&]-7 ]VY3%&%_'5HM(HW;L32(W6:I+:M
MNC$K6<;8M>(63&;ER)>1\O*.&I?T3.)0VGJV2=:@XX.[5C+Y=?VT?X==HGQ%
M!:9:5PUR>?5'.K ^G5B?+IS?+N3)/L$A)025SC5!H"W[!U2\7<A$F\I8J+!$
MDA7$3N*.YE!:*A5B(*3&LOTKH<6G5MGD0 =8!X:Q8(T2JNGRJ4D;,WMS&AX
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M?#LEE4P;:Q?1L-\<L19'+&B%[MODM8A,R6()ZL. 13,A.] ?6_(!?DB.?XE
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MWX:/MP\%,HV.!7=KR0L32^;R.2S\20A([*(L;-IW[SPT3KU?C/8L$51M)XZ
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MO-36]W:Q*4Q3.K!2@X60;5_D5J8I$=W844H-RY1D\CVIRBRS8:P99,?<;!O
M&K;C:<'IJJ)!YDR@#27YR>MJ)]/Q)$AFM3930';8S\&XSK4H4"LRAN\*5LP]
M1@K[K/W>%+6FES\@RKJ#D13WX2.\UX;D]L,Q-R5&'!-8<F6&QS&W'8EOLWRI
M;-AT[P5H16FX1[J/O5*^)R6<?#&8RH7!K>6\:((:V?/NMN8,Q=0R=LS=,),F
MSB(I*BH7 R5,^U $#Q\Q&33>"90XZ*;!\1R>POTN(L'G3Q4)/C]&@O^<D>#]
MD$1O!C OG:[Q$4ST:!R7?["*=8B+G71LSDOG-N2!4F;2\YZH"=R,J=QNQ+ /
M67^)?KSB'I)\M\[[--'A SU1;**_Q<'LH0@6,K6#B([3%JUA=[^P@E-"VO2\
M<'SJQ.-FJ-2K?NKT=K7G'N3IS%F1@M52E\'G<.\9K\>%=XE^XBW#=-R.C]M8
M8.G7=,:(:+QHGBZ1C6?;QG,WO*_8]0F$Z2&8/C<^V?6K1H- _ [S Y3@7L"P
M*#$1]"]AH&F2%6)KT2?7&&##NEJRZV4-PY)6^()<N\"HRGTK02[1%CL.&X90
MEIS!1DB.)QU2%,(J^7\DG2N]B2E6V.AZ,"U_&#P4S_9%Y;VY+R*Q,\RS"Y1X
M\K5#N'Q*K[$"JN@5&"=5?LT$H^1D4;C5]*7A1P7D"40C2.T+ENDM1A\+>H:L
M"YM=-N:HMTR+!EHB0T28B5KM&JN646\-PVNK@<Q'HD!,J7C\2@*EULEZ@O"+
M:_?@IPGS<$AU(S2=$BM1\$DWH\K.I<2XC&^VA$4_)?R >P44:2?]/H=X0,N"
MK71-:4+G/I6QN2:ES"$GDGG(7'?/Y+5=O*0->0-[?$O!S9C#!%W$PL$$,0.J
MS-%]IR06%4@!+!^Q.AI/#PA>/[WQM&^@PG3.-5H_"V')CZ33T13)U@O,O]/!
M6V6EIV6E3^;9LJZ4K] 7#TFT S\7(JUXR'*09V#T)'@$?D!/P']T/  _ULJ/
MM@3Q:M,K;&O$/:2QW.#K$,1 HD6S&]BRRM -@JR*F6H'7@P$VWKN>A'/4@XA
M<4P8S4#FVQLQ-]U3$_6J_IZ9$57HB]6532U\E]*\3,DO4^K;E/YM2O\Z^!#6
MD?(NC/H(=Q..@'>3;5EAPV;W66KGHHP(Y(I)-WK/]VSYP/0:\&[48+Y]P'9<
M2;6NXX#;9^N9G=<O >Z_B+2SW?H=M=3WD'\+Q(/MZN2(%_<B&^0CT+_Y]C\2
MZ+!IP-[W_:0HN(S0C#K&(P+[>WVMB3AL/DU0M1@=,#&XA-G<F5Q,<M2(QP\<
M],/;^M]%)/SY4T7"GQ\CX<=(^"YA/N\5YM2YAF@VKE+,S-LN[;86;<&A!O@C
M6SN*BI%!1V5$1=>Y2K1H36\Z&]?-HP/=$$"\G,;!>,^L+K0K U@#E52WKHA;
MABE&2FI<7"E, O%N# -C*K^Z]!XQS#!\4W!C,KX;YR5QPF;;.)@>?2S(ZMK9
M=66R2I]%GW=9?:S/'+<?*+5ZG3#!*&+3$N)WDR">M)DS^#CE2P\6,Q^SBHY-
M&_4X0@%VU,-_DPS]'YV1!Y'7W+X#RERQ+\+S'$EK'MA^KM,'>2)KC/(F%.%9
MY)2H5F89Z?LAY\$%4F'5LXK3\]KJO1DP_:=2Y@<G^M)!J."'S]&%E%+?$5$F
MMWYDQ+XT?QPCG?##VE^\<DC7C6D[/CHRPIQ$0=N7L8-0KNS!D #,YZ)>DU#D
M=T4DA;#>F,Q4^C2'\UG0[K=?IV08O$>_+V7OPZB7/LT@ 6'7RL=IA%;,5+G[
M8;SS5;:6X.DMWV)SLRV)V+],%BE6[LY+X0DA9G"K=S0Z9A5$K"C4C/_"@W_M
M%);37@WIY+>J=E:R,AQ45Y'.5=;P+%32<!EC=%@@J>V3\&,DL3;D[X&BJ;G*
M<D9P;))*1>V:=V+^1/YB@FMRP^_U^R=1.4>)N1LV\78 -@$2) ']D]TF,T9+
M' [*;D#B.<3"+B$:&WNU(ZMSDDVX0UO0?XNVN=1ZQ"#@N<I#4;9(I<@6)NIL
M*0V"-T<'T9BGL7Y 4RM_J3  VV([Q9?5/^E;@6%B:,%S:,^*O"Q/V;7CR[0Z
MF@,<BM0E8P4-F"5!@'UG%I_(QPU"M8UF8(&, AV!)DF1@ZPDH5NOW3C 7$DW
M-VAF42@7;[5"&,%U&EY9HCXJOJ3*K8\9-M_8@8" ZW0IT9FP/SB!ET\\E8EL
M2_K<DI=PG#W:U%-8-&23PD=M\B4V;>"RO5DZ1SW #]&0L2,5RV5"M)^/Q&-0
MYB88T_16N$\,\%W+4JH%.9Q+E3U.:!N0@K,0:UJ9%>P<7^JBZ/%9/F<8A<NV
M%-XYT;J2LJG%S5NXO>773Q$-.P<;G<#>/]7!:K4;HK_;\__)I#KM.OP0N>37
M.+>Q3\7W*OB\N$[6V?\FC&N(G::6?(+KR..4K+, N"ND;@F+1!41H"5Z_N1W
MO2Z&LTN0J#KA; 2@R.B<5'@5?/,-U8N63D42(:! -TQW1]Q;:Y!--V"_=0 P
M.@*:HN(#]8S>XQH._:)>.BT=<"I8E8UI]BI53OY5/C>2!GSW8BM7I5\7V;+2
MZQC?,L=:Z5J%FSDC;" PYWW[L!08QD?_UISL*UVO#U*V%FXK.D>SCJTE'IVI
MDFA,FZHLEP%%W51@+Q?)7[2>K!0?8I@;XX5A-58:-_ YMJB,-GY[+U&C72QO
M\XE!NA\_B=22;<I!7V[M,X@WI#WH<8\^/.OHNP@.OWBJX/"+8W#X&!S>;>^_
M&[#W+\!K/;WT3ANS=%.,,>$00GE0;L"?E*CN<=#;S<"+(HO;%!2JG5KHMUAC
MHPQT34JLC053CEF4>YPKYLAFF"SNB=*5+R(= FZ1JXH8M7[."Y ]6/U.&Q)T
M%Q*YHK%^P>BC\W=OWC09#G^^_'AA[87(]9,AV\.H0MKL)D*!CL0/:J7+&X.C
MH G:3=?;N8Y5V?H6#" DODK'%.])I[JN>LA&="IVI@!B@ET-&/4EZVF$W:87
MZ2L8HSHQJ1GS>)?QK&/R6CCGX8-W3?/QW#X^W7G;(S Y#@Y'SS.$0^=%2=0(
ML(\*OFKGCNT)GP0W-[F1Y%K\61KHIU0"WQ14+5VYH.Q.XZV@O8I'>ZWA<_9^
M&AUU'=42#IP>Q=1P)3LSJU2,_X[NZI.FPWQW@XVUN!YZR-WJA9$0P)#GE=78
MES6QV"ZWI.#X<YINA-=2_&&%_;)BZFT91Z&OQF><F2+YJ<AI3GXZ)QG%HI>I
M4\GK63S^W4OK;+V 7ZQG.FW)3 C[9HZ</91!T6^X)S+ND?&;%+?<$BKX(T[>
M#T8P8BC"W7G\+2@41CE-F(5*_DIH!7!A LQ=$HG?.J_EV?IP=NCEX=F*&]A@
MXUTX>+ ??F"?ZO;A0]4IY$!CUP1&U_Z&\%V'1*8=QP$ZS.9.*:1!E1GT+\^%
MDNOY-"TI\CAP]ZBMM=Z3 '?)GY5<[''@;5<41;[8%-DR>OXRCIZ?G;_KK.".
MN^'0NZ6K:'*T&YR C!XH<8UN+U5X2;76/B&CJ-5?4$N+I!;,&WY^#THC(-E_
MSBTXU<@C?D]A9(J,T4<Z4I.S$Q.#CB"]N=IZDO6ZY*B8O@0UBO@)^T566I&.
M'[L&0B9X]-O/%Y>!_2<BLN,69&;&UO#\U3<AXI#*);BVLVS)%[VO4=" M"+6
M+EZ+OW-'QJO*E6LTK\,!_"=,YM^3W\%"W JXH/2#UW?D(?P-%G.>KZRLM;.?
MSQ*!I%/L4XPXV&0<^:$^(-ID1I>14"F^A36U;$QOL$/\K7'LHA/7USJ.+NMI
M$D<?B@1>\U<JIOH;+%#"\W!9P"%.J,Q$>GQ\*7!9^=LR/YTEU.#D)U!C5?D%
MQIYOEJE[<3 '*#;O8-_F)[_4-\FZ_R>3Z"0QMKZ.'7YXR>\<1@HYM-8QC:_.
M_A\*/2+Q"&$!Z$1RBM.;KK$&9Y>^MS0E0+TXUJV-HJ#_'/;\Z*0OM&[>2ZX-
MWNLH\.\/@>L1^!T H2Z!.4[DWU^Z>PVAZ?+$$:I1*6!-:;O"V[;.5& .<M@J
MR';)?!YAOUY&&0D9#%\@PC]=7X/5Y&2Z::L3*6&,I<5LGSJ\HK5G6_:<DS2'
MMX&_B\#SRZ<*/+\\!IZ/@>?[0_.Z17(S;S< TA#U[D-.*>AM\"]GA';+UG!Q
M1O@MM708(S5'BQP)7+''-WB1.7GEB@!+)=\GM1=S[OV$[%@DV_'_8L229>G=
M0 ,/B= 8?:"!V3 FI0.X:ZBVOV499%IM5#^(F!KKT\\K31JF?S=@$OK,-<Y=
M4<42::VR:;Z=Y54E6!,JI/;]/3LG.@YF>O>\$NP'B;O?\U#47<"X\,GSY_33
MRV=@49V_?O-#=/[FS=N)+]<LUH(8B-ZOL*W7>@:SK#OF8WZ',%ZZT:NS\$;N
M=F?G--?G/\ _7\.=M:/2NW?O;+%@@<_XQ(31KN.<O!=K]5+FJ(*CC\#@\W>!
MQ^-_TWC/3\B9M](P.!R8M[VC??GV[/STY=O7YYTS\+G 9O$S/%@TG[83*T[D
MY;.?GWUZ1@&1,CI_?J;O_>)L$@SLPN F82*"VYR_"F_SYL79Z9LW+R<=LV$W
M"DP*3(?\\O(FV<"XHW/O-*C'R/FI@2=&,%B[Z?D'.I5-^-"?F(QY'W&^Z$\K
MC:M\0*J9W$'L??I$8"A(H\#_1@0$ N479(8:/)6S@;,U8B2V0TD5S"@63G1T
MFZ5XP_;>:&1##@\T<7@I9A 3_2GF'XO\2UH8IA=06?)7&?T,KD^08-8 M]?B
MR?PV*PU!*5)J(.F+<+Z (-O=XN[YV4@VF?W)'%L>HHG_J8?H([U8(C(4L:/
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M*QP6>,Z1&QI&.?OO^?+\!=S3WO '4\:>:.JB?5N)"=O@J*8RAN7TBY.79Y-
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M7*M\;A*A&)H48FZ1T_2R/.&6TZUKQH5&0PB'A!2/"VS*DJ/O^*^\:!+$=1V
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MFV,@"#^9X.\#$KD=,DR"W3G15H[]H?^JHF8!OK>51)"\6Y<R])G#Z"<:!TU
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M&]=/E.ZIC1U-<,=8&;=9$F'ONB6&-&=DL#.U(S+G,(T-/>X>DS)!,P[#@S(
MC,US"JA>F_ =+A5V!25^=>XVR:\-MGFR3>>3.#3J\/6DNP6]Z2Q!B[F7WPS9
M7%R'1FHZBIUT>F@LTP7N@E(R$'1HN&;%9>.5_ALK'3$4-<OK@ON!.Q^\V7*
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M'C(I[,>28\/6I/+;DXF(<(T;84P7_.)?"0"+:VZRA4^?6HFE+2<</6LR]+S
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M3D!1XXZ#C?1ON6EPHPGH#D2Q5XBTH)T;=0*O^[.NEEM7Q<0)CIU*3Q7%SG5
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M;)#WYN88&GMI;G)PZ_]-A#!.[RN$<3J%,*80QBZ)]M_]I3>6%*V+G7#8JUX
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MIQ-K__?B1=^P_*E_\MC\;K""[7WHTJ=*DUN*:9M,KW74#^0EW<5I2G,JXP:
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MD9DM>RP %6F+!R%7#KM>&P>BN*$$#@TCW@9^2)0-<-4QW'D!H$4Y0I7CCX7
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M<.JOG^\N&M1@JS+"GKPCR#B*>JHP'L\"(!@ C,B1?L96C=,OB'DJ8)3RNB,
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M3.L6?W9V51<([\_!M45X#,,/%Q"%-3^B>J%BM<X7!9YN!K/Z&$!D.3-"+%^
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MYI3%UIKM7!8\@UZ$E2K+\HC'$$+)'(_L<B%U2F8N ;[*K+F):S7'\6VIIF9
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MD'B%8#2XQP]/CSYX90PI=QB$8]4! ?4RBL/G90%%[LZ"8:HSS^@-G2-B@8"
M)4[(Z+#J4<VQVJS:Z7 QRL8?F&WS-VWO3VL&\#Z8?8\J- HI+Z1W$3J,2."
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M!-#]T9A8%,;GVX$(BT\4\3*T=<.A5B">X*7L(#>4;N=<YG1V=I^=R_W.SJ_
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M%<$'WY;0F&J1)BCCZ!]F4>?TKPRQC("2,PLFO(,WR<\(%<2.QF7R&G)@&+W
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M%;+0>(6(3ZJZ>F \WSRCSN%3"?J.$O0CK\]?[/VN,;TIQ'V0"+>1 GRZ=0)
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MI=OJ:(85@O'020))_84K!8"BW[#%*>T%%R4:P:;(\19$S1)?PC64BO"YI(R
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MCI#>3G+&D(,TF6[V>@+:J5BA2U+48(BU=J_MZ31Q(6YJPV>BL;JS*"67ZI#
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M>8O]WY@U/ P87&PSH69&ZQC8",H<F0R564*IV&DSW&8S6"*LL8*6A>38A)O
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MM2;56-!5E8&6!)?E[U77H]8,H76M:^BZ6'P> D:<*W.=TVI.DK+P3R7QAW>
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M$0QNN,Z._F[#CJ"U:H7IL&LK:E&%"TFFH5M<\WQCP2' E8R"SET/,"[_M4B
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M6UBN+OL%+5*\2!#7<,&;9(32^NQX8>,D.F+K=OT3R?X_5?SR'U!+ P04
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M>"$)5OSCXZE$_:A_]N*=_P!02P,$%     @ R8->6^(_D+##+P  YOP  !,
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M"[$<3_25#0H>(,9 __WH=0I^R@_XTS<S7XDXE1X/]!I9&LT.F9J#[;3_1@/
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M/1T.40.%/58^G;N8&G.6?X%G8E(&?Z _96!M,'3=RZ@Q%B&! 7A:0Y#^ '.
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MPW.-*@^0Z\ZUI*DL0V@.:&]I2B>Q] YF[OBX.K^@U:\6#\SF-MP$+ZX;:XO
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MB_"O<*/SU*![[%1;%VK7?5M4I99035WG9(EIX%H=[6EJB_7HH<1+!:<5E/%
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M4U2M]-Z4FFTM) \PL6BK#TU]H/ZPEO[F59%LM%50<H[0[]&>EQ-E+(T'&H6
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M1)BDT^#H_P%02P$"% ,4    " #)@UY;F]:NU&Z= 0!X  P #0
M    @ $     97A?.#<X.#0R+FAT;5!+ 0(4 Q0    ( ,F#7EN#\OAT@P,
M !L.   1              "  9F= 0!Z975S+3(P,C4Q,#(X+GAS9%!+ 0(4
M Q0    ( ,F#7EM^WAQ9VP0  .<L   5              "  4NA 0!Z975S
M+3(P,C4Q,#(X7V1E9BYX;6Q02P$"% ,4    " #)@UY;E&44J/H%  !%/
M%0              @ %9I@$ >F5U<RTR,#(U,3 R.%]L86(N>&UL4$L! A0#
M%     @ R8->6\@T<#5X!   ?RT  !4              ( !AJP! 'IE=7,M
M,C R-3$P,CA?<')E+GAM;%!+ 0(4 Q0    ( ,F#7EOB/Y"PPR\  .;\   3
M              "  3&Q 0!Z975S,C R-3$P,CE?.&LN:'1M4$L%!@     &
-  8 A $  "7A 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>zeus20251029_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="zeus-20251028.xsd" xlink:type="simple"/>
    <context id="d20258K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917470</identifier>
        </entity>
        <period>
            <startDate>2025-10-28</startDate>
            <endDate>2025-10-28</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20258K" id="ixv-357">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20258K" id="ixv-358">0000917470</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20258K" id="ixv-368">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20258K" id="ixv-369">2025-10-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20258K" id="ixv-370">OLYMPIC STEEL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20258K" id="ixv-371">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20258K" id="ixv-372">000-23320</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20258K" id="ixv-373">34-1245650</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20258K" id="ixv-374">22901 Millcreek Boulevard, Suite 650</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20258K" id="ixv-375">Highland Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20258K" id="ixv-376">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20258K" id="ixv-377">44112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20258K" id="ixv-378">216</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20258K" id="ixv-379">292-3800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20258K" id="ixv-380">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20258K" id="ixv-381">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20258K" id="ixv-382">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20258K" id="ixv-383">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20258K" id="ixv-384">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20258K" id="ixv-385">ZEUS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20258K" id="ixv-386">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20258K" id="ixv-387">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
